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Abstract 
Excessive stress during pregnancy can strongly impact the developing offspring, 
leading to long-term changes in the brain that persist into adulthood, in a process 
known as “prenatal programming”. In a rat model, where pregnant dams were 
exposed to five days of social stress from gestational day (GD) 16 to 20, the 
prenatally stressed (PNS) offspring exhibit anxious behaviour, cognitive deficits and 
exaggerated hypothalamic-pituitary-adrenal (HPA) axis responses to stress, with 
outcomes often dependent on the sex of the offspring. However, the mechanisms 
mediating these outcomes are not completely understood. Firstly, it is not 
completely clear what underlies the “programmed” phenotypes in adulthood, and 
secondly, it is not known how the stress signals are transmitted from the mother to 
the foetus during gestation to result in foetal “programming”.  
Steroids are a large class of signalling molecules produced by endocrine organs, 
and include the glucocorticoids (e.g. corticosterone), sex hormones (e.g. 
progesterone and testosterone) and neuroactive steroids (such as 
allopregnanolone). Steroids play key roles in modulating stress responses, and are 
also involved in coordinating pregnancy adaptations and foetal development, 
therefore may be a common factor in the mechanisms underlying the “programmed” 
phenotypes observed in PNS offspring, and in the process of foetal “programming” 
during pregnancy. In order to investigate a role for steroids in foetal programming, it 
was first necessary to develop and validate a liquid chromatography-mass 
spectrometry method (LC-MS) that could reliably quantify a panel of steroids in 
complex tissues such as the brain. 
Neuroactive steroids are known to increase following an acute stressor and can 
rapidly modulate neuronal excitability. It was hypothesised that alterations in 
neuroactive steroid concentrations in the brain may underlie the “programmed” 
phenotype, such as dysregulated HPA axis activity, in adult PNS offspring. Using 
the LC-MS method developed, no obvious differences were found in central 
neuroactive steroid concentrations between control and PNS offspring at baseline; 
however, following an acute stressor (swim stress), the production of certain 
neuroactive steroids which modulate inhibitory neurotransmission seem 
compromised in the brains of PNS offspring as compared to controls, which could 
be further investigated with other acute stress paradigms. 
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The possible mechanisms involved in the transmission of stress signals from the 
mother to foetus during gestation to result in “programming” were then investigated 
at GD20, focusing on glucocorticoid metabolism and the steroidal milieu in the 
mother and the foetus. Glucocorticoid overexposure has been proposed as one of 
the primary mechanisms of foetal programming. However, it was found that despite 
stressed dams having greater circulating corticosterone, stressed foetuses did not 
exhibit greater corticosterone concentrations in the brain. The steroidogenic profile 
was also generally similar in the brains of control and stressed foetuses. The direct 
contribution of altered corticosterone and neuroactive steroid concentration in 
“programming” of the foetal brain, and possibly behaviour, is therefore minimal. 
However, stressed placentae, exhibited greater mRNA expression for 11β-
hydroxysteroid dehydrogenase 2 (11β-HSD2), which inactivates corticosterone, 
indicating that the placenta plays an active role in regulating the transmission of 
gestational stress signals from the mother to the foetus during late pregnancy. 
The role of the placenta was then further investigated, where it was hypothesised 
that placental oxidative stress may play a role in foetal programming. Elevated 
oxidative stress status was observed in the placentae of stressed pregnancies at 
GD20, which was prevented by the administration of an antioxidant drug to the 
pregnant dam before the onset of chronic social stress. Notably, this maternal 
antioxidant treatment, which targets the maternal compartment and placenta but 
does not reach the foetus, rescued the anxiety phenotype of PNS offspring when 
examined in adulthood. Several other physiological markers in the brain linked to 
anxiety and inhibitory neurotransmission, which were altered in PNS offspring as 
compared to controls, were also normalised as a result of the maternal antioxidant 
treatment, and the effects were sex specific. Additionally, both secretions from 
placental explants and foetal plasma from stressed pregnancies contained unknown 
factors that altered neuronal growth in vitro, but this was not observed in stressed 
pregnancies with antioxidant treatment. Together, this suggests that the stressed 
placenta may transmit stress signals to the foetus through secreting, as yet 
unidentified, damaging “factors”. Hence, targeting placental oxidative stress during 
pregnancy could provide a therapeutic option to prevent the transmission of such 




Stress that is experienced by the pregnant mother during pregnancy, can affect the 
growth and development of the unborn offspring, leading to enduring changes that 
are still observable in the offspring during adulthood. These may include an 
increased risk for mental illnesses such as anxiety, and a compromised ability for 
the offspring to cope when faced with stress themselves. However, how maternal 
stress may lead to these outcomes is not completely understood. Firstly, we do not 
fully understand how the behaviours in the adult offspring arise. Secondly, we do not 
know how the stress, which is experienced by the mother, is being transmitted to the 
developing foetus to result in these changes. In order to better understand these 
processes, a rat model was used, where pregnant rats were stressed by exposing 
them to another aggressive rat, to induce social stress and better reflect the type of 
stress experienced by pregnant women.  
Steroid hormones play an important role in helping an organism cope with stress 
and are also crucial for maintenance of the pregnancy and ensuring proper growth 
of the foetus. As steroid hormones may be an important mechanism, a biochemical 
assay that is able to quantify multiple steroids in the brain was first developed. To 
establish if steroid hormones can lead to poor outcomes in the adult prenatally 
stressed offspring, steroids in their brains were quantified, however, no obvious 
differences were found in brain steroid levels between stressed and non-stressed 
offspring. 
Next the factors that are involved in the transmission of stress signals were 
investigated. High levels of the stress hormone, corticosterone, has been proposed 
to cross the placenta to the foetus and directly impact the foetal development in a 
harmful manner. Although the stress hormone increased in the pregnant mother with 
stress, the placenta seemed to play a protective role, preventing the cross over of 
maternal stress hormones to the unborn foetus. 
The placenta however, was also found to be undergoing oxidative stress (a type of 
stress on a cellular level, caused by imbalance between free radical and antioxidant 
production). In order to study the possible role of oxidative stress in prenatal 
programming, an antioxidant drug was given to the pregnant rat before it was 
exposed to stress, thereby blocking increases in oxidative stress. The antioxidant 
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drug given to the mother prevented the anxious behaviour in the stressed offspring 
during adulthood. Oxidative stress could therefore be involved in the transmission of 
stress signals from mother to foetus, and antioxidant treatment to the mother could 
potentially help to prevent the harmful effects of stress during pregnancy.  
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1.1 Developmental Origins of Health and Disease 
The concept of developmental origins of health and disease (DOHaD) was first 
developed in 1989 by Dr. David Barker and colleagues (Barker, 1990), following 
epidemiological observations that chronic diseases in adulthood, such as heart 
disease, hypertension, and stroke was correlated with placental and offspring birth 
weight, which can subsequently be traced back to adverse intrauterine conditions 
during foetal development. Since then, there has been a wealth of epidemiological, 
clinical, and experimental data supporting the notion that in addition to genetics, the 
early life environment also plays a crucial role in setting the stage for disease later in 
life. This phenomenon is referred to as “prenatal programming”, where there is a 
permanent change in the physiology of an organism following a stimulus or insult 
during a critical and sensitive period in early life (Godfrey and Barker, 2001). 
While initial DOHaD studies focussed on the role of maternal undernutrition in foetal 
programming, the DOHaD approach has since been extended to studying the 
effects of foetal exposure to psychobiological-related factors such as maternal 
psychological stress, paternal stress, or even the transgenerational effects of grand-
maternal stress (Matthews and Phillips, 2012). In terms of offspring outcomes, the 
persistent effects of prenatal programming have also been analysed not only from a 
physical health perspective, but also with regards to the offspring’s psychological 
health, for instance, their propensity to develop to stress-related disorders in 
adulthood. The DOHaD approach provides a framework in which stress-related 
disorders can be studied throughout an individual’s life course and across 
generations, and is extremely relevant today, given that mental health and 
behavioural problems are one of the main causes of the overall disease burden and 
disability worldwide (Vos and Global Burden of Disease Study, 2015).  
There has been ample progress made in the past three decades to define the 
molecular pathways that may possibly underpin these associations, however, the 
multidimensional nature of DOHaD means that much more needs to be done in 
order to gain a greater mechanistic understanding of the underlying processes. This 
understanding would then allow the DOHaD concept to be of a greater significance 
not only in the clinic, but also in terms of shaping public health and global economic 
policy.  
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This chapter will first begin with defining what “stress” entails, highlighting basic 
biological and molecular concepts related to stress, with a focus on the 
hypothalamic-pituitary-adrenal (HPA) axis and steroids as a modulatory factor. Next, 
the physiological concepts related to a successful pregnancy are introduced, and 
the impacts of stress on the pregnancy and offspring outcomes during adulthood are 
discussed. There is a particular focus on rodent models, which are the basis of 
experiments carried out in this body of work. Finally, this chapter will briefly 
summarise current mechanistic understanding of how negative phenotypes in 
offspring behaviour may arise, and highlight some of the known or proposed 
mechanisms of stress transmission from the mother to the foetus. As the field is now 
extremely large and underlying processes of foetal programming have been 
revealed to be increasingly complex, it is virtually impossible to fully consider all 
aspects and all the possible mediators and regulators involved. This thesis will 
therefore focus on exploring the role of glucocorticoids, neuroactive steroids and 
oxidative stress in determining offspring behaviour and physiology.  
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1.2 What is stress?  
To begin, an inquiry of what exactly constitutes “stress” first has to be carried out. 
Although the word “stress” seemingly carries negative connotations, it represents an 
important physiological adaptation that is essential for an organism’s survival 
following changes in the environment. The concept of “stress” was first conceived by 
Walter Cannon in the 1920s and describes the phenomena where there is disruption 
of the body’s equilibrium, leading to activation of the sympathetic nervous system 
(SNS) and the “fight-or-flight” response in order to reinstate homeostasis (Cannon, 
1914). Hans Selye, in 1936, discovered when experimenting in rats that in addition 
to the activation of the SNS, several changes occur in the adrenal glands and 
immune system when the animals are exposed to various nocuous stimuli (Selye, 
1936). These changes apply to all mammals and humans, and constitutes what is 
known today as the hypothalamic-pituitary-adrenal (HPA) axis (Miller, 2018, Szabo 
et al., 2012). Selye further recognised that “stress” can not only be acute but also 
can be chronic in nature, and defined it as a “non-specific response of the body to 
any demand for change” (Selye, 1950). In contemporary biology, most agree that 
“stress” can be defined as “a real or interpreted threat to the physiological or 
psychological integrity of an organism that results in physiological and/or 
behavioural responses” (McEwen, 2000). Stress constitutes the activation of both 
the SNS and the HPA axis (elaborated in section 1.2.1), resulting in changes in 
other neuroendocrine, autonomic, immune, and metabolic systems, which 
eventually allows the organism to cope with the stressful event (Chrousos and Gold, 
1992). Therefore, stress in itself, is adaptive and necessary for the survival of the 
organism.   
Although stress responses are adaptive in nature, Selye also recognised that 
prolonged or excessive activation of the neuroendocrine stress system can lead to 
disease, where “stress” then becomes pathological (Selye, 1950). Following 
observations from rats and human patients, Selye proposed that pathological forms 
of stress can arise from the production and action of excess glucocorticoids, leading 
to the exhaustion and failure of bodily systems (Selye, 1950). However, in recent 
decades, the complexity of the stress response has become apparent, and it is 
known that various environmental, genetic, psychological, immune or metabolic 
factors can interact and cause stress-related disorders (Chrousos and Gold, 1992, 
Schneiderman et al., 2005). To address this complexity, a novel concept called 
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“allostasis” initially proposed by Sterling and Eyer (Sterling and Eyer, 1988) was 
introduced by McEwen into the field of stress research (McEwen, 1998). “Allostasis” 
is a term used to describe the dynamic regulatory process that allows the organism 
to adapt to the challenges of its environment, and is also able to explain how stress-
related pathologies can occur when these regulatory processes fail. Stress in the 
context of “allostasis” will be discussed in section 1.2.2, where focus will be placed 
largely on the HPA axis, as its dysregulation is one of the most consistent findings in 
stress-related disorders (e.g. in affective disorders such as depression) (Plotsky et 
al., 1998).  
1.2.1 The classic stress response  
The response to a prototypical acute stressor in humans and mammals involves 
activation of two systems, the SNS and the HPA axis, which then result in 
downstream physiological changes in various organs and systems to cope with the 
stressor. Some of the physiological changes include the mobilisation of the body's 
energy stores, increasing gluconeogenesis, cardiovascular tone and respiratory 
rate, whilst digestive, reproductive and immune systems are inhibited. Behavioural 
adaptations also occur, which includes increased alertness and attention, improved 
cognition, and also central inhibition of appetite, feeding, and reproduction (Thiel 
and Dretsch, 2011, Tsigos et al., 2000).  
1.2.1.1 Sympathetic nervous system 
Upon experiencing stressful stimuli, the SNS is first engaged, where the brainstem 
is activated, leading to activation of preganglionic fibres in the spinal cord. 
Preganglionic fibres innervate the adrenal medulla and directly activates it via 
cholinergic signals, leading to the release of adrenaline and noradrenaline into the 
circulation (Fig 1.1). At the same time, preganglionic fibres innervate the ganglion, 
leading to postganglionic fibres releasing noradrenaline locally in target organs, 
such as those in the cardiovascular, musculo-skeletal, and digestive system. The 
stress-induced release of noradrenaline and adrenaline from the SNS peaks within 
1-5 min, and together, these catecholamines act on α- and β-adrenergic receptors 
throughout the body, bringing about various physiological effects such as increased 
heart rate, dilation of blood vessels in skeletal muscle and increased glycogen-to-
glucose conversion. Reduced blood flow and vasoconstriction of blood vessels also 
occur in the digestive and reproductive organs. In the brain, activation of the 
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brainstem, specifically the locus coeruleus, which has dense noradrenergic 
neurones, also leads to activation of a widespread noradrenergic neuronal network 
throughout the brain, resulting in increased arousal (Aston-Jones et al., 1986). The 
activation of the SNS is counter-controlled by the parasympathetic system, which 
dampens the effect of the SNS when its activation is no longer required (Ulrich-Lai 
and Herman, 2009).  
1.2.1.2 Hypothalamic-Pituitary-Adrenal (HPA) Axis 
The second arm of the stress response, the HPA axis, is also activated but usually 
after a short delay relative to SNS activation. Upon stimulation by stress, neurones 
in the medial parvocellular part of the paraventricular nucleus (mpPVN) of the 
hypothalamus release the peptides corticotropin releasing factor (CRH) and arginine 
vasopressin (AVP) into the hypophyseal portal system, which then enters the 
anterior pituitary gland. In corticotroph cells of the anterior pituitary, another peptide, 
adrenocorticotropic hormone (ACTH), is synthesised from the cleavage of the 
precursor pro-opiomelanocortin (POMC) and is then released by the anterior 
pituitary into the general circulation. ACTH then stimulates the adrenal cortex to 
increase steroid production in the adrenal gland and release glucocorticoids into the 
bloodstream (cortisol in humans and corticosterone in rats and mice) (Fig 1.1).  
Glucocorticoids travel in the bloodstream and have pleiotropic effects at multiple 
target organs and tissues, via their action on the glucocorticoid receptor (GR; Nr3c1) 
and mineralocorticoid receptor (MR; Nr3c2). Their primary effects are the 
redistribution of energy across the body in the face of stressor, promoting processes 
related to energy mobilisation in the brain and skeletal muscles, but inhibiting 
processes related to growth, development, reproduction and immunity (Sapolsky et 
al., 2000, Munck et al., 1984). Given the widespread effects of glucocorticoids and 
that GR and MR are ubiquitously expressed in all cell types and tissues, prolonged 
elevation of circulatory glucocorticoids can lead to deleterious effects and its 
production needs to be tightly controlled. The glucocorticoid response curve has a 
rapid onset, peaking at about 15-30 min, and then gradually decreasing with time 
from inhibitory mechanisms that shut it down (Herman, 2013).  
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Figure 1.1: Two arms of the prototypical stress response – the SNS and the 
HPA axis. Both result in the activation of the adrenal gland, which plays a central 
role in the stress response. The adrenal cortex produces and secretes 
cortisol/corticosterone (CORT), in humans/rats respectively, into the bloodstream 
following activation of the HPA axis, while the adrenal medulla produces 
noradrenaline (NA) and adrenaline (A) following activation by the SNS. The HPA 
axis is self-limiting, where glucocorticoids can act via negative feedback inhibition, 
while the sympathetic nervous system is counter-acted by the parasympathetic 
nervous system. Abbreviations: NA: noradrenaline; A: adrenaline; CORT: 
corticosterone (in rats); cortisol (in humans), MR: mineralocorticoid receptor; GR: 
glucocorticoid receptor; PVN: paraventricular nucleus of the hypothalamus; LC: 
locus coeruleus of the brainstem. Illustrations in the figure are representative of the 
rat anatomy.   
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1.2.1.3 Regulation of the HPA axis 
There exist complex mechanisms in the brain that orchestrate the activation and 
inhibition of the HPA axis. One of the major inhibitory mechanisms of the HPA axis 
is negative feedback control mediated by glucocorticoids, which act on GR receptors 
in the hippocampus, PVN, and anterior pituitary to terminate the HPA axis response. 
Different signals originating from different parts of the brain are ultimately integrated 
at the PVN to result in the appropriate secretion of CRH (Herman et al., 2016, 
Herman et al., 2002, Smith and Vale, 2006). In general, neural communication 
between brain regions are regulated by glutamate and γ-aminobutyric acid (GABA) 
action on ligand-activated ion channel receptors, where glutamate generally elicits 
an excitatory action while GABA exhibits an inhibitory action. Brain regions that are 
involved in the modulation of the HPA axis include not only the hypothalamus and 
the pituitary gland, but also regions of the limbic system (consisting of the prefrontal 
cortex, hippocampus and amygdala), which are responsible for the generation of 
appropriate responses to social or emotional stimuli (Jankord and Herman, 2008, 
Herman et al., 2005). The role of each brain region in stress responses will be 
further examined in Chapter 4. Ultimately, it is the combination of excitatory and 
inhibitory signalling between different brain regions, which can be further modulated 
by other signalling molecules (e.g. other neurotransmitters, neuropeptides and 
neurosteroids), that mediate HPA axis activation and its subsequent termination (Fig 
1.2).  
Activation of the HPA axis: 
Activation of the HPA axis is rapid and generally occurs directly via neural circuits. 
Physical and psychological stressors are processed by different neural circuitries, 
but may overlap in some instances (Godoy et al., 2018). In general, physical 
stressors such as inflammation or pain signal through direct noradrenergic and 
adrenergic projections originating from the nucleus of the solitary tract (NTS) of the 
brainstem to the PVN (Ulrich-Lai and Herman, 2009). CRH-producing mpPVN 
neurones express α1-adrenergic receptors and are directly activated by this 
noradrenaline release (Cole and Sawchenko, 2002, Itoi et al., 1994). Psychogenic 
stressors activate more complex pathways as they require the appraisal of the 
stressor, therefore rely heavily on the activation of several limbic structures and the 
integration of signals from these limbic structures (reviewed in (Godoy et al., 2018, 
de Kloet et al., 2019)). For instance, activation of sequential GABA synapses in the 
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different subregions of the amygdala, followed by the integration of these signals 
alongside those from other brain regions (such as the hippocampus and the PFC) at 
the peri-PVN region, eventually results in the production of CRH in the mpPVN 
neurones (Roland and Sawchenko, 1993, Ulrich-Lai and Herman, 2009, Bains et al., 
2015). Depending on the stressor, other neural mechanisms, such as direct 
serotonergic inputs from the raphe nuclei to the PVN (Herman et al., 2003, 
Sawchenko et al., 1983), and non-neural mechanisms such as the action of 
cytokines and inflammatory factors (e.g. nitric oxide) on the PVN may also play a 
role in initiating stress responses (summarised in (Rivest, 2001)).  
Inhibition of the HPA axis:  
Inhibition of the HPA axis occurs over a longer time scale, and is controlled by both 
neuronal signalling mechanisms, as well as other slower mechanisms that involve 
gene expression changes (Ulrich-Lai and Herman, 2009). One of the key 
mechanisms is the negative feedback inhibition mediated by glucocorticoids binding 
of GR in the PVN, resulting in the rapid release of endocannabinoids, which 
consequently inhibits glutamate release and thereby reducing excitatory drive to 
CRH-producing mpPVN neurones (Di et al., 2003). Apart from this direct inhibition 
on the PVN, indirect inhibition via glucocorticoid signalling can originate from other 
limbic structures such as the hippocampus, where signals are then subsequently 
transmitted to the peri-PVN region. GABA neurotransmission is also an important 
aspect of HPA axis inhibition, as the PVN is directly innervated by GABA projections 
from various brain regions, including the bed nucleus of the stria terminalis (BNST; 
which is a centre for integration of limbic signals) (Cullinan et al., 1993, Herman et 
al., 2016). GABA neurotransmission can further be modulated by the rapid action of 
neuroactive steroids, which will also be further elaborated in sections 1.3.2 and 
1.3.7.  
Although the characterisation of above-mentioned stress activation and inhibition 
pathways have been carried out in rodents, stress response pathways are generally 
well-conserved across species and therefore show good translatabilty to humans 
(Cryan and Holmes, 2005, Hariri and Holmes, 2015). For instance, the neural 
circuits that regulate learning and memory in response to fear, a form of stressor, 
show striking parallels between the human and rats and involves the amygdala 
(reviewed in (Hariri and Holmes, 2015)). Nonetheless, apart from mechanisms of 
HPA axis activation and inhibition mentioned here, which have generally been 
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determined using controlled experiments using single stressors, there also exists a 
plethora of mechanisms that can further modulate glucocorticoid action and HPA 
axis functioning, such as sex, circadian rhythm, and age. Most importantly, the 
processes summarised here also represent the classic stress response to a single 
bout of acute stress, and the same processes may not occur in response to chronic 
or severe stressors, which can have a cumulative effect (Herman et al., 2016). 
These factors add further layers of complexity to the patterns of stress response, 
and this becomes especially salient in higher organisms with more complex social 
lives such as humans. In humans, apart from the more complex nature of stressors, 
greater cognitive abilities also allow for the capacity to process stressful situations in 
ways that are different as compared to that of rodents, and the activation of the 
stress response may lead to different outcomes in terms of vulnerability and 
resilience to stress-related pathology. 
1.2.2 Allostasis and stress-related pathology  
As mentioned earlier, the SNS and HPA axis can have very different patterns of 
response, varying in magnitude based on the type, frequency, and duration of the 
stressor, and also during different periods throughout an organism’s life course. 
Chronic stress, for instance, requires the body to employ new or modified coping 
strategies that can be different from that for acute stress (Herman, 2013). It is known 
that with repeated stress, habituation can occur, where the magnitude of HPA axis 
activation to a stressor declines with repeated exposure to that same stressor 
(Grissom and Bhatnagar, 2009, Natelson et al., 1988). However, different degrees 
of habituation can occur for different types of stressors, and in certain cases, 
habituation may completely fail to happen (Figueiredo et al., 2003a), or sensitisation 
of stress responses occur instead. The HPA axis then becomes hyper-responsive, 
which is associated with the development of pathologies (Belda et al., 2015, 
Natelson et al., 1988). Herein lies two complexities inherent to stress responses – 
firstly, the dynamic nature of the stress response, in that it changes according to 
different contexts, secondly, the problem of pathological stress responses – why is it 
that some stress responses are adaptive, and some are pathological, and at what 
point does the stress response start to become pathological?  
These two complexities in stress responses can be addressed using a framework 
known as “allostasis”, which literally means “maintaining stability through change”. 
Activation of the SNS and HPA axis represent part of the process of “allostasis”, as 
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they both constitute an alteration of physiology to restabilise the body in response of 
an acute challenge. Unlike the traditional concept of “homeostasis”, which focusses 
on the return of physiological systems to an invariant set point, “allostasis” 
emphasises dynamic and flexible regulation, where the set-point is adjustable 
according to different contexts (Ramsay and Woods, 2014).   
There are two key aspects of the allostasis framework (Fig 1.2). Firstly, apart from 
glucocorticoids and catecholamines produced from the HPA axis and SNS, 
respectively, the process of allostasis is controlled by a complex network of other 
inter-dependent mediators, including cytokines, neurotransmitters, neuropeptides, 
and neuroactive steroids etc. These mediators can all interact in a highly inter-
dependent manner, such that a change in one mediator may lead to subsequent 
changes in all the other mediators. This implies that stress responses are inherently 
complicated, and various different outcomes can transpire depending on the 
context. Secondly, the process of allostasis is one that comes with a cost. Insofar as 
glucocorticoids are helpful to deal with stressors, if their catabolic functions are 
allowed to persist indefinitely, an enormous burden is placed on the body. This is 
known as the “allostatic load”, and the body is said to be in an “allostatic state”. 
Given that “allostatic load” is progressive and cumulative, at this point, symptomatic 
disease might not yet show and these deviations are reversible if caught in time 
(McEwen, 2004). However, it is a fragile state and if allowed to persist, a state of 
“allostatic overload” ensues which can lead to disease (McEwen, 2004)(Fig 1.2).  
In the context of the HPA axis, an allostatic state is characterised as a constant 
state of HPA hyperactivity or hyporesponsiveness. Optimal glucocorticoid action has 
been described as an inverted U-shaped curve, where both hyper- and hypo-
secretion can be problematic (De Kloet et al., 1998, Diamond et al., 1992). For 
instance, in the brain, excessive glucocorticoids can decrease hippocampal 
neurogenesis and increase hippocampal apoptosis (Gould and Tanapat, 1999, Kino, 
2015). Hippocampal neuronal morphology can also be also affected, characterised 
by decreases in dendritic length and dendritic branch points (Tata and Anderson, 
2010). These can not only lead to deficits in learning and memory processes, but 
can also further worsen the dysregulation of the HPA axis as hippocampal 
neurogenesis is critical for hippocampal-mediated glucocorticoid negative feedback 
(Snyder et al., 2011). On the other hand, hypoactivation of the HPA axis and 
inappropriately low production of glucocorticoids to a stressor are harmful as well, as 
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they increase susceptibility to inflammatory conditions, where the body is ill-
prepared to face challenges, thereby increasing vulnerability to pathology (Diamond 
et al., 1992; Reber et al., 2007) 
In humans, HPA axis dysregulation can be determined by tests such as the 
dexamethasone suppression test or the dexamethasone/CRH test (Heuser et al., 
1994). Both hyper-responsiveness and hyporesponsiveness are known to occur 
following states of chronic stress (Heim et al., 2000, Fries et al., 2005). In clinical 
studies, HPA axis dysregulation is strongly associated with various disorders. 
Hyper-secretion of cortisol is strongly associated with metabolic disease, such as 
visceral obesity, type 2 diabetes and hypertension (Tirabassi et al., 2014, Min, 
2016), as well as mood disorders such as major depression or bipolar disorder 
(Plotsky et al., 1998), whilst hypoactivation of the axis is more commonly observed 
for autoimmune diseases (Tsigos and Chrousos, 2002) and post-traumatic stress 
disorder (PTSD) for instance (Daskalakis et al., 2016). 
Among potential mechanisms of such allostatic states of HPA axis dysregulation are 
(1) altered biosynthesis or metabolism of the key mediators of the HPA axis (e.g. 
CRH, ACTH, glucocorticoids), (2) altered availability and action of these mediators 
due to alteration of local concentrations (e.g. by local glucocorticoid metabolism), (3) 
altered receptor sensitivity in the key regions associated with the HPA axis (e.g. 
CRH receptors in the anterior pituitary, ACTH receptors in the adrenal glands), (4) 
altered feedback sensitivity of the HPA axis (which may stem from altered GR 
sensitivity in areas associated with feedback inhibition e.g. hippocampus, 
hypothalamus or anterior pituitary or any other mechanisms mentioned in the 
previous section) (Heim et al., 2000), and (5) other morphological, neural circuitry, or 
neurotransmitter changes in various brain regions which can affect the activation of 
the HPA axis (e.g. structures of the limbic system amygdala or hippocampus 
cortex). Throughout this thesis, these common underlying causes will be revisited 
when discussing stress-related pathology.  
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Figure 1.2: Allostasis mediators and allostatic load. (A) A key aspect of 
allostasis is the presence of a non-linear network of allostasis mediators, where one 
a change in one mediator can result in a change in output of another mediator in the 
system (McEwen, 2006). Together, they influence the function of the cognitive, 
reproductive, metabolic, vascular, and immune systems etc. Diagram adapted from 
Fig 2 of McEwen, 2006. (B) Allostatic load accumulates following stress to result in 
an “allostatic state”. Whilst an “allostatic state” may not necessarily result 
symptomatic disease, it is a fragile state and if allowed to persist, will result in 
“allostatic overload” where disease occurs. HPA axis dysregulation begin to occur in 
an “allostatic state” and may worsen in “allostatic overload”. 
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1.3 Steroids and the stress response   
This thesis is focussed on investigating the role of steroids in modulating the 
outcomes of stress, especially in the context of gestational stress. Steroids are a 
class of lipophilic signalling molecules that are all derived from a common 
cholesterol precursor, and constitute key components of the neuroendocrine 
response to stress (Charmandari et al., 2005). They include the sex hormones 
(testosterone, progesterone, and oestradiol), glucocorticoids, mineralocorticoids and 
their downstream metabolites (Fig 1.3). 
The first step of steroid synthesis is the transport of cholesterol from the cytoplasm 
into the mitochondria, which is controlled by the enzyme, steroidogenic acute 
regulatory protein (StAR, Star) (Fig 1.3). Once cholesterol is inside the mitochondria, 
p450 side-chain cleavage enzyme (p450scc; Cyp11a1) converts it to pregnenolone, 
which is considered the master precursor steroid. Pregnenolone is subsequently 
converted to downstream steroids such as progesterone, deoxycorticosterone 
(DOC), and testosterone. Steroids can be interconverted by steroidogenic enzymes 
such as 3α- and 3β-hydroxysteroid dehydrogenase (3α-HSD; Akr1c9 and 3β-HSD; 
Hsd3b) and 5α-reductase (both Srd5a1 and Srd5a2 isoforms) to various metabolites 
that may seem structurally similar, but in fact possess very different functional 
properties. Each individual steroid metabolite is a distinct component of the non-
linear network of mediators of allostasis mentioned in section 1.2.2.  
This section will focus on the molecular characteristics of steroids and how they 
exert their effects on a cellular and system level. On a cellular level, steroid action is 
influenced by two factors, downstream interaction with receptors (section 1.3.1), as 
well as the intricate control of their local concentrations in target tissues or cells 
(section 1.3.2) (summarised in Fig 1.4). On a system level, steroid action can be 
influenced by various physiological factors, such as circadian rhythms (section 
1.3.3), sex (section 1.3.4) or developmental stages (section 1.3.5). Lastly, steroids 
that specifically target neuronal signalling (i.e. neuroactive steroids) and their role in 
the stress response will be briefly introduced (section 1.3.6). A common theme 
emerge from these molecular processes, in that they act in concert to ensure that 
responses to stress occur in a controlled and regulated manner (Herman, 2013). 
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Figure 1.3: Steroid interconversion diagram. Cholesterol enters the mitochondria 
(facilitated by the steroidogenic acute regulatory protein; StAR) and is cleaved by 
the p450 side-chain cleavage enzyme (p450scc) into pregnenolone. Pregnenolone 
can be converted to progesterone by 3β-hydroxysteroid hydrogenase (3β-HSD), 
which can subsequently be converted to deoxycorticosterone (DOC), then 
corticosterone. Corticosterone can be converted to the mineralocorticoid 
aldosterone by aldosterone synthase. Progesterone and DOC can also undergo two 
sequential A-ring reduction steps to form the 5α,3α-reduced steroids, 
allopregnanolone and tetrahydrodeoxycorticosterone (THDOC), respectively. These 
reduction steps are catalysed by the enzymes 5α-reductase (both isoforms of 5α-
reductase 1 and 2) and 3α-hydroxysteroid dehydrogenase (3α-HSD), respectively. 
Pregnenolone and progesterone can be converted to androgens by a two-step 
pathway, catalysed by the 17-hydroxylase and 17,20-lyase activities of a single 
enzyme, cytochrome P450c17. Testosterone can similarly be reduced to form 
dihydrotestosterone (DHT), and subsequently 3α-androstanediol (3α-diol) and 3β-
androstanediol (3β-diol). DHT can also be produced in a “backdoor pathway” 
without the need for testosterone production, through a pathway mediated by 17-OH 
progesterone, 17-OH DHP, 17-OH allopregnanolone, androsterone and 3α-diol, 
catalysed by the same common enzymes (reviewed in (Auchus, 2004). Lastly, 
testosterone can be converted to 17β-oestradiol via the actions of aromatase 
(Cyp19a1). Chemical modifications such as sulfation may also change the 
properties and functions of steroids such as dehydroepiandrosterone (DHEA) and 
pregnenolone. Given these steroidogenic enzymes catalyse several reactions and 
may be bi-drectional, steroid production is therefore determined by a multitude of 
factors such as the availiability of the precursor, concentrations of the enzymes and 
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1.3.1 Molecular mechanism of steroid actions  
At a molecular level, steroids can act via both genomic and non-genomic pathways, 
in both the periphery and in the brain. For genomic actions, steroids exert their 
physiological effects via classical steroid receptor actions and involves alteration of 
gene expression. Non-genomic actions of steroids are mediated through receptor-
dependent or independent pathways, usually over a much shorter timescale 
compared to genomic actions.  
1.3.1.1 Genomic action of steroids 
Steroid receptors such as GR, MR, progesterone receptors (PR: Pgr), androgen 
receptors (AR; Ar), and oestrogen receptors (both ERα; Esr1 and ERβ; Esr2 
isoforms) are nuclear receptors which act as ligand-dependent transcription factors. 
In the absence of ligand, they exist in the cytoplasm as part of an inactive multi-
protein complex, bound to protein chaperones such as heat shock proteins (HSPs) 
(section 1.3.1.3). The binding of the steroid ligand results in a conformational 
change and the dissociation of receptors from the HSPs. The activated steroid-
receptor complex then dimerises and translocates to the nucleus, interacting with 
steroid responsive elements to enhance or repress the transcription of genes 
(Beato, 1989) (Fig 1.4). 
1.3.1.2 Glucocorticoid actions via MR and GR 
Glucocorticoid action, specifically, is mediated by the steroid receptors, MR and GR. 
Although glucocorticoids bind to both MR and GR, the outcomes of binding to the 
two receptors are different, due to differences in binding affinities, regional 
expression patterns, as well as the target genes they regulate (Datson et al., 2001). 
As MRs have a much higher affinity for glucocorticoids than GRs, under basal 
conditions, MRs are preferentially occupied (Reul and de Kloet, 1985). This 
continuous MR activation at a basal state allows for the regulation of electrolyte 
balance, and the control of blood pressure and sympathetic drive (Gomez-Sanchez 
and Gomez-Sanchez, 2012). In contrast, GRs are usually only occupied when 
glucocorticoid levels are higher, for instance following stress exposure, or when 
there is a circadian rise in glucocorticoids (de Kloet et al., 2005, Lightman and 
Conway-Campbell, 2010, Reul and de Kloet, 1985). GR therefore plays a more 
prominent role in inhibition of the HPA axis via negative feedback, and can act for 
Chapter 1: General introduction 17 
instance, by the transcriptional downregulation of CRH and AVP upon glucocorticoid 
binding (Keller-Wood and Dallman, 1984, Tasker et al., 2005). 
Additionally, there are differences in the brain expression pattern of MR and GR. 
GRs are present in most brain regions, while MRs have a much more limited 
distribution and are more concentrated in the limbic regions, especially the 
hippocampus (Reul and de Kloet, 1986). Thus, a balance between MR- and GR-
mediated actions in the limbic system neurones must be maintained for the HPA 
axis to function properly (De Kloet et al., 1998, de Kloet, 2014). Imbalance could be 
one of the underlying molecular mechanisms of HPA axis dysregulation, increasing 
the vulnerability to affective disorders (Harris et al., 2013).  
1.3.1.3 Role of chaperone proteins 
The specificity of the genomic action of steroids is also contingent on the action of 
protein chaperones in the protein complex (Fig 1.4). The genomic action of GR for 
instance, is regulated by heat shock proteins (HSPs) such as HSP90 and HSP70, 
and also the FK506-binding proteins (FKBP), such as FKBP51 (Fkbp5) and FKBP52 
(Fkbp4). HSPs have a role to play in GR intracellular trafficking and activation, while 
FKBPs regulate receptor-ligand binding and also nuclear translocation (reviewed in 
(Pratt et al., 2004, Sivils et al., 2011)). FKBP51 is bound to the inactivated protein 
receptor complex. When glucocorticoid binds to the receptor, the conformational 
change causes FKBP51 to dissociate and FKBP52 to bind instead, which then 
allows for its nuclear localisation (Galigniana et al., 2001). The actions of FKBP51 
and FKBP52 are thus antagonistic, with FKBP51 generally acting as a negative 
modulator of steroid receptor activity, inhibiting nuclear translocation; while FKBP52 
on the other hand, positively modulates nuclear translocation (Wochnik et al., 2005). 
Notably, FKBP51 plays a prominent role in the regulation of stress responses, as 
FKBP51 expression is found to increase in the amygdala and PVN of adult mice 
following acute and prolonged stress (Scharf et al., 2011), whilst FKBP51 knockout 
mice show decreased stress responses and lower basal corticosterone 
concentrations (Hartmann et al., 2012, Hoeijmakers et al., 2014). It is also worth 
noting that FKBP51 and FKBP52 are not only involved in GR signalling, but are also 
required for the optimal function of MR, PR and AR (reviewed in (Sivils et al., 2011, 
Stechschulte and Sanchez, 2011)). 
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1.3.1.4 Non-genomic action of steroids 
It has become clearer that steroids do not only act by classic steroid receptor action, 
as there are many steroid-mediated cellular responses that occur within minutes, 
which is generally considered too short a time frame for genomic effects to occur 
(Simoncini and Genazzani, 2003, Makara and Haller, 2001). These downstream 
effects that are rapid and do not affect gene expression directly, are defined as non-
genomic effects of steroids (Lösel and Wehling, 2003). Having both genomic and 
non-genomic signalling pathways allows for diversity in the way in which steroids 
may impact the HPA axis. There are three major non-genomic mechanisms where 
steroids can exert effects, these are through 1) cytosolic steroid receptors, 2) 
membrane-bound steroid receptors, or 3) non steroid-receptor mediated pathways.  
Cytosolic steroid receptors: The non-genomic effect of steroid action can occur 
concomitantly with the classic genomic effects, where the conformational changes 
following ligand binding to cytosolic receptors can also lead to the release of 
kinases, which can activate signalling pathways. For instance, the binding of 
glucocorticoids to GR releases the tyrosine kinase, Src which was originally in the 
protein chaperone complex, allowing it to be free to phosphorylate its downstream 
targets (Solito et al., 2003). Glucocorticoids also exert their anti-inflammatory 
properties through a non-genomic pathway, as glucocorticoid binding to GR disrupts 
the formation of a T-cell receptor complex, leading to decreased immune function 
(Löwenberg et al., 2007).  
Membrane-bound steroid receptors: Most of the rapid changes in neuronal 
excitability and activity following glucocorticoid binding are mediated by membrane-
bound MR and GR receptors (Groeneweg et al., 2011). In addition to the slower 
transcriptional downregulation of CRH and AVP expression in the PVN via nuclear 
GR, HPA axis negative feedback inhibition is also heavily dependent on the action 
of glucocorticoids on membrane GR. Using male Sprague Dawley rats, it has been 
found that glucocorticoid- membrane GR binding induces endocannabinoid 
synthesis, which acts in a retrograde manner to suppress the excitatory drive to the 
CRH-producing cells in the PVN (Di et al., 2003, Evanson et al., 2010). This is also 
the case for the membrane-bound PR, where progesterone binding can lead to the 
activation of several non-nuclear signalling pathways such as the extracellular 
signal-related kinase (ERK) pathways, cAMP/protein kinase A (PKA) signalling, Ca2+ 
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influx/PKC activation, or the phosphatidylinositol 3-kinases/protein kinase B 
(commonly known as PI3K/Akt) pathway, among many others (Singh et al., 2013).  
Non steroid receptor-mediated: Steroid hormones can also directly exert effects on 
cell membranes by altering membrane permeability and fluidity (Whiting et al., 
2000). In immune cells for instance, glucocorticoids at high concentration can be 
intercalated into plasma and mitochondrial membranes, activating various 
membrane-associated proteins or calcium signalling (Buttgereit and Scheffold, 
2002). Alternatively, neuroactive steroids may have rapid effects by acting 
allosterically on receptors that are not classic steroid receptors, such as 
transmembrane ion-channel proteins (e.g. NMDA or GABAA receptors), thereby 
modulating the effects of the neurotransmitters glutamate and GABA on brain 
function (section 1.3.6) (summarised in (Groeneweg et al., 2011, Gunn et al., 
2011)). 
1.3.2 Regulation of local steroid availability 
The actions of glucocorticoids and steroids are eventually dependent on local 
concentrations in target tissues and cells. Local regulation can occur via a few 
different mechanisms, and can occur quickly in response to perturbations such as 
stress. Firstly, the concentration of steroids in local organs can be dependent on 
binding to carrier proteins, as it limits the amount of steroids that can freely diffuse 
into cells to act on intracellular receptors (section 1.3.2.1) (Hammond, 2016). 
Secondly, apart from steroids produced by the classic endocrine organs (e.g. 
adrenal glands and gonads), it is also known that there exists enzymatic machinery 
in various organs that can inactivate or activate steroids (e.g. 11β-hydroxysteroid 
dehydrogenase enzymes; section 1.3.2.2), or produce downstream steroids from 
circulating, adrenal-derived steroid precursors (e.g. 5α-reductase or 3α-HSD; 
section 1.3.2.3). This in situ production of steroids in the target organs allow for 
steroids to act in an intracrine (i.e. steroid synthesis and signalling are occurring in 
the same cell) or a paracrine (i.e. steroid synthesis for action in a neighbouring cell) 
manner, without requiring secretion into the circulation. The implication of this local 
regulation or production is that changes observed in circulating levels of steroids 
may not necessarily equate to changes in local levels in the brain.  
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1.3.2.1 Binding or carrier proteins 
As steroids are lipophilic, they are transported in the bloodstream bound to proteins 
such as albumin, sex hormone-binding globulin (SHBG; Shbg) and corticosteroid-
binding globulin (CBG; Serpina6) (Hammond, 2016). The binding of steroids to 
these proteins therefore affect their availability to act on their cognate receptors, 
since only free unbound steroids may freely diffuse through the plasma membranes 
to exert cellular actions (Mendel, 1989).  
The levels of SHBG (which binds to androgens and oestrogens) and CBG (which 
binds to glucocorticoids and progesterone) can change according to different 
conditions, such as during stress or inflammation, allowing for more dynamic control 
of the access of steroids into target tissues and cells. In humans, CBG levels are 
altered in a sex-dependent manner following the Trier Stress Test (Kumsta et al., 
2007), while in mice, deficiencies in CBG also affect corticosterone responses to 
stress and hippocampal-dependent memory processes (Minni et al., 2012). Serum 
albumins bind to most steroids without much specificity and with low affinity, 
however, they exist in high concentrations in blood, thus can additionally modulate 
tissue steroid concentrations as they can buffer drastic changes when plasma 
steroid concentrations increase transiently (Hammond, 2016).  
Although it is often assumed that steroids that are bound to these proteins are 
inactive, there may in fact be additional ways in which they may act, as bound 
steroids can activate membrane steroid receptors directly, or can still enter the cell 
by facilitated endocytosis (Chen and Farese, 1999). Additionally, although unbound 
steroids freely diffuse, there is also evidence of membrane transporters that are 
present, especially at the blood brain barrier that can control the influx and efflux of 
steroids such as cortisol, further complicating the modulation of intracellular 
glucocorticoid concentrations in brain regions (Mason et al., 2008). 
1.3.2.2 11β-hydroxysteroid dehydrogenase (HSD) enzymes 
The enzymes 11β-HSD1 (Hsd11b1) and 11β-HSD2 (Hsd11b2) control local pre-
receptor metabolism of glucocorticoids, converting glucocorticoids to their inactive 
11-keto form and vice versa. 11β-HSD1 functions primarily to convert inactive 11-
dehydrocorticosterone to corticosterone (or cortisone to cortisol in humans), while 
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11β-HSD2 catalyses the reverse reaction and inactivates corticosterone to 11-DHC 
(Chapman et al., 2013, Agarwal et al., 1989, Brown et al., 1993) (Fig 1.4). 
In the brain, 11β-HSD1 is highly expressed in regions of the brain that also express 
GR, including the PVN and the hippocampus, and hence it has been suggested to 
play a role in regulating negative feedback control of the HPA axis, as well as 
regulating glucocorticoid effects on mood, learning, and memory (Holmes and Seckl, 
2006). In contrast, the expression of 11β-HSD2 has been predominantly associated 
with peripheral tissues such as the kidney and the placenta. In the kidney, 11β-
HSD2 prevents overt binding of corticosterone to MR, and enabling aldosterone to 
bind to the receptor to exert its action on salt and water balance (Edwards et al., 
1996). In studies of the adult rat brain, 11β-HSD2 is found to be expressed in a few, 
discrete nuclei also involved in the regulation of salt/water balance and blood 
pressure (Robson et al., 1998). 
During pregnancy, 11β-HSD2 is also highly expressed in the placenta, where it acts 
as a protective barrier to inactivate excess maternal glucocorticoids, hence 
preventing excessive glucocorticoids from reaching the foetus. 11β-HSD2 is also 
expressed in the developing foetal brain, possibly acting as a further layer of 
defense against excessively high levels of corticosterone (reviewed in (Holmes and 
Seckl, 2006)). These will be further elaborated in section 1.4. 
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Figure 1.4: Summary of some of the factors affecting the molecular actions of 
steroids, using the example of glucocorticoids. Glucocorticoid action can be 
affected by its different binding affinities to MR and GR, which differ in downstream 
targets. The nature of the receptor (e.g. whether it is cytosolic or located in the 
membrane), and its association with chaperone proteins, can also affect whether the 
downstream action of steroid ligand-receptor binding is genomic or non-genomic. 
There are also mechanisms to control their local concentrations in cells, by carrier 
proteins such as CBG, transporter proteins such as p-glycoprotein and pre-receptor 
regulation by the action of 11β-HSD enzymes. In rats, 11β-HSD2 converts active 
corticosterone to inactive 11-DHC (which is unable to bind to MR or GR), while 11β-
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1.3.2.3 Neurosteroidogenesis in the brain 
The brain has the enzymatic capability to synthesise steroids de novo, evident from 
the observations in rats that steroid levels can change rapidly independent of 
peripheral concentrations, and can still be detected even upon removal of the 
adrenal glands or gonads (Compagnone and Mellon, 2000, Corpechot et al., 1981, 
Corpechot et al., 1983). These steroids that are produced and have local actions in 
the brain are termed as “neurosteroids” (Baulieu, 1991).  
Neurosteroids are produced in the neurones and glia, and have a wide range of 
influences on the brain, ranging from regulating neuronal survival, differentiation, 
myelination, dendritic growth, and synaptogenesis during development, to the basal 
regulation of circadian rhythms, mood, memory, and sleep, or the activation and 
inhibition of the stress response (Mellon, 2007, Borowicz et al., 2011). They are 
present in higher concentrations in tissue from the nervous system than in the 
plasma, and their levels are known to further increase rapidly following conditions 
such as injury and stress (Purdy et al., 1991, Paul and Purdy, 1992, Barbaccia et al., 
1998). 
These steroids work in an paracrine, as well as an autocrine manner to regulate 
stress responses (Girdler and Klatzkin, 2007). At the same time, there also exists 
feedback loops which regulate their own synthesis (Meethal et al., 2009). There has 
also been thorough characterisations of the neurosterodogenic enzyme machinery 
in the brain of rats and mice, and expression of these enzymes has been found to 
be region-, neurone subtype-, and developmental timepoint- specific (Compagnone 
and Mellon, 2000, Agis-Balboa et al., 2006, Mellon and Griffin, 2002). The molecular 
action of neurosteroids is elaborated in section 1.3.7. 
1.3.3 The influence of circadian rhythms 
All organisms have intrinsic biological “clocks” that regulate biochemical, 
physiological, and behavioural changes throughout the day, to control essential 
processes such as the sleep-wake cycle and to meet the body’s energetic demands. 
In neuroendocrine systems, hormonal production shows both circadian patterns (i.e. 
a cycle that occurs once a day) and ultradian patterns (i.e. cycles that repeat 
throughout a 24 hour period). 
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In terms of the HPA axis, there is a strong circadian rhythm where plasma 
concentrations peak just prior to the active part of the day, which in diurnal animals 
(e.g. humans) is in the early morning, and for nocturnal animals (e.g. rodents), in the 
early evening (Gnocchi and Bruscalupi, 2017, Watts et al., 2004). This is controlled 
by the central clock within the suprachiasmatic nuclei (SCN) of the hypothalamus 
(Nader et al., 2010, Ralph et al., 1990). In addition to and underlying this circadian 
rhythm, there also exists an ultradian rhythm, where there are oscillatory pulses of 
ACTH and glucocorticoid throughout the day (Veldhuis et al., 1989). In the rat, this 
exists as an approximately hourly rhythm of corticosterone secretion that is 
regulated by alternating activation and inhibition of the HPA axis (Lightman et al., 
2008). This is controlled by various negative feedback mechanisms, which include 
dynamic pituitary-adrenal interactions, or even chaperone proteins (Walker et al., 
2010, Gjerstad et al., 2018). Disruption of these of glucocorticoid circadian rhythms 
therefore can be a manner in which aberrant stress responses and disease can 
develop both in humans and in rodents, reviewed in (Spiga and Lightman, 2015).  
Circadian cycles have also been described for sex steroids such as testosterone 
(Alvarez et al., 2008) and progesterone (Nakao et al., 2007, Bailey, 1987) in mouse 
studies. In terms of experimental work, the presence of these rhythms mean that the 
time of the day should always be considered an important factor when 
designing/conducting experiments and reporting data (Gumz, 2016).  
1.3.4 The influence of sex  
Apart from expected differences in the concentration of sex steroids, where males 
have greater concentrations of testosterone and females have higher concentrations 
of progesterone and oestradiol, sex differences are present in neuroendocrine 
responses to stress. In rodent studies, females are generally known to have greater 
stress responses in comparison to males (Sze et al., 2018, Bale and Epperson, 
2015, Handa et al., 1994, Tinnikov, 1999). In humans, such patterns are less 
consistent as measurements of HPA axis and SNS output (e.g. plasma cortisol, 
heart rate, blood pressure) show far more variability, as observed in a systematic 
review by (van der Voorn et al., 2017). However, men and women still display 
different risk profiles for stress-related diseases. For instance, women are more 
prone to developing anxiety, depression, panic and eating disorders, while men 
show more antisocial behaviour and substance abuse (Altemus et al., 2014). 
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Women also report higher incidences of stress, which may be attributed to 
underlying differences in stress responsivity (Wellman et al., 2018).  
These sex differences can be explained by the organisational-activational theory of 
sexual differentiation, and are driven by differences in sex steroid concentrations 
between males and females, as reviewed in (McCarthy et al., 2012, Arnold, 2009). 
Sex steroid concentrations in males and females are inherently different due to the 
presence of ovaries in females and testes in males, which in males are in turn are 
determined by the SRY gene on the Y chromosome. During a critical developmental 
period in foetal life, steroids organise the brain by the regulation of gene expression, 
epigenetics and protein synthesis etc., which result in permanent changes in 
neuroanatomy and circuitry (Bingham and Viau, 2008). These effects are known as 
the “organisational” effects of sex hormones. In rats and mice, a testosterone surge 
occurs around gestational day (GD) 18 where its levels are significantly higher than 
levels in female siblings (Ward et al., 2003). There is another additional surge a few 
hours after birth, but levels then remain low postnatally until puberty (Weisz and 
Ward, 1980). This testosterone surge prenatally and at birth is recognised to be the 
dominant organising signal in rodents (Lenz et al., 2012). In humans, a prenatal 
testosterone surge also occurs prenatally at about weeks 8 to 24 of gestation, 
however, in contrast to rats and mice, another testosterone surge also occurs in the 
first few months after birth before decreasing at about 6 months until puberty, where 
levels rise again ((Winter et al., 1976) and reviewed in (Bell, 2018)). Therefore, 
“organisational” effects can also be considered to occur during puberty, where there 
are further maturational changes in the neural circuitry of the brain, due to the 
epigenetic effects of gonadal hormones (reviewed in (Morrison et al., 2014)).  
Apart from this “organisational” effect during these critical windows which alter 
neuroanatomy and circuitry, during adulthood, there are direct “activational” effects 
of these steroids on cellular function. “Activational” effects are only present when the 
steroids are present, and are especially pronounced after puberty, and are 
considered as mechanisms to maintain sex differences in adulthood. Sex steroids 
are part of the hypothalamic-pituitary-gonadal axis (HPG), which controls 
reproduction and fertility, but also has interactions with the HPA axis and is able to 
modulate stress signalling (Oyola and Handa, 2017, Acevedo-Rodriguez et al., 
2018). In general, testosterone suppresses stress reactivity while oestradiol seems 
to enhance HPA axis responses (Viau and Meaney, 1996). High oestradiol 
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concentrations result in elevated basal corticosterone, enhanced and prolonged 
corticosterone secretion following stress, seemingly via an increased adrenal 
sensitivity to ACTH, which may explain why stress responsivity and plasma 
corticosterone concentrations are at maximum levels at pro-estrus in female rodents 
(Atkinson and Waddell, 1997, Viau and Meaney, 1991). Progesterone also play a 
modulatory role in regulation of the female HPA axis, but is likely to be inhibitory 
instead, as it prevents the enhancing effects of oestrogen on ACTH release during 
stress in rats (Viau and Meaney, 1991, Roy et al., 1999). A further complexity exists 
in that testosterone can also exert its actions via its conversion to oestradiol, 
catalysed by the enzyme aromatase, which show different activities in males and 
females, which may lead to differences in various neurobehavioural outcomes (Shay 
et al., 2018). Sex differences observed in male and female HPA axis responses in 
adulthood are therefore a result of permanent “organisational” effects and more 
transient “activational” effects of sex steroids. 
The implications of these sex differences when investigating the role of steroids in 
stress axis regulation is that males and females should be analysed separately as 
there is likely to be mechanistic differences between them, whether or not there are 
phenotypical differences. This is in line with the National Institute of Health directive 
which calls for the need to include both sexes in animal experiments (Clayton and 
Collins, 2014). Moreover, as sex differences in neuroanatomy and circuitry emerge 
at a young age, it is necessary to consider sex even during foetal stages.  
1.3.5 The influence of developmental stage 
Neuroendocrine responses to stress are not homogenous across different ages, 
different outcomes can emerge when individuals are exposed to stress at different 
stages of their lives (Lupien et al., 2009, Koenig et al., 2011, Bale and Epperson, 
2015). Across different stages of rodent development, the basal concentrations of 
corticosterone and sex steroids in the brain and circulation are also not static (Taves 
et al., 2015, Konkle and McCarthy, 2011).  
Firstly, the foetal HPA axis in rats develops at about GD16 (Lugo and Pintar, 1996, 
Brunton, 2013), and are found to be responsive to stressors as early as GD18 
(Ohkawa et al., 1991b). A similar increased HPA activity is observed in the third 
trimester in human pregnancies, where production of glucocorticoids and 
neuroactive steroids peak near parturition (Wood and Keller-Wood, 2016, Morsi et 
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al., 2018). The foetal HPA axis does not participate in the stereotypical “stress 
response” per se, but instead mediates processes such as the timing of birth, and 
prepares the foetus for birth and the extrauterine life (Wood and Keller-Wood, 2016) 
(elaborated in section 1.5). 
After birth, there exists a stress hyporesponsive period (mostly during the first two 
weeks in life for rats), as excess glucocorticoids can disrupt the normal development 
of glucocorticoid-sensitive brain regions (Sapolsky and Meaney, 1986). Neonatal 
rats have low basal levels of corticosterone, and fail to show an adult-like increase in 
plasma corticosterone or ACTH concentrations upon exposure to a variety of 
stressors (including ether, handling, heat, electric shock, and cold stressors), 
(Dallman, 2000, Sapolsky and Meaney, 1986). Studies from rats (Walker et al., 
1990) and mice (Schmidt, 2010)  both suggest that it is likely that the quiescent HPA 
axis during this stage is due to suppression of HPA activity at the level of the 
anterior pituitary, as well as decreased sensitivity of the adrenals to ACTH. In the 
brain, whilst GR expression in the hippocampus is fairly low at birth, it increases 
significantly over the first two weeks of life, with the highest levels of expression 
peaking at PND 12, which potentiates negative feedback inhibition of the HPA axis 
(Schmidt et al., 2003). 
The HPA axis starts to mature during puberty, in tandem with the maturation of brain 
circuitry in the limbic regions, reviewed in several rodent and human studies in 
(Eiland and Romeo, 2013). In contrast to the stress hyporesponsive period during 
neonatal life (in rats) and childhood (in humans), the peri-pubertal period is often 
characterised by increased HPA axis activity in response to acute stress (Romeo et 
al., 2006a). In humans, there are increases in basal activity, as well as enhanced 
HPA axis stress reactivity during adolescence (Gunnar et al., 2009), which may 
place adolescents at higher risk for psychopathology. This may explain the 
increasing incidences of psychiatric disorders, such as anxiety and mood disorders, 
eating disorders, personality disorders and substance abuse that arise during 
adolescence (Gunnar and Quevedo, 2007, Paus et al., 2008). In rats, similar 
observations have been made, where adolescent rats exposed to stressors (e.g. 
hypoxia, foot shock, restraint) have prolonged plasma ACTH and corticosterone 
responses that last twice as long as those observed in adults (Romeo et al., 2006b, 
Goldman et al., 1973).  
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Furthermore, although sex differences in neuroanatomy and circuitry exist before 
the onset of puberty, the sex difference in risk for mood disorders rise sharply after 
puberty (e.g. after puberty, incidences of major depression are two times higher in 
females compared to males until after menopause) (Altemus et al., 2014). Rat 
studies show that the blunting of the male HPA stress axis occurs during puberty, 
due to the rise in testosterone and its interaction with the “organised” brain changes 
induced by neonatal testosterone (section 1.3.4) (Gomez et al., 2004). Differences 
in neuroactive steroid modulation of anxious behaviour also seem to appear during 
puberty, where it has been reported allopregnanolone triggers anxiety in female 
adolescent mice, while it decreases anxiety in adult female mice (Shen et al., 2007). 
In females, reproductive events throughout the life course such as the oestrous 
cycle, pregnancy and also menopause, can all dramatically alter the responsivity to 
stress. Apart from changes during the oestrous cycle, where varying oestrogen and 
progesterone level can affect ACTH levels, observed in rat studies (Viau and 
Meaney, 1991), the HPA axis undergoes dramatic adaptations during reproductive 
events such as pregnancy and lactation, where there is in general dampening of the 
HPA axis activity, which will be explained further in section 1.4 (Brunton and 
Russell, 2008b, Brunton et al., 2008).  
Lastly, the HPA axis tone also increases with age, where there is hyperactivity 
during old age (Herman et al., 2001). Rat studies have attributed these changes to 
central mechanisms such as an increase in extracellular glutamate release in the 
hippocampus and prefrontal cortex following stress (Lowy et al., 1995), while other 
studies summarised in the following reviews have suggested increased local 
amplification of glucocorticoid action (Yau and Seckl, 2012), or a decrease in 
negative feedback inhibition due to decreased GR in the hippocampus (Sapolsky et 
al., 1986). In humans, aging is associated with increased cortisol, and this pattern 
seems to be more pronounced in females, again attesting to the sex differences that 
are present (Larsson et al., 2009, Lavretsky and Newhouse, 2012).  
1.3.6 Neuroactive steroids  
As briefly introduced in section 1.3.2.3, neuronal signalling can be augmented by 
steroids in the brain. These steroids were first termed “neurosteroids” by Baulieu, 
referring to steroids produced de novo in the brain (Baulieu, 1991). However, a 
broader term “neuroactive steroids” is now used to describe these steroids, 
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described by Paul and Purdy in 1992 as “endogenous or synthetic steroids which, 
irrespective of their origin, can rapidly alter the excitability of neurones via actions on 
membrane-bound receptors in the brain” (Paul and Purdy, 1992). Endogenous 
neuroactive steroids can be synthesised in the periphery (e.g. in the gonads or 
adrenal glands) or de novo in the brain.  
In this thesis, the term “neuroactive steroid” will be used to refer to all steroids found 
in the brain that are able to regulate neural functions rapidly, regardless of their 
production site (periphery or in the brain) or the receptors they signal through (i.e. 
the mechanism of action of “neuroactive steroids” does not merely have to be 
restricted to modulating neurotransmitter signalling, as they can act through steroid 
nuclear receptors as well) (Melcangi et al., 2008).  
1.3.6.1 Molecular actions of neuroactive steroids 
Neuroactive steroids can rapidly modulate GABA (inhibitory) and glutamatergic 
(excitatory) signalling, by binding allosterically to the GABAA receptor and the N-
methyl-d-aspartic acid (NMDA) glutamate receptors (Rupprecht, 2003), therefore 
can exert substantial acute modulatory actions on the activation or inhibition of the 
HPA axis (Myers et al., 2014, Herman et al., 2004, Gunn et al., 2011). 
GABAA receptors are pentameric, made up of two α subunits (which can be formed 
from subunits α1-α6), two β subunits (which can be formed from subunits β1-3) and 
one γ subunit (from γ1-3) (Fig 1.5) (Enna, 2007). There is considerable diversity in 
the subunit make-up and regional distribution of GABAA receptors allowing for 
differential interactions with neuroactive steroids (Belelli et al., 2002), and the control 
of different behaviours (Wang, 2011, Sieghart and Sperk, 2002). The most common 
receptor combination within the CNS is the α1β2γ2 configuration (60% of all GABAA 
receptors; which also mediates sedative and anticonvulsant activity), followed by the 
α2β3γ2 configuration (15–20%, which also mediates anxiolytic activity) (Möhler et 
al., 2004). 3α,5α-reduced metabolites of DOC, progesterone and testosterone bind 
to a site distinct from the GABA binding region, opening the ion channel and 
allowing for the enhanced influx of Cl- ions by increasing both channel frequency 
and channel opening duration, leading to sustained hyperpolarisation of the 
neurone, eventually resulting in increased inhibition of neural activity (Fig 1.5) 
(Lambert et al., 2001, Majewska et al., 1986, Morrow et al., 1987, Akk et al., 2007).  
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NMDA receptors assemble as tetrameric complexes, with two GluN1 subunits 
coupled with either GluN2/GluN2 or GluN2/GluN3, forming a channel through which 
the flow of positive ions is permitted (Fig 1.5) (Traynelis et al., 2010). Similar to the 
GABA receptors, there is diversity in NMDA receptors subtypes, where different 
subunit combinations formed from eight GluN1 subtypes, two GluN2 subtypes and 
two GluN3 subtypes can lead to different functional characteristics (Cull-Candy et 
al., 2001, Malayev et al., 2002). Neuroactive steroids such as pregnenolone sulfate 
(PregS) (Wu et al., 1991) and dehydroepiandrosterone (DHEA) (Baulieu and Robel, 
1998) tend to positively modulate NMDA receptors, whilst 17β-oestradiol is a 
negative modulator of the NMDA receptor (Weaver et al., 1997). These steroids act 
together to regulate NMDA activity by altering the channel opening time and 
receptor sensitivity (Traynelis et al., 2010), preventing NMDA receptor over-
activation which can result in excitotoxic cell death (Hilton et al., 2006). Apart from 
modulating stress-responsive circuits, clinically, NMDA receptors are known to be 
also involved in modulating neuronal plasticity, and an enhancement of NMDA 
receptor function has been linked the improvement of outcomes of cognitive decline 
(Collingridge et al., 2013), as well as the alleviation of the negative symptoms of 
schizophrenia (Marx et al., 2011). 
In addition to the NMDA and GABA receptor, other receptors that can be modulated 
by the rapid action of steroids include the α-amino-3-hydroxy-5-methylisoxazole 
propionate (AMPA) receptor, sigma-1 receptors, nicotinic, muscarinic, kainate, 
serotonergic and glycine receptors (Zheng, 2009). Sex steroids for instance, seem 
to also have effects on the brain serotonin system, where 17β-estradiol, 
testosterone and progesterone act as antagonists at the 5-hydroxytryptamine type 3 
(5-HT3) receptor, which are linked to the regulation of mood and anxiety (Rupprecht, 
2003, Birzniece et al., 2006). Sex steroids can also exert rapid signalling actions 
through binding to their cognate receptors in a non-genomic manner (Wierman, 
2007). In fact, their 5α-metabolites, such as dihydroprogesterone (5α-DHP) and 5α-
dihydrotestosterone (5α-DHT), have also been found to be able to bind to the 
progesterone receptor and androgen receptor respectively to exert rapid effects 
(Rupprecht et al., 1993, Foradori et al., 2008). 
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Figure 1.5 Examples of neuroactive steroid regulation of neuronal signalling. 
Neuroactive steroids can impact both excitatory signalling and GABAergic signalling. 
The GABAA receptor contains different ligand binding sites for GABA, 
benzodiazepine, barbiturate and steroids. 
1.3.6.2 Neuroactive steroids and stress responses 
Acute stress results in the robust increase of neuroactive steroid production, 
especially allopregnanolone and THDOC, when investigated in the rat brain (Purdy 
et al., 1991). Given their potentiating effect on GABA-mediated neuronal inhibition, 
their increase has been proposed to constitute a negative feedback mechanism to 
terminate the HPA axis (Gunn et al., 2015, Wirth, 2011). This is evident from 
experiments which show that the pre-treatment of either allopregnanolone or 
THDOC significantly attenuates the stress-induced elevation of plasma ACTH and 
corticosterone in rats, possibly through the inhibition of CRH-producing neurones at 
the mpPVN (Owens et al., 1992, Patchev et al., 1996). However, it has also been 
reported in adult mice that the increase in THDOC is necessary for the mounting an 
HPA axis stress response (Sarkar et al., 2011). 
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In cases of chronic stress, altered baseline neuroactive steroid concentrations can 
be observed, which may represent increased allostatic load that can underlie HPA 
axis abnormalities and eventually lead to disease (e.g. anxiety/depressive-like 
phenotypes) (Evans et al., 2012). HPA axis dysregulation in chronic stress has been 
associated with an imbalance between excitatory and inhibitory signals, where there 
is generally increased excitatory transmission (Flak et al., 2009) and decreased 
inhibitory transmission (Verkuyl et al., 2004) in the PVN of rats. Allopregnanolone 
and THDOC may contribute to the imbalance, as both their brain levels are found to 
be decreased following chronic stress in mice and rats (Dong et al., 2001, Serra et 
al., 2000). 5α-reductase type 1 expression was also reported to be decreased in 
glutamatergic neurons of the FC and BLA following chronic stress in a separate 
study in mice (Agis-Balboa et al., 2007). In humans, levels of endogenous 3α-
reduced neuroactive steroids in plasma and cerebrospinal fluid are reported to be 
decreased in patients with stress-related affective disorders, while elevated 
neuroactive steroid levels are associated with anti-depressant actions (Uzunova et 
al., 2006). In rodent models of psychiatric diseases, exogenous administration of 
THDOC and allopregnanolone brings about potent anxiolytic actions in anxiety 
models (Bitran et al., 1995, Engin and Treit, 2007) and antidepressant-like actions in 
models of depression (Pinna et al., 2009).  
Given the role of neuroactive steroids in rapidly regulating stress responses, 
changes in the levels of neuroactive steroids in the brain can therefore be 
informative in the understanding of molecular basis of differences in stress 
responses, such as in different sexes, or in stress-related disorders. The 
development of a reliable method for the quantification of neuroactive steroids in the 
brain is therefore endeavoured in this thesis, which will be elaborated in Chapter 3. 
The panel of steroids to be quantified are chosen based on their involvement in the 
modulation of the stress response. They include corticosterone (as final output of 
the HPA axis) and its inactive metabolite 11-DHC, the GABAA modulators 
allopregnanolone and THDOC and their precurors (DHP and progesterone, and 
DHDOC and DOC, respectively). Additionally, gonadal hormones such as estradiol 
and testosterone and its metabolites are also included, as these hormones are 
known to modulate the sex differences in stress responses.  
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1.4 What happens during pregnancy?  
Pregnancy is a dynamic period marked by drastic physiological changes in both the 
mother and the foetus (Brunton et al., 2008). These changes include alterations to 
the cardiovascular, immune, and metabolic systems of the mother, which are 
necessary for the proper growth and the development of the foetus, as well as to 
prepare for parturition and lactation (Thornburg et al., 2015). These adaptations are 
mediated by a host of different hormonal signals, which can originate from the 
placenta, maternal or foetal endocrine organs, allowing for cross-talk and 
interactions between the maternal-placental-foetal triad. It is also of note that 
endocrine interrelationships between the mother, placenta, and foetus show species 
diversity, and are different in rodents and in humans (Albrecht and Pepe, 2015).  
1.4.1 Mother 
In the context of this thesis, one of the important adaptations during pregnancy 
(especially late pregnancy) is that the responsiveness of the maternal HPA axis is 
greatly reduced, following observations in rat and mouse studies (Neumann et al., 
1998, Douglas et al., 2003). Given that the foetus is sensitive to the effects of 
glucocorticoids, a reduced maternal stress response system provides a first line of 
defense to prevent excessive foetal exposure to maternal glucocorticoids. Alteration 
of glucocorticoid levels may also aid immune adaptations in the mother, which 
ensures that the foetus is not rejected (Mor and Cardenas, 2010, Arck et al., 2007) 
and metabolic changes to ensure enough nutrients are being provided for the 
optimal development of physiological systems in the growing foetus (Welberg and 
Seckl, 2001). The mechanisms of these HPA axis adaptations are elaborated below 
with observations from both rat and human pregnancies. 
1.4.1.1 Maternal basal HPA axis activity 
In pregnant rats, basal concentrations of circulating corticosterone are elevated, with 
a gradual increase from mid-pregnancy to late-pregnancy (Waddell and Atkinson, 
1994). Whilst the circadian variation in corticosterone secretion in pregnant rats are 
still present, they become flattened due to the increased levels at the nadir of the 
circadian rhythm (Atkinson and Waddell, 1995). ACTH concentrations however, do 
not show a circadian rhythm and levels remain low in late pregnancy (Atkinson and 
Waddell, 1995). The increase in basal corticosterone in pregnant rat is therefore not 
likely to be due to central mechanisms, but can be attributed to increased sensitivity 
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of the adrenal gland to ACTH, mediated by oestrogen, as it has been shown in 
female rats that increasing circulating oestrogen increases adrenal sensitivity to 
ACTH (Figueiredo et al., 2007). However, a compensatory increase in CBG occurs 
as well, thus the total amount of free and unbound corticosterone seem to be 
decreased during pregnancy (Douglas et al., 2003).  
In the maternal rat brain, the basal expression of CRH mRNA in the mpPVN is 
reduced (Johnstone et al., 2000), concomitant with reduced release of CRH into the 
median eminence (Ma et al., 2005), which may explain suppressed ACTH levels 
(Atkinson and Waddell, 1995). Additionally, glucocorticoid-mediated negative 
feedback control also seem to be enhanced. Firstly, there is evidence of a modest 
upregulation of GR mRNA expression in the hippocampal dentate gyrus during late 
pregnancy near parturition, which may promote negative feedback processes via 
GR binding (Johnstone et al., 2000). Secondly, the activity of 11β-HSD1 (which 
reactivates corticosterone from 11-DHC) is increased in the PVN and anterior 
pituitary, which indicates increased local glucocorticoid availability and suggests 
enhanced negative feedback inhibition (Johnstone et al., 2000). Despite elevated 
peripheral corticosterone levels, these brain adaptations suggest that there is a 
reduced central drive of HPA axis activity (Brunton and Russell, 2015).  
Similarly, in human pregnancies, patterns of increase also observed for plasma 
cortisol concentrations (Carr et al., 1981), concomitant with an oestrogen-mediated 
increase in CBG (Demey-Ponsart et al., 1982). Hypercortisolemia in human 
pregnancies however, is mainly driven by the placental production of CRH 
(elaborated in section 1.4.2), which increases the production of ACTH and cortisol in 
a manner that is autonomous and not subject to normal HPA axis negative feedback 
control (Carr et al., 1981, Jung et al., 2011, Wadhwa et al., 1997). 
1.4.1.2 Maternal HPA axis responses to stress 
Whilst the maternal HPA axis can be considered to be in a state of hypersecretion 
under basal conditions, the responsiveness of the HPA axis following stress is 
attenuated during late pregnancy. In the rat, HPA axis hyporesponsiveness, which 
begins in mid pregnancy, is maintained through parturition and lactation until the 
pups are weaned (Neumann et al., 1998, Wigger et al., 1999, Windle et al., 1997). 
Pregnant rats subjected to a psychological stressor such as the elevated plus maze 
(Neumann et al., 1998), a physical stressor such as immune challenge (Brunton et 
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al., 2005), or a combined physical and psychological stressor such as swim stress 
(Neumann et al., 1998, Douglas et al., 1998) all show reduced peak ACTH and 
corticosterone secretion.  
Underlying mechanisms of HPA hyporesponsiveness include a decreased 
noradrenergic drive from the NTS, as no noradrenaline release from NTS neurones 
into the PVN is observed following physical stressors in a rat model (Douglas et al., 
2005). This lack of noradrenaline release in the PVN, in turn, seems to be due to the 
inhibitory action of allopregnanolone at the NTS, via an endogenous opioid pathway 
(Brunton et al., 2005, Brunton et al., 2009).  
Concentrations of allopregnanolone increase in both the maternal blood and brain 
during pregnancy, due to the increase in production of its precursor, progesterone 
(Concas et al., 1998). In late pregnant rats, inhibiting allopregnanolone production 
with the 5α-reductase inhibitor, finasteride, restores normal HPA axis responses to 
systemically administered IL-1β, while administering allopregnanolone to virgin rats 
mimics the HPA hyporesponsiveness observed in late pregnant rats (Brunton and 
Russell, 2008a). Apart from acting through potentiating GABAA-mediated inhibitory 
networks in the brain (Patchev et al., 1996), allopregnanolone also exerts its effect 
on the HPA axis via an endogenous opioid pathway (Brunton et al., 2005).  
Endogenous opioids can suppress HPA axis responsiveness in late pregnancy by 
acting on noradrenergic NTS neurones, preventing noradrenaline signalling to the 
PVN, reducing HPA axis activation and CRH production, and consequently 
decreasing ACTH and corticosterone production (Brunton et al., 2009). In 
pregnancy, there is an upregulation of central inhibitory opioid mechanisms, where 
the mRNA expression for the endogenous opioid, proenkephalin-A, and for μ-opioid 
receptor are increased in the NTS of the brainstem (Brunton et al., 2005). This 
increased inhibitory opioid tone seems to be induced by the increase in 
allopregnanolone, as a similar increase in opioid-related gene expression is 
observed when virgin females are treated with allopregnanolone (Brunton and 
Russell, 2008a). The mechanism by which allopregnanolone increases brainstem 
opioid expression has not been investigated, but may again involve rapid signalling 
through GABAA receptors (Brunton et al., 2012). 
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In pregnant women, the responsiveness of the HPA axis to stress has not been 
extensively studied like in the rat, but is known to be generally dampened as 
compared to non-pregnant females (Duthie and Reynolds, 2013, de Weerth and 
Buitelaar, 2005). Plasma ACTH and cortisol secretion have been observed to be 
suppressed in pregnant women in response to exogenous CRH administration 
(Schulte et al., 1990), whilst salivary cortisol is also reduced in pregnant women in 
response to a physical cold stress (Kammerer et al., 2002). Nonetheless, variation is 
observed, possibly due to the nature of different stressors, as salivary cortisol 
secretion was reported to be instead prolonged following a social stress test in 
pregnant women during the second trimester in pregnancy (Nierop et al., 2006). 
1.4.2 Placenta 
The placenta integrates and communicates environmental factors such as the 
nutritional status and stress status of the mother to the developing foetus by altering 
its vasculature, oxygen, nutrient transport, nutrient concentrations, and also by 
producing factors (e.g. hormones or growth factors) that may directly affect foetal 
growth and development (Albrecht and Pepe, 2015, Burton et al., 2016). 
1.4.2.1 Structure of the placenta 
The placenta is primarily of foetal origin, consisting mostly of foetal trophoblast cells, 
but has a maternal component in the decidua, which contains maternal arteries and 
immune cells (Sadovsky and Jansson, 2015). There are two structurally distinct 
regions of the foetal-derived trophoblastic component, the junctional zone (JZ) and 
the labyrinth zone (LB) (Fig 1.6). The JZ, which is located adjacent to the maternal 
decidua, contains spongiotrophoblast and trophoblast giant cells, the two major 
endocrine cells that contribute to the secretion of hormones (Ain et al., 2006, Hu and 
Cross, 2010). The JZ is devoid of foetal vessels and does not participate in the 
exchange of maternal and foetal materials (Fig 1.6). The LB on the other hand, 
consists of both maternal and foetal blood vessels, although the two circulations do 
not mix. The LB is considered the site of foeto-maternal exchange, where foetal 
blood is separated from maternal blood sinuses by tree-like villi lined by 
syncytiotrophoblasts cells (Fig 1.6), thereby increasing the surface area for the 
exchange (Sadovsky and Jansson, 2015).  
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Given their different functions, gene and protein expression patterns of the different 
zones are expected to be quite different. Indeed, global gene analysis in the human 
placenta have found very different expression patterns among the foetal (mainly 
LB), maternal (basal plate in humans; equivalent to JZ in rats), and middle sections 
(mainly LB) of the placenta (Sood et al., 2006). A similar study using RNA 
sequencing of the rat placenta, reported unique expression patterns for each zone, 
characterised by biological processes specific to the zone. 4000 differentially 
expressed genes were observed between the zones, and genes related to transport 
and vasculature-related processes predominated in the LB, while genes related to 




Figure 1.6: Structure of the rat placenta. Different zones of the placenta have 
different functions. The maternally-derived decidua is important in regulating the 
mother’s immune relationship with foetus, while JZ secretes hormones mainly into 
the maternal circulation. The LB contains both foetal and maternal blood vessels 
and is the site of foetal-maternal exchange of gases, nutrients and other materials. 
11β-HSD2 for instance, is expresses in syncytiotrophoblast cells in the LB. Adapted 
from Bronson and Bale, 2016. 
 
1.4.2.2 Function of the placenta 
The placenta has three basic functions: (i) to facilitate gas exchange and nutrient 
transfer; (ii) to act as an endocrine organ to ensure the viability of the pregnancy, 
and (iii) to act as a protective barrier (Griffiths and Campbell, 2015, Burton et al., 
2016).  
Transfer of gases and nutrients: Both oxygen and carbon dioxide readily diffuse 
across the placenta by passive diffusion, where oxygen is transferred from the 
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maternal blood to the foetal blood, while foetal blood releases carbon dioxide back 
into the maternal circulation. Specific nutrient transporters expressed in the 
syncytiotrophoblast cells of the LB facilitate the transport of glucose (e.g. via the 
GLUT1 transporter), amino acids and fatty acids across the placenta from mother to 
foetus (Sadovsky and Jansson, 2015). 
Endocrine organ: The placenta is an endocrine organ and produces a wide array of 
hormones, including those from the prolactin-growth hormone family (e.g. prolactin, 
placental lactogen and growth hormone), steroid hormones (oestrogens and 
progesterone) and neuropeptides (serotonin, melatonin and oxytocin), reviewed in 
both human and rodent studies in (Napso et al., 2018). Progesterone for instance, is 
an important pregnancy hormone and is essential to the viability of the foetus, as it 
maintains the endometrium and suppresses uterine contractions which would 
invariably terminate the pregnancy. In humans, the syncytiotrophoblasts cells of the 
placenta takes over the synthesis of progesterone from the corpus luteum at 
approximately 8 weeks of pregnancy (Albrecht and Pepe, 2015). In rodents 
however, the placenta produces neglible amounts of progesterone, but produces 
signals (e.g. placental lactogen) that maintains corpus luteal progesterone 
production (Galosy and Talamantes, 1995, Carter, 2012). Apart from physically 
maintaining the pregnancy, progesterone alters the maternal physiology in order to 
accommodate the pregnancy, for instance, by altering the immune system to 
prevent the rejection of the foetus in all mammalian species (Arck et al., 2007). The 
placenta expresses steroidogenic enzymes, although the expression pattern of the 
enzymes depends on the stage of pregnancy, as well as the species (Strauss et al., 
1996). It is known that steroidogenic enzymes 5α-reductase (both isotypes 1 and 2) 
and 3α-HSD are expressed in the human and sheep placenta, which contributes to 
the production of allopregnanolone (Hirst et al., 2009), Allopregnanolone not only 
modulates the maternal HPA axis during pregnancy, but also plays a role in 
regulating foetal brain development (reviewed in (Brunton et al., 2014)).  
Protective function: As the maternal and foetal circulations do not mix, the 
syncytiotrophoblasts cells of the placenta acts as a physical barrier against 
xenobiotic substances, but also mediates the transfer of immunoglobins such as IgG 
to provide the foetal compartment with some form of immune protection (Simister, 
2003). 11β-HSD2 is also expressed in the placenta, which limits the amount of 
active maternal glucocorticoids than can be transferred into the foetal circulation 
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(Brown et al., 1996, Chapman et al., 2013). This adaptation represents the second 
line of defence (in addition to the dampening of the maternal stress response) 
against excessive glucocorticoid exposure of the foetus, following a stressful 
encounter. 11β-HSD2 expression is dynamic and changes according to the 
pregnancy stage, which will be elaborated in Chapter 5.  
Given these important functions, the placenta may therefore play a central role in 
mediating foetal programming as any perturbations to its normal function could lead 
to compromises in foetal growth and development (Sferruzzi-Perri and Camm, 2016, 
Kratimenos and Penn, 2019, Bronson and Bale, 2016). The role of the placenta will 
be further investigated in Chapter 5 and Chapter 6. 
1.4.2.3 Species differences in the placenta 
As a rat model is used in this thesis, differences between the rat and human 
placenta will be briefly discussed. Although mammalian placentation is largely 
conserved, differences in the structure and function of rodent versus human 
placentas exist, and many are also related to the inherent differences between 
rodent and human pregnancies (e.g. different gestational length, number of offspring 
per pregnancy) (Soares et al., 2012, Furukawa et al., 2014, Ilekis et al., 2016, 
Grigsby, 2016). In terms of its role as a endocrine organ, certain key differences 
arise, especially in the expression patterns of enzymes needed to synthesise 
hormones in the rat and the human placenta. 
 
Firstly, the human placenta secretes large amounts of CRH into the maternal 
circulation, whilst the rat placenta does not produce CRH at all (Robinson et al., 
1988, Heussner et al., 2016). Placental CRH secretion increases the production of 
ACTH and cortisol, but unlike the hypothalamus, cortisol in the placenta acts in a 
positive feedback loop to further augment the secretion of placental CRH (Majzoub 
and Karalis, 1999, Robinson et al., 1988). Placental CRH can thus further regulate 
processes like the timing of parturition, stress responses, cortisol-mediated 
metabolic actions and energetics (Gangestad et al., 2012) in pregnant women in a 
manner that is not observed in rats (Alcántara-Alonso et al., 2017).  
 
Additionally, although progesterone and oestrogens are secreted in large amounts 
during both rat and human pregnancies, the contribution of the placenta in secreting 
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these hormones differ between the two species (e.g. the rat placenta does not 
produce large amounts of progesterone, mentioned in 1.4.2.2). The rat placenta also 
does not express aromatase, but instead provides androgenic precursors (e.g. 
androstenedione) for oestradiol production by the maternal ovary (Jackson and 
Albrecht, 1985). On the other hand, in humans, the placenta expresses aromatase 
to convert testosterone into oestradiol, but lacks 17α-hydroxylase to synthesise 
androstenedione, and is thus dependent on the maternal and foetal adrenal glands 
to generate androgenic precursors (see Fig 1.3 for steroid conversion diagram) 
(Strauss et al., 1996). For instance, the human foetal adrenal gland produces a 
majority of the DHEA that the placenta uses as a precursor to make 
androstenedione (via the action of 3β-HSD), then subsequently testosterone and 
oestrogens (Warren and Timberlake, 1964). These findings also demonstrate how 
the placenta in general is dependent on both the maternal and foetal compartments 
for proper functioning, but the specific interactions are different between rats and 
humans. Nonetheless, despite these differences, the rat model is still helpful in its 
ability to allow for manipulations, as long as these differences are kept in mind 
(Bonney, 2013).  
 
1.4.2.4 Sex differences in the placenta 
Sex differences occur not only in the foetus, but also in the placenta (Alur, 2019, 
Clifton, 2010). The male and female placenta are inherently different as they are 
derived from foetal cells, therefore would have unequal expression of X- and Y-
linked genes (Gabory et al., 2013). In human placentae, apart from sex-linked 
genes, there are also clear sex differences in the expression of genes related to 
immune or growth pathways, where they are generally expressed at higher levels in 
females than in males (Sood et al., 2006).  
 
Prenatal stress is known to exert unequal influences on male and female offspring 
and the varying vulnerabilities have been proposed to be mediated by the placenta 
during foetal development (Bale, 2016, Rosenfeld, 2015). Indeed, male and female 
placenta seem to respond differently to excess glucocorticoids in mice (O'Connell et 
al., 2011, Cuffe et al., 2017b) and in humans (Stark et al., 2009), indicating that they 
employ different strategies to ensure foetal growth and survival in the face of 
homeostatic perturbations (Clifton, 2010). In human pregnancies, it seems that male 
Chapter 1: General introduction 41 
foetuses seem to be more affected by in utero compromises (Eriksson et al., 2010, 
Edwards et al., 2000, Kalisch-Smith et al., 2017). In later life, a sex bias is also 
observed for neurodevelopmental disorders such as autism spectrum disorder, 
anxiety and schizophrenia, where males often have a higher disease risk (Bale, 
2011, Baron-Cohen et al., 2011). In mice, expression of placental O-linked N-
acetylglucosamine transferase (OGT), which can modulate glucocorticoid 
responses, are also found to be twice as high in the female placenta (Pantaleon et 
al., 2017), and can be affected in a sex-dependent manner following stress 
(Howerton and Bale, 2014). The implication of this is that in studying foetal 
programming, the consideration of sex need to apply to the placentae as well, in 
addition to the foetus. Moreover, male and female placentae, arising from the same 
pregnancy, should not be assumed to be equivalent. 
1.4.2.5 Oxidative stress in the placenta 
The placenta is characterised by extremely fast growth, and placentation itself is an 
invasive process that involves cell proliferation, differentiation and the restructuring 
of blood vessels (Soares et al., 2014). In rats for instance, a fast growth of the 
placenta from 1–2 mm in diameter at GD4 to 21–23 mm at GD21 can be observed 
(de Rijk et al., 2002); while in humans the growth of the placenta is precocious 
especially in the first trimester of the pregnancy (Burton and Jauniaux, 2018). The 
increased exchange of materials and secretion of hormones in order to meet the 
demands of the pregnancy also mean that the metabolic activity of the placenta is 
extremely high. The outcome of this high metabolism is the generation of large 
amounts of reactive oxygen species (ROS). The placenta is therefore considered to 
be in a constant state of mild oxidative stress (Myatt and Cui, 2004, Wu et al., 2016), 
which may predispose it to dysfunction in the event of additional environmental 
stressors. This concept will be further developed in Chapter 6.  
1.4.3 Foetus 
Foetal growth and development is a complex process determined by the foetal 
genome and is influenced by environmental factors (e.g. the availability of nutrients 
and oxygen to the foetus, maternal nutrition and stress). The process is orchestrated 
by various growth factors and hormones of maternal, foetal and placental origin 
(Murphy et al., 2006). Hormones such as insulin, insulin-like growth factors (IGF) 
and glucocorticoids act as maturational signals in utero, directing foetal metabolism, 
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tissue development and differentiation according to the prevailing intrauterine 
conditions (Gicquel and Le Bouc, 2006, Fowden and Forhead, 2009). During late 
pregnancy, there is also a glucocorticoid surge in foetuses which promotes organ 
maturation, especially lung maturation, in preparation for extrauterine life (Venihaki 
et al., 2000, Fowden et al., 1998). In rats, this surge is contributed by both 
production of corticosterone from the foetal adrenal gland (Dupouy et al., 1975, 
Milkovic et al., 1973b), as well as changes in the placenta.  
Within the foetal brain itself, cellular processes involved in the development of the 
nervous system include proliferation, migration, neuronal differentiation, 
synaptogenesis, myelination and apoptosis of neurones, also involving the glial cells 
(i.e. microglia, astrocytes, and oligodendrocytes) (Rice and Barone, 2000, Stiles and 
Jernigan, 2010). Neurotransmitters are expressed in the nervous system at a very 
early stage of embryogenesis, and in comparison to their role in synaptic 
transmission in adulthood, during foetal life they act instead as morphogens that 
facilitate the growth of neurones, mediating the development of these 
neurotransmitters systems (Herlenius and Lagercrantz, 2004, Rice and Barone, 
2000). Other morphogens include growth factors and steroid hormones also act in 
this narrow temporal window to ensure that brain regions are correctly organised 
and connected. Disruption of any aspect of this precisely orchestrated and pre-
determined developmental trajectory may result in lasting organisational changes, 
acting as the precursor for disrupted brain function and behaviour later in life.  
The specific role of steroids in foetal development, especially in late pregnancy in 
the rat (and a few other animal models), will be thoroughly reviewed and examined 
in Chapter 5. Despite differences between the rodent and human brain, analogous 
structures which are responsible for sensory, motor and cognitive functions can be 
identified (Semple et al., 2013). The sequence of neural development is comparable 
among the two species, although processes occur on considerably different time 
scales (Bayer et al., 1993). 
Although the placenta and maternal steroid hormones play a role in controlling foetal 
growth, it should be emphasised that the foetus itself has an independent capacity 
to modulate its own development, and also to further modulate signals from the 
placenta. For instance, sex steroids and glucocorticoids are produced by the foetal 
gonads and adrenal glands. In the rat foetal brain and liver, 11β-HSD enzymes are 
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also expressed to control local concentrations of glucocorticoids (Diaz et al., 1998). 
Therefore, the foetal compartment should not be viewed as merely an acquiescent 
receiver of environmental signals from the maternal and placental component, but 
also an active contributor in the shaping of the pregnancy and its own growth and 
development. 
1.5 Gestational stress  
The physiological response to an acute stressor was introduced in section 1.2.1, 
and it was recognised in section 1.2.2 that chronic or traumatic stressors can cause 
allostatic overload, leading to pathology. Section 1.4 then briefly introduced the 
alterations in maternal physiology to ensure a successful pregnancy. These 
pregnancy-specific changes (e.g. hypoactivation of the maternal stress response, 
development of the placenta) therefore becomes the new “physiological norm”. Any 
deviation from this “physiological norm”, for instance by constant or prolonged 
stress, may culminate in the dysregulation of neuroendocrine systems, leading to 
compromised pregnancy outcomes (Lobel et al., 2008, Coussons-Read, 2013). 
These outcomes can affect both the mother and the developing child, and can range 
from immediate effects that endanger the pregnancy or health of the mother (e.g. 
preterm birth, miscarriage or gestational diabetes/hypertension), to more subtle 
compromises that may only present themselves later in life (e.g. postnatal 
depression in the mother, or a risk for mood disorders in the offspring in adulthood) 
(Coussons-Read, 2013, Sandman et al., 2012, Wadhwa, 2005).  
In this section, the DOHaD concept is revisited again, and the effects of gestational 
stress on offspring outcomes in later life will be briefly summarised, with a particular 
focus on the rodent prenatal social stress model utilised in this thesis. Known or 
proposed mechanisms mediating these negative outcomes are then covered, 
focusing on two aspects: (i) mechanisms underlying the “programmed” behavioural 
phenotypes in the adult offspring, and (ii) mechanisms underlying how the stress is 
being transmitted from mother to foetus (i.e. foetal “programming”).  
1.5.1 Modelling gestational stress in the rat 
Gestational stress in humans: 
Gestational stress in humans can involve many different kinds of stressors that 
range from malnutrition, mental and metabolic disorders, to the exposure to 
Chapter 1: General introduction 44 
environmental toxins (Lefmann and Combs-Orme, 2014, Coussons-Read, 2013). 
Studies in the past have relied upon data collected from populations experiencing 
natural or man-made disasters such as periods of famine, extreme weather 
conditions, or war (Lumey et al., 2011, Liu et al., 2016a, King and Laplante, 2005). 
However, these events tend to be a rare occurrence, and the form of chronic 
stressors that the majority of pregnant women face on a day-to-day basis are far 
subtler, are inherently more complex, and additionally have various social and 
psychological components (Epel et al., 2018).  Questionnaires have thus been 
designed to assess these forms of “pregnancy-specific stress”, which are 
recognised as a separate entity from distress faced by normal populations, owing to 
different physiology and also the social circumstances surrounding it (Lobel et al., 
2008). They include stress arising from physiological changes, relationship strains, 
anxiety about labour and delivery, and concerns about the baby’s health etc. (Lobel 
et al., 2008, Dunkel Schetter, 2011). Physiological indices such as cortisol, blood 
pressure or heart rate reactivity are often also used as correlates of maternal stress 
(De Weerth et al., 2007, Entringer et al., 2010). Nonetheless, due to ethical 
concerns that render it difficult to manipulate stressful conditions in humans, these 
studies are generally correlative and observational in nature, and the causal 
mechanisms underlying how offspring programming occurs remain largely unclear 
(Dipietro, 2012). 
Animal models of gestational stress: 
The molecular and cellular mechanisms altered by gestational stress can be better 
studied using animal models, which allows for experimental manipulation of the 
type, magnitude, and extent of the gestational stress. Animal models that have been 
used include rodents, with rats generally more popular a model than mice 
(Ellenbroek and Youn, 2016), as well as sheep (Barry and Anthony, 2008, Yawno et 
al., 2007), guinea pigs (Morrison et al., 2018, Kapoor and Matthews, 2005), pigs 
(Jarvis et al., 2006) and non-human primates (Schneider et al., 2001, Meyer and 
Hamel, 2014).  
Immobilisation or restraint stress, ranging from a duration of 30 min to 6 hr, has 
been the most popular stressor used in rodents (Buynitsky and Mostofsky, 2009). In 
fact, one of the first studies regarding prenatal stress in rodents was carried out 
before the clinical DOHaD studies, in the 1970s where prenatal restraint stress was 
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used to study sexual differentiation of the rat foetus (Ward, 1972). Since then, it has 
been favoured by many groups due to its simplicity and also because it allows for 
the easy collection of blood samples from the immobilised dam to track hormonal 
changes across the stressful period. Over the years, other types of experimental 
models of stress have been used in prenatal stress research, including exposure to 
adverse environments (e.g. cold stress, hypoxic environment), fear-based stressors 
(e.g. predator odour, noise stress), or social stressors (Patchev and Patchev, 2006). 
Chronic variable stress, where the pregnant rat is exposed to a combination of 
different stressors randomly, is also commonly used by many groups, as the 
unpredictable nature of the stressor circumvents habituation of the stress response 
(Koenig et al., 2005). 
Prenatal social stress model in rat: 
In this thesis, maternal social stress was used as the stress paradigm, as it has 
good translational value and can better reflect the stressors likely to be encountered 
by pregnant women (e.g. bullying, lack of social support, social pressures or 
instability, domestic abuse) (Dunkel Schetter, 2011). In animal studies, social stress 
during pregnancy has been found to have effects in a range of other non-human 
mammals such as rats, mice, voles and monkeys (Kaiser and Sachser, 2005). 
Social stress is defined as stress that is elicited by a conspecific, and examples 
include social defeat, social submissiveness, establishment of a social hierarchy, 
aggressiveness or overcrowding (Pryce and Fuchs, 2017).  
Social defeat via the resident-intruder paradigm is one way to induce social stress 
and it is usually applied to male rodents (Koolhaas et al., 2013). As female rats are 
not inherently aggressive, in order to apply this paradigm to female rats, lactating 
female rats nursing PND2-8 pups are used as “residents”, as they tend to strongly 
defend the home cage when encountered with an intruder (Rosenblatt et al., 1994, 
Bosch et al., 2004). In this modified resident-intruder paradigm, pregnant “intruder” 
rats were placed into the home cage of lactating “residents” for 10 min per day on 
GD16-20 (Brunton and Russell, 2010) (Chapter 2). Each specific lactating “resident” 
is also only exposed to the same “intruder” once to prevent habituation of responses 
in both the residents and intruders. 
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1.5.2 Effects of chronic gestational stress on offspring outcomes in later life 
1.5.2.1 Human studies:  
Empirical evidence from epidemiological studies linking chronic gestational stress to 
poor offspring outcomes are the foundations on which the DOHaD model was built 
on. In summary, gestational stress can result in negative impacts for the offspring 
across the life course, beginning in infanthood (e.g. difficult temperament), persisting 
through childhood and adolescence (e.g. attention-deficit hyperactive disorder, 
emotional problems, conduct disorder, learning difficulties, higher risk of autism 
spectrum disorder), and into adulthood (higher risk of schizophrenia, depression and 
anxiety) (Van den Bergh et al., 2017, Coussons-Read, 2013, Graignic-Philippe et 
al., 2014, Glover et al., 2010). It has been proposed that many of these conditions 
have underlying HPA axis dysregulation, assessed by measuring salivary or plasma 
cortisol and ACTH, either basally or in response to a mild stressor (e.g. the Trier 
Social Stress Test) (Glover et al., 2010, Entringer et al., 2009). It is however, not 
known if neuroactive steroids could underlie the observed HPA axis dysregulation. 
Alterations of immune function, increased incidence of asthma and allergy, and 
increased risk for metabolic disorders such as diabetes and obesity have also been 
reported (Entringer et al., 2012, Flanigan et al., 2016).  
Alongside behavioural alterations, imaging studies also reveal that offspring of 
anxious mothers also exhibit changes in brain structure and function during 
childhood and adolescence (Buss et al., 2010, Mennes et al., 2009, Charil et al., 
2010). On a molecular level, there is evidence of epigenetic changes in the offspring 
(Palma-Gudiel et al., 2015), as well as changes in telomere biology, where 
prenatally stressed children show lower birth weight and have shorter leukocyte 
telomere length (Entringer et al., 2011). In general populations of patients with mood 
disorders, there is evidence that basal plasma neuroactive steroid concentrations 
are altered, in pathological disorders such as gestational depression and 
premenstrual dysphoric disorder (Girdler and Klatzkin, 2007, Hellgren et al., 2014), 
although the relationship between these disorders and prenatal stress were not 
investigated in those same populations.  
The mechanisms underlying the increased general susceptibility to psychopathology 
in prenatally stressed offspring also have not been fully elucidated. Even though 
children of gestationally stressed parents may show increased risk, they may be 
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affected in different ways, or some may not be affected at all, and these 
observations are likely to be confounded by other factors like gene-environment 
interactions or social factors (O'Donnell et al., 2014, Glover et al., 2010). Casual 
links between maternal stress and specific outcomes can therefore be better studied 
using animal models, where such factors can be better controlled.  
1.5.2.2 Animal models:  
In animal models, the evidence that prenatal stress can lead to deleterious effects in 
the offspring has also been unequivocal. The wide-ranging effects of prenatal stress 
in the rat model have been summarised by many researchers (Weinstock, 2017, 
Brunton, 2013, Boersma and Tamashiro, 2015). Several reviews have also 
discussed animal studies alongside human clinical studies, where many parallels in 
terms of outcomes can be drawn (Bock et al., 2015, Kofman, 2002). Similar to that 
observed in human populations, adult offspring from prenatal stress animal models 
show behavioural phenotypes such as heightened anxiety-like behaviours, 
enhanced or prolonged stress responses, greater occurrence of depressive-like 
behaviours, learning and memory deficits and altered social interactions to name a 
few (Weinstock, 2017). 
Dysregulated HPA axis responses to acute stress, especially, have been reported in 
prenatally stressed offspring using different maternal stress paradigms (McCormick 
et al., 1995, Vallee et al., 1997, Henry et al., 1994, Maccari et al., 1995, Darnaudery 
and Maccari, 2008). In the brain, several changes underlie the PNS phenotype, 
including modifications of dendritic architecture or neuronal connectivity, changes in 
receptor subunit expression, or alterations in levels of neurotrophic factors (Boersma 
and Tamashiro, 2015, Weinstock, 2017). Metabolic outcomes of prenatal stress, 
such as diet-induced obesity, hypertension, cardiac dysfunction, and insulin 
resistance are also common (for reviews see (Vickers, 2011, Bertram and Hanson, 
2001, Marciniak et al., 2017).  
In these studies, striking sex differences are often also observed (Weinstock, 2007, 
Bale, 2011). Studies suggest that prenatally stressed male rats are more susceptible 
to various forms of psychopathology (Cheong et al., 2016, Van den Hove et al., 
2013), however, this is not always the case, especially when only a few groups have 
directly compared the effect of prenatal stress in males versus females using similar 
testing and assessment paradigms (Weinstock, 2017).  
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Similarly, it is worth noting that there has also been considerable variability in terms 
of the nature of the outcomes, despite animal models (especially inbred rodent 
strains) having very similar genetic make-up. Even the same stress exposure 
carried out in different laboratories can result in different offspring effects, whilst 
morphological changes in the brain may not always be correlated to the same 
behavioural outputs (Weinstock, 2017), For instance, even when an identical 
stressor was used in Sprague-Dawley rats, one group found an increase in anxiety-
like behaviour only in the male offsrping (Zuena et al., 2008), whereas others found 
an anxiety effect only in females (Schulz et al., 2011, Van den Hove et al., 2014). 
Stress responses are often very sensitive to even the smallest of changes in the 
environment, and various factors can affect outcomes, including the type and 
duration of stressor, the genetic background of the animal, the gestational period 
when stress is experienced, and postnatal influences, such as variations in maternal 
care (Weinstock, 2017, Boersma and Tamashiro, 2015). Given this inherent 
variability, the next section narrows down some of the factors that may cause 
variability, summarising the impact of prenatal stress from only the social stress 
model used in this thesis.  
1.5.2.3 Rodent prenatal social stress model 
The prenatal social stress model has been used to study the impacts of prenatal 
stress in the Brunton lab for several years, and a number of behavioural phenotypes 
and neurophysiological features have been characterised in the adult offspring 
(Brunton and Russell, 2010, Brunton and Russell, 2015, Grundwald et al., 2016, Lai, 
2016). In summary, there is strong evidence for altered HPA axis function, increased 
anxiety-like behaviour, and learning and memory deficits in adult prenatally stressed 
(PNS) offspring, and these altered phenotypes show a distinct sex-specific 
expression pattern (Fig 1.7). 
Effects of PNS on offspring response to acute stress and HPA axis function: 
Both the male and female PNS offspring exhibit greater plasma ACTH and 
corticosterone responses to systemic IL-1β administration (a physical stressor that 
activates the immune system) or 30 min restraint stress (both psychogenic and 
physical stressor). The peak response is increased, indicating increased activation 
of the HPA axis, and responses are prolonged, possibly indicating impaired negative 
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feedback control and slower termination of the HPA axis (Brunton and Russell, 
2010, Brunton et al., 2015). These are further elaborated in Chapter 4. 
The greater ACTH and corticosterone in the circulation is accompanied by changes 
in the brain, which are also dependent on sex of the offspring. In PNS males, there 
was elevated CRH and AVP mRNA expression in the mpPVN is elevated and 
POMC expression in the anterior pituitary is increased compared to control; whilst in 
the PNS females, this was accompanied by only greater CRH mRNA expression in 
the PVN (Brunton and Russell, 2010). Nonetheless, this implies that there is 
increased excitatory drive to the HPA axis at the level of the PVN in both male and 
female PNS offspring. Underlying mechanisms for the increased drive remain 
unknown, although stronger activation of NTS neurones, which projects directly to 
the CRH-producing mpPVN neurones via noradrenergic signalling, is a possibility 
(Cunningham and Sawchenko, 1988, Rinaman, 2011).  
Secondly, an imbalance in central MR and GR mRNA expression has been reported 
(Brunton and Russell, 2010, Lai, 2016), which suggests regulation of the HPA axis 
via negative feedback mechanisms could be impaired. MR mRNA expression is 
significantly reduced in the hippocampus of both male and female PNS offspring 
compared to same sex control offspring (Brunton and Russell, 2010, Lai, 2016). 
Although GR expression is largely unaffected in the PVN or hippocampus (Brunton 
and Russell, 2010), reduced GR expression is found in the medial prefrontal cortex 
(mPFC) in PNS offspring, which has a role to play in negative feedback inhibition of 
the HPA axis (Sullivan and Gratton, 2002, Lai, 2016). GR expression in the central 
amygdala (CeA) of male PNS offspring is also increased (Brunton and Russell, 
2010), which is relevant as glucocorticoid signalling in the amygdala activates the 
HPA axis (Herman et al., 2005). GR signalling in the CeA may also mediate feed-
forward effects within amygdala regions, leading to enhanced stress excitability and 
sustained CRH, ACTH and corticosterone release (Myers et al., 2012, Schulkin et 
al., 1998, Cook, 2002). 
Thirdly, there is evidence that neuroactive steroid production may be compromised 
in PNS offspring, as lower 5α-reductase type 1 gene expression is found in some 
brain areas, such as the NTS (Brunton et al., 2015). Moreover, administration of 
GABAA-modulatory steroids (e.g. allopregnanolone and 3β-androstanediol to female 
and male PNS offspring respectively) can rescue dysregulated HPA axis responses 
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to stress (Brunton et al., 2015), suggesting that deficient endogenous production of 
neuroactive steroids may underlie HPA axis hyperactivity in PNS offspring. How 
specific neuroactive steroids may act in discrete regions of the brain to affect the 
HPA axis will be further examined in Chapter 4.  
Effects of PNS on anxiety and depression: 
A sex-specific effect of prenatal social stress on anxiety-like behaviour in the 
offspring has been reported (Brunton and Russell, 2010). Only PNS males were 
affected, exhibiting more anxious-like behaviour than control offspring in both the 
light-dark box (LDB) and on the elevated plus maze (EPM), two tests commonly 
used to assess anxious behaviour in rodents (elaborated in Chapter 6).  
The anxiety phenotype may be explained by changes in the CRH system in the 
amygdala, which is important for regulating anxiety-like behaviour (Smagin et al., 
2001, Steimer, 2002). There are two major CRH systems in the brain, one in the 
PVN, and the other in the amygdala/BNST circuitry (reviewed in (Babaev et al., 
2018)). An increase in CRH in the amygdala is usually associated with increased 
anxiety, as transgenic mice with CRH overexpression (van Gaalen et al., 2002, 
Stenzel-Poore et al., 1994) and rats which received lentiviral administration of CRH 
mRNA both show greater anxiety (Flandreau et al., 2012). Experiments from 
receptor knockout mice conclude that effects of CRH on CRH receptor type 1 (CRH-
R1) promotes anxious behaviour (Smith et al., 1998), while action through the CRH 
receptor type 2 (CRH-R2) reduces anxiety behaviour (Kishimoto et al., 2000). In the 
PNS offspring of this rat social stress model, greater CRH-R1 mRNA expression is 
observed in the CeA and basolateral amygdala (BLA); while lower CRH-R2 mRNA 
expression is observed in the basomedial amygdala (BMA), which may explain the 
behavioural observations (Brunton et al., 2011). In female PNS rats, whilst no 
anxious phenotype is observed, there is increased CRH-R1 in the medial amygdala 
(MeA) and CRH-R2 in the BMA (Brunton et al., 2011).  
Other than CRH, inhibitory neurotransmission via GABA also plays a key role in 
anxiety disorders. It is thus possible that alterations in GABA subunit expression, or 
concentrations of GABA modulators (e.g. neuroactive steroids) in the amygdala may 
contribute to the behavioural phenotype (Nuss, 2015, Babaev et al., 2018), although 
it has never been directly investigated in this model. One of the aims of this thesis is 
therefore to pursue these two lines of evidence (in Chapters 6 and 4, respectively). 
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Moreover, depression and anxiety are generally known to be co-morbid, and HPA 
axis dysregulation is generally also associated with a depressive phenotype, yet this 
has also not been investigated in this PNS model. Another aim of this thesis is thus 
to investigate whether depressive-like phenotypes are observed in the PNS 
offspring (Chapter 6). 
Effect of PNS on learning and memory:  
Male and female PNS offspring are differentially affected, depending on the memory 
task. Male PNS offspring show more deficits in spatial learning and memory tasks 
(Lai, 2016), whilst females are more affected for social memory-related tasks 
(Grundwald et al., 2016). The underlying mechanisms of these deficits also appear 
to be different.  
Spatial learning and memory was tested using the Barnes maze, which consists of 
(i) a learning phase, where rats learn over the course of three days the most efficient 
way to locate an escape box in the maze, and (ii) retention tests, which are carried 
out after a period of time to examine memory retention and recall (Rosenfeld and 
Ferguson, 2014, Barnes, 1979). Both male and female PNS offspring do not appear 
to have spatial learning and memory deficits on the Barnes maze under basal 
conditions when compared to the respective controls (Lai, 2016). However, if male 
PNS rats are subjected to acute stress (using restraint) before the learning 
acquisition period, spatial learning and memory deficits are observed, to a greater 
extent than in control offspring (Lai, 2016). Male PNS rats thus show impaired 
spatial learning, but only under stressful conditions (Lai, 2016). However, as 
opposed to the effects of acute stress, pre-exposure to chronic stress (using a one-
week variable stress regimen), instead improved spatial learning in PNS offspring on 
the Barnes maze, and this was more obvious in the male PNS rats than in the 
female PNS offspring. In terms of a sex difference in control rats, whilst control 
females rats outperformed control males in terms of behavioural flexibility on the 
Barnes maze without any stressors, these females instead show more deficits than 
the male controls when acute and chronic stressors are applied (Lai, 2016). 
By using a specific MR antagonist, it was also found that the underlying 
mechanisms of this spatial learning deficit may be linked to decreased MR 
expression in the hippocampus (Lai, 2016, Brunton and Russell, 2010). In offspring 
which exhibited better performance on the Barnes maze following chronic stress, 
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there was also an accompanying elevation of MR hippocampal mRNA in the 
chronically stressed PNS animals (Lai, 2016). This additionally shows the complex 
interaction between prenatal stress, acute stress and chronic stress.  
In the social memory test however, most of the deficits were observed in female 
PNS offspring and not males (Grundwald et al., 2016). The social memory test 
probes for the social recognition and memory of a conspecific and will be described 
further in Chapter 6. Under basal conditions, PNS females exhibit an impairment in 
social olfactory memory in comparison to control females (Grundwald et al., 2016). 
Acute stress exposure immediately prior to the social memory test, on the other 
hand, markedly improved the social memory performance in PNS females (no effect 
was observed in the male offspring). The social memory deficit was associated with 
lower vasopressin receptor type 1a (AVP-R1a; Avpr1a) mRNA expression in the 
anterior part of lateral septum and in the BNST (Grundwald et al., 2016). Improved 
social memory in the PNS females following acute stress is also accompanied by 
elevated AVP-R1a mRNA expression in both of these regions. Non-social olfactory 
memory, which involved recognition of spices, was not affected in either sex.  
Together, these data demonstrate that performance of PNS offspring in different 
types of learning and memory tests is dependent on the brain region involved in 
performing the test, the sex of the animal, and can be further modulated by acute 
stress and chronic stressors.  
Effects of PNS on reproductive traits: 
Prenatal social stress also results in subtle differences in the reproductive axis of 
male offspring, resulting in longer anogenital distances and higher plasma follicular 
stimulating hormone (FSH) concentrations, with a trend towards increased plasma 
testosterone concentrations compared to controls (Ashworth et al., 2016). In PNS 
females, no alterations in the primary follicles or ovarian aromatase expression, and 
no differences in plasma progesterone were observed when compared to control 
female offspring (Ashworth et al., 2016, Brunton and Russell, 2010). These data 
suggest that the developing male reproductive axis is more sensitive to maternal 
stress than females, and increased FSH and testosterone may suggest that prenatal 
stress may enhance aspects of male reproductive development (Ashworth et al., 
2016).  
Chapter 1: General introduction 53 
Prenatal stress also did not have any significant effect on maternal behaviour of the 
female PNS offspring when they became mothers, as the total time spent in 
behaviours such as pup retrieval, pup licking or grooming, arched back nursing were 
unchanged compared to controls (Grundwald, 2016).  
Effects of PNS on glucose homeostasis and peripheral metabolism 
Apart from the brain, offspring from socially stressed dams also show alterations in 
indices related to glucose metabolism and lipid homeostasis, which may indicate 
susceptibility to metabolic disease (Brunton et al., 2013). The effects are also sex-
specific, where male PNS offspring exhibit increased glucose production in 
response to acute restraint stress; while females show poorer glucose tolerance and 
produce excessive levels of insulin following an oral glucose load (Brunton et al., 
2013). Moreover, there is also a sex-dependent change in the expression pattern of 
genes involved in glucocorticoid and lipid metabolism (Brunton et al., 2013). Males 
show changes mostly in the liver and skeletal muscle, whereas in females the 
majority of changes are observed in subcutaneous fat, which may indicate 
differential risk for metabolic dysfunction between the sexes (Brunton, 2013). 
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Figure 1.7: Summary of known behavioural and neurochemical characteristics 
of adult offspring for the prenatal social stress model. Summarised from the 
work of: Brunton and Russell, 2010, Brunton and Russell, 2015, Grundwald et al., 
2016, Lai, 2016, Brunton et al., 2013, Ashworth et al., 2016. Blue: applies to males, 
in red: applies to females. ↑ denotes an increase in PNS, ↓ denotes a decrease in 
PNS, -- denotes no difference. Abbreviations: MR: mineralocortcoid receptor, GR: 
glucocorticoid receptor, POMC: pro-opiomelanocortin, PVN: paraventricular nucleus 
of the hypothalamus, LDB: light-dark box, EPM: elevated plus maze, CRH-R1 and 
R2: CRH receptor 1 and 2, PFC: prefrontal cortex, CeA: Central amygdala, MeA: 
Medial amygdala, BLA: Basolateral amygdala, NTS: nucleus of the solitary tract, Icj: 
the islands of Calleja, BNST: bed nucleus of the stria terminalis, LS: lateral septum, 
3β-diol: 3β-androstanediol, AVP-R1a: vasopressin receptor type 1a, FSH: follicular 
stimulating hormone. Ppar: peroxisome proliferator-activated receptor, Pepck: 
phosphoenolpyruvate carboxykinase, Atgl: adipose triglyceride lipase, Dgat2: 
diglyceride acyltransferase 2, 11βHSD1: 11β-hydroxysteroid dehydrogenase type 1, 
Pgc1a: peroxisome proliferator-activated receptor gamma coactivator 1α   
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1.5.3 Mechanisms mediating “programmed” offspring outcomes in later life 
A common theme to emerge in the outcomes of prenatally stressed offspring in later 
life is HPA axis dysregulation, which underlies many of the mood and affective 
orders described in the offspring (both human studies and animal models). 
Alterations in HPA axis functioning represents an allosteric state (section 1.2.2), 
which implies increased vulnerability to environmental challenges of any kind, 
increasing the risk of psychopathology, thus can also be considered an adverse 
outcome in itself (Huizink and de Rooij, 2018). The mechanisms underlying 
dysregulation of the HPA axis is multi-faceted (section 1.2.2) and some of the 
underlying processes pertinent to the prenatal social stress model have been 
covered in section 1.5.2. Here, other mechanisms that may underlie the aberrant 
phenotypes in the “programmed” offspring are introduced. 
Imbalance of excitatory and inhibitory signals 
HPA axis activation and inhibition are controlled by complex glutamate and GABA 
neurotransmitter pathways, which allows for the communication between different 
brain regions (section 1.2.1.2) (Herman, 2013). In rats, prenatal restraint stress 
increases glutamate transport in the hippocampus and reuptake in the frontal cortex 
of adult offspring (Adrover et al., 2015), and these rats also exhibit higher levels of 
NMDA receptors in frontal cortex, striatum and hippocampus compared to control 
rats (Berger et al., 2002). Moreover, subunit expression patterns of the NMDA 
receptor in the hippocampus are altered, which seem to contribute to anxiety-like 
behaviour in prenatally stressed rats (Sun et al., 2013, Kinnunen et al., 2003). 
Prenatal stress can alter inhibitory circuits, especially GABAergic circuits within and 
projecting to the hypothalamus, which are critical for regulating HPA axis reactivity 
(Fine et al., 2014). Subunit composition of GABAA receptors may also be altered in 
limbic regions following prenatal stress in rats and mice (Laloux et al., 2012, 
Jacobson-Pick et al., 2012). Whether or not some of these changes also occur in 
the prenatal social stress is not known and will be investigated in Chapter 6. 
The role of neuroactive steroids 
Altered excitatory or inhibitory neurotransmission may also be an indirect outcome 
of disrupted neurosteroidogenesis (section 1.3.6) (Brunton et al., 2015), which 
seems plausible given that the HPA axis hyperactivity and behavioural dysfunction 
associated with prenatal stress can be ameliorated by the administration of GABAA-
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modulating neuroactive steroids during adulthood in rat studies (Zimmerberg and 
Blaskey, 1998, Brunton et al., 2015). However, due to the difficulties associated with 
measuring steroids in brain tissue, only a few studies have attempted to directly 
quantify neuroactive steroid concentrations in the brain. Following the optimisation 
and development of a LC-MS method for the quantification of a panel of steroids in 
the brain, an investigation of whether neuroactive steroid production may be 
affected by prenatal stress, and if it underlies offspring behavioural phenotypes, is 
carried out in Chapter 4. 
Neuroanatomical changes 
In both rodent (Soares-Cunha et al., 2018, Mychasiuk et al., 2012) and human 
(Sarkar et al., 2014) studies, there is evidence for neuroanatomical changes 
especially in the limbic regions of the brain of PNS offspring, which may underlie 
aberrant behaviour (Lupien et al., 2009). Using a prenatal restraint stress model in 
the rat, a reduced number of granule cells in the hippocampus of adult female PNS 
offspring is observed, which could be a predisposing factor for the development of 
depression (Schmitz et al., 2002). There is also evidence of decreased 
neurogenesis in the rat hippocampus of offspring following prenatal stress, which 
could be linked to decreased learning and memory performance (Fatima et al., 
2019, Lemaire et al., 2000). Dendritic morphology of neurones are also found to be 
altered in PNS rats, where there are reduced dendritic length and branching of 
neurones within hippocampal, prefrontal cortex and striatal regions, which can then 
affect neurotransmission (e.g. dopaminergic transmission in the nucleus accumbens 
of the striatum) (Mychasiuk et al., 2012, Martinez-Tellez et al., 2009).  
It has been proposed that these changes arise from prenatal stress altering 
organisation of neuronal circuits of the neocortex and hippocampus during early 
brain development, thereby influencing the course of experience-dependent 
synaptic changes in later life (Mychasiuk et al., 2012). It is not known if 
neuroanatomical changes are altered in offspring of the social stress model, 
however some of these possible alterations will be investigated in Chapter 6. 
Epigenetic mechanisms 
Lastly, altered phenotypes in prenatally stressed offspring may involve epigenetic 
mechanisms (Meaney et al., 2007). Epigenetic “marks” are modifications on DNA, 
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such as DNA methylation and histone modifications, which provide a means through 
which gene expression can be altered (Kundakovic and Jaric, 2017, Zucchi et al., 
2013). There is evidence that early prenatal stress in mice results in increased 
methylation of the GR promoter in the hippocampus of adult male offspring (Mueller 
and Bale, 2008). The methylation status of the GR promoter in cord blood 
mononuclear cells of 3 month old infants is also found to be increased if they were 
born to depressed mothers (Oberlander et al., 2008). Studies utilising synthetic 
glucocorticoids during guinea pig pregnancies have indicated that profound changes 
in DNA methylation, acetylation, and gene transcription begin in the foetal 
hippocampus (Crudo et al., 2013a), but specific patterns may change as the 
offspring develops (Crudo et al., 2013b). Therefore, maternal stress can be thought 
of as leaving an epigenetic ”mark” that is imprinted on the offspring genome during 
the foetal stages, which can either persist or be subsequently altered throughout the 
offspring’s life. These epigenetic marks thereby define the offspring’s behavioural 
phenotypes and also the vulnerability for diseases over their lifespan (Meaney et al., 
2007, Cao-Lei et al., 2017) 
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1.5.4 Mechanisms mediating the transmission of stress signals from mother to 
foetus 
A large majority of the research regarding the impact of chronic gestational stress 
has been focussed on the offspring outcomes (section 1.5.3). However, the 
mechanisms underlying the transmission of stress signals are also not fully 
understood. This section details some of the known mechanisms postulated to 
mediate the transmission of stress signals from the mother to foetus, reviewed in 
(Maccari et al., 2014, Boersma and Tamashiro, 2015, Brunton, 2013, Rakers et al., 
2017). Mechanisms which usually involves all three components of the maternal-
placental-foetal triad.  
During stress in pregnancy, the mother plays an important role as the stress 
response is often maternally-initiated, especially in the case of psychological or 
social stress. Despite attenuation of the maternal stress axis during late pregnancy, 
as reviewed in rat studies in (Johnstone et al., 2000, Douglas et al., 2003, Brunton 
and Russell, 2008a) (section 1.4.1), the stress response is not completely abolished 
and stressful stimuli still results in the engagement of the maternal SNS and HPA 
axis and production of stress mediators (section 1.2.1). As the maternal and foetal 
blood systems do not mix, the maternal-foetal transfer of these mediators need to be 
facilitated by the placenta (Sadovsky and Jansson, 2015). These mediators can 
either cross the placenta directly, or lead to indirect changes in the physiology of the 
placenta (e.g. by affecting placental transport capacity or changing its endocrine 
function), which consequentially alters foetal physiology. Downstream effects of 
these mediators are also dependent on how the foetus interprets or modifies the 
signals, for instance through the metabolism of these mediators, or by controlling 
receptor expression for these mediators. Permanent changes may be induced in the 
foetus, or its physiology may be modified in a way that it increases its vulnerability to 
disease only in the event of a second hit in adulthood (Huizink et al., 2004). 
Glucocorticoid programming: 
Glucocorticoids, the end product of the HPA axis, are lipophilic and are often 
assumed to readily diffuse across the placental barrier into the foetal compartment 
(Cottrell and Seckl, 2009). Excessive glucocorticoid production from the maternal 
adrenal glands may therefore result in detrimental effects in the offspring, and this 
process is known by many as glucocorticoid programming, one of the key 
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mechanisms underpinning foetal programming (Barbazanges et al., 1996, Holmes et 
al., 2006, Seckl and Meaney, 2004, Cottrell and Seckl, 2009, Drake et al., 2007).  
Two lines of evidence support this hypothesis, firstly, treatment with a synthetic 
glucocorticoid (e.g. dexamethasone) during pregnancy results in offspring having 
similar phenotypes to those prenatally stressed, observed from rat, human and 
guinea pig studies (Welberg and Seckl, 2001, Kapoor and Matthews, 2005), and 
secondly, maternal adrenalectomy, which prevents the production of maternal 
glucocorticoids, abrogates some of the effects of prenatal stress, observed in the rat 
model (Barbazanges et al., 1996).  
However, these experiments do not provide a full mechanistic picture of how 
glucocorticoid programming occurs, as synthetic glucocorticoids do not truly mimic 
the action of maternal endogenous glucocorticoids like corticosterone and cortisol, 
as they are not a substrate for 11β-HSD2 and thus can cross the placenta freely, 
bypassing one of the natural “lines of defence” during pregnancy. Adrenalectomy 
also abrogates other compounds that may be secreted by the adrenal glands during 
stress (for instance, catecholamines from the medulla) and completely changes the 
HPA axis of pregnant dam, which may additionally confound the conclusions drawn 
from that experiment. Therefore, in as much as the effects of glucocorticoid 
programming is indisputable, how exactly maternal stress-induced programming 
occurs still remains much of an enigma in the field. Much of the focus has turned 
onto investigating the three endogenous lines of defence which serve to limit foetal 
overexposure to acute increases glucocorticoids (summarised in Fig 1.8), and 
whether they could be compromised in the event of chronic maternal stress.  
There is evidence that chronic stress may affect the first line of defence, the 
maternal HPA axis in both rodents and in human populations, for instance, through 
disruption of negative feedback mechanisms, such that there is an elevated or 
prolonged production of plasma glucocorticoids (i.e. HPA axis is no longer 
hyporesponsive) (Takahashi et al., 1998, Duthie and Reynolds, 2013). Regardless, 
it is worth noting that even if maternal stress responses are dampened, responses 
are not completely abrogated and glucocorticoids are still produced whenever the 
stressful stimuli is present. As such, the integrity of the second line of defence, 
placental 11β-HSD2, may play an even more crucial role (Seckl et al., 1990, Seckl, 
2017). Indeed, it has been found that increased levels of stress in pregnant mice 
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and rats results in significantly reduced activity and mRNA expression of placental 
11β-HSD2, which could mean compromised ability to inactivate excess maternal 
corticosterone, allowing for increased corticosterone transfer (Welberg et al., 2005, 
Mairesse et al., 2007, Jensen Peña et al., 2012). In humans, maternal distress 
(measured by the Perceived Stress Scale) is associated with increased methylation 
of the HSD11B2 gene in the placenta, which leads to downregulation of 11β-HSD2 
mRNA and protein expression (Monk et al., 2016b). Lastly, there is also evidence 
that the rat foetus can produce glucocorticoids itself following stress (Ohkawa et al., 
1991a), adding complexity to the mechanisms of glucocorticoid programming. 
Therefore, in as much as glucocorticoids are recognised in the field as playing a role 
in the transmission of stress signals, gaps still remain, especially regarding how or 
the extent of which it occurs. Chapter 5 aims to further investigate whether some of 
these protective mechanisms are compromised in the gestational social stress 
model, thereby leading to aberrant offspring outcomes. 
 
Figure 1.8: Three lines of endogenous defence against glucocorticoid 
overexposure. To recap, the first line of defence lies in the mother, where the HPA 
axis response to stress is dampened, and there is a reduced amount of ACTH and 
glucocorticoids produced following an acute stressor. Secondly, there is substantial 
expression of 11β-HSD2 in the placenta, which converts corticosterone/cortisol to 
their inactive 11-keto form, serving as the “glucocorticoid barrier” to control the 
maternal-foetal glucocorticoid transfer (Benediktsson et al., 1997). Lastly, in the 
foetus, 11β-HSD1 and 11β-HSD2 are expressed in the foetal tissues including the 
brain, and 11β-HSD2 serves as the third line of defence to further regulate local 
concentrations of glucocorticoids (Seckl, 1997, Chapman et al., 2013). 
Compromises in any of these lines of defence may result in foetal glucocorticoid 
exposure, leading to detrimental outcomes.  
 
Chapter 1: General introduction 61 
Catecholamines: 
The sympathetic nervous system is also attenuated in pregnant rats, especially for 
adrenaline production following acute stimuli. Adrenaline production is decreased in 
pregnant as compared to non-pregnant women in response to heat stress (Vaha-
Eskeli et al., 1992) and similarly, adrenaline responses are subdued in pregnant 
mice in response to air puff startle (Russell et al., 2008), although underlying 
mechanisms remain unknown. In both studies however, noradrenaline responses 
are not attenuated (Vaha-Eskeli et al., 1992, Brunton and Russell, 2015, Russell et 
al., 2008).  
Noradrenaline is a potent vasoconstrictor which reduces blood flow via activation of 
α-adrenergic receptors present in the uterine and the placental vasculature (Rakers 
et al., 2017, Resch et al., 2003). There has been ample evidence in the sheep that 
an acute physical or psychological stressor can rapidly reduce uterine blood flow 
(Rakers et al., 2015, Dreiling et al., 2016). Chronic stress may further affect 
noradrenaline breakdown or reuptake, decreasing the capacity of the placenta to 
clear noradrenaline, and hence further reducing utero-placental perfusion (Piquer et 
al., 2017, Blakeley et al., 2013). This reduced utero-placental perfusion can 
potentially alter foetal metabolism by decreasing nutrient transfer and/or gaseous 
exchange, leading to foetal hypoxia or undernutrition (Gu et al., 1985, Gu and 
Jones, 1986). Consequently, this foetal hypoxia and nutrient restriction may then 
activate the foetus’ own HPA axis, which in turn contribute to the foetal programming 
of HPA axis responsivity and anxiety-like behaviour in the adult offspring (Brunton, 
2013, Nunez et al., 2008, Fan et al., 2009, Edwards and McMillen, 2002).  
Oxidative stress: 
Psychological stress is known to result in increased oxidative stress, both in humans 
and in rodents (Brunst et al., 2017, Picard and McEwen, 2018b, Irie et al., 2001). In 
humans, elevated markers of oxidative damage are observed with increased work 
stress in females (Irie et al., 2001); while in rodents, oxidative status is significantly 
increased in the brain, blood cells, heart, liver, and spleen following acute restraint 
stress (Spiers et al., 2016, Chen et al., 2014). 
Although a moderate increase in maternal oxidative stress status is one of the 
physiological adaptations of pregnancy (Myatt and Cui, 2004, Burton and Jauniaux, 
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2011), constant or severe stress may tip this mild oxidative state over to one that 
causes adverse pregnancy outcomes. In clinical studies, increased oxidative stress 
status is correlated with lower birth weight and higher incidences of preterm delivery 
(Weber et al., 2014). This is also supported by the observation that maternal 
antioxidant administration in rats (e.g. hydrotyrosol and docosahexaenoic acid, 
DHA) can prevent deleterious offspring outcomes associated with gestational stress 
(Zheng et al., 2015, Feng et al., 2012). 
In contrast to maternal stress hormones such as glucocorticoids, pro-oxidant 
molecules generally act as intracellular signalling molecules and do not have 
endocrine properties (Schieber and Chandel, 2014), and are unlikely to be directly 
transferred across the placenta due to their instability (Munro and Pamenter, 2019). 
Hence pro-oxidants probably act through an indirect mechanism via altering 
placental physiology (e.g. placental morphology, structure, function, or gene and 
protein expression patterns) (Sferruzzi-Perri and Camm, 2016). Antioxidants on the 
other hand, can be transferred to the foetal circulation (Kaempf-Rotzoll et al., 2003), 
but have similarly been found to exert some of their beneficial actions through 
altering placenta function in the sheep (Thakor et al., 2010) and rat (Richter et al., 
2009). Oxidative stress as a potential mechanism of stress signal transmission in 
the prenatal stress model will be further explored in Chapter 6. 
Immune system and cytokines: 
It has also been proposed that the maternal immune system and the maternal 
release of cytokines may play a significant role in transferring psychological stress 
signals to the foetus. Cytokines are polypeptides that act as mediators of cellular 
signalling, modulating many processes involved in inflammation (Elenkov and 
Chrousos, 2002). Although there is a degree of immune suppression in human 
pregnancies in order to prevent rejection, the immune system is generally regarded 
to be modulated rather than attenuated (Mor and Cardenas, 2010), as there is still 
evidence that chronic psychosocial stress during pregnancy may result in an 
increase in maternal plasma pro-inflammatory cytokines (e.g. IL-6 and TNF-α) and 
poorer infant outcomes (Gustafsson et al., 2018, Coussons-Read et al., 2007). As 
for the maternal-foetal transfer mechanism, some cytokines (e.g. IL-6) have been 
found to be able to cross the placental barrier from the maternal to foetal circulation 
in the rat (Dahlgren et al., 2006). In mice, maternal immune activation can also 
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trigger placental production of IL-6 and release directly into the foetal circulation 
(Hsiao and Patterson, 2011). Cytokines are extremely important for neurogenesis 
and also the development of glial cells during foetal brain development (Deverman 
and Patterson, 2009). Alteration in levels of cytokines in the foetal compartment 
therefore can disrupt normal brain development in rat and human foetuses 
(Ratnayake et al., 2013). Cytokines can also interact with the stress response 
system by further stimulating the HPA axis and promoting glucocorticoid release, 
thereby contributing to glucocorticoid programming (Silverman and Sternberg, 
2012).  
Serotonin (5-HT) system 
It has been suggested that psychosocial stress by crowding during rat pregnancy 
increases maternal plasma tryptophan (precursor of serotonin) concentrations, 
together with elevated foetal brain levels of tryptophan, serotonin, and 5-
hydroxyindoleacetic acid (5-HIAA; breakdown product of serotonin) (Peters, 1990). 
Given that serotonin is crucial for normal placentation and normal brain development 
during embryonic, foetal as well as postnatal stages, in both rat and human studies, 
the stress-induced increase of serotonin and 5-HT metabolites in the foetal brain 
may therefore interfere with developmental processes (Bonnin and Levitt, 2011).  
Neuroactive steroids 
Neuroactive steroids are modulatory in nature, which imply that they can further 
modify any of the mechanisms mentioned above. In the foetus, increases in 
allopregnanolone production following acute stress, such as hypoxia, and has been 
proposed to represent an endogenous neuroprotective mechanism in the foetal 
sheep to acute stressors (Nguyen et al., 2004). It is possible that chronic stress-
induced changes in the mother could impair this endogenous protective mechanism 
in the foetal brain, especially when it has been shown that synthetic corticosteroid 
administration to the guinea pig foetus suppresses expression of the enzymes 
involved in neurosteroidogenesis (McKendry et al., 2010). Allopregnanolone 
treatment in the mother during late gestation was also able to reduce the deleterious 
effects of prenatal stress on the offspring in rats, again suggesting that reduced 
allopregnanolone levels during pregnancy could be an underlying factor contributing 
to adverse developmental outcomes (Zimmerberg and Blaskey, 1998).  
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Maternal behaviour of stressed dams 
Lastly, prenatal stress may also lead to changes in the maternal brain that can affect 
post-partum maternal care (Champagne and Meaney, 2006). Although the post-
partum period is not a key focus of this thesis, maternal care is known to affect the 
growth and development of the neonate’s HPA axis postnatally.  
The period of HPA axis hyporesponsiveness in the rat neonate is maintained by the 
dam's behavioural interaction with the pups, as 24 hr separation from the mother 
results in the deprived neonate having elevated basal levels of corticosterone, and 
exhibiting a robust corticosterone and ACTH response to stressors (Levine, 2002). A 
lower frequency of licking and grooming of the pups by the dam also leads to a more 
anxious phenotype in the offspring during adulthood, coupled with a hyperactive 
HPA axis (Liu et al., 1997). Altered maternal-pup interactions can therefore be a 
mechanism that can affect postnatal brain development, and similar to in utero 
stress, can consequently produce long-lasting alterations that extends into 
adulthood, again fitting into the DOHaD framework (Kalinichev et al., 2002, Wigger 
and Neumann, 1999). In children, early neglect can impact the development of brain 
circuitry that regulate stress and emotional function, increasing the likelihood of 
psychopathology (Bremner and Vermetten, 2001, Gunnar and Quevedo, 2007).  
For the mother, the transition between pregnancy to the post-partum period also 
requires significant physiological and behavioural changes, and gestational 
stressors could alter these adaptive processes, leading to poorer maternal care. For 
instance, stress during pregnancy is known to decrease the expression of licking 
and grooming behaviour in rats and mice, which can in turn affect development of 
the neonatal HPA axis (Champagne and Meaney, 2006). Moreover, gestational 
stress can result in sustained production of elevated levels of corticosterone during 
the postnatal period in rat dams, which may further affect maternal behaviour 
(Pfister and Muir, 1989). These lines of evidence provide an alternative view that 
gestational stress can indirectly lead to programming effects in the offspring not only 
in utero, but indirectly via changes in postnatal maternal behaviour and maternal 
care. Nonetheless, unpubished observations from the Brunton lab indicate no 
significant differences in maternal care following exposure to social stress during 
pregnancy, suggesting this does not explain the altered phenotypes observed in the 
offspring.  
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1.6 Specific aims and hypothesis:  
Thus far, the introduction has identified some gaps that are present in the field of 
foetal programming and the developmental origins of health and disease (DOHaD), 
and briefly pointed out in each section how this work aims to address them. The 
general aims of this work can be classified into three main themes, and is 
summarised in Fig 1.9, with the specific aims elaborated below.  
Aim 1: To develop a liquid chromatography-mass spectrometry (LC-MS) method to 
quantify a panel of steroids, especially those that are involved in modulating stress 
responses. These include corticosterone, the final output of the HPA axis, and its 
precursors (e.g. DOC), and inactive metabolite 11-DHC. Other important steroids 
considered include the GABAA positive modulators allopregnanolone and THDOC 
due to their anxiolytic nature and their role in attenuation of the stress response, and 
their respective precursors (e.g. DHP and progesterone; DHDOC and DOC). The 
method also aimed to include several sex steroids (e.g. progesterone, oestradiol, 
and testosterone and its metabolites DHT, 3α-androstanediol and 3β-
androstanediol) which may be informative in accounting for the sex differences in 
the response to stress (Chapter 3). 
Aim 2: To investigate the factors mediating prenatal “programming” of the offspring, 
i.e. the mechanisms that are transmitting the stress signals from the mother to 
foetus, at GD20. Specific questions include: 
1. Are glucocorticoids involved in the transmission of maternal stress to the 
foetuses? (Chapter 5) 
2. Are there altered steroid levels (in the placenta and foetal tissues) following 
social stress? (Chapter 5) 
3. Is there a role for oxidative stress in mediating the transmission of stress signals 
during pregnancy? (Chapter 6) 
Aim 3: To investigate the mechanisms underlying the expression of prenatally 
“programmed” phenotypes in the adult offspring. Specific questions include: 
1. Do PNS offspring exhibit HPA axis hyperactivity in response to acute swim 
stress? (Chapter 4)  
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2. Are there differences in neuroactive steroid production between control and PNS 
offspring, under basal conditions and in response to acute swim stress? 
(Chapter 4)  
3. Do PNS offspring express depressive-like phenotypes? (Chapter 6)  
4. Are there other morphological and neurochemical changes in the brain of PNS 
offspring that may underlie altered behaviour? (Chapter 6)  
This work first begins with the development of an LC-MS technique to quantify 
steroids in the brain (Chapter 3), which allows for the testing of several hypotheses 
related to aims 2 and 3.  
It is first hypothesised that changes in concentrations of neuroactive steroids in the 
brain and periphery of adult PNS offspring is a mechanism that underlies their 
aberrant behaviours and physiology, such as HPA axis dysregulation (Aim 3; 
Chapter 4). Secondly, focussing on events occurring during the pregnancy, it is 
hypothesised that prenatal stress leads to a compromise in the protective functions 
of the placenta (e.g. decreased 11β-HSD2 expression), and subsequently increased 
glucocorticoid exposure in the foetus (Chapter 5). Nonetheless, as the mechanisms 
regulating the transmission of stress from the mother to foetus is complex, it is also 
hypothesised that other mechanisms such as a decrease in neuroactive steroid 
concentrations in foetal tissues (also Chapter 5), or an increased oxidative stress 
status in the placenta (Chapter 6) can contribute. Finally, it is also hypothesised that 
interventions during pregnancy, such as maternal antioxidant treatment (Chapter 6), 
may be a viable method to prevent detrimental outcomes associated with prenatal 
stress in the offspring.  
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Fig 1.9: Summary of thesis aims.
Aim 2: How is the stress transmitted from mother to foetus?
Aim 2: How is the stress transmitted from mother to foetus?
Adult offspring
Aim 3: What are the mechanisms 
underlying offspring phenotypes?
Glucocorticoids transfer? (Chapter 5)
Regulation by neuroactive steroids? (Chapter 5)
Oxidative stress? Altered placenta function? (Chapter 6)
Neuroactive steroid production? (Chapter 4) 
Other morphological and neurochemical changes? 
(Chapter 6) 
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This chapter first provides a list of all the in vivo, in vitro, molecular and chemical 
techniques used to achieve the three aims mentioned in the introductory chapter 
(Table 2.1). It then elaborates on some of the common techniques that are utilised 
repeatedly in this work (e.g. animals used, stress paradigm used, tissue collection, 
in situ hybridisation, LC-MS), whilst techniques that are unique to each chapter will 
be detailed in the relevant chapters. Although a finalised LC-MS method for steroid 
quantification is included in this chapter, the optimisation and validation of the 
method, which forms a substantial part of the thesis, will be presented in Chapter 3.  
 
Chapter Summary of the techniques used 
3 1. Liquid chromatography-mass spectrometry (LC-MS) 
quantification of steroids 
a. Optimisation of the method 
b. Validation of the method 
c. Application of the method 
 
4 1. Prenatal social stress  
2. Acute swim stress (adult offspring) 
3. Conscious decapitation and tissue collection  
4. Dissection of brain regions  
5. LC-MS quantification of steroids 
 
5 1. Prenatal social stress 
2. Conscious decapitation and tissue collection  
3. LC-MS quantification of steroids 
4. In situ hybridisation 
a. Placenta: 11β-HSD2, GR 
b. Foetal brain: 11β-HSD1, 11β-HSD2 
5. Western blotting (placenta, 11β-HSD2) 
 
6 1. Prenatal social stress  
2. Intravenous administration of antioxidants to pregnant rat 
3. Behavioural tests 
a. Anxiety (light-dark box and elevated plus maze) 
b. Depression (Forced swim test and sucrose 
preference test) 
c. Social memory test 
4. Assessment of HPA axis dysregulation  
a. Surgery 
b. Acute restraint stress 
c. Blood collection 
5. Radioimmunoassay (plasma corticosterone and ACTH) 
6. In situ hybridisation 
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a. Placenta: 11β-HSD2 
b. Adult and juvenile brain: CRH 
7. CO2 overdose and tissue collection 
8. Conscious decapitation and tissue collection  
9. Oxidative stress assay  
10. Ex vivo placental culture and in vitro neuronal culture 
11. LC-MS quantification of steroids 
 
 
Table 2.1 Overview of all techniques used in this thesis. Techniques that are 
common to all chapters are underlined and are detailed in this chapter.  
 
2.1 Animals  
All animal experiments were carried out in the Roslin Institute Biological Resource 
Facility, approved by the Institute’s Animal Welfare and Ethical Review Body and 
performed in accordance with the UK Animals (Scientific Procedures) Act 1986 and 
the European Directive (2010/63/EU). Sprague-Dawley (SD) rats were used for all 
experiments.  
Female SD rats were purchased from Charles River (Margate, Kent, UK) and were 
acclimatised to the facility for at least a week before any procedures. Rats were 
group-housed (4 females) in individually ventilated cages (IVCs). Female rats that 
were intended to be used as aggressive lactating dams (i.e. to induce social stress) 
arrived in the facility one week before the experimental batch, were heavier (250 – 
300 g) as compared to the experimental dams (200 – 225 g). Rats were maintained 
on a 12:12 hr light-dark cycle (lights on at 07:00 hr), under controlled temperature 
(22oC) and humidity (55%). Rats were provided with food and water ad libitum, and 
pregnant and lactating dams were given a 50:50 mixture of 14% and 19% protein 
diet (Harlan Teklad). 
For mating, one female was housed in a breeding cage with a wire mesh with one 
sexually experienced male (either bred within the facility or also purchased from 
Charles River). Mating was confirmed by the presence of a semen plug in the 
breeding cage the following morning, and this was designated as gestational day 
(GD) 1. Females were returned to same sex group-housing until GD16 (for 
experimental dams) where they were transferred to single IVCs. For lactating 
aggressive “residents”, they were group housed until GD21, where they were 
transferred to individual open top cages in a separate room in the animal facility.  
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Following parturition, both dam and pups were left largely undisturbed except for 
routine husbandry. Pups were not cross-fostered, and were checked for litter size 
and weights at postnatal day (PND) 0, PND 8 and PND 23. Pups were weaned and 
separated by sex at PND 23 into IVCs. Depending on the litter size, sex ratio, nature 
of the experiments, as well the age and weights of the rats, the number of animals in 
each cage at any one time (from after weaning through to adulthood) varied from 4 
to 10. Rats were never individually housed unless otherwise stated. 
Three cohorts of pregnant rats were generated for the purposes of the thesis, the 
details of which are briefly outlined below. Detailed experimental design for each 
cohort of rats will be elaborated in the corresponding chapters.   
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Pregnant rats were exposed to 
5 days of gestational stress 
from GD16-20 and gave birth 
to offspring. 
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Pregnant dams were 
administered antioxidant or 
saline at GD16, exposed to 5 
days of gestational stress 
(GD16-20), and gave birth to 
offspring. 
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administered antioxidant or 
saline at GD16, underwent 5 
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before birth on GD20. 
 
Effects of gestational 
stress on foetal 
physiology was 
investigated on GD20. 
 
 
Chapter 5 and 
Chapter 6 
Table 2.2: Overview of three cohorts of pregnant rats used for this thesis 
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2.2 Prenatal stress/ Resident intruder paradigm 
A modified resident-intruder paradigm was carried out as described in (Brunton and 
Russell, 2010). Aggressive lactating dams (i.e. “residents”) were generated by 
mating them one week ahead of the experimental dams. Lactating dams were 
housed individually in open-top cages two days before parturition and throughout 
lactation, in a separate room from experimental pregnant rats. Experimental 
pregnant females (“intruders”) were transferred to the home-cage of the “residents”, 
for 10 min each day from GD16 to GD20, between 10:00 – 14:00. Experimental 
pregnant dams (“intruders”) were always paired with an unfamiliar lactating 
“resident” each time to prevent habituation. Behaviours were observed and manually 
scored (where biting – 1 point, biting and pinning down – 2 points, biting and 
tumbling over – 3 points) to monitor severity of the encounters. Latency to the first 
attack was also recorded. Experimental pregnant dams were returned to their IVCs 
immediately after the 10 min social stress, except for experiments where tissues 
were collected on GD20, where pregnant dams were immediately killed after the 10 





Figure 2.1: Resident intruder paradigm and examples of attacks. A) Pregnant 
‘intruder’ introduced into the home cage of the aggressive lactating ‘resident’. B) 
Lactating ‘resident’ pinning down and biting the face of the pregnant ‘intruder’. C) 
Lactating resident pinning down and biting torso of pregnant ‘intruder’. D) Pregnant 
intruder assuming a submissive position following a bout of attack.  
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2.3 Killing and tissue collection  
At the end of procedures, killing was carried out either by conscious decapitation or 
CO2 overdose for tissue collection for ISH and LC-MS. As CO2 inhalation and other 
forms of inhalation anaesthesia are known to act as acute stressors that alter the 
concentrations of neuroactive steroid in brains of rats (Barbaccia et al., 1994, 
Barbaccia et al., 1996, Taves et al., 2011), conscious decapitation was carried out if 
neuroactive steroid concentrations needed to be determined. In both cases, killing 
was carried out in a “post-mortem” room separated from the experimental or 
housing rooms, and rats were rapidly transferred from housing/experimental rooms 
to the “post-mortem” room using a transport container. Killing was carried out 
between 10:00 – 14:00 each day. 
For conscious decapitation, the killing of the rats was carried out swiftly by placing 
the rats in a pliable plastic cone and were decapitated with a guillotine immediately. 
The loss of consciousness following decapitation occurs rapidly (within seconds) 
and is humane (van Rijn et al., 2011). Trunk blood was collected from rats following 
conscious decapitation, into chilled collection tubes containing 0.5 ml of 0.5% (w/v) 
EDTA kept on ice. For CO2 overdose, rats were placed in a chamber with a rising 
concentration of CO2 until respiration ceases (process takes approximately 3 min) 
and were decapitated to confirm death and to remove the brain. 
In all cases, the brain was rapidly and carefully removed from the skull. The process 
involves chipping away the bone using rongeurs, starting at the back of the skull (the 
foramen magnum), over the cerebellum and forward towards the eyes (Paul et al., 
2008). Once the brain is exposed, the meninges were carefully removed, olfactory 
bulb is severed and the cerebellum and brainstem were separated from the rest of 
the brain by cutting along the transverse fissure. The brain is gently pried away from 
the base of the skull with a spatula, the optic and trigeminal nerves severed with 
scissors and transferred onto a piece of foil for freezing on dry ice, or directly into 
15% sucrose in 4% paraformaldehyde in the case of fixed brains. Killing with 
perfusion is described in Chapter 6.  
In Chapters 5 and 6, where pregnant rats were decapitated, placenta and foetuses 
were also collected. A ventral midline incision was made on the torso of the 
decapitated pregnant dam, through the subcutaneous layer and peritoneum, and the 
uterus was pulled out of the abdominal cavity. Foetuses were rapidly removed from 
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the amniotic sacs, detached from the placenta by cutting of the umbilical cord. Upon 
determination of sex (on the basis of anogenital distance), foetuses were 
decapitated using scissors and trunk blood was collected using EDTA-coated 
capillary collection tubes (Microvette CB 300 µL, Sarstedt, Germany). Foetal trunk 
blood were collected from all foetuses and were pooled by sex within a litter due to 
the small volumes of blood that could be obtained, and were kept on ice once 
collected. Foetal brains were carefully removed from the skull using scissors and a 
spatula and were laid out on foil. The placentae were gently dabbed on clean tissue 
to remove excess blood and the maternal decidua was removed. Samples of 
maternal and foetal liver were also collected in 1.5mL Eppendorf tubes. 
Brains, placenta and liver were frozen on dry ice or in liquid N2, and stored at -80oC 
until further use. At least three placenta and foetal brains per sex were collected for 
each litter (total of 7-8 litters per treatment group). One male placenta, one female 
placenta, one male brain, one female brain per litter were then picked at random for 
in situ hybridisation, while another similar set consisting one of each were picked at 
random for homogenisation for LC-MS. Both maternal and foetal trunk blood were 
centrifuged at 1500 g for 20 min at 4oC, and the plasma was separated, aliquoted 
into fresh tubes and stored at either -80oC or -20oC until further use in 
radioimmunoassays or LC-MS analysis.  
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2.4 In situ hybridisation 
In situ hybridisation (ISH) was carried out to investigate mRNA transcript expression 
in tissue sections. Radioactive ISH used in this thesis is based on the principle of 
complementary binding of a radiolabelled nucleic acid probe to specific target 
sequences of DNA or RNA in fixed tissue, followed by visualisation of the 
radioactive signal. Single-stranded RNA probes were used in this study. The 
advantage of ISH is that it provides information about the mRNA expression of 
single cells in its true anatomical location, which is especially helpful given the 
cellular heterogeneity present in the brain (Carter et al., 2010). The hybridisation 
signal in the form of silver grains is also fairly permanent, and can be visualised on 
bright-field light microscopy without the need for confocal microscopy.  
The ISH process carried out in this thesis using riboprobes incorporating 35S-labeled 
UTP has been carried out routinely in the laboratory and was first published in 
(Brunton et al., 2009). An overview of the ISH process, which requires generation of 
probes, hybridisation, and the detection and analysis of signal is provided in Fig 2.2. 
Briefly, following propagation, plasmids containing cDNA of the gene of interest 
were linearised and purified. Using this linearised template, radioactive probes were 
then synthesised via RNA transcription, where 35S–UTP were incorporated into 
probes. Radioactive probes were then hybridised with tissue sections on slides 
(section 2.4.3), which have been cut, fixed and pre-treated beforehand (section 
2.4.1). Hybridised probes were then exposed to radiosensitive emulsion before 
development and counterstaining (section 2.4.4).  
Prior to the ISH experiment, all stainless steel equipment, slide racks, and 
glassware were heat-sterilised in a 200oC oven and all surfaces were sprayed with 
an RNAse Surface Decontaminant (RNAse Away, ThermoFisher, UK) to reduce 
RNAse contamination. Diethylpyrocarbonate (DEPC; from Sigma UK) treated 
ultrapure water (ddH2O) and 0.1M PBS were autoclaved before use. All steps were 
performed at room temperature (RT) unless otherwise stated. 
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Figure 2.2: Schematic showing a summary of the ISH process. 
 
2.4.1 Tissue sections  
Frozen tissue was mounted (but not embedded) on OCT (Tissue-Tek) and 16µm 
sections were cut using a cryostat at -19oC (Leica CM1850), then thaw-mounted on 
Polysine adhesion slides (ThermoScientific). Rat brains were cut coronally, and 
relevant regions in the adult and juvenile rat (i.e. the amygdala) were identified with 
the help of marker sections (collected every 16th section) stained with toluidine blue, 
referenced to a stereotaxic brain atlas (Paxinos and Watson, 2007). Foetal brains 
were cut at the level of the hippocampus with the help of an atlas for the developing 
rat brain (Paxinos et al., 1994). Placenta were cut transversely, so that the junctional 
zone and labyrinth layer were represented in each section. Marker sections were 
collected on gelatine subbed slides (1% gelatine with chromium), and fixed with 
acetic alcohol fixative (4% w/v formaldehyde and 5% v/v acetic acid in ethanol) and 
stained with 1% toluidine blue for visualisation. Tissue sections on slides were 
stored in -80oC until processing for ISH.  
2.4.2 Generation of riboprobes  
Plasmid propagation: Plasmids containing an ampicillin-resistance gene and target 
DNA sequences inserted into the multiple cloning region were obtained from various 
sources, detailed in the relevant chapters. Plasmids were transformed and 
propagated using HB101 competent cells (Promega, UK). Ampicillin-resistant 
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colonies were cultured overnight, and then purified using the Qiagen HiSpeed 
plasmid midi kit as per manufacturer’s instructions. DNA concentration of the 
purified plasmids were then quantified using a NanoDrop ND-1000 
spectrophotometer, after which plasmid DNA was aliquoted and stored at -20oC. 
Propagation of the plasmids were carried out by Mrs Helen Cameron (for CRH and 
GR) and Ms Joana Fernandes (for 11b-HSD1 and 11b-HSD2). 
 
Linearisation of plasmid DNA: Plasmid cDNA was linearised using restriction 
enzymes. Restriction enzymes for each of the different probes are detailed in the 
relevant chapters. Additionally, plasmid cDNA were incubated with different 
restriction enzymes to generate antisense or sense probes. Antisense probes, which 
are complementary to and therefore will hybridise to mRNA transcripts of interest, 
are the probes used in the quantification of target mRNA expression. Sense probe 
sequences, on the other hand, are identical to the mRNA sequence of interest and 
will not bind, and were used as negative controls. Additionally, a double digest 
reaction was also set up, where both restriction enzymes were incubated with the 
DNA as a diagnostic method to verify insert size.  
 
Purification of linearised DNA: Linearised cDNA (for both sense and antisense 
digests) were purified using phenol chloroform extraction, where equal volumes of 
phenol/chloroform/isoamyl alcohol (Sigma, UK) was first added to the solution 
containing linearised plasmid and the mixture was vortexed and centrifuged (13000 
rpm, 5 min). The top layer was removed and then extracted again by the addition of 
an equal volume of chloroform/isoamyl alcohol (Sigma, UK), and were vortexed and 
centrifuged as above. The top layer was collected again and precipitated with 2 
volumes of ethanol and 1/10th volume of 0.5 M NaCl on dry ice for 10 min. After 
centrifugation, the pellet was air-dried and resuspended in 15 µL of DEPC-treated 
ddH2O. Purified linearised cDNA (for both antisense and sense probes), and the 
double digests were separated by agarose gel electrophoresis, to check for the 
insert size, integrity of the plasmid cDNA and to ensure complete linearisation, 
without contaminants or supercoiled DNA. Linearised cDNA were then quantified 
using the NanoDrop before being RNA transcribed. 
 
Synthesis of 35S riboprobes via RNA transcription: Riboprobes were generated by 
transcription of the linearised cDNA, using RNA polymerases which initiates RNA 
Chapter 2: General methods 80 
synthesis at the specific promoters. Transcription was carried out using the 
Promega Riboprobes System kit as per manufacturer’s instructions. Linearised 
cDNA template (2 ng in 2 µL) was added to solution containing 4 µL of 5X 
transcription-optimised buffer, 4 µL mixed bases (containing 2.5 mM each of ATP, 
GTP and CTP), 5 µL of 35S-UTP (Perkin-Elmer #NEG039, 0.46 MBq/µL), 2 µL of 
100mM DTT, 1 µL of RNAse inhibitor (2500U/ml, RNasin, Promega), 2 µL of 
appropriate RNA polymerase and incubated for 2 hrs. Following transcription, 2 µL 
DNAse was added and incubated at 37oC for 15 mins, to degrade the cDNA 
template. To remove unincorporated nucleotides, the solution underwent size-
exclusion chromatography using Illustra NICK Columns (GE Healthcare Life 
Sciences, Little Chalfont, UK). Purified 35S-UTP labelled riboprobes were eluted in 
400 µL TE buffer solution (1M Tris, 500 mM EDTA at pH 7.4). 1 µL of the eluted 
radioactive riboprobe was aliquoted into 3.5ml scintillation fluid (Optiphase HiSafe 3, 
Perkin Elmer) and the radioactivity (in counts per minute; cpm) was measured in a 
β-scintillation counter. Radioactive riboprobes (both sense and antisense) were 
stored at -20oC until further use. 
2.4.3 Hybridisation  
Tissue fixation: Slides stored in -80oC were pre-selected on dry ice depending on 
the region of interest, with the help of marker sections. 4% (w/v) paraformaldehyde 
(PFA) was prepared a day earlier by dissolving PFA (Sigma) in DEPC-treated 0.1M 
PBS with NaOH pellets, pH adjusted to 7.2-7.4 at RT and chilled overnight at 4oC. 
Sections were first fixed in 4% PFA (in DEPC-treated 0.1M PBS, pH 7.2-7.4) for 10 
min, then washed twice in DEPC-treated 0.1M PBS, all carried out using slide racks. 
Sections were then acetylated in TEA (consisting of 1.5% (v/v) triethanolamine, 
0.25% (v/v) acetic anhydride, pH 3 in ddH2O) for 5 min, then washed twice for 3 min 
in DEPC-treated 0.1M PBS. Sections then underwent dehydration with alcohol of 
increasing concentrations prepared in DEPC-treated ddH2O (50%, 70% and 90%) 
for 2 min each, and then were air-dried before pre-hybridisation.  
Prehybridisation: Pre-hybridisation saturates tissues with buffer before a probe is 
introduced, decreasing the risk of unspecific binding. Slides were pre-hybridised with 
200 µL of 1X prehybridisation buffer in a humidified chamber at 50oC. 
Prehybridisation buffer was prepared and stored as a 2X solution in -20oC and were 
thawed and diluted 1:1 with deionised formamide to form 1X prehybridisation buffer 
(Severn Biotech, UK) on the day of use. 2X prehybridisation buffer consisted of a 
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final concentration of 1.2 M NaCl, 20 mM Tris pH 7.6, 2x Denhardt’s Solution, 2 mM 
EDTA, 1mg/ml salmon testes DNA, 0.25 mg/ml yeast tRNA in DEPC-treated ddH2O 
(all from Sigma, UK). 
Hybridisation: After 2 hr of pre-hybridisation, 1X prehybridisation buffer was drained 
off and the sections were flooded with 200 µL of hybridisation solution containing the 
radiolabelled probe. To prepare the hybridisation solution, probes were added to 1X 
hybridisation buffer, heated for 10 min at 70oC and then briefly cooled on ice before 
adding 0.015% (v/v) 1M DTT. The volume of radiolabelled probe required (from 
section 2.4.2) was calculated based on radioactivity measurements obtained in the 
β-scintillation counter. The hybridisation solution has a final radioactivity of 2.6 x 106 
cpm per 200 µL of solution. Slides were flooded with 200 µL of hybridisation solution 
and incubated in a humidified chamber at 55oC overnight (ca. 18 hr). Hybridisation 
buffer was prepared and stored as a 2X solution, diluted 1:1 with deionised 
formamide (Severn Biotech, UK) into 1X hybridisation buffer freshly before the 
addition of the radiolabelled probe. 2X hybridisation buffer consisted of 1.2 M NaCl, 
20 mM Tris pH 7.6, 2x Denhardt’s Solution (Sigma), 2 mM EDTA, 0.2 mg/ml salmon 
testes DNA, 0.25 mg/ml yeast tRNA, 200 mg/ml dextran sulphate in DEPC treated 
ddH2O (all from Sigma, UK).  
Post-hybridisation RNAse treatment and washes: After overnight hybridisation (18 
hr), the hybridisation solution was drained off and the slides were rinsed in 2X saline 
sodium citrate (SSC), first individually three times, then in a slide rack for another 
three times. 2X SSC consisted of 0.3M sodium chloride and 0.03M sodium citrate in 
ddH2O. 200 µL of RNAse A solution was added to slides, incubated in a humidified 
chamber for 60 mins in 37oC to digest any unbound probes. RNAse A solution is 
prepared using 0.05% (v/v) RNAse A (30-33mg/ml, Sigma) in 0.5 M NaCl, 10 mM 
Tris (pH 7.6) and 1 mM EDTA. Following 60 min of incubation, RNAse A were 
drained off and slides were first rinsed in 2X SSC, once individually, and one 
additional time using a slide rack. Washes were then carried out, where they were 
first incubated in 2x SSC for 30 min RT, followed by more stringent “hot” washes, 
where sections were incubated in 0.1X SSC in a 60oC water bath for 50 min three 
times. After the final wash, slides were dehydrated with increasing amounts of 
alcohol (2 mins each in 50%, 70% and 95% of ethanol in 0.3M ammonium acetate) 
before being air-dried.  
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2.4.4 Detection of radioactive signal  
Emulsion dipping and exposure: Slides were then dipped in molten auto-
radiographic emulsion (Ilford K5 nuclear emulsion, diluted to 70% with ddH2O). 
Emulsion dipping was carried out in a warm water bath (42oC) under safelight 
conditions. Slides were left in a light-proof lead box at RT until dry, then packed into 
slide boxes with desiccants and left to expose in the dark in 4oC. Exposure times 
ranged from 3.5 weeks to 5 weeks, depending on probe. 
Development and staining: Sections were incubated in developer solution (Phenisol 
Developer, Ilford; 6 min incubation) and rinsed in ddH2O before being fixed (Hypam 
Rapid Fixer, Ilford; 2 x 6 min incubation). Following two washes with ddH2O (5 mins 
each), sections underwent haematoxylin & eosin (H&E) counterstaining and 
dehydration on the Leica Autostainer XL, to enable visualisation of cell nuclei. Slides 
were incubated with haematoxylin (30 sec), washed, followed by Scot’s tap water 
substitute (2 min), washed, and lastly with eosin (2 min). After washing, slides were 
then dehydrated through a series of alcohols of increasing concentration (70%, 95% 
and 99%), followed by alcohol/xylene (1:1 v/v) and finally xylene. Slides were 
immediately cover-slipped with DPX mounting media (Sigma, UK) and left to dry 
overnight. 
2.4.5 Image acquisition and data analysis 
Silver grains were visualised with the Nikon Ni1 brightfield microscope and acquired 
as TIFF images using the ZEN 2 blue software (Carl-Zeiss, Oberkochen, Germany). 
Hybridisation was quantified by either positive cell counts or grain density.  
Positive cell counts analysis was carried out at 10X or 20X magnification, and cells 
with grain density >5 times above the background were considered positive. 
Background refers to non-specific hybridisation signal, and was defined as the grain 
density in adjacent brain regions where the gene is not known to be expressed.  
Grain density calculation were carried out in images captured at 20X magnification. 
For the digitisation of the images, white balance was set at automatic for each 
image and exposure was kept consistent across images. Images were saved in 
TIFF format, and converted into 16-bit using Fiji software (ImageJ, NIH, Washington, 
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DC). The “Adjust Threshold” function was used to obtain grain area. The threshold 
was adjusted until only grains were selected but any underlying cells were not, and 
a measurement of the selected area was taken. In order to obtain grain density, the 
threshold was adjusted again for the same image to select for the underlying cells 
and tissues as well (i.e. total area sampled), and a second measurement of the 
selected area was taken. The grain density was calculated as grain area/total area 
with cells sampled. It has been proposed that adjusting the threshold manually for 
each field of view in this manner, rather than using the same threshold 
measurement, gives more reliable results as it accounts for the variations in lighting 
and the staining density of the underlying tissue (Lewis et al., 1989, O'Shea).  
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2.5 LC-MS quantification of steroids  
LC-MS was used for the quantification of steroids in Chapters 4, 5 and 6. The 
optimised LC-MS method is presented here, whilst the validation of the assay with 
quality control standards are presented in section 3.3.4, alongside the details of the 
development and optimisation process.  
2.5.1 Steroid standards 
Standards for corticosterone, 11-DHC, deoxycorticosterone (DOC), 5α-DHDOC, 
progesterone, 5α-DHP, allopregnanolone, pregnenolone, testosterone were 
purchased from Steraloids Inc (Newport, RI, USA) and 3α,5α-THDOC from Sigma 
(Leicester, UK), with catalogue numbers detailed in Table 3.1. All 
solvents/chemicals used were LC-MS grade. Individual steroid standards were 
dissolved in methanol (Honeywell Riedel-de Haën, Germany) into 1 mg/ml stock 
solutions, and were combined and diluted in methanol into a working stock solution 
containing 10 μg/ml of each steroid. Prior to each study, 10 μg/ml steroid standard 
mix was further diluted in 4% BSA into a stock solution containing 250 ng/ml of each 
steroid, and were aliquoted and frozen at -20oC. 
On the day of sample processing, one aliquot of the 250 ng/ml standard mix was 
further diluted 10-fold in 4% PBS, followed by a serial 2.5-fold dilution in 4% BSA to 
produce seven standard calibrants. The calibration standards used ranged from 
102.4 - 25000 pg/ml for all steroid analytes (Table 3.5 and Figure 3.14). Samples 
from the same brain region were always run in the same batch, and each batch of 
samples were processed with seven standard calibrants and a zero sample 
containing only 4% BSA. The deuterated internal standards progesterone-D9 
(Steraloids Inc), allopregnanolone-D5 (Tocris) and corticosterone-D5 (Sigma, 
Leicester, UK) were also diluted and combined from 1 mg/ml stock solution into 50% 
methanol/50% PBS.  
2.5.2 Sample processing 
Sample homogenisation: Frozen tissue samples (brain, placenta or liver) were 
weighed prior to sample processing, and transferred to Eppendorf tubes. For 
standard calibrants and plasma, 100 μL was aliquoted. Samples were homogenised 
in 500 µL of methanol/1% formic acid (FA) and sonicated on ice. For standard 
calibrants and plasma, 400 µL of methanol/1% FA was added. 20 μL of deuterated 
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internal standard mix (25 ng/mL of allopregnanoloned-d5, corticosterone-d4 and 
progesterone-d9; Table 3.1) were added and homogenates were briefly sonicated. 
After incubation on dry ice for 30 min to aid protein precipitation, homogenates were 
centrifuged for 10 min (13000 g at 4oC). The supernatant was decanted into a 
borosilicate tube and the pellet was homogenised and sonicated again with another 
500 µL of methanol/1% FA. After centrifugation, supernatants were combined, then 
diluted with LC-MS grade water to a final concentration of 30% methanol. 
Solid phase extraction: Steroids in both plasma and brain samples were extracted 
by solid phase extraction using DSC-Discovery C18 100 mg columns (Supelco, UK). 
Columns were activated with 1 mL of methanol and equilibrated with another 1 mL 
of 30% methanol. Diluted supernatants from homogenates (ca. 3 mL) were then 
loaded, followed by two 1 mL washes of 40% or 50% methanol (40% methanol if 11-
DHC was quantified). All steps were assisted by centrifugation at 50 g (average flow 
rate of 0.5 mL/min). Steroids were eluted with 1 mL of 85% methanol by gravity flow. 
The collected eluate was dried in a vacuum overnight. Dried samples were stored at 
-20oC until the day of analysis.  
Derivatisation: On the day of LC-MS analysis, 400 μL of freshly prepared 
derivatisation agent (1 mg/mL of Girard’s T reagent, Sigma #89397; dissolved in 
methanol containing 0.2% formic acid) was added to the dried samples. After 
incubation at 37oC for 30 min, the reaction was stopped by the addition of 50 μL of 
5% ammonium hydroxide (ACROS Organics, New Jersey, USA) in methanol. 
Samples were dried in the SpeedVac then reconstituted in 50 μL of 50% methanol. 
The sample was transferred to Chromacol vials (ThermoScientific) for analysis. 
2.5.3 LC-MS/MS analysis 
Analysis of steroids was performed using an Ultimate 3000 Dionex HPLC system 
with a refrigerated autosampler, coupled to an AmaZon ETD ion trap mass 
spectrometer. Full details of the development, optimisation and validation of the 
method used is provided in Chapter 3. Briefly, separation of steroids on reverse 
phase HPLC was achieved on the ACE UltraCore 2.5 µM Super C18 column, 
maintained at 40oC. Mobile phase A consisted of 50 mM ammonium formate pH 3 
and while mobile phase B consisted of methanol with 0.1% formic acid, prepared 
freshly for each batch of analysis. Gradient separation was used, with gradient 
characteristics detailed in Figure 3.10. Steroids were analysed simultaneously using 
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multiple reaction monitoring, with positive electrospray ionisation and collision-
induced fragmentation, and transitions monitored are detailed in Table 3.4. 
Injections for all samples, including calibrants, were carried out in duplicate.  
 
Data was acquired using Hystar software and peak area under curve (AUC) was 
extracted and automatically integrated using QuantAnalysis v2.0 (both from Bruker 
Daltonics). The ratio of the peak AUC of the target analyte and the peak AUC of 
respective internal standards was used to construct the calibration curve. 
Concentrations of samples were extrapolated and converted to ng/mL (for plasma) 
or normalised to the wet weight of the tissues (ng/g; for brain tissues). All runs in this 
thesis are based on the assay performance characteristics documented section 





Figure 2.3: Schematic of LC-MS sample preparation procedure. Adapted from 
supplementary Fig S1 of Sze et al., 2018 (Appendix B). 
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2.6 Data analysis and statistics 
All statistical analysis was performed using GraphPad Prism 6.0 or on R-studio (R 
scripts are attached in Appendix A). Graphical data are presented as group means 
with error bars representing the standard error of the mean (s.e.m.). Individual data 
points have also been overlaid on the bar graphs to show the spread of data and 
variation within a sample group.  
Comparing between two groups  
For the comparison of means between two groups, an unpaired Student’s t-test was 
performed using GraphPad Prism 6.0. F-test for unequal variances was carried out 
and if variances were significantly different, a Welch’s correction was performed. 
Significant differences (p<0.05) are annotated on the graphs, where * p<0.05, ** 
p<0.01, *** p<0.001, whilst t-values and degrees of freedom are reported in the text.  
Comparing between more than two groups: ANOVA 
For comparison of means between more than two groups, where there were two 
independent variables (e.g. prenatal stress status and acute stress in Chapter 4, sex 
and prenatal stress status in Chapter 5, and drug treatment and stress status in 
Chapter 6), two-way ANOVA was carried out using R-Studio (Appendix A). 
Normality and variance were first visually examined by the plotting of graphs of 
residuals, before performing ANOVA. Following which, post-hoc multiple pairwise 
comparisons was performed using the Student Newman Keuls post-hoc testing, also 
using R-studio. F-values and degrees of freedom of two-way ANOVA are reported in 
the text or under the graphs, whilst significant results from the post-hoc multiple 
pairwise comparisons were annotated on the graphs itself, using asterisks for effect 
of the first factor, and hashes for effect of the second factor. Significance level was 
set at 0.05 in all cases. There were instances in this thesis where there were three 
factors are involved in this study (e.g. acute stress, prenatal stress and sex in 
Chapter 4). These were analysed by three-way ANOVA and were also carried out 
using R-studio (Chapter 4, Appendix A and C), in consultation with Dr Crispin 
Jordan of the Centre for Discovery Brain Sciences, University of Edinburgh.  
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3.1 INTRODUCTION 
Given that this thesis is focussed on investigating the role of steroids in prenatal 
programming and stress-related disorders, a fundamental component of such 
studies is the ability to reliably measure steroid concentrations, especially in the 
tissues where they are expected to exert their effects (i.e. the brain). However, the 
physical and chemical nature of steroids and the complexity of biological 
tissues/fluids mean that this process is often fraught with difficulties (Taves et al., 
2011, Wudy et al., 2018, Handelsman, 2017).  
The following chapter first elaborates on the physical and chemical properties of 
steroids and the implications for their reliable quantification. A few common 
techniques in the quantification of steroids are then introduced, and for each case, 
their limitations are also considered. As this thesis relies on LC-MS as the primary 
method for steroid quantification, the basic principles of LC-MS will be explained. 
The chapter then details the process of developing and validating a reliable method 
for the analysis of biological compounds such as steroids using LC-MS. This 
process will then be applied the development of a LC-MS method to quantify a list of 
steroids, namely corticosterone, 11-DHC, DOC, DHDOC, THDOC, progesterone, 
DHP, allopregnanolone, testosterone, DHT, 3α-diol, 3β-diol and oestradiol (briefly 
introduced in Section 1, Aim 1). The chapter then ends with a study involving the 
administration of an acute stressor (i.e. swim stress) to male and female adult rats, 
which is known to increase neurosteroid levels in the brain and plasma, to 
biologically validate the LC-MS method.  
3.1.1 General structure and properties of steroids 
All steroids, natural or synthetic, consist of a four-carbon ring core (three six-carbon 
rings A, B and C; and 1 five-carbon ring, D). All steroids have 21 or fewer carbons, 
and are all derivatives of cholesterol (C27)(Fig 3.1). The first rate limiting step in 
steroid synthesis involves the cleavage of the bond between C20 and C22 catalysed 
by the enzyme p450scc, leading to the removal of 6 carbon atoms from cholesterol 
into pregnenolone (C21) (Fig 3.1) (Berg et al., 2002). Steroid hormones can be 
classified according to the number of carbon atoms they possess and their biological 
function into four major groups, the progestogens (C21), adrenocorticoids (C21), 
androgens (C19) and oestrogens (C18) (Figure 3.2). Within each class, individual 
steroids differ by the location, type and configurations of their functional groups, 
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which determine their overall 3D conformation and their physical and chemical 
properties. These in turn determine their interactions with receptors, co-chaperones 
and enzymes, which ultimately contribute to their biological functions. In the context 
of this chapter, these physical and chemical properties also contribute to the 
complexities in the method used to extract, identify and measure them.  
 
 
Figure 3.1: Side chain cleavage of cholesterol. The first and rate-limiting step of 
neurosteroidogenesis consists of the cleavage of cholesterol (C27) into 
pregnenolone (C21), the precursor of all neuroactive steroids, catalysed by the 
enzyme cytochrome p450 side chain cleavage enzyme (p450scc). Steroidogenic 
acute regulatory protein (StAR) facilitates the transport of cholesterol from outer 
mitochondrial membrane (OMM) into the mitochondrial matrix, where p450scc acts 
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Figure 3.2 The different major classes of steroids. Several of the key steroids 
which are involved in modulating stress responses are selected for quantification in 
this chapter are underlined. They include corticosterone, 11-dehydrocorticosterone 
(11-DHC), deoxycorticosterone (DOC), dihydrocorticosterone (DHDOC), 
tetrahydrocorticosterone (THDOC), progesterone, testosterone, dihydrotestosterone 
(DHT), 3α-androstanediol (3α-diol), 3β-androstanediol (3β-diol), allopregnanolone, 
pregnenolone, and 17β-Oestradiol. Other abbreviations: DHEA, 
Dehydroepiandrosterone; HSD: Hydroxysteroid dehydrogenase, StAR: 
Steroidogenic acute regulatory protein. 
 
All natural steroids have an oxygen function at C3 (Fig 3.3), which could exist as a 
hydroxyl group (C-OH; in the α or β configuration), as a phenolic hydroxyl group 
attached to an aromatic A ring (e.g. in the oestrogens) or as a carbonyl group (C=O) 
where oxygen is double bonded to the C3 carbon (Kasal, 2010). This functional 
group at C3 is of particular interest, due to the metabolic reactions that rely on it, 
catalysed by the enzymes 5α- and 5β-reductase, and 3α- and 3β-hydroxysteroid 
dehydrogenase (HSD). 5α and 5β-reductase targets steroids with a C3 ketone 
group (C=O) and a C4-C5 double bond (i.e. 3-keto-Δ4,5 steroids). The C4-C5 double 
bond is broken and the unsaturated carbonyl group is reduced, which can allows the 
C3 ketone group to be further reduced to a saturated alcohol by 3α- or 3β-HSD. 
These two reactions, illustrated in Fig 3.3, are important in the metabolism of many 
sex hormones and neuroactive steroids. Each of these reactions alter the structure 
of the steroid, and therefore their binding properties to receptors. For instance, the 
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the saturated, 3α,5β-reduced pregnanolone sulfate has a cis junction resulting in a 




Figure 3.3: 5α and 3α reduction of steroids. 5α-reductase targets 3-keto- Δ4,5 
steroids (such as testosterone in this example) with a C3 ketone group (C=O) and a 
C4-C5 double bond, and irreversibly breaks the Δ4,5 bond in a stereospecific 
manner, inserting a hydride ion (H-) at the alpha face of C5 (Jin and Penning, 2001). 
This reduction rearranges the structure of the rings of the steroid, allowing it to be 
further reduced by 3α-HSD into 3α-diol in this case. 
Additionally, the presence of α- and β-configuration, which refer to the functional 
group being below and above the plane of the steroid backbone, means that there 
are four possible stereochemical configurations that can exist for saturated steroids. 
Stereoisomers have the same molecular weight, but differ in their physical and 
chemical properties, which have implications in their biological activity. For instance, 
the spatial configuration of the C5 functional group is especially important for the 
potency of steroids on GABAA receptors and their function as anaesthetics as they 
determine cis-trans isomerism at the A:B steroid rings (Covey et al., 2000). The α 
orientation at C5 yields a A:B trans isomer with a nearly planar structure, whereas β 
orientation gives a A:B cis-isomer with a bent structure (Berg et al., 2002). 
Metabolites with 5α-reduction (e.g. allopregnanolone and 3α,5α-THDOC) generally 
have more potent agonist actions than its 5β-isomer (e.g. pregnanolone and 3α,5β-
THDOC respectively) (Mennerick et al., 2004, Gee and Lan, 1991). Methods used to 
quantify steroids would therefore need to have the selectivity to differentiate these 
stereoisomers.  
Given their hydrocarbon skeleton, another physical property of steroids is that they 
are largely hydrophobic in nature and are therefore found in biological fluids either 
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As mentioned in section 1.3, steroids can bind to corticosterone corticosteroid-
binding globulin (CBG) and sex hormone-binding globulin (SHBG) with high affinity, 
and can also bind non-specifically to albumin, which is present in the plasma in large 
amounts (Makin, 2010). Steroids can also form conjugates by the modification of 
functional groups, such as through the addition of a glucose or sulfate group, which 
renders them more hydrophilic (Makin, 2010). 
These physical and chemical properties have certain implications for the extraction 
and quantification of steroids. Firstly, given their hydrophobicity, steroids are more 
soluble in organic solvents rather than in aqueous solvents, thus their extraction 
solvent needs to be carefully considered. However, their varying degrees of 
hydrophobicity (and therefore solubility in different solutions) may also serve as an 
advantage which may aid their separation and identification, especially in the case 
of LC-MS. Secondly, the existence of binding globulins calls for the need to 
differentiate between “free” and “total” amounts of steroids quantified, which has 
implications for the method of sample processing chosen. 
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3.1.2 Immunoassay methods for quantifying steroids 
The quantification of steroids has traditionally been carried out using 
immunoassays, which includes both radioimmunoassays (RIA) and enzyme-linked 
immunosorbent assays (ELISA). Immunoassays rely on the specificity of antibody 
binding to quantify steroids of interest and can often be conducted without the need 
for extraction or purification of biological fluids. In recent decades, kits that contain 
all the necessary reagents to perform these immunoassays have been developed 
commercially, making them convenient and accessible to researchers (Stanczyk et 
al., 2007).  
However, there are some disadvantages associated with using immunoassays to 
quantify steroids, with the most familiar criticism being the assay’s proneness to 
cross-reactivity (Selby, 1999, Klee, 2004). Antibodies, especially polyclonal 
antibodies, may have varying degrees of specificity for their antigen, and some may 
also bind to molecules other than the target molecule. This can be problematic for 
steroids, due to their close structural similarities. For instance, an antisera against 
progesterone that was generated in rabbits was found to cross-react with its 
metabolites 5α- and 5β-DHP, allopregnanolone, epi-allopregnanolone and epi-
pregnanolone (Murphy and Allison, 2000). Secondly, although multiplexed 
immunoassays have been developed in recent years for other analytes such as 
cytokines, this is not the case for steroids, due to their propensity for cross-reactivity. 
Steroid immunoassays therefore generally do not allow for the quantification of more 
than one type of steroid hormone in a single analysis, which limits the utility of the 
method, especially if a more complete picture of the steroidal milieu is required 
(Taylor et al., 2015). For such instances, detection of steroids using mass 
spectrometry (next section) offers much more potential and is the method of choice. 
Nonetheless, for laboratories with no significant capabilities to own a mass 
spectrometer, immunoassays are accessible and thus still have value in many 
studies today, especially for the routine quantification of single steroids that are 
present in high concentrations in the plasma (e.g. cortisol or corticosterone) (Wudy 
et al., 2018). In this thesis, both immunoassays and LC-MS methods were used, as 
some studies were carried out before the LC-MS method in this chapter had been 
fully developed.  
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3.1.3 Mass spectrometric quantification of steroids 
3.1.3.1 Basic principles of mass spectrometry and chromatography 
Mass spectrometry (MS) separates compounds based on their mass-to-charge ratio 
(m/z). It functions on the basic principle that when a charged particle moves through 
either a magnetic or electric field, the deflection of its path is dependent upon both 
the mass and charge of the particle (i.e. heavier and less charged molecules deflect 
less) (McDonald et al., 2011).  
There are three basic components in a mass spectrometer, (i) the ion source where 
analytes are ionised, (ii) the mass analyser where ions are separated according to 
their m/z ratio, and (iii) the detector and data system where an output is given as a 
graphical form, with ion intensity plotted against m/z ratio. In biological applications, 
tandem mass spectrometry (MS/MS) is often used, where more than one stage of 
mass analysis occurs, adding another level of selectivity in the method (Soldin and 
Soldin, 2009, Kushnir et al., 2005). MS/MS involves the first step of detecting and 
isolating the precursor ion (MS1), then fragmenting it into product ions (MS2) (Fig 
3.4). A common method of fragmentation, especially in small molecule analysis, is 
collision-induced fragmentation, where inert gases such as argon and nitrogen are 
used to break down molecules at weak points in their chemical structure. Different 
molecules of the same molecular mass can fragment differently, and the 
fragmentation patterns can aid the identification of the molecule.  
However, differentiating compounds simply by their m/z, even with fragmentation, is 
insufficient, especially in the case of steroid stereoisomers, as they are likely to have 
the same fragmentation pattern given their similarity in structure (Kushnir et al., 
2005). As such, an additional separation step is often required before introducing 
the sample into the mass spectrometer, e.g. the use of chromatographic 
applications such as gas chromatography (GC) or liquid chromatography (LC). 
Chromatography is the technique of separating components in a mixture, and relies 
on two phases, the “mobile phase” and the “stationary phase” (Hage, 2018). The 
components of the mixture are carried in the mobile phase and interacts with the 
stationary phase, which usually exists in the form of a solid support such as a 
column. Separation is based on the affinity the components have for the mobile or 
stationary phase, and components that interact strongly with the stationary phase 
will move through the column more slowly (Fig 3.5). On the other hand, components 
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which have weaker interactions with the stationary phase will move through the 
system quickly due to lower retention. The resulting outcome is that different 
components of a biological mixture will have different rates of travel through the 
chromatographic system (Hage, 2018). Combinatorial techniques, like GC-MS or 
LC-MS, thus allows for different analytes to enter the mass spectrometer in a time-
staggered manner, before undergoing ionisation and fragmentation as described in 
Fig 3.4. Thus, even if more than one component in the mixture has the same mass 
and fragmentation patterns, they can be differentiated by their distinct retention 
times. By combining the separation power of chromatography, and the selectivity of 
MS, a potentially powerful method can be generated to identify and quantify 




Figure 3.4: Basic principles of tandem MS/MS. Using the example of 
testosterone, which is the precursor ion and has a m/z of 289 and is isolated at 
MS1. Following fragmentation, product ions with m/z 97, 253, and 271 are being 
produced, and the intensity of these product ions are being quantified. These 
product ions are the signature fragmentation pattern of testosterone, and molecules 
that are of m/z 289 but do not fragment in this manner (i.e. contaminants) are 
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Figure 3.5: Basic principles of chromatography. Both GC-MS and LC-MS 
consists of a mobile phase and a stationary phase, and is based on the basic 
principle of differential interactions of different compounds of the analyte with the 
stationary phase.  
 
3.1.3.2 GC-MS quantification of steroids 
In gas chromatography, components of the analyte mixture are vaporised into an 
inert carrier gas which acts as the mobile phase. Separation of components of an 
analyte are based on their volatility and their interactions with the stationary phase, 
usually a solid column or one that is coated with a liquid. More volatile components 
spend more time in the mobile phase, therefore elute more quickly.  
The advent of GC-MS was a major breakthrough in the study and quantification of 
steroids in the 1960s. Although often regarded as the older technique, GC-MS 
technologies are constantly being improved, and optimised GC-MS methods offer 
very good resolution and sensitivity and are widely used in the field of endocrinology 
(Shackleton et al., 2018, Krone et al., 2010). Several published GC-MS methods 
have been used to reliably quantify neuroactive steroids in the brain, where they 
were able to successfully distinguish between structural and stereoisomers with 
good detection limits. For example, using GC-MS, Vallée and colleagues have 
shown that testosterone, DHEA, pregnenolone, allopregnanolone and its isomer 
isoallopregnanolone could be quantified to a level of < 0.5 ng/g in male rat frontal 
cortex (Vallee et al., 2000). Another group has shown that in the rat prefrontal cortex 
and hippocampus, GC-MS methods could similarly detect pregnenolone and 
allopregnanolone at the lowest limit of quantification (LOQ) of 0.5 ng/g in the male 
rat brain (Servatius et al., 2016).  
However, the drawback of GC-MS is that it is labour-intensive, requiring extensive 
sample work-up in order for steroids to become volatile (McDonald et al., 2011, 
Stationary phase (column)Mobile phase
Constant flow of gas 
(GC-MS) or solvent (LC-MS) 
containing vaporised (GC-MS) 
or dissolved (LC-MS) analytes
Different components of the analyte interact with the stationary phase to 
different extents on the basis of volatility (GC-MS) and hydrophobicity (LC-MS), 
therefore have different retention times 
To MS
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Shackleton et al., 2018). Sample derivatisation, which involves chemically modifying 
the analyte to allow for analytes to be vaporised, is an absolute necessity in GC-MS, 
and is often seen as a disadvantage as it increases sample processing time and 
adds considerable variability to the method. The nature of sample processing in GC-
MS also necessitates the hydrolysis of conjugated groups (such as glucoronides 
and sulfates), limiting the use of GC-MS in the study of conjugated steroid 
metabolites (McDonald et al., 2011). As such, this led to the next era in steroid 
quantification, where LC-MS was gradually introduced.  
3.1.3.3 LC-MS quantification of steroids  
LC-MS differs from GC-MS by the use of a liquid solvent as the “mobile phase”, and 
molecules are separated based on polarity differences and its solubility in the carrier 
solvent. In steroid analysis, “reverse phase” LC is the preferred method, where the 
“stationary phase” consists of a LC column containing silica linked to hydrocarbon 
tails (C18), rendering them non-polar/hydrophobic. The speed at which components 
of the mixture travel through the column are based on their hydrophobicity, where 
more hydrophobic components interact more strongly with the material in the 
column, and therefore have longer retention times.  
The most direct advantage of LC-MS is that it allows for the analysis of non-volatile 
compounds, and does not always require sample derivatisation, leading to the 
relative ease of sample preparation. Another advantage of LC is that it consists of a 
high-pressure pump system that is capable of mixing two solvents, therefore has the 
ability to change the mobile phase polarity over the course of the analysis. This 
allows for shorter run times as compared to GC, and also more flexibility in 
determining how analytes of interest are eluted, therefore can be considered to have 
higher throughput (Taylor et al., 2015). LC-MS has been successfully applied to the 
quantification of many steroids in a variety of different tissues with high sensitivity, 
even without sample derivatisation. For instance, Caruso and colleagues managed 
to detect 9 steroids with a LOQ ranging from 0.02 – 0.10 pg per sample in the rat 
brain without derivatisation (Caruso et al., 2010). A LC-MS method quantifying a 
panel of 12 steroids was also applied to human serum samples, with limits of 
detection (LOD) that range from 1.5 to 10 pg/mL (Guo et al., 2006).  
However, to date, due to the complexity of the composition of brain tissue and the 
differing capabilities of MS instrumentation in different facilities (for example, 
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different modes of ionisation), a substantial number of analyses involving 
neuroactive steroids require derivatisation (Higashi and Shimada, 2004, Higashi and 
Ogawa, 2016). For electrospray ionisation (ESI) especially where analytes are 
ionised by applying a strong electrical current, derivatisation aids the generation of 
charged ion due to the permanent charge present in derivatisation agents (Higashi 
and Ogawa, 2016). Derivatisation with 2-hydrazino-1-methylpyridine (HMP) for 
example  improved LOQ of allopregnanolone, epi-allopregnanolone and 5α-DHP 60- 
to 150-fold lower as compared to a method without derivatisation (Higashi et al., 
2007). More recently, Dury et al. also managed to quantify several key 
neurosteroids in the monkey brain, with Girard’s T derivatisation (Dury et al., 2016).  
Despite being a powerful tool, LC-MS is subject to pitfalls and may generate 
erroneous data if there is inadequate sample workup or inappropriate choice of 
procedures (Liere and Schumacher, 2015, Vogeser and Seger, 2010). Furthermore, 
even if similar methods are developed elsewhere, specific differences or limitations 
in instrumentation between laboratories mean that one assay might not be readily 
applied in another laboratory without significant method development and 
optimisation (Liere and Schumacher, 2015). For every new in-house LC-MS assay, 
an analytical workflow must thus be properly delineated and followed, which is 
covered in the next section.  
  
Chapter 3: Development of LC-MS method 101 
3.1.4 Developing and optimising a LC-MS method for the quantification of 
steroids 
The LC-MS method development process is a reiterative one, and a summary is 
presented in Fig 3.6 based on published guidelines (Sargent, 2013) and other 
articles (Honour, 2011, Makin, 2010, Nair, 2017). Decision points exist at several 
stages of the workflow and often, compromises and trade-offs will have to be made 
depending on logistical, technical or time constraints. Eventually, the finalised 
method will have to balance efficacy, speed and cost (McDonald et al., 2011). 
The process begins with the first step of MS optimisation, where precursor and 
product ions are identified, and fragmentation parameters are determined. Analytes 
that are able to ionise and fragment adequately are then brought forward to the next 
step for LC optimisation. The main aim of LC optimisation is to ensure that there is 
adequate separation of chromatographic peaks, so that different analytes enter the 
MS in a staggered manner. Along with the choice of column, the composition of the 
mobile phase and the gradient profile during the run will also have significant 
impacts on resolution and peak shapes, and need to be carefully considered. Upon 
satisfactory results at the end of this stage, the LC and MS aspects are combined 
and a preliminary LC-MS method with multiple reaction monitoring (MRM) is 
developed, where an entire panel of steroids can be detected and quantified with 
one single sample injection.  
Using this preliminary LC-MS method, the sensitivity of the assay is then 
investigated. If the sensitivity of the assay is not satisfactory at this point (i.e. not 
close to physiological concentrations), derivatisation will need to be carried out to 
improve signals. Derivatisation, as mentioned earlier, chemically changes the 
functional groups of analytes. This effectively creates a new compound for analysis, 
and the process of MS tuning and LC optimisation needs to be repeated from the 
first step again. Several derivatisation agents may need to be screened until an 
optimal one is found, whilst derivatisation conditions will also need to be optimised 
to ensure maximal yield and stability of the derivative.  
Once the sensitivity of the chosen method is established, it can subsequently be 
tested on biological tissues, where matrix effects may come into play. The term 
“matrix effect” refers to the alteration of the intensity of the MS response of a target 
analyte in a biological matrix (such as plasma or brain tissue) as compared to its 
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response in a calibrant solution (Panuwet et al., 2016, Taylor, 2005). This is due to 
the presence of co-eluting matrix components (e.g. lipids) which can affect the 
behaviour of target analytes of interest. The presence of interfering compounds at 
high concentrations could mask the detection of target analytes which tend to be of 
low abundance (Keshishian et al., 2007), compete with target analytes for charges 
during ionisation (Panuwet et al., 2016), or even react with target analytes to change 
their physical or chemical properties (Gosetti et al., 2010). These alterations may 
either decrease (i.e. ion suppression) or increase (i.e. ion enhancement) the signal 
of the target analyte, leading to inaccuracies in quantification. This is an especially 
pertinent issue for brain tissues, which is a complicated matrix given its high lipid 
and protein content in comparison to that of steroids (Taves et al., 2011).  
One of the strategies to mitigate matrix effects is to include appropriate sample 
clean-up procedures in the quantification method. The aim of sample clean-up is to 
ensure that interfering substances are removed, whilst analytes of interest are 
retained. Sample clean-up also ensures that a relatively “clean” sample is injected 
into the LC column and mass spectrometer, protecting the instruments in the long 
run. Solid-phase extraction (SPE) is by far the most common method of sample 
clean-up, where it exploits the same principles of analyte and solid phase 
interactions as in LC (Campíns-Falcó et al., 2012). The solid phase is however, 
packed in smaller one-use cartridges with greater particle sizes, and is a far more 
rudimentary form of separation as compared to the LC column. Various types of 
SPE cartridges are available commercially, the choice of which is dependent on the 
characteristics of the analyte of interest and also the biological matrix.  
The addition of internal standards can also help to decrease the impact of matrix 
effects, as they can compensate for variations in MS and LC conditions, and also 
errors in sample preparation. An internal standard is a compound that is added in a 
known amount to every sample, and should be similar but not identical to the 
analyte of interest. Its chemical and physical properties should resemble the analyte, 
such that it behaves similarly to the analyte of interest in all aspects of the LC-MS 
method (Makin, 2010). In the LC, it should be well-resolved from other peaks, but 
have similar retention to the column as the analyte of interest, whilst in the MS, it 
should have similar ionisation and fragmentation patterns (Sargent, 2013). The ratio 
of the signal response between the internal standard and that of the analyte of 
interest is used for plotting the calibration curve. Therefore, the idea is that in cases 
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where there is interference from the matrix or if random experimental errors arise, 
both the internal standard and analytes will be affected in the same manner and to 
the same extent, and the ratio remains unaffected. The selection of an appropriate 
internal standard is therefore a major part of the method development process. After 
the selection of appropriate internal standards, known concentrations of internal 
standards should then be incorporated to all standard calibrants and tissue samples 
prior to sample processing. 
Once a reasonable method which takes into account aforementioned two points is 
developed, it has to undergo a full validation procedure before it can be 
implemented in biological studies (Sargent, 2013). If the accuracy and precision of 
the method are within acceptable limits, bioanalytical results can then be considered 
reliable. Conversely, poor validation results can reveal problems in the method 
and/or instrumentation that need to be addressed. Ultimately, if the method is to be 
established as a routine assay, the validation should also be carried out in a routine 
manner. As such, the method development and optimisation process can be 
considered a continuous one, involving troubleshooting and also modifications which 
can lead to constant improvements in the assay.  
Lastly, as an extension of the validation process, the biological verification of the 
assay can additionally be carried out. Biological verification demonstrates the 
assay’s ability to detect biologically relevant differences between treatment groups. 
In the context of this study, the biological verification of the assay would be the 
ability to detect differences in steroid concentrations between samples that are 
expected to show significant differences in steroid concentatrations (for instance, 
greater testosterone concentrations in male plasma as compared to female plasma, 
or greater corticosterone concentrations following a stressor).  
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Figure 3.6: Workflow for the development and validation of a LC-MS method 
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3.1.5 Aims 
The work in this chapter aims to: 
1. Develop a method to quantify as many as possible of these 14 steroids of 
interest in a single analysis: Corticosterone, 11-dehydrocorticosterone (11-
DHC), DOC, DHDOC, THDOC, Progesterone, 5α-Dihydroprogesterone (DHP), 
Allopregnanolone, Pregnenolone, Testosterone, 5α-Dihydrotestosterone (DHT), 
3α-androstanediol (3α-diol), 3β-androstanediol (3β-diol) and 17β-Oestradiol 
using the workflow in section 3.1.4. As it is expected that not all of these steroids 
may be successfully quantified in a single method, several steroids that are 
deemed to be more heavily involved in the modulation of the HPA axis (e.g. 
corticosterone, and the positive GABAA modulatory steroids allopregnanolone 
and THDOC) are prioritised.  
 
2. Validate the method as closely as possible according the guidelines for 
bioanalytical methods issued by the Royal Society of Chemistry (Sargent, 2013). 
This includes assessment of the linearity of standard curves, limit of 
quantification (LOQ), limit of detection (LOD), recovery percentage, 
measurement accuracy, intra- and inter-assay variability for all steroids.  
 
3. Biologically validate the developed method and demonstrate that the LC-MS 
method is sensitive enough to detect significant differences in steroid 
concentrations between different treatment groups. In order to achieve this aim, 
steroid concentrations were measured in the plasma and brains of male and 
female rats, with and without acute stress (swimming stress). The study aims to 
assess the ability of the LC-MS method to (i) replicate expected patterns of 
increase in neuroactive steroids following stress (for instance, an increase in 
neuroactive steroids such as corticosterone and allopregnanolone in the plasma 
and the brain following acute stress), (ii) show expected differences in sex 
hormone concentrations between males and females (for instance, testosterone 
is greater in males as compared to females). Additionally, this study also aims to 
assess the feasibility of using swimming stress as a form of acute stress to elicit 
a response involving several neuroactive steroids not previously investigated in 
other studies, thereby laying the foundation for the designing of studies 
incorporating acute and prenatal stress in the subsequent chapter. 
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3.2 MATERIALS AND METHODS 
3.2.1 Reagents 
All steroid standards and internal standards were purchased in solid form from either 
Steraloids Inc. (Newport, RI, USA), Sigma (Leicester, UK) or Tocris Bioscience 
(Bristol, UK) (Table 3.1). The structure of the steroids as well as the deuterated 
internal standards are presented in Figure 3.7. All solvents/chemicals used were LC-
MS grade. Methanol was purchased from Honeywell Riedel-de Haën (Seelze, 
Germany), whilst LC-MS grade water, formic acid (FA; LC-MS Optima) and 
ammonium formate powder were procured from Fisher Scientific (Leicester, UK). 
Steroid standards were carefully weighed, dissolved in methanol and stored in -20oC 
as 1 mg/mL stock solutions.  
Steroid CAS no. Catalogue no. 
Corticosterone 50-22-6 Steraloids; Q1550-000 
11-dehydrocorticosterone 72-23-1 Steraloids; Q3690-000 
DOC 64-85-7 Steraloids; Q3460-000 
5α-DHDOC 298-36-2 Steraloids; P3750-000 
3α,5α-THDOC 567-02-2 Sigma; #P2016 
Progesterone 57-83-0 Steraloids; Q2600-000 
5α-Dihydroprogesterone (DHP) 566-65-4 Steraloids; P2750-000 
Allopregnanolone 516-54-1 Steraloids; P3800-000 
Pregnenolone 145-13-1 Steraloids; Q5500-000 
Testosterone 58-22-0 Steraloids; A6950-000 
5α-Dihydrotestosterone (DHT) 521-18-6 Steraloids; A2570-000 
3α-androstanediol (3α-diol) 1852-53-5 Steraloids; A1170-000 
3β-androstanediol (3β-diol) 571-20-0 Steraloids; A1220-000 
17β-oestradiol 50-28-2 Steraloids; E0950-000 
Progesterone-D9  Steraloids; Q2600-014 
5α-dihydroprogesterone-D8  Steraloids; P2750-030 
Allopregnanolone-D5  Tocris Bioscience; #5532  
Corticosterone-D4  Sigma; #802905 
 
Table 3.1: Steroid analytes used and tested in this thesis and associated CAS 
numbers and catalogue numbers. Deuterated internal standards are in grey.  
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Figure 3.7: Structure of the steroid analytes investigated in this study. The 
steroids differed from each other by functional groups, and are interconverted by 
steroidogenic enzymes. Internal standards are also shown (in the dotted boxes) to 
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3.2.2 Instrumentation and software  
All LC-MS experiments were carried out in the Roslin Institute Proteomics and 
Metabolomics Facility, in collaboration with Dr Andrew Gill.   
MS was carried out on the amaZon ETD ion trap mass spectrometer (Bruker 
Daltonics, Bremen, Germany) and the mode of ionisation was ESI. Operating 
conditions for MS was capillary temperature of 200°C, capillary voltage of -4500V, 
nitrogen nebuliser gas at 16 psi, dry gas at 8L/min and dry temperature of 150oC. 
Argon was used as the collision gas.  
LC was carried out on the Ultimate 3000 Dionex HPLC system, with a refrigerated 
autosampler maintained at 8oC. The injection volume was 5μL, with a partial loop 
injection. The syringe was rinsed with 20% methanol after each sample injection.  
The TrapControl software was used for MS tuning while Hystar software was used 
for LC-MS. Spectral data was viewed and visually compared on DataAnalysis 
software. Following LC-MS, the peak area under the curve was extracted and 
automatically integrated using QuantAnalysis v2.0 (all software from Bruker 
Daltonics). Each chromatogram was visually inspected to ensure that AUC was 
correctly integrated and that there were no interfering peaks.  
3.2.3 MS optimisation methodology 
Mass spectrometry detection was the first procedure to be optimised. Solutions 
consisting of individual steroids were prepared separately in methanol (5 μg/mL) 
and infused directly into the source via a Hamilton syringe pump at a rate of 5 
μL/min. Scanning for the precursor ion (MS1) was first carried out using the 
UltraScan resolution as scan mode (32500 m/z per second). Fragmentation mode 
(MS2) was then enabled and fragmentation conditions (amplitude and cut-off) were 
optimised using the SmartFrag module in TrapControl. This was carried out for both 
underivatised steroids at the early stages of the optimisation process, as well as the 
various derivatised steroids at the later stages. 
3.2.4 LC optimisation methodology 
Column: ACE UltraCore 2.5 µM Super C18 column (75 mm by 2.1 mm i.d.; #CORE-
25A-7502U, Advance Chromatography Technologies, Aberdeen, UK) was selected 
as the column of choice based on a literature review where C18 columns were used 
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for various studies (Taylor et al., 2017, Ma and Kim, 1997, Jin et al., 2013, 
Rustichelli et al., 2013) as well as its solid core technology which allows for better 
separation without increasing back pressure on the system (Ahmed et al., 2018). 
The flow rate of 0.2 ml/min was selected to match its internal diameter of 2.1 mm. 
The column was maintained at 40oC. Columns were replaced every 5000 injections, 
and were regenerated via a reverse flow wash protocol comprising of methanol, 
acetonitrile, acetronitrile/isopropanol (3:1 v/v), isopropanol, dichloromethane, 
hexane in succession when the back pressure of the system became too high.  
Mobile phase: For mobile phase A (the aqueous/ more polar component), (i) 50 mM 
ammonium formate (pH 3.0) and (ii) water (with 0.1% FA) were tested while for 
mobile phase B (the organic/ less polar component), (i) methanol and (ii) 
acetonitrile, both with 0.1% FA, were tested. Mobile phase optimisation was carried 
out in the initial stages using underivatised steroids in MS1 mode, using a gradient 
protocol where the % of B was increased gradually from 50-100%, with a total run 
time of 10 min. AUC of extracted ion chromatograms (EIC) at MS1 were compared 
for the different combinations of mobile phase A and B. Chromatograms were also 
compared for the best peak shapes, where parameter such as peak intensity and 
peak symmetry were compared visually (Sargent, 2013). A good peak should have 
reasonable peak intensity (a signal to noise ratio of at least 103 for a steroid with 5 
μg/mL concentration), is symmetrical, with minimal peak broadening, or peak 
fronting and tailing at the base (Sargent, 2013). The combination of 50 mM 
ammonium formate (A) and methanol/0.1% FA (B) gave the highest peak intensity 
and reasonable peak shapes, and was thus selected as the mobile phase. This 
mobile phase combination was used for all subsequent optimisation protocols with 
derivatised reagents. All solvents were prepared fresh prior to a run and were 
degassed for 20 min in a water-bath sonicator, which aids the consistency of 
retention time.  
Gradient optimisation: Steroids were first individually injected into the LC to 
determine the retention time. The relative composition (%) of solvents A and B 
during the course of the run was then altered to ensure that each specific steroid of 
interest eluted with a different retention time. This was first carried out using MS1 
mode, with a high concentration of steroids (5 μg/mL, similar to direct infusion 
levels). Once the retention time was determined, MS2 mode was carried out, where 
the efficacy of fragmentation was re-assessed with the mobile phase composition 
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taken into consideration. Chromatograms were again visually inspected here for 
reasonable peak shapes. Additionally, an equilibration step prior to sample injection 
(maintained at 5% B), and a washing step after the end of the run (maintained at 
100% B) was also added to aid the consistency of the elution time and to prevent 
carry-over effects. A divert valve was also used in which contaminants eluting before 
the gradient reached 40% B, and after 100% B were being diverted to waste so as 
to not overload the electrospray nozzle.  
Preliminary LC-MS method with multiple reaction monitoring (MRM): Once a 
satisfactory gradient profile was constructed, the LC method and the MS method 
were then combined into a single preliminary LC-MS method, with multiple reaction 
monitoring. The method was split into several time segments, with each segment 
detecting specific MRM transitions (not more than 5 per time segment), allowing the 
detection of more than one analyte in a single injection. Steroid standards were then 
combined into a single sample, serially diluted, and analysed using this preliminary 
LC-MS method to establish the sensitivity of the assay.  
3.2.5 Optimisation of derivatisation  
The development and optimisation process began with underivatised steroids. 
However, it became apparent midway through the method development process 
that without derivatisation, the method was not sensitive enough to detect analytes 
in a physiologically relevant manner (target LOQ was approximately 10 pg on 
column). The lack of sensitivity of the underivatised method was probably 
contributed by poor ionisation of neutral steroids with electrospray ionisation (ESI), 
which was the ionisation mode that was available for our instrument in the facility. 
Thus, a screening for the most suitable derivatisation agent had to be carried out. 
Five derivatisation agents were chosen based on a literature review, and advice 
provided by Prof Ruth Andrew and Dr Shazia Khan from the Mass Spectometry 
Core Facility at the Centre for Cardiovascular Science within the University of 
Edinburgh. 
2 μg of each steroid standard was individually prepared from the 1 mg/mL stock and 
dried in the vacuum concentrator (SpeedVac), following which derivatisation agents 
were added according the conditions listed in Table 3.2. Derivatised steroids then 
underwent the same optimisation procedures as the underivatised steroids, first with 
MS optimisation via syringe infusion (as per section 3.2.3). Due to the nature of the 
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derivatisation reagents, PTSI-derivatised steroids were analysed in negative ESI 
mode while the rest of the derivatised steroids were analysed in positive ESI mode. 
After determining the optimal fragmentation and cut-off parameters, LC optimisation 
was then carried out (as per section 3.2.4), using the same choice of column and 
mobile phase optimised for underivatised steroids. A combined preliminary LC-MS 
method with multiple reaction monitoring was generated if the method proved to be 
promising.  
As Girard’s T showed the most potential, derivatisation conditions of Girard’s T were 
further optimised. Incubation time and three types of acid catalyst (formic acid, 
acetic acid, trifluoroacetic acid) in different concentrations (0.1%, 0.2%, 0.5%, 1%) 
were tested, and the AUC were compared. The conditions that gave the largest 
AUC for extracted ion chromatograms (EIC) in the MS2 mode (i.e. incubation at 
37oC for 30 min with 0.2 % formic acid) were subsequently used as the Girard’s T 
derivatisation protocol accompanying sample processing optimisation. 
Derivatisation 
agent 
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mg/mL HTP in acetonitrile with 










First, resuspend in 100 μL 
acetonitrile. Then add 20 μL of 
10% PTSI, vortex in room 
temperature for 2 min. Quench 










Add 100 μL of 100mM NaHCO3 
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First, add 100 μL of 2% (v/v) N,N-
diisopropylethylamine in CH2Cl2 to 
sample, followed by 100 μL of a 
solution of 10 mg/mL DnCl and 10 
mg/mL DMAP in CH2Cl2, incubate 









Add 400 μL of 1 mg/mL of Girard’s 
T reagent, in methanol with 
0.2%FA, incubate at 37oC for 30 
min. Stop reaction with the 
addition of 50 μL of 5% 
ammonium hydroxide in methanol. 
Carbonyl 
(=O) 
(Dury et al., 
2016) 
Table 3.2: Derivatisation agents utilised in this study. Derivatisation conditions 
were taken from the respective references and modified for our method. 
Abbreviations: TFA: Trifluoroacetic acid, DMAP: 4-(dimethylaino)-pyridine, FA: 
Formic acid. 
 
3.2.6 Sample processing optimisation 
3.2.6.1 Samples used for sample processing optimisation 
The LC-MS and derivatisation optimisation in the previous section was carried out 
using steroid standards in neat solvent (methanol). Sample processing optimisation 
however, needed to be carried out in samples that would closely mimic the 
biological tissues of interest (in our case, rat plasma and brain). 
Standards in surrogate matrix: 4% (w/v) bovine serum albumin (BSA; VWR, 
Leicester, UK) in PBS (pH 7.4) was selected as the surrogate matrix, due to its 
similarity in albumin content to plasma, and can therefore form conjugates with 
steroids (van de Merbel, 2008). To reduce endogenous steroid contamination from 
BSA, 4% BSA was treated with 2% (w/v) activated charcoal (Sigma, UK) on a roller 
at 4oC overnight and then filtered with 0.22 μm filters (Millipore) before being used 
as a surrogate matrix for standard calibrants. 
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Brain samples: A female rat brainstem was homogenised in methanol and was used 
during the initial stages of sample clean-up optimisation. The homogenate was split 
equally into various tubes, and each tube was spiked with 0.5 μg of steroids so as to 
compensate for the low amounts of some endogenous steroids present (e.g. 
testosterone). 
3.2.6.2 Tissue homogenisation and extraction 
A sample extraction and homogenisation protocol was devised based on a 
combination of various different studies in our literature review (Caruso et al., 2010, 
Higashi et al., 2007, Rustichelli et al., 2013). For most studies, homogenisation was 
carried out in acidified methanol or acetonitrile (with either formic acid or acetic 
acid). The organic solvent ensures the solubility of the steroids, whilst acid aids 
protein precipitation, as well as the disruption of protein-steroid complexes so that 
total amount of steroids can be measured (Makin, 2010). 500 μL of methanol with 
1% FA was selected as the sample extraction solvent, based on previous studies, 
and partly due to its similarity with the mobile phase B in the LC-MS method 
(Rustichelli et al., 2013). Physical homogenisation was carried out with a handheld 
homogeniser (KIMBLE, VWR Ltd, Leicestershire, UK), with removable polypropene 
pestles that were replaced for each sample, so that numerous brain samples could 
be processed in a batch, increasing throughput. Samples were then briefly 
sonicated on ice, a procedure that was also observed in many protocols, which aids 
in further breaking up the tissue and cell membranes, releasing steroids from the 
cytosol. The homogenates were then incubated on dry ice for 30 min to aid protein 
precipitation. Following which, the samples were centrifuged and re-extracted again 
(with another 500 μL of methanol/1% FA) to ensure thorough extraction.  
3.2.6.3 Sample clean-up 
Two commercially available sample clean-up methods were selected for 
comparison, (i) a phospholipid removal cartridge (Supelco Hybrid SPE Phospholipid 
Cartridge, Sigma, #55261-U, bed weight 30 mg) and (ii) a C18 solid phase 
extraction cartridge (Supelco Discovery DSC-18 SPE Cartridge, Sigma, #52602-U, 
bed weight 100 mg). Given the abundance of phospholipids in cell membranes, the 
presence of phospholipids can be a major contribution to matrix effects. The Hybrid 
SPE cartridge removes phospholipids by interaction with zirconia ions present on 
the sorbent (Bylda et al., 2014). C18 SPE, on the other hand, works through 
Chapter 3: Development of LC-MS method 114 
hydrophobic exchange, where analytes and contaminants are first retained on the 
sorbent on the basis of hydrophobicity, and are differentially eluted depending on 
the elution solvent. The Hybrid SPE and C18 SPE methods were compared using 
rat brainstem samples spiked with steroid standards, which is rich in white matter 
and will have largest amounts of contaminating lipids, as well as using steroid 
standards in 4% BSA.  
The two methods were compared based on two parameters, (i) the intensity of 
“background” signals, and (ii) signal intensity of the analytes of interest. 
“Background” signals are assessed by comparing total ion chromatogram (TIC) 
peaks in MS1 mode. The intensity of TIC peaks represents the total number of ions 
passing through the detector at any one point, and given the complex nature of 
biological matrices, are likely to represent contaminants. The method that generates 
TIC peaks of lower intensity is preferred. Signal intensity of the analytes were 
compared by assessing extracted ion chromatograms (EIC) in fragmentation mode 
(MS2). The method that generates greater EIC peaks representing analytes of 
interest is preferred.  
In Hybrid SPE and C18 SPE sample clean-up, the first step of the procedure is 
always conditioning, usually with methanol, which activates the ligands on the 
surface of the sorbent. This is followed by equilibration, using the solvent that the 
analyte is dissolved in, in order to maximise the analyte-sorbent interaction in the 
subsequent steps, which then differ for Hybrid SPE and C18 SPE (Fig 3.8).  
For Hybrid-SPE cartridges, following conditioning (1 mL of methanol) and 
equilibration (0.5 mL of methanol/1%FA), samples (in 900 μL of methanol/1%FA) 
were then loaded through the column, and flow through was collected in a fresh 
1.5mL Eppendorf tube. As the sorbent traps phospholipids, and the steroids of 
interest are in the flow-through fraction. An additional 400 μL was loaded as wash, 
and flow-through was also collected in the same tube. 
For C18 SPE, the process is more laborious, as it works via hydrophobic exchange, 
where steroids are first trapped in the sorbent, and then eluted in the subsequent 
steps. The analyte is first suspended in solvent with a lower organic composition 
(e.g. 30% methanol), and then loaded into the cartridge, where they will adsorb on 
the sorbent. The washing step, at a higher percentage of methanol (e.g. 40 or 50% 
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methanol), will remove a portion of these contaminants. Elution, at an even higher 
percentage of methanol (e.g. 85%) will elute target steroid analytes, whilst the 
residual highly hydrophobic contaminants remain trapped in the sorbent.  
To ensure that none of the analytes of interest are lost in the process, a separate 
test with increasing amounts of methanol was first carried out to determine the 
fractions in which analytes will elute. A combined steroid standard was first diluted in 
a 10% methanol solution. Methanol concentration was then sequentially increased 
by 10% each time, and the flow-through was collected, dried, derivatised and 
analysed on the LC-MS. This trial experiment showed that most steroids are eluted 
in the 50% to 80% methanol fraction. Based on the results, as well as several other 
studies, a wash of 50% methanol was chosen for analyses where 11-DHC was not 
included in the detection, while 40% methanol was chosen as a wash for analyses 
where 11-DHC was included in the measurements. An elution step using 85% 
methanol was chosen for all cases.  
In both cases, the collected eluate was then dried in a vacuum concentrator (Savant 
SpeedVac, ThermoFisher) overnight, derivatised using Girard’s T reagent as per the 
conditions outlined in section 3.2.5, then analysed on the LC-MS as per the 
conditions outlined in section 3.2.3 and 3.2.4.  
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Figure 3.8: Comparison of two sample clean-up methods, phospholipid 
































A. Hybrid SPE Phospholipid removal
B. C18 Solid phase extraction
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3.2.7 Assay validation parameters  
3.2.7.1 Standard calibrants and internal standards 
A combined sample containing 10 μg/mL of each steroid standard in methanol was 
diluted 40-fold in the surrogate matrix, 4% BSA, into a 250 ng/mL solution. A seven-
point calibration curve was generated by diluting 25 ng/mL standards 2.5-fold, 
generating calibration points of 10 ng/mL, 4 ng/mL, 1.6 ng/mL, 640 pg/ml, 256 
pg/mL and 102.4 pg/ml. 100 μL of standard calibrants were used for sample 
processing. A BSA only blank sample was prepared with each standard curve as a 
negative control, but was not used in the calibration.  
Deuterated internal standards (ISTDs) consisting of progesterone-d9, 
corticosterone-d4 and allopregnanolone-d5 were combined into a 10 μg/mL solution 
in methanol. They were diluted 400-fold into a 25 ng/ml solution consisting of 50% 
methanol/ 50% PBS. 20 μL of the ISTD mix was added to each sample, including 
the BSA only blank sample.   
3.2.7.2 Assessment of linearity 
Calibration curves were constructed using the ratio of peak area of the target 
analyte to the peak area of the ISTD using regression analysis in the QuantAnalysis 
software. Coefficients of determinant (r2) indicate how well the regression line fits 
the data, and the calibration curves are acceptable if values were >0.99. Weightings 
of 1, 1/x, and 1/x2, with and without forcing the intercept through zero, were 
compared.  
3.2.7.3 Limit of quantification (LOQ) and limit of detection (LOD) 
The lower limit of quantification (LOQ) was defined as the lowest standard calibrant 
with a peak that is identifiable and discrete with a relative standard deviation of less 
than 20% and at least five times the signal of the blank. The lower limit of detection 
(LOD) is defined as the lowest amount of analyte necessary to obtain a signal that 
can be distinguished from the background noise (signal to noise ratio >5). Only the 
LOQ was investigated in this assay validation procedure.  
3.2.7.4 Recovery 
Recovery was assessed by comparing the signal intensity of standards spiked 
before and after C18 solid phase extraction (n=3), using 4% BSA as sample matrix. 
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Recovery was investigated at three concentration levels, where low (50 pg), mid 
(200 pg) or high (800 pg) amounts of steroids were added into the sample. 
Recovery (%) was calculated as: 
 
 
3.2.7.5 QC standards 
Assessment of accuracy and precision was carried out using quality control (QC) 
samples consisting of steroid standards prepared in 4% BSA, in low (500 pg/ml), 
mid (2000 pg/ml) or high (8000 pg/ml) concentrations. 100 μL of each QC sample 
was used for sample processing, and 20 μL of ISTD was added as per standard 
calibrants. QC standards were processed alongside a set of standard calibrants, 
and the values obtained were used to determine accuracy and variability. 
3.2.7.6 Accuracy  
Accuracy refers to how closely the values reflect the actual concentration of steroids 
in the sample. Accuracy was calculated from the means of three independent 





Variability is presented as % coefficient of variation (%CV), calculated with the 
following formula: 
 
Four forms of variability are investigated here, which contribute to the precision of 
the assay.  
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Intra-assay variability refers to the %CV of the values obtained from three 
independent samples measured in duplicate in a single run, against a single 
calibration curve. Intra-assay variability assesses the consistency of sample 
preparation, the stability of the analyte and fluctuations in performance of the LC-
MS.  
Inter-assay variability refers to the %CV of mean measurements across three 
different runs, against three different calibration curves. Inter-assay variability 
accounts for the variation in sample and standard curve preparation on different 
days. Apart from the fluctuations in instrumental performance, the consistency of the 
slope of the standard curve on different days, as well as possible variations in the 
preparation of different solvent batches are taken into account. 
Injection-to-injection variability is calculated from the mean %CV value of the 
duplicate injections. This accounts mainly for fluctuations in LC-MS performance 
within a single run, which can include the fidelity of injection volume, carry-over, 
ionisation and fragmentation efficiencies and column performance.  
Total variability refers to the %CV of all the single injections obtained across various 
runs, irrespective of the day samples were run. This accounts for whether the intra-
assay, inter-assay and injection-to-injection variability may have a cumulative effect. 
The total variability is calculated using the %CV formula mentioned above, where 
standard deviation of values obtained from all single injections across all days 
(n=15) was divided by the the mean of all single injections across all days (n=15). 
3.2.8 Biological validation of the method in rat plasma and brain tissues 
The LC-MS method was biologically validated on rat plasma and brain tissues 
collected from control and swim-stressed adult rats. The study has been published 
in Sze et al. (2018) and is attached in Appendix B. At the time of publishing, the LC-
MS method could only reliably detect 8 steroids (corticosterone, DOC, DHDOC, 
progesterone, DHP, allopregnanolone, pregnenolone, testosterone), and only used 
only progesterone-d9 as internal standard. The publication (Sze et al., 2018; 
Appendix B) contains both a validation assay for these 8 steroids, as well as results 
of steroid concentration measurement from the stressed and non-stressed rat 
plasma and brain tissues. As the method used in the publication (Sze et al., 2018; 
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Appendix B) differs with the slightly modified method used in the rest of the thesis, it 
is referred to as the “initial published method” in this chapter.   
3.2.8.1 Animals and acute stress paradigm (forced swimming) 
Briefly, male and female Sprague-Dawley rats (n=7 per group per sex) were bred in-
house and underwent forced swimming for 2 minutes when they were 21 weeks old. 
Stressed rats were returned to their home cage after the swimming bout. Thirty 
minutes after the onset of swimming stress, rats were killed by conscious 
decapitation. For the control group, rats (n = 7 per group per sex) remained 
undisturbed in their home cage prior to killing. Upon decapitation, trunk blood was 
collected and brains were rapidly removed. The regions of interest (frontal cortex, 
hypothalamus, amygdala, hippocampus, brainstem) were dissected and frozen on 
dry ice. All experiments and tissue collection were performed in male and female 
(randomly cycling) rats between 10.00 am and 12.30 pm at the Roslin Institute, 
carried out by Mrs Helen Cameron and Dr Yu-Ting Lai.  
Forced swimming was chosen as a stressor because firstly, it is a robust activator of 
the HPA axis, and has been shown to rapidly induce an increase in concentrations 
of corticosterone, pregnenolone and allopregnanolone in the brain (Purdy et al., 
1991, Vallée et al, 2000), therefore is likely to bring out differences between 
treatment groups. This time-point of killing and collecting of samples (30 minutes) 
has also previously been shown to correspond with a peak in stress-induced 
corticosterone and allopregnanolone concentrations in the brain following swim 
stress (Cullinan et al., 1995). Secondly, forced swimming is a combined physical 
and psychological stressor, therefore activates stress-responsive nuclei in both the 
forebrain and hindbrain (Cullinan et al., 1995), and various brain regions would be 
affected by the manipulation.  
3.2.8.2 Sample processing and initial published LC-MS method 
Samples from all four groups from any given region were processed in the same 
run, together with standard calibrants (prepared as per section 2.5.1). Brain samples 
were processed as per the methods mentioned in section 2.5.2, where plasma and 
brain regions were weighed, homogenised in methanol/1% formic acid and 
underwent C18 solid phase extraction. Samples then underwent Girard’s T 
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derivatisation (as per section 2.5.2) before being subjected to LC-MS analysis, 
which are detailed in Appendix B. A validation assay using QC standards was also 
included (Appendix B, Supplementary Info), and the assessment of assay 
performance was based on calculations detailed in section 3.2.7.  
3.2.8.3 Differences between the initial published method and the method used 
in this thesis  
The method used in this thesis (in Chapter 4, 5 and 6) and assay validation (from 
section 3.3.4) reflects an improved method from this initial published assay (Sze et 
al., 2018; Appendix B), due to an upgrade of the instrumentation (to a refrigerated 
autosampler), as well as the addition of two more additional internal standards, 
corticosterone-d4 and allopregnanolone-d5. THDOC was also not included in this 
initial published assay due to its poor validation characteristics (calibration curve 
was not linear).  
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3.3 RESULTS 
3.3.1 Results of screening for different derivatisation agents 
Table 3.3 compares the AUC for extracted ion chromatograms (EIC), detected at 
MS1 mode for underivatised steroids and steroids derivatised with the five 
derivatisation agents detailed in Table 3.2. In MS1 mode, EICs represent the 
intensity of the precursor ion without fragmentation.  
Underivatised steroids could be detected in MS1 mode, however, fragmentation was 
poor for all the underivatised steroids in MS2 mode, leading to overall poor 
sensitivity. The LOD of the underivatised steroids using that method was >10 ng/ml 
for most steroids in our pilot study, which was insufficient given the much lower 
physiological concentrations of steroids in the brain (a target LOQ of approximately 
100 pg/ml was set).  
DMABC derivatisation, which targets hydroxyl groups, showed potential, resulting in 
the largest number of steroids being quantified. 3α-diol and 3β-diol, which has never 
been detected in any published studies, could be detected with DMABC 
derivatisation. However, the derivatisation agent was sensitive to both moisture and 
air, and the reaction yield became significantly lower as time progressed, possibly 
due to the degradation of the reagent. The development of a method with DMABC 
derivatisation was thus abandoned. Additionally, as allopregnanolone was a focus in 
our studies, it was important to also quantify progesterone and DHP, the precursors 
of allopregnanolone. The focus was shifted then to finding a derivatisation agent that 
could target carbonyl groups (which progesterone, DHP and allopregnanolone all 
possess).  
Girard’s T derivatisation and HTP derivatisation, targeting carbonyl groups, both 
proved to be robust derivatisation agents at the early stages of optimisation. 
However, HTP showed slightly lower EIC signal in MS2 for most analytes. Higher 
temperature was also needed for the derivatisation reaction, which was less ideal. 
Girard’s T was thus chosen as the preferred derivatisation agent in this study.  
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Analyte 
Area under curve for EICs in MS1 mode 
None DMABC DnCl PTSI HTP Girard's T 
Corticosterone 1.8 x 109 1.4 x 109 n.d. n.d. 1.1 x 109 2.4 x 109 
DOC 1.8 x 109 2.3 x 109 3.8 x 108 2.1 x 107 1.6 x 109 2.2 x 109 
DHDOC 3.8 x 108 2.1 x 108 n.d. 3.6 x 107 1.5 x 108 1.6 x 108 
THDOC 1.5 x 108 1.7 x 109 3.0 x 108 2.8 x 107 1.4 x 106 2.9 x 108 
Progesterone 2.8 x 109 n.d. n.d. n.d. 1.6 x 109 2.6 x 109 
DHP 7.2 x 108 n.d. n.d. n.d. 3.5 x 108 9.2 x 108 
Allopregnanolone 3.7 x 108 1.5 x 109 n.d. 3.1 x 107 2.5 x 108 1.3 x 109 
Pregnenolone 3.4 x 108 1.1 x 109 n.d. 1.1 x 107 3.9 x 108 8.8 x 108 
Oestradiol n.d. 2.1 x 109 6.4 x 108 1.1 x 107 n.d. n.d. 
Testosterone 1.5 x 109 3.8 x 109 1.7 x 109 1.8 x 107 2.9 x 109 8.7 x 108 
DHT 5.6 x 108 2.0 x 109 6.8 x 108 1.8 x 107 1.0 x 108 3.2 x 107 
3α-diol n.d. 7.0 x 108 6.0 x 108 5.1 x 107 n.d. n.d. 
3β-diol n.d. 4.2 x 108 2.3 x 108 1.5 x 107 n.d. n.d. 
Table 3.3: Area under curve for extracted ion chromatograms for precursor 
ions in MS1 only mode. None: No derivatisation, DMABC: 4-Dimethylamino 
benzoyl chloride, DnCl: Dansyl chloride, PTSI: p-toluenesulfonyl isocyanate, HTP: 2-
hydrazino-4-(trifluoromethyl)-pyrimidine. For derivatisation conditions see Table 3.2. 
3.3.2 Finalised MS and LC parameters development based on Girard’s T 
derivatisation 
The finalised LC-MS method based on Girard’s T derivatisation was able to detect 
and quantify 10 steroids in a single injection. The representative MS2 chromatogram 
is shown in Fig 3.9, where the peaks were well-resolved and had good shapes. The 
LOQ of this method was 102.4 pg/ml for all analytes, whilst its accuracy and 
precision based on QC standards is presented in the assay validation section 
(section 3.3.4). This LC-MS method was also used for the optimisation of sample 
processing (section 3.3.3). 
The 10 steroids that were quantified are corticosterone, 11-DHC, corticosterone, 
DOC, DHDOC, THDOC, progesterone, DHP, allopregnanolone, pregnanolone and 
testosterone. Three internal standards were used in this method, corticosterone-d4, 
progesterone-d9 and allopregnanolone-d5. A total run time of 19 min was required 
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to detect these 10 steroids (Fig 3.10A). In addition, a condensed gradient profile with 
a shorter run time of 10 min was developed for the detection of corticosterone and 
11-DHC only, which will be relevant in Chapter 5 (Fig 3.10B).  
The transitions monitored for MRM and optimised fragmentation parameters are 
listed in Table 3.4. The m/z of the all the precursor ions and fragment ions 
corresponded to the chemistry of the Girard’s T reaction and the fragmentation 
patterns of the Girard’s T hydrazone (Fig 3.11). Mass spectral peaks showing 
fragmentation patterns of each analyte in MS2 mode are shown in Fig 3.12.  
Even though DHT contains a carbonyl group and could be detected in MS1 mode 
during the MS optimisation stage (Table 3.3), albeit with a lower intensity, it had 
poorer signals for MS2 and could not be detected at all during LC optimisation 
stage. It was thus not included in the final LC-MS method.  
 
 
Figure 3.9: Extracted ion chromatograms of 4 ng/ml standards in 4% BSA. 
Girard’s T derivatisation resulted in double peaks for some analytes, possibly due to 
the syn and anti-configurations of the derivatisation agent. The major peak (always 
the peak that had a later retention time) was used for quantification and the ratio 
between the minor and major peak was always the same. 
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Figure 3.10: Gradient characteristics. Two gradient profiles were used in this 
thesis, one for the quantification of an entire panel of steroids (A), and the other an 
abbreviated protocol for the quantification of only corticosterone and 11-DHC (B).  
In (A) Full steroids panel: Total run time of 19 min.  -4.0 min to 0 min: 5% B, 0 min to 
1.0 min: 0% B to 45% B, 1.0 min to 6.0 min: 45% B to 50% B, 6.0 min to 11.0 min: 
50% B, 11.0 min to 12.0 min: 50% to 100% B, 12.0 min to 14.0 min, 100% B (wash), 
14.0 min – 15.0 min 100% B to 5% B.  
In (B) Corticosterone and 11-DHC only panel: Total run time of 10 min. -3.5 min to 0 
min: 5% B, 0 min to 1.0 min: 0% B to 40% B, 1.0 min to 3.0 min: 40% B to 45% B, 
3.0 min to 4.0 min: 45% B to 100%B, 4 min to 6.0 min: 45% to 100% B, 6 min to 6.5 







































A Full steroids panel
B Only corticosterone and 11-DHC

























































11-DHC 344.5 458.2 399.2 2.8  1 117; 0.80 
Corticosterone 346.5 460.2 401.1 3.5 1 117; 0.80 
Corticosterone-d4 350.5 464.3 405.1 3.5 1 117; 0.80 
Testosterone 288.4 402.2 343.1 4.4 1 117; 0.80 
DOC 330.5 444.2 385.1 4.6 1 120; 0.95 
DHDOC 332.5 446.2 387.1 6.1 2 116; 0.80 
Pregnenolone 316.5 430.2 371.1 6.3 2 116; 0.75 
THDOC 334.5 448.2 389.1 8.0 3 116; 0.55 
Progesterone-d9 323.5 437.5 368.3 8.2 3 116; 0.70 
Progesterone 314.5 428.2 369.1 8.4 3 116; 0.75 
DHP 316.5 430.2 371.1 8.6 3 116; 0.75 
Allopregnanolone 318.5 432.2 373.1 10.4 4 116; 0.70 
Allopregnanolone
-d5 
323.5 437.6 368.3 10.5 4 120; 0.75 
 
Table 3.4: Transitions monitored and optimised mass spectral settings for 
Girard’s T derivatised analytes. Derivatisation with Girard’s T reagent produced a 
precursor ion [M + G.T.]+, resulting in an addition of 114 Da to its absolute mass 
(see Figure 3.11 for chemical reaction and proposed fragmentation scheme). Upon 
fragmentation by collision-induced fragmentation, a product ion with neutral loss of 
59.1 Da (corresponding to the loss of the trimethylamine moiety) was produced, 
which was used for identification and quantification. Detection was carried out via 
multiple reaction monitoring, with no more than 5 analytes monitored for each 
segment. The width of detection was ± 2.0 m/z for the precursor ions, and ± 0.5 m/z 
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Figure 3.11: Girard’s T derivatisation and proposed fragmentation scheme. 
The reaction of the C3 carbonyl group (red circle) of corticosterone with Girard’s T 
reagent at 37oC for 30 min produces a Girard’s T-corticosterone-hydrazone, which is 
detected on the MS1 mode with a m/z of 460.2, with an addition of 114 Da to its 
absolute mass (corticosterone has a molecular weight of 346). Upon fragmentation 
by CID, a product ion with neutral loss of 59.1 Da (corresponding to the loss of the 
trimethylamine moiety) is produced, and a product ion of m/z 401.1 is detected on 
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Figure 3.12: Mass spectra in MS2 mode showing relative intensities of the 
precursor and fragment ions. Mass spectra of the corresponding chromatographic 
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3.3.3 Results of sample clean-up optimisation  
In MS1 mode, sample clean-up with Hybrid SPE resulted in higher TIC intensities as 
compared to that of C18 SPE (Fig 3.13A). As TIC quantifies the total number of ions 
that are detected at any one time and are likely to represent contaminants, C18 SPE 
is therefore a better choice due to its lower TIC intensity. In MS2 mode, the analytes 
of interest were isolated and fragmented. C18 SPE clean-up had slightly better 
responses for all analytes investigated (Fig 3.13B and C).  
 
 
Figure 3.13: Comparison of extraction methods. (A) Sample clean-up with hybrid 
SPE (in red) showed greater levels of contamination as compared to that of C18 
SPE (in blue), evident from the higher TIC intensity in the MS1 mode. (B) C18 SPE 
showed better EIC signals for almost all analytes, indicating better ionisation and 
fragmentation of analytes in the MS2 mode. Comparison is carried out using a rat 
brainstem sample spiked with 0.5 μg of steroid standards. 
  

















MS1 only (without fragmentation)A
Time (min)























C AUC MS2 mode (Arbritary units)
Chapter 3: Development of LC-MS method 130 
3.3.4 Assay performance of finalised method  
3.3.4.1 Linearity of calibration curve 
Calibration curves were linear between the range of 102.4 pg/ml to 25 ng/ml. 
Average R2-values representing the linearity of the curve are presented in Table 3.6 
and representative calibration curves are presented in Fig 3.14. Fitting of 1/X 
improved back-calculated accuracy of the standard calibrants. The intercept was 
close to y=0, however, forcing the intercept through zero for all curves improves the 
consistency of the method across different days (i.e. decreases inter-assay 
variability).  
Analyte R2 ISTD 
11-DHC 0.998 Corticosterone-d4 
Corticosterone 0.998 Corticosterone-d4 
DOC 0.998 Corticosterone-d4 
DHDOC 0.997 Progesterone-d9 
THDOC 0.994 Progesterone-d9 
Progesterone 0.998 Progesterone-d9 
DHP 0.998 Progesterone-d9 
Pregnenolone 0.998 Allopregnanolone-d5 
Allopregnanolone 0.996 Allopregnanolone-d5 
Testosterone 0.997 Corticosterone-d4 
Table 3.5: Summary of R2 values which relate to the linearity of these curves, 
alongside the internal standards used. Standard calibration curves were all fitted 
to 1/X weightage and intercept set to y=0. 
3.3.4.2 Limits of quantification 
Limits of quantification were 102.4 ng/ml for all analytes. Representative peaks of 
the lowest standards (which equates to the LOQ in this case) are presented in 
Figure 3.15, overlaid on a BSA only blank sample. In general, peaks were of good 
shape and were distinct from the blank sample, and a signal-to-noise ratio was more 
than 5, calculated by the QuantAnalysis software.  
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Figure 3.14A: 
Representative graphs 
of calibration curves 
with cortisterone-d4 as 
ISTD. Black circles 
represent each replicate 
of the standard calibrants, 
while white circles 
represent the mean of the 
two duplicates. Green 
squares represent the 













y = 1.079611 x + 0.000000
R = 0.998247
Curve Coefficients 
y = 4.053013 x + 0.000000
R = 0.998228
Curve Coefficients 
y = 1.228294 x + 0.000000
R = 0.998816
Curve Coefficients 
y = 1.255442 x + 0.000000
R = 0.997583
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Figure 3.14B: 
Representative 
graphs of calibration 
curves with 
progesterone-d9 as 
ISTD. Black circles 
represent each replicate 
of the standard 
calibrants, while white 
circles represent the 
mean of the two 
duplicates. Green 
squares represent the 













y = 1.856349 x + 0.000000
R = 0.999869
Curve Coefficients 
y = 2.658723 x + 0.000000
R = 0.997284
Curve Coefficients 
y = 3.963191 x + 0.000000
R = 0.993225
Curve Coefficients 
y = 3.967538 x + 0.000000
R = 0.993532
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Figure 3.14C: Representative graphs of calibration curves with 
allopregnanolone-d5 as ISTD. Black circles represent each replicate of the 
standard calibrants, while white circles represent the mean of the two duplicates. 







y = 1.771621 x + 0.000000
R = 0.999692
Curve Coefficients 
y = 1.406034 x + 0.000000
R = 0.999331
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Figure 3.15: Representative peaks at limit of quantification. Peaks (coloured) at 
the LOQ, 102.4 ng/ml for all analytes, overlaid on a BSA only sample (grey). Signal-
to-noise ratio was more than 5, as calculated by the QuantAnalysis software. The 
dotted line represents the line drawn for manual integration of peaks to obtain AUC. 
For most analytes, LOD could be lowered if standards were further diluted, while 
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3.3.4.3 Recovery  





QC Low QC Mid QC High 
Corticosterone 74 71 84 
DOC 78 72 92 
DHDOC 95 82 108 
Progesterone 71 80 83 
DHP 73 70 82 
Pregnenolone 88 81 95 
Allopregnanolone 88 87 94 
Testosterone 95 105 106 
Table 3.6: Recovery of steroid analytes following C18 SPE. Recovery was 
investigated by spiking low (50 pg), mid (200 pg) or high (800 pg) amounts of steroid 
standards before and after C18 SPE into 4% BSA.  
3.3.4.4 Accuracy 




QC Low QC Mid QC High 
Corticosterone 114 103 99 
11-DHC 105 104 102 
DOC 100 95 92 
DHDOC 91 76 62 
THDOC 95 67 63 
Progesterone 125 125 108 
DHP 101 98 85 
Allopregnanolone 117 119 110 
Pregnenolone 116 132 118 
Testosterone 97 84 79 
Table 3.7: Accuracy of the quantification. Accuracy was determined in low (500 
pg/ml), mid (2 ng/ml) and high (8 ng/ml) concentrations of quality control (QC) 
standards. Accuracy was calculated as the concentration/theoretical concentration x 
100%.  
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3.3.4.5 Variability 














QC Low 14.0 10.6 12.3 15.6 
QC Mid 9.8 5.2 3.0 8.0 
QC High 10.0 7.0 5.8 11.7 
11-DHC 
QC Low 7.6 12.8 9.4 10.6 
QC Mid 4.4 5.7 6.3 9.7 
QC High 8.1 5.0 7.0 9.7 
DOC 
QC Low 4.3 12.8 6.8 7.6 
QC Mid 3.7 5.7 3.4 4.8 
QC High 6.0 5.0 10.2 10.7 
DHDOC 
QC Low 0.9 14.0 9.9 17.3 
QC Mid  17.9 23.3 12.9 28.5 
QC High 10.2 24.3 6.1 16.8 
THDOC 
QC Low 8.9 4.4 8.5 11.5 
QC Mid 19.4 17.7 15.6 26.6 
QC High 12.3 16.7 9.9 21.1 
Progesterone 
QC Low 7.5 11.7 8.7 19.5 
QC Mid 14.2 6.5 13.6 16.2 
QC High 7.3 22.5 8.9 25.1 
DHP 
QC Low 9.0 11.2 11.4 22.1 
QC Mid 9.0 15.5 7.7 18.3 
QC High 4.2 28.0 8.1 28.2 
Allopregnanolone 
QC Low 2.7 10.7 4.2 11.2 
QC Mid 2.4 2.9 5.9 5.1 
QC High 5.2 5.7 5.7 7.8 
Pregnenolone 
QC Low 5.7 12.6 5.4 14.1 
QC Mid 3.3 13.3 5.6 14.3 
QC High 6.9 15.1 4.8 14.9 
Testosterone 
QC Low 4.5 18.3 7.5 13.9 
QC Mid 9.8 5.3 5.1 10.7 
QC High 2.1 11.7 7.4 11.1 
Table 3.8: Intra-assay, inter-assay, injection-to-injection and total variability. 
Three independent samples from each concentration (QC Low, 500 pg/ml; QC Mid, 
2000 pg/ml; or QC High, 8000 pg/ml) were used to assess variability, for samples 
that underwent SPE, derivatisation and LC-MS analysis on the same day (intra-
assay) or on different days (inter-assay). Injector reproducibility assesses the 
variability present between duplicates. Total variability assesses variation across the 
different individual injections irrespective of day of injection.  
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3.3.5 Application of the method in rat plasma and brain tissues  
An initial LC-MS method was applied to the quantification of neuroactive steroids in 
rat brain samples where concentrations are expected to be different, as proof-of-
concept that the method can be successfully implemented in biological applications. 
Whilst detailed results of the measurements can be found in the published paper 
(Sze et al., 2018; Appendix B), several main findings are summarised here.  
Firstly, the results from both validation assays, in this thesis (in section 3.3.4) and 
the initial published paper (Appendix B) are similar and are both within acceptable 
limits, indicating the consistent performance of this LC-MS method despite small 
modifications to the method. 
Secondly, the published LC-MS method (Sze et al., 2018) was able to detect 
expected patterns of increase in neuroactive steroids following stress, as well as 
detect sex differences in hormone concentrations. It confirmed earlier reports using 
male rats by Purdy et al. (1991) and Vallée et al. (2000) that there is a robust 
increase in the concentrations of neuroactive steroids, especially pregnenolone and 
allopregnanolone, in the brain following acute stress. Expected sex differences in 
absolute steroid concentrations were also observed, where testosterone 
concentrations was far greater in the males in the plasma and all brain regions, 
while for other hormones such as pregnenolone and progesterone, the 
concentrations were clearly greater in the females. Moreover, when the values were 
compared to published data from other groups (Table 3.9), most of the values were 
close to these previously published. Given these observations, the LC-MS method 
can be considered to be biologically validated.  
Lastly, apart from replicating these previous data, other notable findings include the 
observation that whilst steroid precusors such as progesterone and DOC showed an 
increase in the plasma, this was not the case for downstream steroids such as DHP 
and DHDOC, where the increase was only found in brain regions, reflecting the 
observation that neuroactive steroids can be synthesised de novo in the brain. This 
was also the first time that neuroactive steroids such as DHP and DHDOC was 
quantified after acute stress, and the results showed that these changes following 
stress were also not uniform across the brain regions, and sex differences were 
observed. As the biological significance of these results are not a highlight with 
respect to the aims of this chapter, which focuses on the LC-MS method, these are 
elaborated in Appendix B.  
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A Male Cortex Sze Caruso Vallée 
Tobi- 
ansky Park Meffre 
 Pregnenolone 1.3 4.5 0.3 - 1.5 4.9 
 Progesterone 1.7 1.4 - - n.d. 0.4 
 DHP 0.5 8.4 - - n.d. 0.8 
 Allopregnanolone n.d. 3.6 0.1 - n.d. 0.4 
 Testosterone 2.2 4.0 - 0.9 - 1.4 
 Corticosterone 10 - - 25 10 50.1 
 DOC 1.2 - - - 0.1 - 
        
B Male Plasma Sze Caruso Vallée 
Tobi-
ansky Park Meffre 
 Pregnenolone 5.5 0.4 n.d. - n.d. 0.58 
 Progesterone 0.7 0.61 - - 1.5 2.17 
 DHP 2.5 2.15 - - n.d. n.d. 
 Allopregnanolone 0.2 0.23 0.1 - 0.1 n.d. 
 Testosterone 1.0 3.08 - 1.5 - 1.24 
 Corticosterone 32 - - 100 120 54.4 
 DOC 0.21 - - - 2.5 - 
        
C Female Cortex Plasma  Sze Caruso Meffre Sze Caruso Meffre 
 Pregnenolone 2.7 6.6 9.0 9.9 0.8 0.5 
 Progesterone 7.2 11.4 25.0 9.8 12.3 25.0 
 DHP 1.2 9.0 50.0 2.3 2.2 6.0 
 Allopregnanolone 0.6 4.2 3.0 3.8 1.6 3.5 
 Testosterone n.d. 0.0 - n.d. n.d. - 
 Corticosterone 19 - - 154 - 100 
        
D Male with and without 
swim stress 
Sze Vallée  
 Basal Stress Basal Stress  
 Pregnenolone Plasma  5.5 7.0 n.d 0.1  
 PFC 1.30 8.6 0.3 7.0  
 Allopregnanolone Plasma  0.18 0.3 0.1 1.5  
 PFC <0.1 0.3 0.1 1.3  
Table 3.9: Comparison of neuroactive steroid measurements from Sze et al. 
(2018) and other studies. Values are in ng/ml for brain measurements and ng/ml 
for plasma measurements. Concentrations of neuroactive steroids are different 
between cortex and plasma, and a sex difference can be observed, even at basal 
conditions (comparing panel A, B with C). Stress also increases the concentrations 
of neuroactive steroids in both plasma and prefrontal cortex (PFC) (Panel D). 
Previous studies utilised GC-MS (Meffre et al., 2007, Vallee et al., 2000) or LC-MS 
(Caruso et al., 2010, Tobiansky et al., 2018, Park et al., 2017) to quantify steroids.  
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3.4 DISCUSSION  
3.4.1 Main findings of this chapter 
The aim of this chapter was to develop and validate a method which allows for the 
reliable and simultaneous quantification of a panel of neuroactive steroids in the rat 
brain. The LC-MS assay presented in this chapter could successfully quantify 10 out 
of the 14 steroids initially intended for measurement, namely corticosterone, 11-
DHC, DOC, DHDOC, THDOC, progesterone, DHP, allopregnanolone, pregnenolone 
and testosterone. DHT, 3α- and 3β-diol and oestradiol unfortunately could not be 
detected using this method, as carbonyl groups (which the GABA modulatory 
steroids allopregnanolone and THDOC, as well as its precusors possessed) were 
targeted for derivatisation. Chromatographic peaks were well-separated with good 
peak shapes, and the accuracy and precision of the assay is within acceptable 
limits. The method was also biologically validated using rat plasma and brain 
samples (section 3.3.5; Sze et al., 2018; Appendix B), where it was confirmed that 
the method can detect expected differences in neuroactive steroid concentrations 
between different groups (i.e. with and without stress, and in different sexes). 
This LC-MS method is valuable in that it allows for the direct examination of 
changes in concentrations of neuroactive steroids in the rat brain, which is the 
location in which they exert their actions. Measuring a panel of steroids can also 
allow for one to investigate how concentrations of different metabolites change in 
relation to each other. Methods that can quantify a similar, but not identical, panel of 
neurosteroids have been developed previously, using GC-MS (Meffre et al., 2007) 
and LC-MS (Park et al., 2017) albeit using different sample processing and 
detection methods. Values obtained in the biological validation study closely aligned 
to these previous studies. Whilst most of these previous methods have focussed on 
quantifying the GABAA-modulating steroids allopregnanolone and THDOC, the 
method presented in this thesis also additionally considered DHP and DHDOC, the 
5α-intermediate of progesterone and DOC, which can allow one to indirectly 
determine the activity of the enzymes 5α-reductase and 3α-HSD, thereby giving a 
more complete picture of steroid metabolism in different physiological states.  
Most importantly, the successful development and validation of this in-house LC-MS 
assay within the Roslin Metabolomics Facility is the first step towards elucidating the 
role of steroids in mediating the outcomes of prenatal stress, the focus of this thesis. 
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Notably, the biological validation study with acute swimming stress as a 
manipulation also suggest that it is promising form of acute stress model to use to 
assess the response of several neuroactive steroids, which laid the foundation of 
designing studies that incorporate both acute and prenatal stress in the subsequent 
chapters. Nonetheless, as of all quantification methods, this LC-MS method is not 
without its limitations, which will be elaborated in this section. 
3.4.2 Assay performance 
The sensitivity of the assay was adequate to detect almost all neuroactive steroids 
in the rat brain. Peak shapes were also generally satisfactory at the LOQ, although 
certain steroids performed better than the others (e.g. LOQ of THDOC was its 
potential LOD, while corticosterone could have lower LOQs). Any further 
improvement of the LOQ (sensitivity) may require drastic changes to the 
instrumentation. For instance, the same C18 column of a smaller internal diameter 
(0.5 mm) was also tested as part of the method optimisation process. Although the 
signal intensity was amplified, the change also introduced variability that needed to 
be compensated by introducing more modifications to the entire instrumental set-up, 
which was not logistically feasible. For the same reason, other columns such as 
phenyl columns, which were thought to be able to provide better resolution were 
also purchased, but were not tested. Ultimately, the main limiting factor in the study 
is the mass spectrometer that is available for LC-MS analyses in the facility. Whilst 
the ion trap Amazon ETD mass spectrometer is a robust workhorse instrument, it 
has shortcomings as compared to more sensitive equipment such as a triple 
quadrupole instrument, which is able to monitor transitions for a longer period of 
time, and is more commonly used as the mass spectrometer of choice for such 
MS/MS targeted analysis. 
Three forms of variability were assessed in the validation procedure (section 3.3.4). 
In general, variability was within limits (15%) for most analytes. As a multistep 
procedure, it is often difficult to pinpoint the exact points in which variability has been 
introduced. Injection-to-injection variability suggests that inherent fluctuations in the 
performance of the LC-MS itself exist, and this can often be due to subtle changes 
like temperature or ion source pressure, which are difficult or impossible to control 
(Stokvis et al., 2005). Intra- and inter-assay variation on the other hand suggests 
that despite precautions, certain aspects of sample processing and derivatisation 
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may also have contributed to some of the variability. Whilst the intra- and inter-assay 
variation did not have a cumulative effect on each to other, in general, the inter-
assay variation seemed to be greater than intra-variation for most analytes, which 
accounted for most of the total variation reported for each analyte (Table 3.8).  
One of the key problems could have been the stability of the analyte. Steroids are 
generally heat-stable and can withstand heating of up to 60oC (Taves et al., 2011), 
and none of the procedures in this LC-MS method involved high heat, therefore it is 
unlikely that steroids would have been degraded during sample processing. 
However, the problem could lie with the stability of the final derivatised product. 
Whilst previous studies have determined that the derivative is stable for 30 min at 
room temperature (Cobice et al., 2013), batch runs in the LC-MS assays here could 
take up to 18 hours, therefore it is not known whether the Girard’s T derivatives 
would have degraded in the autosampler on a longer time scale. Nonetheless, in a 
batch run, effects to minimise this source of variability were taken, where samples 
were reconstituted and loaded into the autosampler in batches, with different 
treatment groups well-represented in each batch. Additionally, the purchase of a 
refrigerated autosampler halfway through the method development process aided 
sample stability.  
3.4.3 Girard’s T derivatisation  
Girard’s T derivatisation was fundamental to the success of the assay. Girard’s T 
reagent is cheap and extremely stable at room temperature, and the reaction was 
quick and easy to perform, requiring only a 30 min incubation on a heat block. 
Neutral steroids were converted to positively-charged hydrazones, which 
augmented their ionisation drastically, giving an intense precursor ion signal. 
Additionally, when Girard’s T hydrazones are fragmented, the specific transition of 
[M]+ à [M-59]+ always occurred (Wood, 2017). These advantages have rendered 
Girard’s T derivatisation to be a fairly popular method, and several other studies 
have also utilised this form of derivatisation (Cobice et al., 2013, Cobice et al., 2016, 
Dury et al., 2016, Lavrynenko et al., 2013, Johnson, 2005). However, as of all 
derivatisation agents, the use of it is not without its drawbacks.  
Firstly, as can be seen in our chromatogram (Fig 3.9), the Girard’s derivatisation 
reaction is not stereospecific, and syn- and anti-isomers are introduced, resulting in 
two peaks. This is not surprising and has been observed in other studies utilising 
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Girard’s reagents (DeBarber et al., 2011, Karu et al., 2007). However, the ratio 
between the smaller and the larger peak is always the same, and the larger peak is 
always used for quantification. In our case, the smaller peak did not interfere with 
any other peaks. The calibration curves were always linear, which indicated that 
derivatisation reaction occurred in the same manner, with the same stoichiometric 
ratio, even with differing steroid concentrations. 
Secondly, the Girard’s T reaction itself although straightforward, poses an inherent 
problem that could have contributed to the variability of the assay. Whilst the forward 
reaction of forming a hydrazone required an acid catalyst, the reverse reaction of 
hydrolysis occurs when a strong acid is present (Wheeler and Rosado-Lojo, 1962). 
The acid content of the reaction thus needs to be carefully controlled. Optimal 
catalytic conditions were determined to be 0.2% formic acid, which was strong 
enough to catalyse the forward reaction, but at the same time, does not allow for too 
much hydrolysis. Additionally, a neutralising step was added where ammonium 
hydroxide was added at the end of the 30 min incubation. This not only quenches 
the reaction, ensuring that yield is consistent in all samples, but also limits the 
hydrolysis of the formed derivative. The pH was checked to ensure that the final 
product was neutral. 
The third potential problem with Girard’s T derivatisation is the possibility of having 
multiply-derivatised compounds. Some analytes possess three carbonyl groups (11-
DHC), and some possess two carbonyl groups (e.g. corticosterone, DOC, DHDOC, 
progesterone and DHP). However, this has been checked and it was confirmed that 
no major peak could be detected for double- or triple-derivatised compounds on 
MS1 mode. Wheeler and Rosado-Lojo (1962) also showed that there were 
differential reaction efficiencies for different ketone groups (Wheeler and Rosado-
Lojo, 1962). The reaction was complete for 3-ketones and Δ4,5 -3-ketones, partially 
complete for 20-ketones and incomplete for 11-ketones. As such, it is probable that 
mono-derivatisation occurred in each instance, with one only ketone group being 
preferentially derivatised as long as the acidity is controlled. Studies have indeed 
shown that with controlled acidity, mono-derivatisation instead of di-derivatisation is 
likely to have occurred (Johnson, 2005).   
While the additional derivatisation steps complicate sample preparation and 
introduces more potential areas of errors and may not be ideal for detecting all 
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analytes, it is worth highlighting again that the optimised Girard’s T derivatisation in 
this study enhanced MS2 EIC signals for the steroids of interest more than 100-fold. 
Thus, these drawbacks associated with derivatisation seem like an inevitable 
compromise in light of the drastically improved sensitivity.  
3.4.4 Specificity 
Specificity in detecting an analyte is determined based on three criteria, the 
retention time, the precursor mass, and the transition. However, steroid isomers 
exist in the study (e.g. pregnenolone and DHP have the same precursor mass and 
transition), thus the assessment of specificity for these analytes relies largely on 
retention time. The retention time was checked for each individual analyte in every 
sample to ensure that it conformed closely to that of the standard peaks. Each 
chromatographic peak was also visually inspected to ensure that there are no split 
or riding peaks, which can indicate the presence of stereoisomers (Ahonen et al., 
2013) . Although stereoisomers were not formally investigated in this study, it is 
likely that Girard’s T derivatisation would result in stereoisomers possessing a 
different elution time from one another. For example, in Dury’s method, which used 
a similar gradient profile to separate Girard’s T derivatised steroids, all isomers of 
pregnanolone (including allopregnanolone, epipregnanolone and 
epiallopregnanolone) were well-separated without any interference or riding peaks 
(Dury et al., 2016). Here, in the preliminary experiments using the derivatisation 
agent DMABC (data not shown), 3α- and 3β-diol could also be successfully 
separated, adding weight to the concept that LC, with derivatisation, has the ability 
to separate stereoisomers. 
Nonetheless, the detection of a few of these stereoisomers could be a future line of 
work, as studies have shown that concentrations of stereoisomers might be altered 
differentially following experimental manipulations. For example, differential 
concentrations of 3α,5α- and 3α,5β-reduced neuroactive steroids were observed 
after exogenous administration of neuroactive steroid precursors such as 
pregnenolone (to rats) and progesterone (to women) (Porcu et al., 2009). It is 
therefore likely that following an acute stressor, such differences would be observed 
as well, which could have physiological consequences.  
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3.4.5 Detection of other remaining steroids 
DHT, oestradiol, and 3α- and 3β-diol could not be detected using this Girard’s T 
method. DHT has a carbonyl group, thus it is likely that the prevailing derivatisation 
and LC-MS conditions were not ideal for its reaction and detection. Formation of a 
DHT-Girard hydrazone may require a stronger acid catalyst (e.g. 1% TFA) (Tamae 
et al., 2013), however, 3-ketones are also reported to undergo hydrolysis to a 
greater rate than the Δ4,5 -3-ketones, 17-ketones and 20-ketones (Wheeler and 
Rosado-Lojo, 1962). Thus, the problem may have arisen from a combination of 
lower yield from the reaction, but also increased hydrolysis, rendering DHT-Girard T 
hydrazones undetectable. Thirdly, it may also be plausible that the ionisation 
method employed in this LC-MS method may not be suitable for the DHT-Girard 
compound, as the Girard’s T derivatised DHT could be detected using mass spectral 
imaging on tissue sections (Cobice et al., 2016). 
Nevertheless, using the workflow in section 3.1.3, the expertise gained from the 
development of this method can be used in the future to screen and develop a 
method using other derivatisation agents to detect these other steroids of interest. 
Dansyl chloride for example, has been widely used to detect oestradiol and its 
metabolites (Faqehi et al., 2016). In the derivatisation screening experiment, DnCl-
derivatised oestradiol indeed show remarkably intense MS1 EIC signals as 
compared to non-derivatised oestradiol (Table 3.3). However, this was not pursued 
as the detection of oestradiol alone was not a main focus of this study.  
3.4.6 Matrix effects 
Matrix effects refer to how the co-eluting components in the biological matrix may 
alter the behaviour of the analytes of interest, thereby impacting the accuracy of the 
assay. There are two ways in which matrix effects can be investigated, firstly by 
comparing the AUC of an analyte in the matrix (e.g. brain tissue) versus the AUC of 
the analyte in a neat solution (e.g. in methanol only), or by post-column infusion, 
where the analyte of interest is infused in a steady stream whilst the matrix is being 
eluted through the column. Points on the elution profile where unexpected dips (i.e. 
ion suppression) or peaks (i.e. ion enhancement) occur would indicate matrix 
effects. Although these matrix effects were not formally investigated in this study, 
efforts were made to reduce the impact of these potential effects in this study by the 
addition of internal standards.  
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The ideal internal standard is a stable isotopically labelled analogue of the analyte, 
usually 13C or deuterium (2H), which elutes at the same time and is subject to the 
same matrix effects as the analyte (Makin, 2010). Deuterated standards should 
have three or more deuteriums replacing hydrogens (i.e. D3 and above), in order to 
prevent interference with naturally-occuring isotopes (Stokvis et al., 2005). Although 
each analyte should theoretically be accompanied by an isotopically labelled internal 
standard, this is not always possible in reality. Deuterated internal standards are 
costly, and may not always be commercially available for every single compound. 
Moreover, addition of more internal standards increases the possibility of signal 
interference. For example, DHP-d8 was initially also included as an internal 
standard in this method, however, as DHP-d8 eluted closely to and had a molecular 
weight that is only 1 Da away from progesterone-d9, riding peaks were observed 
where their naturally occurring isotopes interfered with each other. Addition of an 
internal standard in itself therefore does not guarantee a reliable method and may in 
fact introduce more inaccuracies and variability.  
Therefore, the general consensus is that the use of few internal standards that elute 
at different parts of the run, with properties corresponding to the properties of a few 
key analytes, is generally sufficient for a LC-MS method. Upon reviewing the initial 
method which was published in Sze et al. (2018), two additional internal standards 
were added to the method, corticosterone-d4, which elutes earlier on in the gradient 
profile and allopregnanolone-d5, later on in the gradient profile, which should render 
it more robust than the previously published method. 
3.4.7 Sample processing 
The sample clean-up method of C18 SPE was better than the Hybrid SPE 
phospholipid removal method, evident from the greater signal intensity of target EIC 
peaks, and the decreased presence of contaminants and background noise. One 
drawback of the C18 SPE method is that the sample processing method is fairly 
laborious as compared to the Hybrid SPE method, and multiple steps could increase 
the chance of steroids being lost at each stage. However, the assay validation 
showed that the recovery was satisfactory (71-108%).  
Comparing the starting material required, this method also required far less starting 
material than several other published methods. The method presented here only 
required 100 µL of plasma as compared to the 300 µL previously needed to profile a 
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similar panel of steroids (Porcu et al., 2009). For the rat brain, the minimum starting 
material required here (20 mg) was also lower compared to some other protocols, 
some of which required 100 mg of tissue (Caruso et al., 2008). However, recently, a 
method requiring only 3 mg of starting material was developed in which micro-
dissected brain samples of mesocorticolimbic areas was used for LC-MS 
quantification of steroids (Tobiansky et al., 2018). Although such low amounts of 
starting material were not attempted here, micro-dissection, which ostensibly offers 
more regional specificity than the gross dissection used in this protocol, could be a 
further refinement to the current sample processing and tissue collection method.  
3.4.8 Conclusions and future work 
Despite these limitations, neuroactive steroids could still be successfully quantified 
in the rat brain in a physiologically relevant manner (Sze et al., 2018, Appendix B), 
and the absolute values for most steroids were close to those reported by other 
laboratories (Table 3.9). Intra-laboratory variations still exist, as LC-MS is far from a 
perfect technique and its successful implementation requires great care and 
attention to detail, which may be difficult to standardise across different laboratories 
(Taylor et al., 2015). Nonetheless, optimisation of the LC-MS method is a reiterative 
and constantly ongoing process, and various aspects of the method can always be 
subject to constant modifications and improvements. Although major changes like 
the changing of mass analysers to newer and more sensitive models are not always 
financially viable, small changes can be made, e.g. procuring guard columns for the 
LC-MS to improve column performance. 
Given that there is a limit to the number of analytes a targeted analysis approach 
can reliability quantify, a possible next step could be to extend this targeted steroid 
profiling to an untargeted omics strategy to study steroid metabolism in a more 
holistic manner. Although a MS-based “steroidomics” requires a different workflow 
and also the processing of large datasets, certain aspects such as sample 
processing to extract steroids, LC separation and MS detection are all based on the 
same fundamental understanding of steroid chemistry and the basic principles of LC 
and MS that this work was based on (Jeanneret et al., 2016). 
As a concluding note, even with precautions in place to ensure better performance 
of the method, a much more complex issue at the heart of LC-MS quantification in 
biological applications is that experimental manipulations or physiological states 
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would not only alter the analyte of interest, but may also alter the concentration of 
any co-eluting compounds. The nature of LC-MS means that even with the best 
equipment and ability to quantify multiple analytes, there is always an inevitable and 
disconcerting possibility that differences could be caused by other unknown 
compounds augmenting the signal intensity of the analytes of interest, rather than 
changes in the actual concentrations of the analytes of interest per se. Therefore, 
rather than attempting to develop an impeccable method, it is perhaps more 
practical to place these measurements in a biological context and focus on 
interpreting the results with these caveats in mind, instead of taking them at face 
value. The rest of the thesis is therefore focussed on the application of this method 
to quantify steroids and thereby investigate their role in the regulation of different 
physiological states (e.g. following acute stress or the long-term effects of prenatal 
stress)
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4.1 INTRODUCTION  
In the previous chapter, a LC-MS method was developed and validated for the 
quantification of a panel of neuroactive steroids. In this chapter, the method was 
used to quantify neuroactive steroids in the plasma and brain of control and PNS 
offspring, with and without an additional acute stressor. The acute stressor used in 
this chapter was swimming stress, replicating the procedure used in the biological 
validation study in the previous chapter.   
4.1.1 Conceptualisation of this study 
The conceptualisation of this study was based on three previous observations from 
experiments in the Brunton laboratory. These observations, summarised in Figure 
4.1, were: (i) HPA axis regulation is altered in PNS offspring, (ii) Neuroactive steroid 
concentrations increase rapidly and robustly following acute swim stress, and (iii) 
neuroactive steroid production seems compromised in PNS offspring, and treatment 
with neuroactive steroids rescues the HPA axis dysregulation present in PNS 
offspring. This led to the hypothesis that HPA axis dysregulation in the PNS 
offspring could be explained by compromised levels of neuroactive steroids in the 
brain at baseline, and following acute stress.  
 
Figure 4.1: Relationship between prenatal stress, responses to acute stress 
and neuroactive steroids. While the relationship between these three factors have 
been determined in separate studies, neuroactive steroids have never been directly 
quantified in the PNS offspring, either basally or following an acute stressor, and not 
in the same experiment.  
Acute stress
Prenatal stressNeuroactive steroids
PNS offspring have greater HPA axis 
responses to acute stress
(IL-1β and restraint stress)
(Brunton and Russell, 2010, 
Brunton et al., 2015)
Neuroactive steroids are produced 
rapidly following an acute stressor
(swim stress) (Purdy et al., 1991, 
Vallée et al., 2000, Sze et al., 2018)
PNS offspring seem to have 
compromised neurosteroidogenic
 enzyme expression (basal)
(Brunton et al., 2015)
Neuroactive steroid 
adminstration can rescue 
aberrant HPA axis reponse to 
stress (IL-1β adminstration) in PNS 
offspring (Brunton et al., 2015)
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4.1.1.1 HPA axis regulation is altered in prenatally stressed (PNS) offspring: 
HPA axis dysregulation has been well studied in this prenatal social stress model, 
mainly through repeated blood sampling experiments where one could obtain time-
course information on plasma ACTH and corticosterone concentrations following an 
acute stressor. In general, plasma ACTH and corticosterone response to acute 
stressors in adulthood are greater in the PNS offspring, in response to systemic IL-
1β administration, a physical stressor (Brunton et al., 2015, Brunton and Russell, 
2010), and restraint stress, a psychogenic stressor (Brunton and Russell, 2010). 
In these previous studies, there were no differences in basal ACTH and 
corticosterone secretion between male control and PNS rats. In females, the pattern 
was less clear, as female PNS rats had higher basal ACTH and corticosterone 
concentrations in some experiments (Brunton and Russell, 2010), but not in others 
(Brunton et al., 2015). Following both forms of acute stress, the absolute 
concentrations of ACTH and corticosterone were always greater in PNS groups as 
compared to control groups, in both males and females. As repeated blood sampling 
was carried out, the amplitude of the response (i.e. delta value from baseline) and 
the duration of the response could also be investigated. Both the amplitude and the 
duration of the ACTH and corticosterone response were greater in PNS males 
compared to controls. In females, although the absolute values of ACTH and 
corticosterone concentrations were always higher in PNS groups, there were 
instances where the amplitude (i.e. delta value) of the corticosterone response was 
not always greater than controls, possibly due to the higher baseline levels (Brunton 
et al., 2015).  
Discrepancies between studies are likely due to individual differences in stress 
responses in the dam following social stress, which then translates to possible 
variations in the epigenetic programming of the offspring prenatally, as well as 
possibility of variations in post-natal maternal care, leading to differential outcomes 
in the offspring during adulthood (Claessens et al., 2011, Boersma and Tamashiro, 
2015). Although these previous experiments were carried out in the same facility, 
they were carried out in different time periods with different batches of rats. It is 
possible that between these batches of rats, subtle environmental differences were 
present, which can result in different microbiota in different groups of rats, which is a 
strong influencing factor that may may inadvertently affect corticosterone 
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concentrations both basally and in response to stressors (Franklin and Ericsson, 
2017). 
4.1.1.2 Neuroactive steroid concentrations are rapidly increased following 
acute swim stress in rats 
Forced swim was shown in the previously published study (Sze et al., 2018) as well 
as in several other rat studies (Vallee et al., 2000, Purdy et al., 1991) to induce a 
robust increase in both corticosterone and other neuroactive steroids in the brain of 
control rats. Acute swim stress is a potent combined physical and psychogenic 
stressor that results in various physiological, endocrine, and immune changes (Abel, 
1993, Connor et al., 1997). Previous studies have reported an increase in plasma 
corticosterone and allopregnanolone within 5 min of the onset of a swim stress 
session, along with an increase in plasmatic prolactin, ACTH, and glucose (Abel, 
1993, Purdy et al., 1991, Armario et al., 1995). Swim stress also results in 
widespread activation of various brain regions, including stress responsive nuclei in 
both the forebrain and the hindbrain (Cullinan et al., 1995).  
In the previous acute swim stress experiments, the increase in allopregnanolone 
and pregnenolone in the brain also occurred prior to the increase in the plasma, 
indicating that these neuroactive steroids are likely to be produced within the brain 
after stress rather than entering from the periphery (Purdy et al., 1991). It appears 
that whilst upstream neuroactive steroids such as progesterone, DOC, and 
corticosterone are produced by the adrenal gland and then transported into the 
brain, GABAA-active steroid metabolites are produced de novo in the brain, as 
strong correlations between the plasma and the brain were observed for the 
precursors but not the metabolites (Sze et al., 2018). Although it is not known 
whether acute swim stress would result in similar hyperactivity of the HPA axis in 
PNS offspring, for these above reasons, forced swim was used to induce stress in 
this study.  
4.1.1.3 Neuroactive steroid production may be compromised in PNS offspring  
Alterations in neuroactive steroid production could be one of the mechanisms by 
which the aberrant HPA axis responses to stress in the PNS offspring occur. In 
previous studies carried out using the prenatal social stress model (Brunton et al., 
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2015), three lines of evidences suggested that neuroactive steroid production could 
be affected in the brains of males and female PNS rats.  
Firstly, mRNA expression of 5α-reductase type 1 was altered. In males, PNS 
offspring had decreased 5α-reductase type 1 mRNA expression in the PVN and the 
NTS, but increased expression in the prefrontal cortex, the islands of Calleja (ICj) in 
the ventral striatum, and dorsal part of lateral septum as compared to control males 
(Brunton et al., 2015). In females, a similar decrease in 5α-reductase type 1 mRNA 
expression was observed in the NTS, whilst an increase in the ICj was observed 
(Brunton et al., 2015). 3α-HSD mRNA expression on the other hand, was not 
affected in either males or females in any of the brain areas investigated.  
Secondly, upregulating 5α-reductase type 1 and 3α-HSD mRNA expression in the 
NTS via adenoviral-mediated injection to PNS female rats rescued the aberrant HPA 
axis ACTH and corticosterone responses to IL-1β administration (Brunton et al., 
2015). Thirdly, aberrant HPA axis responses to IL-1β administration were also 
rescued when neuroactive steroids were administered 20 and 2 hr prior to acute 
stress exposure (female rat offspring were pre-treated with allopregnanolone, whilst 
male rat offspring were pre-treated with 3β-androstanediol) (Brunton et al., 2015).  
Together, these observations indicate that in this model of prenatal stress, there 
appear to be deficits in neuroactive steroid production (especially the 3α,5α-reduced 
GABAA positive modulatory steroids) in the offspring following stress exposure, 
which may underlie the heightened ACTH and corticosterone responses following 
IL-1β administration. However, neuroactive steroid concentrations have never been 
directly measured. It was therefore the aim of this study to measure neuroactive 
steroid concentrations in the brain of control and PNS rats under basal conditions 
and following exposure to acute stress, in tandem with plasma corticosterone (as a 
readout of the HPA axis), to reveal if there are indeed deficits in 
neurosteroidogenesis that may be related to the changes in steroidogenic enzyme 
expression mentioned above.  
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4.1.2 Neuroactive steroids investigated in this chapter 
The nine steroids quantified in this study were: corticosterone, DOC, DHDOC, 
THDOC, progesterone, DHP, allopregnanolone, pregnenolone and testosterone. 
The significance of quantifying each steroid in the plasma and the brain, with 
respect to stress responses, are reviewed in this section. 
Corticosterone: Plasma corticosterone was quantified in this study as a readout of 
HPA axis responsiveness. Brain corticosterone concentrations were also quantified 
as they have a role in various processes such as activation of the HPA axis, 
negative feedback mechanisms, or memory processing, depending on the brain 
region (Osborne et al., 2015, Sapolsky et al., 2000). In the rat brain, most of the 
corticosterone in the brain is of adrenal origin, although local concentrations can 
also be altered by the action of 11β-HSD1 and 11β-HSD2 (section 1.3.2.2) (Ye et 
al., 2008). It has been established that female rats generally have higher 
concentrations of basal plasma corticosterone, and also secrete larger amounts of 
corticosterone following acute stress (Sze et al., 2018, Handa et al., 1994, Tinnikov, 
1999). In control rats, it has been established that despite sex differences in the 
plasma, it did not seem like sex differences were present in the brain following 
stress, except for the brainstem (Sze et al., 2018), probably due to females having 
greater CBG concentrations (Gala and Westphal, 1965).   
Pregnenolone: Pregnenolone was quantified in this study as it is the precursor of 
all neuroactive steroids, and any changes in pregnenolone concentrations may point 
to changes in the efficacy of the p450scc enzyme, and may have consequences on 
levels of downstream steroid metabolites. It has been difficult to draw conclusions 
about pregnenolone’s effect on the HPA axis from experiments involving the 
exogenous administration of pregnenolone or trilostane (a 3β-HSD inhibitor) to rats, 
as its effects are confounded by both its metabolism to excitatory steroids (such as 
pregnenolone sulfate and DHEA), and also inhibitory steroids such as GABAA-
enhancing progesterone metabolites (Naert et al., 2007). Nonetheless, 
pregnenolone itself is generally considered to be inactive on GABAA receptors 
(Harrison et al., 1987). In previous studies on control rats, acute swim stress did not 
increase pregnenolone levels in the plasma, however, an robust increase was 
observed in the brain (Vallee et al., 2000, Sze et al., 2018), and a sex difference 
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exists where females show greater pregnenolone concentrations in all brain regions 
(Sze et al., 2018) (Appendix B).  
Deoxycorticosterone (DOC): Deoxycorticosterone was quantified in this study as it 
is able to participate in stress responses possibly through binding to MR and GR, 
and also by conversion to the downstream GABAA-enhancing metabolites DHDOC 
and THDOC, which are involved in stress responses (Reddy, 2006). DOC 
concentrations are increased robustly in both the plasma and in the brain following 
swim stress in control rats (Sze et al., 2018) (Appendix B). Similar to corticosterone, 
its secretion is also under the control of ACTH and it is produced mainly in the zona 
fasciculata of the adrenal gland (Reddy, 2006, Tan and Mulrow, 1975). It is known to 
have glucocorticoid properties and can bind to the GR (Reddy, 2006), has anti-
convulsant properties when administered to rats, and may potentially modulate 
stress-sensitive conditions in humans such as panic disorder, PTSD, major 
depression, and epilepsy (Sapolsky et al., 2000, Reddy and Rogawski, 2002, 
Reddy, 2006). Additionally, it is considered a mineralocorticoid which involved in the 
regulation of sodium balance and blood pressure (Vinson, 2011). 
DHDOC: DHDOC is the 5α-reduced intermediate of DOC, and was considered in 
this study as alterations to its concentrations could signify altered efficacy of 5α-
reductase (Fig 1.3). DHDOC is a known agonist of PR (Rupprecht et al., 1993), and 
may also act as a positive allosteric modulator of the GABAA receptor (Reddy and 
Rogawski, 2002). Similar to its precursor DOC and metabolite THDOC, DHDOC 
also has anti-convulsant properties in the rat (Reddy and Rogawski, 2002). In 
control rats, it has been previously been reported that greater levels of DHDOC is 
only observed in the brain and not in the plasma following acute swim stress (Sze et 
al., 2018) (Appendix B), indicating that it is likely to be synthesised de novo in the 
brain following an acute stressor. 
THDOC: THDOC was investigated in this study as it is a positive allosteric 
modulator of GABAA receptors and can alter inhibitory transmission that are involved 
in the stress responses. The administration of THDOC to rats attenuates stress-
induced increases in plasma corticosterone (Owens et al., 1992), whilst 
electrophysiology experiments in mpPVN neurones have demonstrated a role for 
THDOC in decreasing sympathetic output (Womack et al., 2006). Basally, THDOC 
has been found to be involved in tonic inhibition of the HPA axis, however, it has 
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also been reported to be involved in the activation of the HPA axis in mice, via 
actions on GABAA receptor subtype δ on CRH neurones (Sarkar et al., 2011). It is 
thus suggested that neurosteroids like THDOC (and perhaps allopregnanolone) not 
only have a role in dampening the HPA axis response, but may also be required to 
mount a HPA axis response to stress (Sarkar et al., 2011).  
Progesterone: Progesterone was investigated in this study as it has complex 
interactions with the HPA axis and glucocorticoids (Wirth, 2011). Apart from binding 
to PR and having a generally inhibitory effect on the HPA axis (Section 1.3.4), 
progesterone is also able to bind to GR, acting as an antagonist to reduce GR-
glucocorticoid binding and therefore impairing feedback (Svec, 1988). Furthermore, 
progesterone is the precursor to downstream metabolites DHP and 
allopregnanolone, which regulate the HPA axis in their own manner (Wirth, 2011). 
Progesterone is produced rapidly following stress alongside corticosterone from the 
adrenal cortex, and this is observed even in male rats and in ovariectomised female 
rats, suggesting the contribution of the adrenal gland (Hueston and Deak, 2014), 
possibly also from CRH- and ACTH-mediated mechanisms (Torres et al., 2001). A 
sex difference is found previously in control rats, where females show greater 
plasma progesterone concentrations at baseline, and also elevated concentrations 
following stress compared to males, in both the plasma and various brain regions, 
especially the hypothalamus (Sze et al., 2018) (Appendix B).  
DHP: DHP was investigated as it is the intermediate between progesterone and 
allopregnanolone, and it also has rapid effects on the brain, exerting its effects 
possibly through binding to membrane-bound PR, which it has a high affinity for as 
compared to intracellular PRs (Singh et al., 2013). Baseline levels of DHP in the 
mouse brain were found to be decreased under prolonged stress (e.g. social 
isolation), which possibly reflects its ability to modulate changes in gene 
transcription following long-term stress (Dong et al., 2001). However, it has recently 
been proposed to also have anti-seizure properties in rats (Wu and Burnham, 2018). 
Plasma DHP does not increase following acute swim stress in control male and 
female rats, however, DHP was increased in the brain following acute swim stress, 
and females again had greater DHP concentrations in most regions of the brain 
(Sze et al., 2018) (Appendix B).  
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Allopregnanolone: In contrast to its precursors progesterone and 5α-DHP, 
allopregnanolone does not bind to PR, but like THDOC, allopregnanolone is a 
positive modulator of GABAA receptors, playing an important role in stress 
responses (Morrow et al., 1987). Allopregnanolone is one of the most well-
characterised neuroactive steroid, especially since the discovery that it increases 
robustly in the brain following acute swim stress in rats, often with a slower or a 
negligible increase in the plasma, suggesting de novo synthesis in the brain (Purdy 
et al., 1991, Vallee et al., 2000, Sze et al., 2018). Studies which employ exogenous 
allopregnanolone administration have determined that allopregnanolone attenuates 
stress-induced HPA axis activity in rats, preventing the increase in plasma ACTH 
and corticosterone following acute stress (Patchev et al., 1996). When administered 
to PNS females offspring in the prenatal social stress model, allopregnanolone 
normalises stress-induced HPA axis hyperactivity (Brunton et al., 2015).  
Testosterone: Testosterone is the principal male sex hormone produced by the 
Leydig cells of the testes, whilst in females, small amounts are also produced by the 
ovaries and the adrenal cortex (Burger, 2002). Testosterone was investigated in this 
study due to its involvement in determining sex differences in HPA axis responses. 
Testosterone administration to rats and mice has been shown to play an inhibitory 
role over HPA axis responses to stress, either via a medial preoptic area (mPOA)-
mediated pathway or through a serotonin signalling pathway (Viau and Meaney, 
1996, Goel et al., 2011). Although these effects may be mediated by rapid non-
genomic testosterone actions on AR (Deng et al., 2017), many of testosterone’s 
rapid effects also arise through the action of its metabolites (e.g. DHT, 3α- and 3β-
diol) and their effects on other receptors (Foradori et al., 2008). For instance, 3α-diol 
is known to mediate anti-anxiety effects through a GABAA-mediated pathway 
(Edinger and Frye, 2005, Frye et al., 1996), whereas 3β-diol could alter HPA axis 
activity via an oestrogen receptor-β (ERβ) and oxytocin-mediated mechanism 
(Handa et al., 2009, Lund et al., 2006, Foradori et al., 2008) Unfortunately the 
metabolites of testosterone could not be quantified using the LC-MS method 
developed here (for reasons explained in Chapter 3). In the prenatal social stress 
model, PNS male rats had significantly greater plasma testosterone concentrations 
in one study (Brunton et al., 2015) but not the other (Ashworth et al., 2016). 
However, it is not clear whether testosterone concentrations in the brain were 
altered. Additionally, testosterone concentrations in the plasma and brain were not 
modified with acute swim stress in control rats (Sze et al., 2018) (Appendix B).  
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4.1.3 Brain regions investigated in this study  
Given the heterogeneity of the brain, regional differences in steroid concentrations 
exist (Sze et al., 2018), and these differences are known to occur even in early 
developmental stages in the rat brain (Konkle and McCarthy, 2011). Similarly, 
regional differences have also been observed in post-mortem human brain tissue 
(Bixo et al., 1997). These differences can arise from the differential uptake of 
steroids from the circulation (Karavolas et al., 1976, Bixo and Backstrom, 1990), or 
differing rates of local metabolism due to varying expression levels of 
neurosteroidogenic enzymes (Konkle and McCarthy, 2011, Bixo and Backstrom, 
1990). The five brain regions investigated in this study have key roles in modulating 
the stress response (Fig 4.2), and a brief introduction of each region in relation to its 
role in stress response regulation is given in this section.  
In brief, the hippocampus and amygdala and the prefrontal cortex are limbic areas 
that together process stressful experiences, and subsequently interface with other 
more primitive brain areas such as the hypothalamus and brainstem to produce a 
response that copes with the stressor (McEwen and Gianaros, 2010). Whilst each 
brain region are important in modulating stress responses in their own right, the 
level of involvement of each brain area can be different depending on the type of the 
stressor, and also other factors such as temporal dynamics. For instance, it has 
been proposed that changes in the amygdala precedes the hippocampus following a 
stressor (Tottenham and Sheridan, 2009). Additionally, stress can affect different 
regions differently, and acute stress can impair PFC function but instead enhance 
amygdala function (Arnsten, 2009). Moreover, it is worthy to note that the 
contribution of each structure to the regulation of the stress response is also subject 
to finer regulation from its sub-regional structures and also the nature of stressor 
(e.g. psychological or physical) administered. Additionally, although each region is 
reviewed separately, there exists cross-talk between these brain regions, adding 
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Figure 4.2: Overview of the brain regions investigated in this study. Limbic (i.e. 
hippocampus, amygdala and frontal cortex) and brainstem structures project to the 
PVN to enhance or inhibit HPA axis activity. Solid lines represent excitatory 
projections whilst dashed lines represent inhibitory projections. In general, systemic 
stressors that are a direct threat to the survival of the organism have been 
associated with direct signalling pathways from the midbrain or brainstem to the 
PVN, whilst psychogenic stressors rely more heavily on the limbic system (Jankord 
and Herman, 2008, Herman et al., 2005). Abbreviations: PVN: paraventricular 
nucleus, PFC: prefrontal cortex, LS: lateral septum, BNST: bed nucleus of the stria 
terminalis, mPOA: medial preoptic area, LC: locus coeruleus, NTS: nucleus of the 
solitary tract, Raphe: dorsal and medial raphe nuclei. Schematic representation not 
drawn to the scale of any particular sagittal plane, adapted from (Heck and Handa, 
2019).  
Frontal Cortex: The frontal cortex was investigated as it is the higher order brain 
region that regulates the processing of stressful signals (reviewed in (Arnsten, 
2009)). The prefrontal cortex has abundant GR-containing neurones, and these 
neurones are activated following restraint stress in male rats (Ostrander et al., 
2003), suggesting that the frontal cortex is a direct target of stressful stimuli, at least 
in the case of psychogenic stressors. Corticosterone in the frontal cortex is thought 
to exert a net inhibitory effect over the HPA axis, as corticosterone implants 
decrease ACTH and corticosterone responses to restraint stress in rats, whilst 
lesions increase HPA axis responses to stress (Diorio et al., 1993). However, even 
within the frontal cortex itself, different sub-regions can contribute to different 
aspects of stress output. In the rat, the prelimbic prefrontal cortex (PFC) has been 
reported to inhibit autonomic stress responses, especially in terms of response 
termination, whilst the infralimbic PFC on the other hand, is generally associated 
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with the initiation of autonomic and HPA axis responses (Ulrich-Lai and Herman, 
2009, Figueiredo et al., 2003b). Additionally, there seems to be evidence of 
stressor-specific regulation, where the prelimbic PFC seems to inhibit responses to 
restraint stress but not systemic stressors, whilst the infralimbic PFC has the ability 
to limit HPA axis responses to systemic stressors, but initiate HPA axis responses to 
psychogenic stressors like restraint (Radley et al., 2006, Figueiredo et al., 2003b, 
Crane et al., 2003, Herman et al., 2005). As an added layer of complexity, the frontal 
cortex also has various different interconnections with the hippocampus and 
amygdala, which can further modify the final stress output (McKlveen et al., 2015). 
Amygdala: The amygdala is involved in fear processing, mediating social behaviour 
and anxiety, plays a critical role integrating autonomic and neuroendocrine stress 
responses. Activation of the amygdala is generally associated with HPA axis 
activation (Smith and Vale, 2006). However, like the PFC, there exists substantial 
sub-regional differences, and the final output is also stressor-specific (Dayas et al., 
1999). The CeA for example, densely innervates NTS and PVN-projecting structures 
such as the BNST (Herman et al., 2005) and is especially sensitive to systemic 
stressors such immune challenge (Xu et al., 1999). The CeA contains large 
numbers of CRH neurones, and activates the HPA axis through CRH-mediated 
pathways (Gallagher et al., 2008). Conversely, increased corticosterone in the brain 
can increase CRH in the amygdala, which is linked to an anxious phenotype in rat 
studies (Schulkin et al., 1998).The MeA, which has some direct projections to the 
PVN but also heavily innervates the BNST, is activated following stimuli such as 
noise, restraint, and forced swim stress (Dayas et al., 2001) but not by systemic 
stressors (Dayas et al., 1999). Various sub-regions of the amygdala (e.g. CeA and 
BLA) are also comprised of GABA neurones, implying that GABAergic signalling 
plays an important role in the amygdalar regulation of stress responses (reviewed in 
(Jie et al., 2018)).  
Hippocampus: The hippocampus show abundant expression of both GR and MR 
(Reul and de Kloet, 1986) and is involved in the negative feedback inhibition of the 
production of glucocorticoids (Jacobson and Sapolsky, 1991), therefore exerts a 
predominantly inhibitory influence over the HPA axis. Additionally, its inhibition is 
also stressor-specific, for instance, lesions of the hippocampus enhance 
corticosterone responses to psychogenic stressors such as restraint and novelty, 
but the response to systemic stressors like ether inhalation seems unaffected 
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(reviewed in (Jankord and Herman, 2008)). Therefore, like the frontal cortex and 
amygdala, the stress response following activation of the hippocampus is stressor-
dependent, but the final output is largely inhibitory.  
Hypothalamus: The role of the hypothalamus in the HPA axis has been introduced 
in depth Chapter 1, where it is the centre of stress signal integration in the brain 
(Herman and Tasker, 2016). The hypothalamus itself consists of various sub-
regions and these connections between sub-regions (e.g. from the peri-PVN or 
dorsomedial hypothalamus to the PVN) are mostly controlled by local GABAergic 
networks (Cullinan et al., 2008). The sexually dimorphic nucleus of the medial 
preoptic area (mPOA) is also located in the hypothalamus and expresses high levels 
of AR. Whilst it is known to be of a larger in volume in males of many species, 
including humans and rodents, and its volume can be impacted in event of prenatal 
stress (Kerchner and Ward, 1992, Swaab and Fliers, 1985). 
Brainstem: The brainstem plays an integral role in autonomic signalling following 
stress, and its activation generally results in HPA axis activation. Apart from direct 
NTS signalling to the PVN through noradrenergic and adrenergic signals (Plotsky et 
al., 1989), the locus coeruleus, also located in the brainstem, is also involved in 
arousal and also projects to the amygdala, PFC and hippocampus, thereby adding 
an additional layer of complexity in the brainstem regulation of stress (Ziegler and 
Herman, 2002). The role of corticosterone in the brainstem has largely been shown 
to be excitatory (Tasker et al., 2005), it could be affected by sub-regional differences 
and the nature of the stressor. For instance, the effect of corticosterone is primarily 
excitatory in the locus coeruleus, but in the reticular formation, the effect of 
corticosterone on caudal and rostral reticular formation neurones seems to be 
conflicting (Avanzino et al., 1983). In another example, lesions to the ventral 
noradrenergic neurones inhibits corticosterone responses to ether inhalation but not 
to restraint stress (Ziegler and Herman, 2002), whilst lesions to medullary 
projections blocks neuronal activation following IL-1β injection but not footshock (Li 
et al., 1996). The brainstem is deemed to be of particular relevance to the prenatal 
social stress model, as decreased 5α-reductase type 1 mRNA expression are 
particularly obvious in the NTS of PNS rats from both sexes (Brunton et al., 2015). 
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4.1.4 Aims of this chapter 
Using the method developed in Chapter 3, this study aims to obtain a steroid profile 
for the plasma and the brains of control and prenatally stressed male and female 
offspring, under acute stress and non-stress conditions. The panel of steroid and 
brain regions have been chosen due to their involvement in the stress response, as 
explained in section 4.1.2 and 4.1.3, respectively. Swimming stress was used as the 
acute stressor as it has previously been shown to result in a robust increase in 
neuroactive steroids, explained in section 4.1.1.2 and in Sze et al., 2018. The 
specific aims of this study were to determine:  
1) Whether HPA axis hyperactivity is observed following acute swim stress in 
PNS offspring, by comparing plasma corticosterone concentrations between 
controls and PNS 
2) Whether there are any differences in neuroactive steroid concentrations 
between controls and PNS rats under basal conditions and following acute 
stress, in the plasma and the various brain regions; and 
3) Whether there are sex differences in the neuroactive steroid response, 
especially in the PNS rats  
The hypotheses of this chapter are: 
1) Following acute swim stress, plasma corticosterone concentrations are 
greater in PNS offspring as compared to control offspring 
2) Concentrations of neuroactive steroids, especially GABAA modulatory 
neurosteroids and their precursors are lower in the all brain regions of PNS 
offspring, both basally and following acute stress, leading to a general loss of 
inhibitory tone, therefore greater and more prolonged HPA axis activation 
and greater plasma corticosterone concentration in the PNS offspring (as in 
point 1) 
3) Females mount a greater stress response (i.e. greater amount of plasma 
corticosterone as compared to males) and may produce greater amounts of 
neuroactive steroids as compared to males following acute stress. Prenatal 
stress may affect this sex difference between females and males. 
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4.2 MATERIALS AND METHODS  
4.2.1 Animals 
Control and prenatally stressed (PNS) offspring were generated in the Roslin 
Institute Biological Resource Facility. Twenty experimental female rats were 
purchased from Charles River (Margate, Kent, UK), and ten of them underwent 
social stress from gestational days 16 - 20 using the resident intruder paradigm, as 
described in section 2.3.1.  
Following birth, the offspring stayed with their mothers until the day of weaning 
(PND23), where one rat of each sex from each litter was tail-marked and regrouped 
into individually ventilated cages of ten rats each. Rats were group-housed with 
other rats of the same prenatal stress status (i.e. controls or PNS). For the purposes 
of this experiment, this generated 8 cages of 10 rats each (2 cages each of control 
males, PNS males, control females, PNS females). Weaned offspring were left 
undisturbed, except for routine husbandry as well as some light handling once a 
week, for the marking of tails until the commencement of the experiment.  
4.2.2 Acute swimming stress 
When animals were 7 weeks old (between 49-52 days old), an acute stressor was 
given to half of the groups. Swim-stressed rats were placed in a glass cylinder 
(diameter, 25cm; height, 50cm) filled with water (22-23oC) to a depth of 30 cm. After 
2 min of swimming, they were gently dried in a towel and then returned to their 
home cage. Swim-stressed rats were culled 30 min after the onset of swimming 
stress via conscious decapitation (Chapter 2) in a separate room, for the collection 
of trunk blood and brain tissue. Non swim-stressed (or basal) groups were 
undisturbed and brought directly into the separate room for culls. Swimming stress 
was carried out with the help of PhD student Daniela Schnitzler, while I performed 
the conscious decapitation and tissue collection. Swimming stress and the killing of 
rats was carried out between 10:00 – 14:00h The experiment was carried out within 
a 1 week period, with 16 rats culled each day (Table 4.1).  
 
Chapter 4: Neuroactive steroid profile in stressed adult offspring 164 
 
Figure 4.3 Pictorial representation of experimental design. Four groups of rats 
of each sex was used. Controls and PNS rats, with and without swim stress were 
housed separately. Rats that did not undergo swim stress were killed immediately 
from the home cage, while rats that underwent swimming stress were returned to 
their home cage and killed 30 min after the induction of stress. 
 
Cage Rats Day 1 Day 2 Day 3 Day 4 Day 5 
1 Male, Control, No Swim/Basal 4 4 2   
2 Male, Control, Swim Stress 4 4 2   
3 Male, PNS, No Swim/Basal 4 4 2   
4 Male, PNS, Swim Stress 4 4 2   
5 Female, Control, No Swim/Basal   2 4 4 
6 Female, Control, Swim Stress   2 4 4 
7 Female, PNS, No Swim/Basal   2 4 4 
8 Female, PNS, Swim Stress   2 4 4 
Table 4.1: Number of rats in each group and number of rats killed each day.  
4.2.3 Tissue collection and gross dissection  
Upon conscious decapitation, trunk blood (ca. 5 - 6 ml) was collected in a tube 
containing 0.5 ml 5% w/v EDTA and kept on ice until centrifugation at 4oC to 
separate the plasma. Plasma was stored at -20oC until steroid measurement using 
LC-MS was performed. The skull was then removed to expose the brain (section 
2.3). Whilst still in the skull, the brain was cut in front (Bregma -8.00) and at the back 
of the cerebellum, separating the hindbrain from the forebrain and midbrain. Both 
blocks were removed from the skull with care, and were bissected along the midline. 
In this experiment, the left hemisphere of the brain was frozen on dry ice for future 
use, while the right hemisphere was subjected to gross dissection (Fig 4.2). The 
right cerebellum was removed and discarded, leaving the right brainstem, which 
includes both the pons and the medulla. The cerebral cortex was first peeled open 
Conscious decapitation
2 min forced swim






Killed 30 min after the induction of stress
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to expose the hippocampus, which was separated out easily. The cortex was then 
placed back into position and the frontal cortex excised (at Bregma 2.00 mm). The 
brain was then flipped to the ventral side, and a block was made by cutting along 
Bregma -1.60 mm and Bregma -5.60 mm with a scalpel, using the optic chiasma as 
an anatomical landmark. The hypothalamus and amygdala were then separated, 
using the rhinal fissure and optic tract as anatomical markers. Dissected brain 
regions were placed in a 1.5 mL Eppendorf tubes and frozen immediately on dry ice. 
They were transferred to -80oC for storage until sample processing for LC-MS.  
4.2.4 Sample processing and LC-MS  
Sample processing was carried out as described in chapter 2 (section 2.5). Weights 
of brain regions from the right hemisphere were taken before homogenisation, while 
100 µL of plasma was used for sample processing. Samples from all four treatment 
groups, from the same region and sex (n = 40 in total), were processed on the same 
day, alongside 7 standard calibrants and a blank. Samples from males and females 
were processed on separate days. Calibration curves were diluted from 250 ng/mL 
aliquots of a master stock solution containing nine steroids. Due to the laborious 
process of sample homogenisation and clean-up, the process was staggered and 12 
– 18 samples were handled at any one time. The derivatisation reaction was carried 
out at the same time for all samples within a batch. 
For LC-MS analysis, samples from all four stress conditions the same region, and 
the same sex, were analysed on the same day, using the same standard calibrants 
and same batch of reagents and solvents. A batch run was set up, where standard 
calibrants were always first to be injected and analysed. Duplicate injections were 
carried out for all calibrants and samples. Due to the length of the run and the 
number of samples, samples were reconstituted and loaded into the autosampler in 
sample subsets, and each subset had equally divided groups. Data acquisition and 
analysis for LC-MS was carried out as described in chapter 2.  
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Figure 4.4: Brain regions collected for LC-MS quantification of steroids. Gross 
dissection was carried out on one hemisphere of the brain, where regions were 
collected according to the anatomical landmarks outlined in the figure. (Adapted 
from supplementary figure 1, Sze et al., 2018)  
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4.2.5 Data Analysis  
Although there were three factors involved in this study (acute stress, prenatal 
stress and sex), the main aim of the experiment was to study the effects of prenatal 
stress on neuroactive steroid concentrations, with and without an additional stressor 
during adulthood. As it is known that steroid concentrations are different in males 
and females, it was planned for the two sexes to be analysed separately by the use 
of two 2X2 ANOVAs, where prenatal stress and acute stress were the two main 
factors. Significance level was set at 0.05. Post-hoc testing utilising Student-
Newman-Keuls multiple pairwise comparisons were also carried out, using R-studio 
(Chapter 2, Appendix A). 
The results of the two-way ANOVA were reported under each graph with F-values 
and degrees of freedom, and effects that are not significant are denoted “n.s.”. 
Significant results from the post-hoc Student-Newman-Keuls testing were annotated 
on the graphs itself, using asterisks for effect of acute stress (where significant 
differences between swim-stressed and non-stressed groups were denoted as 
*p<0.05, **p<0.01, ***p <0.001) and hashes for effect of prenatal stress (where 
significant differences between control and PNS groups were denoted as # p<0.05, 
##p<0.01, ###p<0.001).  
Individual data points were plotted, and outliers with two standard deviations away 
from the mean were removed, especially for baseline groups. Outliers always 
consisted of the same rat from corticosterone, DOC, DHDOC and THDOC 
measurements; the same individual rat from pregnenolone, progesterone, DHP and 
allopregnanolone measurements; whilst for testosterone, data from a separate rat 
was removed.  
As an alternative way of analysing the dataset, three-way ANOVAs were additionally 
carried out where the male and female dataset were combined, which could 
potentially increase statistical power. Normality and variance were first visually 
examined by the plotting of residuals (Appendix A). Due to unequal variance 
between males and females, natural log transformation had to be carried out for all 
analytes except for corticosterone. However, it was difficult to present this data or do 
post-hoc testing due to the number of comparisons involved, therefore the results of 
the three-way ANOVA are included in Appendix C (Table C1) and only used to 
comment on the presence of sex differences. 
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Comparisons of concentrations between plasma and brain regions were also carried 
out using a two-way ANOVA, with results also attached in Appendix C (Table C2 
and Table C3). Region (i.e. plasma vs brain region) and acute stress status are 
assessed as the two main factors, whilst post-hoc comparisons were carried out 
using Student-Newman-Keuls test, to compare plasma steroid concentrations 
versus steroid concentrations in the various brain regions. As 1 ml of plasma weighs 
close to 1 g of tissue (Taves et al., 2010), the absolute values for plasma 
concentrations (in ng/ml) and brain concentrations (in ng/g) were directly compared.  
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4.3 RESULTS  
4.3.1 Corticosterone 
Plasma: As expected, corticosterone secretion into the plasma was significantly 
greater in rats that were exposed to acute swim stress as compared rats which did 
not undergo swim stress in both males (Figure 4.5A) and females (Figure 4.5G), 
regardless of prenatal stress status. PNS offspring (both males and females) did not 
differ in plasma corticosterone concentrations as compared to controls, both basally 
and 30 min after acute swimming stress. There were no sex differences in plasma 
corticosterone concentrations between males and females (three-way ANOVA; 
Appendix C). Plasma corticosterone concentrations are also greater than 
concentrations in all the brain regions, both in males and females.  
Male brain regions: In all brain regions of the male offspring, swim stressed groups 
had significantly greater corticosterone concentrations as compared to non-swim 
stressed groups (Fig 4.5B-F). Corticosterone concentrations did not differ between 
PNS and control rats in all brain regions investigated except for the male brainstem 
(Fig 4.5F), where corticosterone concentrations were significantly greater in swim-
stressed PNS offspring as compared to swim-stressed control offspring. 
Female brain regions: Swim-stressed groups had significantly greater corticosterone 
concentrations as compared to their respective non swim-stressed groups, in both 
control and PNS rats, in all female brain regions (Fig 4.5H-L). Corticosterone 
concentrations were not significantly different between control and PNS groups in all 
brain regions. A significant main effect of sex was also found in the frontal cortex, 
hypothalamus, and brainstem using a three-way ANOVA (Appendix C), indicating 
that corticosterone concentrations in these regions were generally greater in 
females than males in the respective treatment groups. 
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Figure 4.5: Corticosterone concentrations in the plasma and brain regions of 
male and female control (Con) and PNS offspring. Two-way ANOVAs were 
carried out separately for males and females, with F values and p-values reported 
below each graph. n.s.: not significant. A significant main effect of acute stress was 
observed in all regions investigated, for both males (A-F) and females (G-L). Post-
hoc comparisons between basal and swim groups indicated that swim-stressed 
groups had significantly greater corticosterone concentrations in the plasma and all 
brain regions as compared to control groups (where *p<0.05, **p<0.01, ***p <0.001). 
There was an additional main effect of prenatal stress observed only in the male 
brainstem (F), where male PNS swim-stressed rats had greater brainstem 
corticosterone concentrations as compared to male control swim-stressed rats 
(where ## p<0.01). Due to higher concentrations of corticosterone in the plasma as 
compared to the brain, scale of Y-axes are different between plasma (A and G) and 












































































































































































































Prenatal stress: F1,34= 5.20, p=0.029











































































































































Prenatal stress: F1,36= 3.26, p=0.079
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4.3.2 DOC, DHDOC and THDOC  
Plasma: In males, DOC concentrations (Fig 4.6A) were significantly greater in the 
swim-stressed groups as compared to basal groups regardless of prenatal stress 
status. There were no differences in plasma concentrations of DHDOC (Fig 4.7A) 
and THDOC (Fig 4.8A) in males across all four groups. In the females, greater 
plasma concentrations of DOC (Fig 4.6G) and THDOC (Fig 4.8G) were detected in 
the swim-stressed females as compared to the basal group, regardless of prenatal 
stress status. There were no differences in plasma DHDOC concentration across all 
four female groups (Fig 4.7G). In the three-way ANOVA investigating sex effects 
(Appendix C, Table C1), a main effect of sex was observed for DOC, DHDOC and 
THDOC, where females had significantly greater concentrations as compared to 
males. DOC concentrations were not different between plasma and brain regions, 
whilst DHDOC and THDOC were slightly greater in the brain regions, in but only in 
certain brain regions like the brainstem, hippocampus and hypothalamus (Appendix 
C, Table C3).  
Male brain regions: 
DOC: Swim-stressed rats had significantly greater DOC concentations than non-
swim stressed rats in all brain regions regardless of prenatal stress status, in most 
brain regions (Fig 4.6A-E), apart from the brainstem (Fig 4.6F). PNS and control 
groups also did not differ in the DOC concentrations in most of the brain regions (Fig 
4.6A-E), apart from the brainstem (Fig 4.6F). In the brainstem (Fig 4.6F), only PNS 
but not control swim-stressed rats had greater DOC concentrations as compared to 
the respective non-swim stressed group. Additionally, PNS swim-stressed rats also 
had significantly greater brainstem DOC concentrations as compared to the swim-
stressed control group (Fig 4.6F).  
DHDOC: Swim-stressed rats had significantly greater DOC concentations than non-
swim stressed rats regardless of prenatal stress status, in all brain regions except 
for the hypothalamus (Fig 4.7C). In the hypothalamus (Fig 4.7C), only control swim-
stressed rats had significantly greater DHDOC concentrations as compared to the 
respective basal group, whilst the difference in the basal and swim-stressed PNS 
groups were not statistically significant (p=0.063). PNS and control groups did not 
differ in DHDOC concentrations in all brain regions. 
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THDOC: In the hypothalamus, THDOC concentrations were greater in swim-
stressed groups as compared to non-swim stressed basal group, for both control 
and PNS male offspring (Fig 4.8D). In the frontal cortex, amygdala and brainstem, 
THDOC concentrations were significantly greater only in the control swim-stressed 
group as compared to control basal groups. In the PNS rats, differences between 
basal and swim-stressed PNS groups were not statistically significant (frontal cortex, 
p=0.06, brainstem, p=0.08, amygdala, p=0.20). There were no differences in 
THDOC concentrations in PNS and control groups in these brain regions. In the 
hippocampus (Fig 4.8E), there were no differences across all four groups. 
Female brain regions:  
DOC: Swim-stressed female rats had significantly greater DOC concentations than 
non-swim stressed rats in all brain regions regardless of prenatal stress status, in all 
brain regions (Fig 4.6H-L). Concentrations of DOC were not significantly different 
between control and PNS groups, in both basal and swim-stressed conditions, in 
most brain regions apart from the hippocampus (Fig 4.6I). In the hippocampus (Fig 
4.6I), PNS swim-stressed females had lower concentrations of DOC as compared to 
the swim-stressed control group, indicating that PNS rats had a smaller DOC 
response following acute stress as compared to the controls. In all female brain 
regions, a main effect of sex was observed in the three-way ANOVA (Appendix C, 
Table C1), indicating that females had greater DOC concentrations in all brain 
regions as compared to males.  
DHDOC: Swim-stressed female rats had significantly greater DOC concentations 
than non-swim stressed rats in all brain regions regardless of prenatal stress status, 
in most brain regions apart from the frontal cortex. In the frontal cortex (Fig 4.7H), 
control swim-stressed rats had significantly greater DHDOC concentrations as 
compared to control basal rats, however, in the PNS groups, swim-stressed and 
basal groups did not have significantly different DHDOC concentrations (p=0.0675). 
In all brain areas, PNS and control groups did not differ in DHDOC concentrations, 
in both the basal and swim-stressed conditions. In most brain areas apart from the 
hypothalamus, a main effect of sex was observed in the three-way ANOVA 
(Appendix C, Table C1), where females had greater DHDOC concentrations as 
compared to males except for the hypothalamus.  
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THDOC: Swim-stressed female rats had significantly greater THDOC concentations 
than non-swim stressed rats regardless of prenatal stress status in the 
hypothalamus, amygdala and the brainstem. In frontal cortex, only control swim-
stressed females had greater THDOC concentrations than its respective basal 
group, whereas in the hippocampus, only PNS swim-stressed females had greater 
THDOC concentrations than the respective basal group. In all cases, THDOC 
concentrations in the PNS groups were not significantly different from the control 
group, both basally and after swimming stress. In most brain areas apart from the 
hypothalamus, a main effect of sex was observed in the three-way ANOVA 
(Appendix C, Table C1), where females had greater THDOC concentrations as 
compared to males except for the hypothalamus. 
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Figure 4.6: DOC concentrations in the plasma and brain regions of male and 
female control (Con) and PNS offspring. A significant main effect of acute stress 
was observed in all regions investigated, for both males (A-F) and females (G-L). 
Post-hoc comparisons revealed that all swim-stressed groups have significantly 
greater DOC concentrations when compared to control groups in the plasma and 
most brain regions (where * p<0.05, ** p<0.005, *** p <0.005), except for the male 
brainstem, where the difference between the control swim-stressed group and 
control basal group was not significant (p=0.084). Additionally, in the male 
brainstem, post-hoc testing also showed that PNS swim-stressed rats had  
signicantly greater DOC concentrations as compared to control swim-stressed rats 
(where ## p<0.01). A main effect of prenatal stress was also present for the female 
hippocampus (K), where female PNS swim-stressed rats had a lower hippocampal 
corticosterone concentration as compared to female control swim-stressed rats 
(where ## p<0.01). Due to a sex difference in the concentrations of DOC, range of 






































































































































































Prenatal stress: F1,34= 3.76, p=0.06
















































































































Prenatal stress: F1,36= 5.3, p=0.027
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Figure	4.7: DHDOC concentrations in the plasma and brain regions of male and 
female control (Con) and PNS offspring. Two way ANOVAs were carried out 
separately for males and females, with F values and p-values reported below each 
graph. n.s.: not significant. There were no differences in all four groups for both male 
(A) and female plasma (G). Significant main effects of acute stress were observed in 
most brain regions investigated in both sexes, where swim-stressed rats had greater 
DOC concentrations than rats that did not undergo swim stress (*p<0.05, **p<0.01, 
***p<0.001), except for the male hypothalamus (C) and female frontal cortex (H) 
where the differences between PNS basal and swim-stressed groups were not 
significant. There were no main effects of prenatal stress nor interactions, and 
controls and PNS rats did not have different basal DHDOC concentrations and did 
not respond differently to acute stress. Due to differences in the range of DHDOC 
concentrations in plasma and brain, as well as sex differences, range of Y-axes are 
different between plasma and various brain regions, notably the female brainstem 
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Figure 4.8: THDOC concentrations in the plasma and brain regions of male 
and female control (Con) and PNS offspring. A significant main effect of acute 
stress was observed in female plasma (G) but not in male plasma (A), where swim-
stressed female groups had significantly greater THDOC concentrations as 
compared to basal groups (where **p<0.01). Significant main effects of acute stress 
were observed in most of the brain regions investigated, except for the male 
hippocampus where there were no differences across all four groups (E). Post-hoc 
testing revealed that swim-stressed groups had greater THDOC concentrations in 
both controls and PNS conditions in the male hypothalamus (C), female 
hypothalamus (I), female amygdala (J) and female brainstem (L), where *p<0.05 
and **p<0.01. In the male frontal cortex (B), male amygdala (D), male brainstem (F) 
and female frontal cortex (H), differences between swim-stressed and control 
groups were only significant in the control groups, while in the female hippocampus 
(K), differences between swim-stressed and control groups were only significant in 
the PNS group. Note that the scale of Y-axes are different between the sexes, in the 
plasma and in different brain regions. Females generally have greater THDOC 
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4.3.3 Progesterone, DHP and allopregnanolone 
Plasma:  
Progesterone: In males, swim-stressed groups had significantly greater plasma 
progesterone concentrations as compared to basal groups, irrespective of prenatal 
stress status (Fig 4.9A). In females, a trend for significantly greater plasma 
progesterone concentrations was observed in the swim-stressed groups as 
compared to the basal groups, but the difference was not significant, in both control 
and PNS rats (Fig 4.9G). A main effect of sex was present in the three-way ANOVA, 
where females had greater plasma progesterone concentrations as compared to 
males. Progesterone concentrations were generally greater in the brain than in the 
plasma, except for the amygdala (both male and female), male frontal cortex and 
female hippocamus, where concentrations were similar (Appendix C, Table C3). 
DHP: In males, control swim-stressed groups had significantly greater DHP plasma 
concentrations than control basal males, while PNS swim-stressed groups did not 
have greater concentrations as compared to the PNS basal group (Fig 4.10A). 
Additionally, following swimming stress, male control rats had significantly greater 
concentrations of plasma DHP as compared to male PNS rats. In females, there 
were no differences in plasma DHP concentrations across all four groups (Fig 
4.10G). A main effect of sex was present in the three-way ANOVA, where females 
had greater plasma DHP concentrations as compared to males. DHP concentrations 
were generally greater in the brain except for the amygdala, frontal cortex, and 
female hippocampus, where concentrations were not different (Appendix C).  
Allopregnanolone: In males, plasma allopregnanolone concentrations were greater 
in swim-stressed groups as compared to basal groups, regardless of prenatal stress 
status (Fig 4.11A). There were no differences across all four groups for plasma 
allopregnanolone concentrations in females (Fig 4.11G). A main effect of sex was 
present in the three-way ANOVA, where females had greater plasma 
allopregnanolone concentrations as compared to males. Allopregnanolone 
concentration were greater in the brain regions as compared to that in the plasma in 
males, however in the females, plasma concentrations were greater than that in the 
brain, except for the brainstem, where concentrations were not different as 
compared to plasma (Appendix C, Table C3). 
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Male brain regions:  
In all male brain regions, concentrations of progesterone (Fig 4.9B-F), DHP (Fig 
4.10B-F) and allopregnanolone (Fig 4.11B-F) were greater in swim-stressed rats as 
compared to the respective basal groups, irrespective of prenatal stress status. 
Concentrations of brain progesterone, DHP and allopregnanolone all did not differ 
significantly between PNS rats and control rats, both basally and after acute 
swimming stress, in all brain regions investigated. The three-way ANOVA (Appendix 
C, Table C3) revealed that there was a main effect of sex in all brain regions, 
indicating that males had lower brain progesterone, DHP and allopregnanolone 
concentrations as compared to females. 
Female brain regions:  
Progesterone: In the female brain, progesterone concentrations were significantly 
greater in PNS swim-stress groups as compared to the PNS basal groups only in 
the frontal cortex (Fig 4.9H) and the hypothalamus (Fig 4.9I). There were however 
no differences in progesterone concentrations observed between swim-stressed and 
basal progesterone levels in control groups in the frontal cortex and the 
hypothalamus. No significant differences across all four groups were observed in the 
amygdala, hippocampus and brainstem.  
DHP: In the female frontal cortex (Fig 4.10H), swim-stressed PNS females had 
significantly greater DHP concentrations as compared to the basal PNS females. No 
significant differences were observed between the swim-stressed control group as 
compared to the basal control group in the frontal cortex. In all other brain regions 
(Fig 4.10I-L), there were no significant differences observed across all four groups.  
Allopregnanolone: In the female frontal cortex (Fig 4.11H), hypothalamus (Fig 4.11I), 
and brainstem (Fig 4.11L), allopregnanolone concentrations were significantly 
greater in swim-stressed PNS females compared to the basal PNS females, 
however, no significant differences were observed between the control swim-
stressed and the control basal groups. In the amygdala and hippocampus, no 
significant differences were observed across all four groups.  
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Figure 4.9: Progesterone concentrations in the plasma and brain regions of 
male and female control (Con) and PNS offspring. A significant main effect of 
acute stress was observed in plasma and all brain regions investigated in males (A-
F), where *p<0.05, **p<0.01, ***p<0.001. In females, two-way ANOVA revealed that 
a main effect of acute stress was significant for the plasma (G) and some brain 
regions (H, J) but approaching significance for the others (I, K, L). Post-hoc testing 
revealed that in the frontal cortex (H), hypothalamus (I) and brainstem (L), only PNS 
but not control groups showed significant differences when comparing swim-
stressed and basal conditions, whilst there were no differences in all four groups in 
the plasma (G), amygdala (J) and hippocampus (K). Additionally, in the female 
frontal cortex (H), an acute x prenatal stress interaction was present, and PNS 
swim-stressed rats had greater progesterone concentrations compared to control 
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Figure 4.10: DHP concentrations in the plasma and brain regions of male and 
female control (Con) and PNS offspring. In the male plasma (A), a significant 
main effect of acute stress was observed, with additional effects of prenatal stress 
that was approaching significance. Post-hoc testing revealed that only control rats 
showed differences between swim-stressed and basal groups (where *p<0.05), and 
PNS swim-stressed group additionally had lower plasma DHP compared to control 
swim-stressed group (where # p<0.05). Significant main effects of acute stress were 
also observed in all brain regions investigated in males (B-F), where swim-stressed 
rats had greater concentrations of brain DHP as compared to basal groups in both 
control and PNS conditions (*p<0.05, **p<0.01, ***p<0.001). In females (G-L), a 
main effect of acute stress was only observed in the frontal cortex (H), where only 
PNS, but not control, swim-stressed rats had a greater concentration of DHP as 
compared to the respective basal group (*p<0.05). Note that the scale of Y-axes are 
different between the sexes, both in plasma and the different brain regions due to 


























































































































































































Prenatal stress: F1,34= 2.75, p=0.106






















































Prenatal stress: F1,34= 3.75, p=0.06
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Figure 4.11: Allopregnanolone concentrations in the plasma and brain regions 
of male and female control (Con) and PNS offspring. A significant main effect of 
acute stress was observed in plasma and all brain regions investigated in males (A-
F), where swim-stressed groups had greater allopregnanolone concentrations 
compared to the respective stressed groups (*p<0.05, **p<0.01, ***p<0.001). In 
females (G-L), two-way ANOVA revealed that a main effect of acute stress was 
approaching significance for the frontal cortex (H), hypothalamus (I), and brainstem 
(L), and a acute x prenatal stress interaction which was close to significance for 
female brainstem (L). In these three areas (H, I, L), post-hoc testing showed that the 
difference between swim-stressed and basal groups were only significant in the 
PNS rats but not control rats. In the female plasma (G), amygdala (J) and 
hippocampus (K), there were no differences in allopregnanolone concentrations 













































































































































































































































































































































































Acute stress: F1,36= 3.55, p=0.068
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4.3.4 Pregnenolone  
Pregnenolone concentrations were significantly greater in all swim-stressed groups 
as compared to the respective basal groups in the plasma and in all of the brain 
regions, regardless of prenatal stress status and sex (Fig 4.12A-L). No significant 
differences in pregnenolone concentrations were observed between controls and 
PNS rats, both under basal conditions and following acute swim stress. A sex 
difference was observed (Appendix C) where females had greater absolute 
concentrations of pregnenolone as compared to males, in the plasma and in all the 
brain regions. Concentrations of all brain regions were greater than that found in the 
plasma, for both males and females (Appendix C, Table C3).  
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Figure 4.12: Pregnenolone concentrations in the plasma and brain regions of 
male and female control (Con) and PNS offspring. A significant main effect of 
acute stress was observed in plasma and all brain regions investigated in both 
sexes, where pregnenolone concentrations were greater in swim-stressed groups as 
compared to respective basal groups (*p<0.05, **p<0.01, ***p<0.001). There were 
no main effects of prenatal stress nor interactions, indicating that controls and PNS 
rats did not differ in plasma and brain pregnenolone concentrations. Scale of Y-axes 
are different between males and females, while the scale of plasma and 
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4.3.5 Testosterone  
Testosterone was not significantly different between any of the four groups within 
each sex (Fig 4.13A-L). As expected, a sex difference was observed in the three-
way ANOVA (Appendix C) where males had significantly greater concentrations of 
testosterone in the plasma and all brain regions investigated. Testosterone 
concentrations were similar in the plasma and in the brain, except for the male 
hippocampus, female brainstem and female hypothalamus, where brain 
concentrations were greater (Appendix C, Table C3).  
 
Figure 4.13: Testosterone concentrations in the plasma and brain regions of 
male and female control (Con) and PNS offspring. Two-way ANOVAs were 
carried out separately for males and females. There were no main effects of acute 
stress nor prenatal stress for both males (A-F) and females (G-L), and testosterone 
concentrations were not different across all four groups. Males have greater 
testosterone concentrations in the plasma and all brain regions, which is reflected in 
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4.3.6 Summary of results 
The key findings in this chapter are summarised in the table below (Table 4.2). 
There were no differences in basal concentrations of any of the steroids investigated 
between control and PNS groups within each sex, in both plasma and in all of the 
brain regions examined. As expected (Sze et al., 2018), an effect of acute stress 
was noted for most neuroactive steroids in the brain, where the swim-stressed 
groups had significantly greater concentrations than the non-stressed groups. 
Notably, differences between the PNS and control groups were present in some 
cases with acute swim stress, where PNS swim-stressed groups seemed to have 
either greater or lower concentrations as compared to the control swim-stressed 
groups within each sex. These differences seemed to be sex-dependent (i.e. 
observed in one sex but not the other), and brain region-dependent (i.e. observed in 
some regions but not in the others).  
Steroid/ Region Male Female 
Plasma 
corticosterone 
• Acute stress resulted in greater 
corticosterone concentrations 
• PNS and control are not 
different 
• Acute stress resulted in 
greater corticosterone 
concentrations  




• Acute stress resulted in greater 
corticosterone concentrations in 
all brain regions 
• PNS > Control only in acute 
stress conditions in brainstem 
• PNS and controls were not 
different in other brain regions 
• Acute stress resulted in 
greater corticosterone 
concentrations in all brain 
regions 
• PNS and controls were not 
different 
Plasma DOC 
• Acute stress resulted in greater 
DOC concentrations 
• PNS and controls were not 
different 
• Acute stress resulted in 
greater DOC concentrations 
• PNS and controls were not 
different 
Brain DOC 
• Acute stress resulted in greater 
DOC concentrations in all brain 
regions except for the brainstem 
• Acute stress resulted in greater 
DOC concentrations only in 
PNS group in the brainstem 
• PNS > Control only in acute 
stress conditions in brainstem 
• PNS and controls were not 
different in other brain regions 
• Acute stress resulted in 
greater DOC concentrations in 
all brain regions  
• PNS < Control only in acute 
stress conditions in 
hippocampus 
• PNS and controls were not 
different in other brain regions 
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Plasma DHDOC 
• Acute stress did not change 
plasma DHDOC concentrations 
• No differences between PNS 
and controls 
• Acute stress did not change 
plasma DHDOC 
concentrations 
• No differences between PNS 
and controls 
Brain DHDOC 
• Acute stress resulted in greater 
DHDOC concentrations in all 
brain regions except for PNS 
group in hypothalamus 
• No differences between PNS 
and controls 
 
• Acute stress resulted in 
greater DHDOC 
concentrations in all brain 
regions except for PNS group 
in FC 
• No differences between PNS 
and controls 
Plasma THDOC 
• Acute stress did not change 
plasma THDOC concentrations 
• No differences between PNS 
and controls 
• Acute stress resulted in 
greater plasma THDOC 
concentrations 
• No differences between PNS 
and controls 
Brain THDOC 
• Acute stress resulted in greater 
THDOC concentrations in both 
PNS and control in 
hypothalamus 
• Acute stress resulted in greater 
THDOC concentrations in 
controls but not PNS rats in FC, 
amygdala and brainstem 
• Acute stress did not alter 
THDOC concentrations in the 
hippocampus 
• No significant differences 
between PNS and controls 
 
• Acute stress resulted in 
greater THDOC 
concentrations in both PNS 
and control in hypothalamus, 
amygdala and brainstem 
• Acute stress resulted in 
greater THDOC 
concentrations in controls but 
not PNS rats in FC 
• Acute stress resulted in 
greater THDOC 
concentrations in PNS but not 
control rats in hippocampus 
• No significant differences 
between PNS and controls 
Plasma 
Progesterone 
• Acute stress resulted in greater 
plasma progesterone 
concentrations 
• PNS and controls were not 
different 
• Acute stress did not alter 
plasma progesterone 
concentrations 




• Acute stress resulted in 
progesterone concentrations in 
all brain regions  
• PNS and controls were not 
different 
• Acute stress resulted in 
greater progesterone 
concentrations in PNS but not 
control rats in FC, 
hypothalamus and brainstem 
• Acute stress did not alter 
progesterone concentrations 
in the hippocampus and 
amygdala 
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• PNS > Controls only in acute 
stress condition in FC 
• PNS and controls were not 
different in other brain regions 
Plasma DHP 
• Acute stress resulted in greater 
plasma DHP concentrations in 
controls but not PNS rats  
• PNS < Controls only in swim-
stress condition 
• Acute stress did not alter 
plasma DHP concentrations 
• PNS and controls were not 
different 
Brain DHP 
• Acute stress resulted in greater 
DHP concentrations in all brain 
regions 
• PNS and controls were not 
different 
• Acute stress resulted in 
greater DHP concentrations in 
PNS but not control rats in FC 
• Acute stress did not alter DHP 
concentrations in all other 
brain regions 




• Acute stress resulted in greater 
plasma allopregnanolone 
concentrations  
• PNS and controls were not 
different 
• Acute stress did not alter 
plasma allopregnanolone 
concentrations 




• Acute stress resulted in greater 
allopregnanolone 
concentrations in all brain 
regions 
• PNS and controls were not 
different 
• Acute stress resulted in 
greater allopregnanolone 
concentrations in PNS but not 
control rats in FC, 
hypothalamus, brainstem 
• Acute stress did not alter 
allopregnanolone 
concentrations in the 
amygdala and hippocampus 
• PNS and controls were not 
different 
Plasma and brain 
pregnenolone 
• Acute stress resulted in greater 
pregnenolone concentrations  
• PNS and controls were not 
different 
• Acute stress resulted in 
greater pregnenolone 
concentrations  
• PNS and controls were not 
different 
Plasma and brain 
testosterone 
• Acute stress did not alter 
testosterone concentrations 
• PNS and controls were not 
different 
• Acute stress did not alter 
testosterone concentrations 
• PNS and controls were not 
different 
Table 4.2: Summary of the main observations in this study. A summary of 
whether swim stress altered concentrations of neuroactive steroids in the brain and 
plasma, and if PNS rats had different concentrations of neuroactive steroids as 
compared to controls. FC: Frontal cortex 
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Fig 4.14 Pictorial representation of the summary of differences between PNS 
and control offspring. Arrows indicate if swim-stressed offspring have increased 
neuroactive steroid concentrations as compared to the respective non-stressed 
offspring, with (↑) representing greater concentrations with swim stress, whilst (↔) 
represents no significant differences between swim-stressed and basal groups. As 
for the comparison between control and PNS swim-stressed groups, (>) indicates 
significantly greater steroid concentrations in PNS groups as compared to control 
swim stress, whilst (<) indicates PNS groups having significantly lower steroid 
concentrations compared controls, and (≈) represents no significance differences 
between PNS and control swim-stressed groups. For steroids that are not 
mentioned in this diagram, controls and PNS did not respond differently with swim 
stress (i.e. both PNS and controls are either (↑) or (↔)), and steroid concentrations 
are also not different between PNS and controls (≈). F: Female, M: Male, ALLO: 
Allopregnanolone, PROG: Progesterone, CORT: Corticosterone. Figure is a 
representation of the different brain regions and does not anatomically represent 
any particular sagittal plane.  






PNS (↑) > Con (↑): M CORT
PNS (↑) > Con (↔): M DOC









M THDOC PNS(↔), Con (↑): M THDOC
PNS(↔), Con (↑): M THDOC
PNS (↑), Con (↔): F THDOC
PNS(↑), Con (↔):
F PROG, F Allo
PNS(↑), Con (↔):
F PROG, Allo
PNS(↑) > Con (↔):
F PROG
PNS(↑), Con (↔):
F DHP, F Allo
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4.4 DISCUSSION  
Three main conclusions emerge from these results, based on the hypotheses 
mentioned in section 4.1.4. (i) Firstly, PNS swim-stressed rats did not exhibit 
hypersecretion of corticosterone into the circulation when compared to the control 
swim-stressed group (section 4.4.1). Nonetheless, there were alterations in 
glucocorticoid concentrations in certain brain regions (notably, the male brainstem) 
of these PNS swim-stressed rats as compared to the control swim-stressed rats 
(section 4.4.2). (ii) Secondly, across the board, neuroactive steroid concentrations 
were not obviously different between control and PNS offspring, whether or not 
acute stress was given. There were no differences in the concentrations of 
neuroactive steroids under basal conditions between control and PNS offspring. 
However, there was some evidence that stress-induced concentrations of 5α- and 
3α-reduced steroids, such as DHP and THDOC were lower in the PNS rats as 
compared to the controls, and this seemed to occur in more brain areas in the male 
offspring (section 4.4.3). Female data was however, may be confounded by 
oestrous cycle changes that were not considered in this study (section 4.4.4). (iii) 
Lastly, although there were no stark differences between PNS and controls in terms 
of neuroactive steroid concentrations within each sex and region, sex differences 
(section 4.4.5) and regional differences (section 4.4.6) were still observed, which 
may have functional implications. 
4.4.1 HPA axis activity in PNS rats following acute swim stress 
PNS offspring did not result exhibit an exaggerated plasma corticosterone response 
as compared to controls following swim stress, contrary to the hypothesis (section 
4.1.4, point 1) and to previous studes, where there is greater plasma corticosterone 
observed in response to systemic IL-1β administration and restraint stress in PNS 
offspring exposed to the same prenatal social stress (Brunton et al., 2015, Brunton 
and Russell, 2010).  
Nature of different stressors: 
The observations in this study can most likely be attributed to different stressor 
types activating the HPA axis to different extents. IL-1β administration is a physical 
stressor, restraint is a psychogenic stressor, whilst swim stress has both physical 
and psychogenic components (Briski, 1996, Sawchenko et al., 2000, Dayas et al., 
2001). The neural pathways associated with systemic IL-1β signalling to the PVN 
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have been elucidated in studies carried out in rats, where brainstem A2 NTS 
neurones activate CRH neurones in the PVN directly via a noradrenergic input 
(Cunningham and Sawchenko, 1988, Sawchenko et al., 2000). 
The neural pathways activated by swim stress however, are more complex and 
have not been fully elucidated, but may involve brainstem noradrenergic signals 
(Douglas et al., 2005) and input from limbic structures (Duncan et al., 1996). In 
addition, stress signals from acute swim stress could have also been transmitted 
through a serotonergic pathway that originates from GABA neurones in the raphe 
nuclei of the brainstem (Roche et al., 2003). 
Although both acute swim stress and restraint stress have psychogenic 
components, it is likely that differences still exist between these stressors. Swim 
stress can be considered a forced exercise, which could have metabolic 
consequences such as changes in blood pH, lactate, and/or CO2 concentration 
(Abel, 1994). Although swim stress and restraint stress activate similar regions in 
the brain, including the limbic regions (Cullinan et al., 1995), there is evidence that 
these two stressors result in differential cellular outcomes, which could suggest 
activation of different neural circuits in the brain. For instance, differential patterns of 
phosphorylation of mitogen-activated protein kinases (MAPKs) are observed after a 
15 min swim stress versus 30 min restraint stress in various different brain regions, 
possibly due to differences in NMDA receptor activation (Shen et al., 2004). In 
support of the complicated neural pathways that swim stress may induce, it was 
additionally found that behaviour during the swimming bout does not correlate with 
serum corticosterone levels (Marti and Armario, 1996). After all, the stress response 
is multifaceted, and individual variations in coping styles in response to a 
psychogenic stressor is likely to further complicate the final neuroendocrine output 
(Koolhaas et al., 2010). 
Technical differences: 
Additionally, there were several differences in terms of experimental set-up and 
blood sampling protocols, which makes direct comparison of this study and previous 
experiments problematic.  
Firstly, in this experiment, the comparisons between non-stressed and acutely 
stressed steroid profile were carried out in different groups of rats. This was in 
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contrast with the previous blood sampling experiments, where blood was taken from 
the same rat, enabling one to measure pre-stress and post-stress corticosterone 
concentrations. Given the individual differences in steroid concentrations that are 
present, especially with the added influence of acute and prenatal stress (Williams, 
2008, Boersma and Tamashiro, 2015, Koolhaas et al., 2010), it may be more difficult 
to detect differences between PNS and control groups with this experimental set-up. 
Secondly, here, plasma corticosterone data was only obtained at a single time point 
(30 min after the induction of 2 min swim stress), thus conclusions were unable to 
be drawn for whether there was a difference in the amplitude of the response in 
PNS rats or whether the corticosterone response to stress was prolonged in PNS 
offspring which is another way in which HPA axis dysregulation can manifest (i.e. 
area under curve of the cumulative corticosterone response). In addition, the acute 
swim stress paradigm here lasted for only 2 minutes, and at the time of blood 
collection, the stressor has ceased. This is in contrast with the restraint stress 
paradigm, where at 30 min after stress induction, rats were still undergoing restraint. 
The clearance of intravenously administered IL-1β also takes longer than 30 min 
(Klapproth et al., 1989). Hence, as well as the nature of the stressors being different, 
differences in the duration of the stressor could also contribute to the different 
neuroendocrine responses in the PNS offspring.   
Moreover, in this experiment, rats were killed by conscious decapitation and trunk 
blood was collected. Although the collection of trunk blood versus venous blood 
should not make a huge difference in the quantification of circulating corticosterone 
concentrations, the rats in this experiment were naïve and did not undergo 
cannulation surgery before undergoing acute stress, in contrast with previous 
experiments. Cannulation surgery, although carried out four days before blood 
sampling, could be considered an additional chronic stressor to the rats (Vahl et al., 
2005), and it is possible that the immune status of rats could possibly have been 
altered in the blood sampling experiment (DeKeyser et al., 2000). In these previous 
experiments, the cannulation surgery therefore could have contributed to the 
allostatic load, and the administration of the acute stressor (e.g. restraint or IL-1β 
administration) could then be considered as an additional stressor on top of the 
surgical stress, thereby augmenting the differences in corticosterone secretion 
between PNS and control offspring.  
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4.4.2 Glucocorticoids in the brain 
Although there were no differences in plasma corticosterone concentrations 
between PNS and control offspring, brain corticosterone concentrations could still be 
different. Here, there were no differences in basal concentrations of corticosterone 
between control and PNS offspring in either sex in any of the brain regions, 
however, in the swim-stressed groups, there were instances where the PNS 
offspring had altered concentrations of corticosterone and DOC in certain brain 
regions as compared to controls, and these differences seem to be sex-dependent, 
suggesting that GR signalling in the brain following stress may be different in control 
and PNS rats. 
Firstly, male swim-stressed PNS offspring had significantly greater concentrations of 
corticosterone and DOC as compared to the control swim-stressed group. This 
observation was specific for the male brainstem, and was not observed in other 
brain regions in the males, nor in the brainstem of the females. This observation 
could be a result of different rate and extent of uptake of glucocorticoids, depending 
on brain region and sex. In control rats, differences in the local uptake of 
corticosterone in different brain regions has indeed been reported (McEwen et al., 
1969). In addition, a study which intravenously injected radioactively-labelled DOC 
into rats showed that the highest concentration of radioactive label corresponded to 
the reticular formation in the brainstem (Kraulis et al., 1975), attesting to the 
differential uptake of DOC in different brain regions. Whether or not the uptake 
process was altered in the PNS males as compared to control males and/or females 
remains unclear. Additionally, it is not known if the enzymes 11β-HSD1, 11β-HSD2, 
and 11β-hydroxylase (Fig 1.3) are affected in PNS offspring, as these enzymes can 
also control local corticosterone concentrations. 
The functional significance of higher brainstem corticosterone and DOC 
concentrations in the brainstem of PNS male offspring following acute stress is also 
unclear, although glucocorticoid and noradrenergic pathways can interact to result in 
various coping and adaptation behaviours following stress (Krugers et al., 2012). 
Corticosterone administration in rats has been shown to alter noradrenergic 
metabolism in the locus coeruleus of the brainstem, upregulating the expression of 
the noradrenaline transporter, which has a role in noradrenaline uptake and 
controlling noradrenergic synaptic transmission (Fan et al., 2014). However, given 
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the complex interactions involved in the neural circuitry of stress signalling and the 
indirect innervations that the brainstem has with other brain regions, functional 
implications of altered corticosterone and DOC concentrations here remain only 
speculative.  
In females, concentrations of DOC also seem to be affected by prenatal stress. 
However, in contrast to the males, the brain region affected was different, 
differences were also observed in the direction of change. DOC concentrations was 
lower in the hippocampus in the PNS swim-stressed group compared to the control 
swim-stressed group. Like the males, this observation could be a result of 
differential glucocorticoid uptake in PNS versus control offspring. Stress, in the form 
of social crowding and social isolation, has previously been shown to alter 
corticosterone uptake in the hippocampus of mice (Valeri et al., 1978), however, it is 
not known if prenatal stress will affect the hippocampus of the PNS female rats in 
the same manner. In terms of functional significance, it can be postulated that such 
a decrease could represent disrupted negative feedback inhibition on the HPA axis. 
Additionally, corticosterone in the hippocampus may be involved in the rapid non-
genomic modulation of dendritic spines (Komatsuzaki et al., 2012, Murakami et al., 
2018), thus a decrease in corticosterone concentrations may impact synaptic 
plasticity and therefore other behaviours (e.g. learning and memory related 
activities) in the PNS female.   
4.4.3 5α- and 3α- reduced neuroactive steroids in PNS versus control rats 
Although there was no hypersecretion of corticosterone into the circulation following 
acute swimming stress (as discussed in section 4.4.1) in PNS rats as compared to 
controls, concentration GABA modulatory steroids were still compared between 
controls and PNS, especially since mRNA expression of 5α-reductase type 1 is 
known to be altered in PNS offspring (Brunton et al., 2015). In general, in terms of 
5α- and 3α,5α-reduced steroids (DHP, allopregnanolone, DHDOC, and THDOC), 
there were no obvious differences in concentrations of steroids when PNS and 
control animals are compared, under both basal and acute stress conditions, except 
for plasma DHP in PNS males. However, in females, DHP and allopregnanolone did 
not increase following acute stress in the control groups, possibly due to oestrous 
cycle variations, which may additionally confound the interpretation of the results in 
the PNS groups, which will be explained in the next section (section 4.4.4). Again, 
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these results are contrary to the hypothesis (section 4.1.4, point 2), however, these 
may be confounded by the fact there was no HPA axis hyperactivity as mentioned 
earlier.  
In males, concentrations of plasma DHP were not increased in the PNS groups 
following swim stress, and additionally, swim-stressed PNS males had lower plasma 
DHP concentrations than that of the swim-stressed control group. The lower 
concentrations of peripheral DHP following stress in PNS males may imply that the 
production of DHP from the adrenal gland or liver is affected. Although 5α-reductase 
activity in the adrenal gland following early life insults have thus far not been 
investigated, there is evidence that hepatic 5α-reductase isoform 1 is downregulated 
as a result of prenatal programming (Brunton et al., 2013). In the brain, male PNS 
rats did not differ in DHP concentrations as compared to controls. Although it was 
also previously shown that 5α-reductase 1 mRNA expression was increased in the 
mPFC of PNS male rats (Brunton et al., 2015), the results here indicated that the 
mRNA changes did not affect DHP production in the brain, both basally and after 
swimming stress. For allopregnanolone, there was also no evidence that brain 
production of allopreganolone is compromised in the PNS male offspring, both 
basally and following swimming stress.  
Conversely, for THDOC, the other neuroactive steroid that potentiates GABA 
signalling, although concentrations in the PNS groups were not statistically different 
from their respective controls, when comparing within the PNS groups, swim-
stressed PNS rats did not have statistically greater concentrations of THDOC as 
compared to their non-swim stressed counterparts. This observation occurred in the 
male frontal cortex, amygdala and brainstem and the female frontal cortex. This 
could imply decreased THDOC generation and hence signalling, however, the 
functional implications of this are again unknown. It is tempting to suggest that 
inhibitory signalling in PNS offspring may be affected, impacting the regulation of the 
HPA axis at multiple levels, however, since allopregnanolone and THDOC binds to 
the same receptor, it is possible that allopregnanolone can compensate for the 
deficits in the production of THDOC. Nevertheless, it is known from 
electrophysiology studies in rats that THDOC and allopregnanolone can alter 
synaptic inhibition differently (Schwabe et al., 2005), probably due their differential 
potencies in modulating GABAA receptors of different subunit compositions. More 
studies will need to be carried out to determine if these differences have 
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physiological implications. Additionally, the fact that more brain regions in males 
were affected could point to the increased tendencies for such deficits in THDOC 
production in males as compared to females. In fact, differences were reported in 
the maximal GABAA receptor potentiation between male and female rats for THDOC 
(Wilson and Biscardi, 1997), attesting to sex differences in THDOC regulation.  
The conclusion for this section is that concentrations of neuroactive steroids were 
not drastically impacted in PNS offspring, but there may be modest deficits in 
THDOC production after swim stress. Nevertheless, it is worthwhile highlighting 
again that in this experiment, contrary to the hypothesis, HPA axis hyperactivity was 
not clearly observed following stress in the PNS offspring, which may relate to the 
lack of differences in concentrations GABAergic neuroactive steroids between 
control and PNS offspring.  
4.4.4 Changes in progesterone and its metabolites in females 
Whilst progesterone and its metabolites were greater following swim stress in the 
male control offspring, in plasma and all the brain regions investigated, swim stress 
did not result in an increase in progesterone, DHP nor allopregnanolone 
concentrations in the control females, in both plasma and the brain regions. This is 
contrary to the hypothesis and in contrast to observations in previous studies, where 
progesterone, DHP and allopreganolone were increased in control swim-stressed 
animals regardless of sex (Sze et al., 2018).  
The female data might have been confounded by oestrous cycle variations, which 
was not accounted for in either study. Although previous studies have determined 
that there is very little variation in brain concentrations of pregnenolone, 
progesterone, DHP, or allopregnanolone across the oestrous cycle in female mice 
(Corpechot et al., 1997), and that corticosterone secretion is not affected by 
oestrous cycle in female rats (Guo et al., 1994, Ogle and Kitay, 1977), plasma 
progesterone concentrations do vary across different stages of the oestrous cycle. 
Higher levels of progesterone occur twice in the 4-day oestrous cycle, with one peak 
between metoestrus and dioestrus, and another pre-ovulatory peak during pro-
oestrus (Butcher et al., 1974). Additionally, although basal levels of corticosterone 
are not known to be affected by oestrous cycle changes, stress-induced secretion of 
ACTH and corticosterone can be affected by oestrous cycle changes, and are 
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highest when oestradiol levels were elevated (e.g. in pro-oestrus) (Viau and 
Meaney, 1991). 
Additionally, the previous study (Sze et al., 2018) was also carried out in adult rats 
that were aged 21 weeks old, while this study was carried out in rats that were 7 
weeks old (ca. 50 days old). Age therefore, could be a factor that affected 
progesterone production following stress. Although male and female rats reach 
sexual maturity at around 48 days of age and 34 days of age, respectively (Lewis et 
al., 2002), and HPA axis maturation is considered to be largely complete by that age 
(Evuarherhe et al., 2009), some studies have argued that that the period between 
PND 50 - 60 represents the grey zone between adolescence and adulthood, and 
some neurobehavioural responses may not have reached adulthood patterns yet 
(Spear, 2000). 
Therefore, whilst the PNS female group largely did not differ from the control 
females in terms of progesterone and its metabolites, except in the frontal cortex, 
hypothalamus and brainstem, where a trend towards increased allopregnanolone 
was observed, the female controls did not seem to mount a neurosteroid response 
as reported in previous studies (Hueston and Deak, 2014, Sze et al., 2018). Further 
experiments with oestrous cycle and age taken into consideration may need to be 
carried out in order for the results observed in this study to be generalised to all PNS 
female offspring. 
4.4.5 Sex differences in neuroactive steroid concentrations 
Studies involving the direct measurement of male and female concentrations of 
neuroactive steroids in the same study have been limited, and to our knowledge, 
this is the third study, following our previous study (Sze et al., 2018), and a study by 
(Caruso et al., 2013), that has measured male and female neuroactive steroid levels 
in Sprague-Dawley rats in the same experiment. Absolute concentrations of 
neuroactive steroids were markedly different between males and females. Females 
had greater concentrations of DOC, DHDOC, THDOC, progesterone, DHP, 
allopregnanolone and pregnenolone as compared to males in plasma and in the 
various brain regions. In this study, whilst females did not have greater plasma 
corticosterone concentrations as compared to males, greater corticosterone 
concentrations in females was observed for the hypothalamus, frontal cortex and 
Chapter 4: Neuroactive steroid profile in stressed adult offspring 197 
brainstem. Testosterone was also more than ten-fold greater in the male plasma 
and brain regions as compared to that in the females.  
Other than differences in absolute concentrations of neuroactive steroids, there 
were a few instances where the pattern of difference between controls and PNS 
were different between males and females. As discussed in section 4.4.2, 
corticosterone and DOC were greater in PNS swim-stressed male brainstem as 
compared to control swim-stressed group, but lower in PNS swim-stressed female 
hippocampus as compared to its respective control swim-stressed group. It thus 
seems that here, the manner by which steroid concentrations changed in PNS rats 
when compared to the controls is dependent on sex and brain region. In section 
4.4.3, THDOC concentrations following stress were also more affected in the male 
brain as compared to the female brain, where three regions were affected in males, 
whilst for the female brain, only the frontal cortex was affected. Whilst the functional 
significance of these differences cannot be determined here, the presence of 
differences demonstrate the importance of taking both sexes into consideration 
when quantifying steroids.  
Although it has been previously reported that prenatal stress in rats can de-
masculinise males (Ward, 1972), possibly due to a decrease in testosterone, this 
was not the case here. Testosterone concentrations were not altered in the plasma 
nor brain of PNS offspring. This was in agreement to the previous study where there 
was no change in plasma testosterone observed for PNS offspring (Ashworth et al., 
2016), when plasma from trunk blood was used for quantification. 
4.4.6 Differences in neuroactive steroid concentrations in plasma and brain 
regions  
Throughout the chapter, there are differences observed in concentrations between 
circulatory amounts of steroids and those that are in the brain. In previous studies 
using male rats, steroids such as pregnenolone, DHEA and oestradiol are known to 
be 6-10 times greater in the hippocampus as compared to those in the plasma (Hojo 
et al., 2004, Mukai et al., 2006).  
Here, it was established that while corticosterone concentrations were always 
greater in the circulation than in the brain, DOC concentrations were not different 
between the brain and in the circulation. For allopregnanolone, concentrations were 
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greater in the brain than the plasma in males, but were greater in female plasma as 
compared to the female brain. For the other steroids, concentrations were either 
generally greater in the brain as compared to the plasma, although for some 
steroids and brain regions, these differences were only significant after acute stress 
(Appendix C, Table C2). In general, it has been suggested that local synthesis in the 
brain occurs when steroid levels are greater in the brain than in the circulation 
(Taves et al., 2010), again attesting to the fact that neuroactive steroids are 
produced de novo in the brain, especially after an acute stressor. Previously, it has 
also been shown that there is a correlation between plasma and brain steroid 
precursors, but not for downstream, 3α,5α-reduced steroids (Sze et al., 2018). 
Therefore, using circulatory steroids as a proxy measurement for brain steroids may 
not be appropriate, especially for 3α,5α-reduced steroids, which tend to be produced 
in the brain after an acute stressor.  
Regional differences in the brain were also present, where differences between PNS 
and controls were noted for some brain regions, but not the others (Fig 4.14). Again, 
given the presence of sub-regions and different cell types within each region, it is 
difficult to ascribe functional significance to these differences, but it highlights the 
importance of measuring steroids with regional specificity in mind (i.e. not using 
whole brain homogenates if possible), and to not to use plasma concentrations to 
approximate brain levels of neuroactive steroids. 
4.4.7 Conclusions and future directions 
All in all, these results show that neuroactive steroid concentrations in PNS offspring 
did not differ to a large extent from the controls, both basally and 30 min following a 
single 2 min bout of swimming stress, contrary to the hypothesis, although small 
deficits in the production of 5α- and 3α,5α-reduced steroids were indicated. 
However, the lack of differences in concentrations of GABAA positive modulators 
between controls and PNS may be related to the lack of corticosterone 
hypersecretion in the PNS offspring this study. It is also worthy to note that the 
single time-point of sample collection here represents a momentary glimpse at the 
steroid profile of a rat after an acute stressor, and does not provide information 
about the timecourse of the stress response. Therefore, in order to obtain more 
definite conclusions, this study may be repeated using another type of stressor (e.g. 
restraint stress), and plasma could also be collected via tail nick in order to obtain 
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samples at multiple time-points, giving us an understanding of how the stress 
response is resolved. It would also be sensible to carry out the study on female rats 
where the oestrous cycle stages are taken into account.  
Ultimately, this study is only exploratory in nature and measuring steroid 
concentrations itself is insufficient to determine the role that neuroactive steroids 
might play. Additional markers can be probed for to confirm and support the results 
that were observed here, for instance, to establish if a deficit in steroidogenic 
machinery could have contributed to the compromised responses in PNS animals, 
quantification of 5α-reductase mRNA expression following swim stress could be 
carried out in the frontal cortex or adrenal glands.  
This study however, contributes and adds weight to the hypothesis that deficits in 
neurosteroidogenesis might occur in PNS rats. Given these deficits, the possibility of 
using neuroactive steroids as a therapeutic agent is therefore still feasible, and the 
LC-MS method used in this study can in fact be used to study effects of such steroid 
replacement strategies. The absolute concentrations of neuroactive steroids 
determined in this study can also aid the development of a suitable therapeutic dose 
to be used in future experiments. Additionally, if a suitable method can be 
established, it would be of interest to carry out a larger scale metabolomics study 
profiling a larger number of steroids or even neurotransmitters (Ruoppolo et al., 
2018), in order to obtain a fuller picture of how different stress mediators may 
change relative to each other in PNS offspring as compared to controls.  
 200 
Chapter 5: Role of steroids in foetal programming 201 
Chapter 5: Role of steroids in mediating the transmission 
of stress signals from mother to foetus 
5.1 INTRODUCTION ................................................................................... 203 
5.1.1 Glucocorticoid metabolism during late pregnancy ..................................... 203 
5.1.2 Changes in glucocorticoid metabolism following gestational stress .......... 206 
5.1.3 Changes in neuroactive steroid concentrations in placental and foetus 
following gestational stress ................................................................................. 211 
5.1.4 Role of sex steroids during foetal development ......................................... 213 
5.1.5 Aims of this chapter ................................................................................... 215 
5.2 METHODS............................................................................................. 217 
5.2.1 Animals, social stress and tissue collection ............................................... 217 
5.2.2 LC-MS quantification of steroids ................................................................ 219 
5.2.3 ACTH quantification in maternal plasma ................................................... 220 
5.2.4 In situ hybridisation .................................................................................... 220 
5.2.5 Western blotting ......................................................................................... 223 
5.2.6 Statistical analysis ..................................................................................... 225 
5.3 RESULTS .............................................................................................. 226 
5.3.1 Glucocorticoids are increased in the maternal circulation following stress but 
not in the foetal brain .......................................................................................... 226 
5.3.2 Placental 11β-HSD2 expression was not compromised with stress .......... 229 
5.3.3 Glucocorticoid sensitivity in the placenta ................................................... 232 
5.3.4 Glucocorticoid metabolism in the foetal brain ............................................ 233 
5.3.5 Effects of stress on steroid concentrations in the placenta and foetuses .. 234 
5.3.6 Summary of results .................................................................................... 238 
5.4 DISCUSSION ........................................................................................ 239 
5.4.1 Changes in maternal and foetal glucocorticoid levels following stress ...... 239 
5.4.2 Changes in placental 11β-HSD2 expression following stress ................... 241 
5.4.3 Other mechanisms regulating trans-placental glucocorticoid transfer ....... 243 
5.4.4 Changes in foetal HPA axis following stress ............................................. 244 
5.4.5 Changes in placenta glucocorticoid metabolism and action following 
maternal stress ................................................................................................... 245 
5.4.6 Foetal exposure to glucocorticoids following stress: Foetal liver and brain ..... 
 ............................................................................................................................ 247 
5.4.7 Other changes in the maternal compartment following chronic stress ...... 251 
Chapter 5: Role of steroids in foetal programming 202 
5.4.8 Changes in neuroactive steroids concentrations in the foetal brain and liver 
following stress ................................................................................................... 252 
5.4.9 Sex differences in the steroidal milieu during late pregnancy .................... 254 
5.4.10 Limitations ................................................................................................ 257 
5.4.11 Conclusions and future work ................................................................... 257 
 
  
Chapter 5: Role of steroids in foetal programming 203 
5.1 INTRODUCTION 
In Chapter 4, the neuroactive steroid profiles in the plasma and brain of control and 
PNS adult offspring were characterised. Here, the aim was to find out of if these 
steroids (glucocorticoids and neuroactive steroids) are different between control and 
stressed groups at foetal stages, which may point to their role in foetal 
programming. It is hypothesised that there may be (i) foetal overexposure to 
maternal corticosterone; and (ii) altered levels of neuroactive steroids in the foetal 
compartment following chronic social stress.  
5.1.1 Glucocorticoid metabolism during late pregnancy 
Adaptations related to glucocorticoid metabolism during pregnancy have been 
introduced in Chapter 1. Here, further details with respect to the late pregnancy 
period where tissues were collected (GD20) will be given.  
5.1.1.1 11β-HSD expression pattern in the placenta during late pregnancy 
Placental 11β-HSD1 and 11β-HSD2 expression differs in a zone-specific and 
temporal manner in the placenta (Fig 5.1). Using in situ hybridisation, it was 
previously determined that on GD16, 11β-HSD1 expression is present in the 
junctional zone (JZ) but barely detectable in the labyrinth zone (LB). Conversely, for 
11β-HSD2, on GD16, high expression was observed in the LB, but low expression 
was observed in the JZ (Waddell et al., 1998, Burton et al., 1996). However, at 
GD22, the expression of 11β-HSD1 in the LB increased tremendously, whilst for 
11β-HSD2, a higher expression was observed in the JZ, but a very low expression 
in the LB (Fig 5.1) (Burton et al., 1996, Mark et al., 2009, Waddell et al., 1998). 
When whole placental homogenates were used to measure 11β-HSD2 expression 
using quantitative PCR, lower 11β-HSD2 mRNA expression was also observed in 
GD22 rat placentae as compared to those at GD16 (Staud et al., 2006). In the 
mouse placenta during late pregnancy, a similar pattern is observed in the LB, 
where 11β-HSD2 expression decreases towards term, concomitant with an increase 
in 11β-HSD1 (Brown et al., 1996, Thompson et al., 2002). Together, the reciprocal 
change in placental 11β-HSD1 and 11β-HSD2 expression in late pregnancy is 
thought to promote the trans-placental passage of corticosterone from the mother to 
the foetus near term, thereby contributing to the necessary glucocorticoid surge in 
the foetus before birth (Fowden et al., 1998).  




Figure 5.1: Patterns of 11β-HSD1 and 11β-HSD2 expression in the rat placenta 
during late pregnancy. 11β-HSD1 converts inactive 11-dehydrocorticosterone (11-
DHC) to active corticosterone (in the rat), possibly regulating local intracellular 
glucocorticoid concentrations, while 11β-HSD2 inactivates corticosterone, 
establishing the “placental glucocorticoid barrier” (Benediktsson et al., 1997, Seckl, 
2017). Expression patterns of 11β-HSD1 and 2 in the junctional zone (JZ) and 
labyrinth zone (LB) are not static and switch between GD16 to GD22. LB contains 
foetal blood vessels and is the site of maternal-foetal exchange. Data summarised 
from (Waddell et al., 1998). Decrease in 11β-HSD2 in the LB towards term is 
thought to promote the glucocorticoid surge. 
 
5.1.1.2 Foetal and maternal plasma corticosterone levels in late pregnancy 
Accordingly, foetal rat plasma corticosterone concentrations were also found to rise 
rapidly from GD17 to 18, peaking at GD19, before falling slightly again before birth 
(Ward and Weisz, 1984, Cohen et al., 1990, Boudouresque et al., 1988). Apart from 
the contributory role of the switch in 11β-HSD1 and 11β-HSD2 expression, the 
foetus’ own HPA axis starts to be active around GD18, and corticosterone can be 
produced by the foetal adrenal glands (Boudouresque et al., 1988). 
Maternal corticosterone concentrations are also reported to be the highest during 
this period (Atkinson and Waddell, 1995). Whilst maternal corticosterone 
concentrations has always been thought of as exceeding foetal concentrations 
(Murphy et al., 1974), this is not necessarily the case during late pregnancy. An 
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investigation into the maternal:foetal corticosterone ratios in late pregnancy in the 
rat, revealed that foetal baseline plasma corticosterone concentrations in the foetus 
can be almost six times higher than the maternal values on GD19, but fell to values 
approximately equivalent to maternal values closer to term (Holt and Oliver, 1968). 
In another study, Dupouy et al. showed that during GD19 and GD20, the 
concentrations in the foetuses were respectively 3-fold and 2-fold greater than that 
of the maternal circulation. 
Additionally, it has been proposed that the transfer of corticosterone may not in fact 
be unidirectional, and there possibly also exists foetal-to-maternal transfer via the 
umbilical arteries (Boudouresque et al., 1988). This is supported by the finding that 
adrenalectomising  pregnant dams does not drastically affect maternal plasma 
corticosterone concentrations (Milkovic et al., 1973a), and that maternal 
corticosterone levels can be correlated to the number of live foetuses in utero, 
suggesting that the foetal adrenal glands make a major contribution to maternal 
plasma corticosterone concentrations (Dupouy et al., 1975). As such, glucocorticoid 
metabolism in the foetal, placental and maternal compartments during late 
pregnancy, and the role of 11β-HSD2 in mediating the intricate balance of 
glucocorticoid concentrations, appear to be more dynamic and complicated than 
previously thought, which this study will shed further light on. (Dupouy et al., 1975).  
5.1.1.2 MR and GR in the placenta 
The placenta is also a target of glucocorticoid action, and is dependent on the 
expression patterns of its its target receptors MR and GR. MR does not seem to be 
present in placental tissues, but GR is found in both the JZ and LB of the rat 
placenta in late pregnancy (Waddell et al., 1998). Whilst in situ hybridisation studies 
show that its expression remains unchanged from GD16 to 22 (Waddell et al., 
1998), a later study from the same group using quantitative PCR reported that the 
expression of GR in the LB increased three-fold from GD16 to 22 (Mark et al., 
2009). There is also a substantial increase in placental corticosterone 
concentrations from GD16 to 22 (Mark et al., 2009), which could imply increased 
glucocorticoid availability, in addition to increased glucocorticoid sensitivity, in the 
placenta towards late pregnancy. 
Local glucocorticoid action through GR modulates a wide range of functions within 
the placenta, such as the control of placental vascularity (Hewitt et al., 2006) and its 
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interaction with steroid hormones. For instance, glucocorticoids can have a 
stimulating effect on progesterone production, when investigated in minced rat 
placentae (Matt and Macdonald, 1985), yet at the same time, GR in the rat placenta 
may also be a target of progesterone action (Ogle et al., 1989). In mice, the loss of 
GR can alter the methylation pattern of the murine placenta genes profoundly and in 
a sex-dependent manner (Schmidt et al., 2019a), suggesting that the placenta is not 
only a regulator of steroid and glucocorticoid metabolism in the foetal component, 
but itself is also an important target of glucocorticoids. 	
5.1.1.3 Glucocorticoid metabolism in the foetal liver and foetal brain 
An increase in corticosterone concentrations in foetal tissues is required for the 
foetal growth spurt and organ maturation towards the end of pregnancy. GR is also 
widely expressed in the developing rat brain (Kitraki et al., 1997), rendering the 
foetal brain extremely sensitive to changes in glucocorticoid levels. There is a 
gestational stage specific-pattern of 11β-HSD1 and 11β-HSD2 expression in the 
developing foetal brain, allowing intricate control of final maturation of neurones 
(reviewed in (Chapman et al., 2013, Seckl, 1997)).  
Brain 11β-HSD2 expression declines from mid-to late-gestation (Diaz et al., 1998). 
11β-HSD1 on the other hand, cannot be detected in the foetal brain until GD16, but 
increases with gestational age, during the time where 11β-HSD2 is declining (Diaz 
et al., 1998, Moisan et al., 1992), though one report failed to detect 11β-HSD1 
mRNA in foetal brain at all (Thompson et al., 2002). The role of foetal 11β-HSD1 in 
foetal programming has yet to be investigated, however, they may play a role in 
controlling local concentrations of corticosterone by reactivating 11-DHC that is 
produced from the inactivation of corticosterone by placental 11β-HSD2 (Wyrwoll et 
al., 2011).  
5.1.2 Changes in glucocorticoid metabolism following gestational stress 
The three lines of defence that can protect against glucocorticoid overexposure in 
the foetus were reviewed in Chapter 1 (Fig 1.8). However, despite these 
physiological adaptations, chronic gestational stress may still result in negative 
foetal programming. It has been therefore proposed that chronic gestational stress 
could compromise these lines of defence), such that foetal exposure to 
glucocorticoids would exceed what is considered acceptable at this stage 
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(Barbazanges et al., 1996). Some examples have been given in section 1.5.4, which 
will be further developed in this section. 
Cortisol levels in human studies: 
Maternal cortisol levels are known to be correlated with foetal (Gitau et al., 2004) 
and newborn cortisol levels (Smith et al., 2011). High maternal endogenous cortisol 
levels during pregnancy (when measured in blood, saliva and urine) are also linked 
to high amniotic fluid cortisol levels (Sarkar et al., 2007), and are associated with 
altered length of gestation and low infant birth weight, which are predictors of poor 
infant outcomes (reviewed in Duthie and Reynolds, 2013). Whilst the link between 
maternal distress during pregnancy and poor offspring outcomes (e.g. 
neurodevelopmental disorders) are known, in line with the DOHaD hypothesis 
(Monk et al., 2012, Bale et al., 2010), inconsistencies arise on whether these 
outcomes are mediated via altered maternal and foetal HPA axis and increased 
cortisol levels following maternal distress (Duthie and Reynolds, 2013). A recent 
systematic review showed that majority of the studies found no significant 
associations between prenatal maternal cortisol and child outcomes (Zijlmans et al., 
2015). This is probably due to the subjectiveness of “maternal distress” in humans 
(Dipietro, 2012) and also inconsistencies in the measurement of cortisol, as 
concentrations can vary depending on how and when samples are collected 
(Dahlerup et al., 2018). This is especially so during late pregnancy, where maternal 
HPA axis responses to stress are dampened, maternal distress is not always 
associated with a greater cortisol level (Voegtline et al., 2013, Obel et al., 2005)., 
Nonetheless, the fact that most studies do not find significant associations suggests 
that maternal cortisol is not the sole mediator between perceived stress and child 
outcomes (Zijlmans et al., 2015).  
Apart from maternal distress, several studies have also investigated the effects of 
antenatal synthetic glucocorticoid administration (e.g. dexamethasone or 
betamethasone) in pregnancies with pre-term birth risk. Synthetic glucocorticoid 
administration aids foetal lung maturation, however, their administration is also 
known to be detrimental to infant growth and development (Ilg et al., 2019). Whilst 
large doses of synthetic glucocorticoids also lead to the inappropriate activation of 
GR, these synthetic glucocorticoids are not metabolised in the same manner as 
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cortisol and are not subject to regulation from placental 11β-HSD2, therefore do not 
directly mimic the action of cortisol in foetal programming.  
Placental 11β-HSD2 expression in human studies: 
Reduced placental 11β-HSD2 activity is linked to a range of pathological conditions 
during pregnancy, such as preeclampsia, preterm birth and intrauterine growth 
restriction (IUGR), presumably due decreased inactivation of maternal cortisol in the 
placenta and subsequently, increased exposure of the foetus to maternal cortisol 
(O'Donnell et al., 2009). Offspring of women who consumed large amounts of 
liquorice, which contains an 11β-HSD2 inhibitor glycyrrhetinic acid, also exhibited 
impairments in cognitive development and HPA axis function (Raikkonen et al., 
2010). There is also evidence that placental 11β-HSD2 is sensitive to maternal 
distress and most studies report decreased placental 11β-HSD2 expression with 
maternal distress, possibly as an outcome of the hypermethylation of the HSD11B2 
gene promoter (Monk et al., 2016a). Nonetheless, there are conflicting results as 
well, as placental 11β-HSD2 expression is found to be upregulated with materal 
depression (Reynolds et al., 2015a), whilst in another study, maternal anxiety 
decreases 11β-HSD2 expression, but to a greater extent than maternal depression 
(O'Donnell et al., 2012). Apart from being sensitive to maternal mood, male and 
female placenta can be affected differently, and female offspring tend to be more 
affected than males, showing greater HSD11B2 methylation and also lower mRNA 
expression as compared to that of males (Green et al., 2015, Mina et al., 2015).  
Corticosterone levels in rodent studies: 
Studies investigating foetal corticosterone concentrations following stress are more 
easily carried out in rodents. Circulatory foetal corticosterone concentrations in the 
rat have been shown to increase following exogenous maternal corticosterone 
injection (Montano et al., 1993, Bingham et al., 2013), or with stressors that increase 
maternal corticosterone, such as exercise (Carlberg et al., 1996), tail shock 
(Takahashi et al., 1998), immobilisation stress (Erisman et al., 1990, Bingham et al., 
2013), or immune stress (Cui et al., 2011). Although there are variations in (i) the 
time elapsed before tissues were collected following the stressor and (ii) the 
gestational day in which the tissues collected, most studies report a significant 
increase in foetal corticosterone concentrations, concomitant with the significant 
increase in maternal corticosterone levels, although a closer investigation into 
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absolute values reveals that fold changes within maternal groups always tend to be 
greater (Montano et al., 1993, Bingham et al., 2013, Carlberg et al., 1996, Cui et al., 
2011). The mechanisms underlying these changes in foetal corticosterone are not 
always clear, but changes in placental 11β-HSD2 function are thought to contribute.  
Placental 11β-HSD2 expression in rodent studies: 
Similar to findings observed in human studies, several rodent studies have reported 
that chronic stress can decrease the expression and activity of placental 11β-HSD2, 
which implicates increased transfer of maternal corticosterone to the foetus. Chronic 
unpredictable stress from GD11 to 20 was found to reduce 11β-HSD2 activity and 
mRNA expression in the rat placenta (Mairesse et al., 2007), whilst maternal 
undernutrition during late gestation reduces 11β-HSD2 mRNA expression at term 
(Lesage et al., 2001). Likewise, it has been suggested the decrease in placental 
11β-HSD2 expression occurs through epigenetic mechanisms, as increased 
methylation was found in several sites of the Hsd11b2 gene promoter following 
chronic restraint stress in pregnant rats from GD14 to 20 (Jensen Peña et al., 2012). 
However, there are also reports which contend that 11β-HSD2 expression increases 
in response to stress. Using a mouse model, it was found that an increase in 
maternal corticosterone released from an osmotic pump can alter normal placental 
growth and development in a sex and gestational stage-specific manner (Cuffe et 
al., 2012). Whilst glucocorticoid receptor expression mRNA expression was 
increased at both E14.5 and E17.5 following maternal corticosterone overexposure, 
11β-HSD2 mRNA expression was increased in E14.5 but decreased instead in 
E17.5 (Cuffe et al., 2012). In another model where pregnant mice were treated with 
betamethasone, a synthetic glucocorticoid, an increase in 11β-HSD2 protein 
expression was observed in all stages of pregnancy investigated from E11.5 to 
E17.5 (Ni et al., 2018).  
The duration and nature of the stress seems to affect how 11β-HSD2 expression 
changes as well, as it was found that whilst acute restraint stress increased rat 
placental 11β-HSD2 activity, a chronic stress regime prior to the acute stressor 
abolished this increase (Welberg et al., 2005). It was thus proposed that the 
upregulation of 11β-HSD2 could be an adaptive response to a short term elevation 
of maternal glucocorticoids, while chronic exposure may lead to reduced placental 
11β-HSD2 instead. Sex-dependent changes were also noted, for instance, where 
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prenatal alcohol exposure for two weeks resulted in a decrease in 11β-HSD2 mRNA 
levels in female rat placenta, but increased 11β-HSD2 mRNA in male placentae on 
GD21 (Wilcoxon et al., 2003). 
Prenatal social stress model: 
Previous studies using the prenatal social stress model have established that 
despite attenuated HPA axis reactivity in late pregnancy, corticosterone secretion is 
greater in stressed rat dams compared to non-stressed dams (Brunton and Russell, 
2010). However, it has not been investigated in this model, whether maternal social 
stress results in increased corticosterone in the foetal circulation or altered placental 
11β-HSD2 expression. In fact, in many of the earlier experiments reviewed above, 
quantification of 11β-HSD2 expression (either gene or protein expression) was 
typically never carried out in tandem with foetal corticosterone measurements. For 
instance, even in 11β-HSD2 global knockout mice, where placental 11β-HSD2 is not 
expressed, it has not been established whether foetal circulatory corticosterone 
concentrations are affected or whether there is increased maternal-foetal 
corticosterone transfer (Wyrwoll et al., 2009, Holmes et al., 2006). The 
concentrations of the inactive metabolite 11-DHC were also rarely quantified in 
previously published experiments, therefore conclusions about the role of placental 
11β-HSD enzyme in glucocorticoid conversion cannot be drawn. Therefore, this 
study aims to elucidate whether both foetal corticosterone and 11-DHC 
concentrations are affected following maternal social stress, and if the observed 
patterns could be linked to changes in 11β-HSD2 expression patterns in the 
placenta. 
Placental GR: 
The actions of glucocorticoids are mediated not only by their circulating levels, but 
also by their local metabolism (via 11β-HSD enzymes) and intracellular signalling 
through MR and GR. Changes in placental GR gene expression have been 
associated with compromised pregnancies in humans, where for instance, a 
decrease in placental GR gene expression is associated with maternal depressive 
symptoms (Reynolds et al., 2015b). In rodents, patterns of GR protein expression 
following gestational stress seem to be variable and are dependent on the 
characteristics of the dam. In socially dominant mice dams, restraint stress for three 
days elevated placental GR and 11β-HSD2 protein expression, whilst in socially 
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submissive mice, GR protein expression was reduced without changes in 11β-HSD2 
protein expression (Gross et al., 2018). Placental GR mRNA expression was 
therefore also quantified in this study using in situ hybridisation, as changes could 
imply altered glucocorticoid sensitivity of the placenta, which can affect the 
outcomes of the pregnancy.  
5.1.3 Changes in neuroactive steroid concentrations in placental and foetus 
following gestational stress 
Neuroactive steroids in the foetal compartment regulate growth and development of 
the central nervous system, ensuring the right amount of inhibitory and excitatory 
signals at the right time, for proper neurogenesis, neuronal survival, myelination and 
neurotoxicity (section 1.4.3). Changes in their levels in the brain, or levels in the 
placenta (which can be a source, or possibly provides the precursors; section 1.4.2) 
following stress could result in detrimental effects in the offspring.  
Human studies:  
In humans, one study showed that the 5α-reductase (both isoforms 1 and 2) protein 
expression was lower in placental tissues from pre-term pregnancies, compared 
with term pregnancies (Vu et al., 2009). Yet at the same time, placental 5α-
reductase expression was positively correlated to foetal cortisol levels, suggesting a 
potential link between foetal HPA axis function and placenta steroidogenesis (Vu et 
al., 2009). 
Rat studies:  
In GD19 male rat foetuses, reduced 5α-reductase type 1 activity is observed in the 
cerebral cortex and hypothalamus when their mothers are stressed by 
immobilisation on GD15 to 18 (Ordyan and Pivina, 2005). Another form of stress, 
uteroplacental insufficiency, induced by bilateral uterine vessel ligation, results in rat 
foetuses having increased brain allopregnanolone concentrations compared with 
control foetuses on GD20 (Westcott et al., 2008). However, at postnatal day 6, 
growth restricted rat offspring show reduced brain allopregnanolone concentrations 
compared to controls, which indicate there may be some loss of steroidogenic 
capacity in the neonatal adrenal gland during gestation, but deficits only surface 
during the postnatal period due to the loss of precursors from the placenta (Westcott 
et al., 2008). 
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Other animal species:  
The majority of studies investigating foetal steroidogenesis in the brain have been 
carried out in species with longer gestation periods than the rat (22 days), such as 
the sheep (150 days) and guinea pig (70 days). The levels of allopregnanolone in 
the foetal sheep brain are extremely high, exceeding those found in the postnatal 
and adult brain, whilst steroidogenic enzymes are also present and increase steadily 
towards term (Nguyen et al., 2003b). The high allopregnanolone content protects 
the foetal sheep brain from traumatic insults and excitotoxic injury (Yawno et al., 
2007), but also suppresses CNS activity, maintaining the low level of arousal-like 
behaviour in foetuses (Nicol et al., 1997, Crossley et al., 1997). 
Allopregnanolone concentrations in the offspring are also affected by prenatal 
stress, and the direction of change is likely to be dependent on the stressor (Hirst et 
al., 2006). Acute asphyxia induced by 10 min of umbilical cord occlusion results in 
increases in allopregnanolone concentrations in both brain tissue and brain 
extracellular fluid of foetal sheep, accompanied by increased 5α-reductase type 2 
and p450scc protein expression in the brain (Nguyen et al., 2004). However, no 
increase in allopregnanolone concentrations are observed when the stressor was 
longer in duration, for instance, where chronic hypoxia is induced using microsphere 
embolisation of the sheep placental arteries for a period that ranges from 17 to 23 
days (Nguyen et al., 2003a).  
In the foetal guinea pig brain, high levels of allopregnanolone are also observed 
towards term (Kelleher et al., 2011). Repeated betamethasone administration during 
the guinea pig gestation results in reduced 5α-reductase 2 expression in the foetal 
hippocampus and in the placenta (McKendry et al., 2010). Inhibiting neuroactive 
steroid production during gestation using the 5α-reductase inhibitor, finasteride, also 
results in increased anxiety-like behaviour in the female offspring during adulthood, 
implying its importance in foetal brain development (Cumberland et al., 2017). Whilst 
maternal allopregnanolone treatment increases foetal plasma allopregnanolone 
levels, prenatal stress prevents this increase, suggesting that neuroactive steroid 
production, transfer or metabolism could be disrupted following prenatal stress 
(Bennett et al., 2013).  
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Prenatal social stress model: 
It is not known whether similar effects occur in the rat maternal social stress model. 
In Chapter 4, it was demonstrated that the PNS offspring did not display altered 
neuroactive steroid concentrations in the brain in adulthood under basal conditions, 
and only slight deficits were observed following stress exposure. Nonetheless, 
altered neuroactive steroid production may have occurred during foetal 
development, impairing proper brain development, indirectly leading to the 
development of other aberrant phenotypes (summarised in Fig 1.7) such as anxiety 
and HPA axis dysregulation in adulthood.  
5.1.4 Role of sex steroids during foetal development 
Sex steroids in foetal development are involved not only in sexual differentiation 
(section 1.3.4), but also control neuronal growth and synaptogenesis, dendritic 
branching and myelination (Garcia-Segura and Melcangi, 2006, Haraguchi et al., 
2012). Sex hormone alterations during foetal life are known to induce permanent 
alterations in the brain architecture (Nugent et al., 2011). Given the sex differences 
observed in the PNS offspring, where adverse programming seems to affect males 
to a greater extent than females (Brunton and Russell, 2010), sex hormone changes 
could underlie these sex-specific outcomes of prenatal stress.  
Progestogens:  
During foetal development, progesterone plays a role in ensuring normal neuronal 
development in both male and female foetuses, by promoting myelination for 
instance (Garcia-Segura and Melcangi, 2006). Although there does not appear to be 
sex differences in foetal plasma progesterone concentrations in the rat (Weisz and 
Ward, 1980), progesterone receptor distribution and expression are reported to be 
very different in males and females, suggesting that progesterone action could play 
an important role in sexual differentiation of the brain (reviewed in (Wagner, 2008)).  
Androgens: 
A testosterone surge occurs in male rat foetuses at GD18-19, and sex differences in 
plasma testosterone are also observed to be greatest at this stage (Weisz and 
Ward, 1980, Habert and Picon, 1984), representing a critical point in the sexual 
differentiation of the male foetal brain (McEwen, 1981, Perakis and Stylianopoulou, 
1986). Prenatal stress has been suggested to alter the characteristics of the 
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testosterone surge (Ward and Weisz, 1980, Barrett and Swan, 2015), either 
resulting in a premature surge on GD17 instead, or lower peak concentrations of 
testosterone (Ward et al., 2003). Previous rat studies investigating the impact of 
gestational stress on testosterone levels showed that two days of maternal 
lipopolysaccharide (LPS) endotoxin administration decreases testosterone in male 
foetuses on GD19 (Cui et al., 2011), whilst chronic immobilisation stress increases 
testosterone levels only in male foetuses on GD17, but not during the testosterone 
surge on GD18-19 (Ward and Weisz, 1984).  
The placenta also contains androgen receptors (AR) and AR-mediated testosterone 
action on the placenta could lead to deleterious outcomes such as preeclampsia 
(Kumar et al., 2018). In humans, foetal testosterone concentrations correlate with 
both foetal and maternal cortisol concentrations, thus stress and the associated 
changes in cortisol secretion, may interact with androgen actions and contribute to 
sex-specific programming effects (Gitau et al., 2005). 
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5.1.5 Aims of this chapter 
Gestational social stress using the modified resident-intruder paradigm is 
administered to pregnant rats from GD16 to GD20 during late pregnancy, when the 
changes in glucocorticoid metabolism are occurring (as explained in section 5.1.1). 
Whilst past studies have investigated the effects of this chronic social stress the 
offspring in adulthood, the effects of the form of stress on the placenta or foetus 
during pregnancy have yet to be investigated. In this study, pregnant rats were killed 
at GD20 and tissues from the pregnant dam, placental and foetus were collected. 
Various aspects of glucocorticoid metabolism were first investigated via LC-MS 
quantification of corticosterone and 11-DHC, as well as in situ hybridisation for 
genes involved in glucocorticoid metabolism (11β-HSD1 and 2) and action (GR). 
Additionally, a full neuroactive steroid profile, similar to that carried out in the adults 
was determined in the placenta and foetal tissues. A summary of the changes 
occurring during late pregnancy is presented in Figure 5.2, as well as the specific 
questions for this study.The specific aims of this chapter are to determine if there 
are differences between stressed and non-stressed groups at GD20, with respect to: 
1. Maternal and foetal circulatory corticosterone and 11-DHC concentrations  
2. 11β-HSD2 mRNA and protein expression in the placenta 
3. GR mRNA expression in the placenta 
4. Corticosterone and 11-DHC concentrations in the foetal liver and foetal brain 
5. Local glucocorticoid metabolism in the foetal hippocampus (by quantifying 
11β-HSD1 and 11β-HSD2 mRNA expression)  
6. The steroidal profile in the placenta, foetal liver and foetal brain 
It is hypothesised that following chronic stress, maternal corticosterone 
concentrations increase, whilst a concomitant decrease in 11β-HSD2 expression 
occurs in the placenta. These two events together result in increased foetal 
overexposure to corticosterone, where greater corticosterone concentrations will be 
observed in plasma, liver and the brain of stressed foetuses as compared to 
controls. Local glucocorticoid regulation in the developing foetal brain (11β-HSD1 
and 2 expression) may also be altered. Secondly, it is also hypothesised that there 
may be a decrease in neuroactive steroid concentrations in the developing foetal 
brain, indicating compromised neuroactive steroid-mediated protection. 
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Figure 5.2: Summary of physiological changes in the pregnant rat dam, 
placenta and foetus occurring at GD20 and potential changes to be 
investigated following gestational stress. To recap, the placenta is the site of 
maternal-foetal exchange, and contains both maternal and foetal blood vessels in 
the labyrinth zone. Blood leaving the placenta on the foetal side enters the umbilical 
vein and enters the foetal liver directly, and a portion of the blood is supplied to the 
rest of the body via the ductus venosus. Adaptations that are characteristic of late 
pregnancy are listed below each organ, whilst potential changes following 
gestational stress which are investigated in this chapter are listed in the boxes in 
yellow. Oxygenated blood flow is represented in red, while deoxygenated blood flow 
is represented in blue.   
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5.2 METHODS 
5.2.1 Animals, social stress and tissue collection 
The generation of pregnant rats and social stress were carried out as described in 
Chapter 2. Dams in the stressed group (7 dams) underwent social stress using the 
modified resident-intruder-paradigm from GD16 to 20 of gestation, and were killed 
immediately after the last stressor on GD20 (approximately 10 min after the 
induction of stress). Unstressed control dams (7 dams) were removed from the 
home cage immediately and killed. Social stress and tissue collection was carried 
out between 10:00 – 14:00 each day.  
Following decapitation, tissue collection occurred swifly, detailed in Chapter 2 
(section 2.3), with the assistance of Dr Paula Brunton. Brieftly, trunk blood was 
collected from pregnant dams following conscious decapitation, into chilled 
collection tubes containing 0.5% (w/v) EDTA kept on ice. The foetuses and placenta 
were quickly removed from the dam and the sex was determined (Chapter 2). 
Foetuses were decapitated and trunk blood was collected using EDTA-coated 
capillary collection tubes, also kept on ice. Foetal brains, maternal and foetal liver 
were then collected. Placenta, foetal brains and liver were frozen on dry ice, and 
stored at -80oC until further use. Both maternal and foetal trunk blood were 
centrifuged at 1500 g for 20 min at 4oC, and the plasma was separated and stored 
at -20oC until further use.  
The experimental plan outlined above, including the various biochemical markers 
investigated, is summarised in Figure 5.3. 




Figure 5.3 Experimental plan for this study. Pregnant dams were culled on 
gestational day (GD) 20, following which placental, maternal, and foetal tissues and 
plasma were collected. The biochemical tests carried out using each tissue is listed 
below each tissue type. CON: Control, CORT: Corticosterone, 11-DHC: 11-
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5.2.2 LC-MS quantification of steroids 
LC-MS quantification of steroids was carried out in as described in Chapter 2 
(section 2.5) and 3. Maternal and foetal plasma used for the quantification of 
corticosterone and 11-DHC were processed separately from the other tissues, and 
were subjected to a modified LC-MS detection method. Maternal liver, placenta, 
foetal liver and foetal brain were processed as described in Chapter 3 for steroid 
quantification. The steroids quantified were corticosterone, 11-DHC, DOC, DHDOC, 
THDOC, progesterone, DHP, allopregnanolone, pregnenolone and testosterone.   
Sample processing for maternal and foetal plasma: Both maternal plasma and foetal 
plasma were first diluted 1:100. 100 µL of 1:100 diluted plasma was used for LC-MS 
quantification of steroids. 7 calibration standards for corticosterone and 11-DHC 
were prepared as previously described with serial dilution, however, the surrogate 
matrix used was 0.2% BSA to mimic the albumin concentrations in the 1:100 diluted 
plasma. The samples were processed as described in section 2.5, where 100 µL of 
diluted plasma were used, extracted twice with methanol/1% formic acid, and 
underwent C18 solid phase extraction. All maternal (n=7, two groups) and foetal 
plasma samples (n=6-7, four groups) were processed on the same day using the 
same standard curves. All samples were derivatised within a single batch using 1 
mg/ml Girard’s T reagent, in methanol/ 0.2% formic acid, dried and reconstituted in 
50% methanol.  
LC-MS method for corticosterone and 11-DHC only: A modified gradient was used 
for the detection of corticosterone and 11-DHC only, using diluted maternal and 
foetal plasma, with a shorter run time of 10 min (see Figure 3B). Multiple reaction 
monitoring was carried out, but only corticosterone (460.2à401.1), 11-DHC 
(458.2à399.2) and corticosterone-d5 (464.3à405.1) were monitored. Area under 
the curves for corticosterone and 11-DHC were normalised to corticosterone-d5 
(internal standard), and the ratios were used to construct the calibration curves and 
extrapolate corticosterone and 11-DHC concentrations from samples. 
Sample processing for maternal liver, placenta, foetal liver, and foetal brain: A small 
sample of maternal and foetal liver tissue (approx. 50 mg) was excised and used for 
sample processing. 1/8th of a placenta (containing both JZ and LB) and one 
hemisphere of a foetal brain (containing both cortex and the brainstem) were used. 
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Samples were cut and weighed while frozen, on dry ice. Sample processing was 
carried out as described in section 2.5.  
LC-MS method for steroids panel: A full gradient was used for the detection of the 
steroids panel, which also includes corticosterone and 11-DHC (see Figure 3A). 
Transitions were monitored as detailed in Table 3.4.  
5.2.3 ACTH quantification in maternal plasma 
Total ACTH in the maternal plasma were measured using the MP Biomedicals 
ACTH Double Antibody RIA Kit (Cat. 07106102) as per the manufacturer’s 
instructions, by Dr Paula J Brunton. 100 µL of undiluted plasma sample kept in -
20oC was used, and samples were run in duplicate. 
5.2.4 In situ hybridisation  
In situ hybridisation was carried out to probe for placental 11β-HSD2 and GR mRNA 
expression, and foetal hippocampal 11β-HSD1 and 11β-HSD2 mRNA expression. 
Probes were kindly donated by Prof Megan Holmes and Prof Karen Chapman 
(Table 5.1).  
Tissue sectioning: Tissue sectioning was carried out by MSc student Joana 
Fernandes. Frozen tissue was mounted (but not embedded) on OCT (Tissue-Tek) 
and 16µm sections were cut using a cryostat at -19oC (Leica CM1850), then thaw-
mounted on Polysine adhesion slides (ThermoScientific). Foetal brains were cut at 
the level of the hippocampus, while placentae were cut transversely, ensuring both 
JZ and LB were represented in each section. Every 4th section was collected on 
each slide, and each slide contained 8 sections. Marker sections were collected on 
gelatine subbed slides, and fixed with acetic alcohol fixative (4% w/v formaldehyde 
and 5% v/v acetic acid in ethanol) and stained with 1% toluidine blue for 
visualisation. Tissue sections on slides were stored at -80oC until processing for in 
situ hybridisation.  
In situ hybridisation: In situ hybridisation was carried out as described in Chapter 2, 
with specific conditions for each probe detailed in Table 5.1.  
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Table 5.1: Conditions for in situ hybridisation. AS: Antisense, S: Sense. 
Hybridisation was carried out at 55oC for all three probes, while post-hybridisation 
washes consisted of the first step of 2x SSC at RT for 30min, followed by 0.1x SSC 
at 60°C for 50 min three times.  
 
Sense probes, which do not bind to the mRNA sequence, were used as negative 
controls and processed as described above. For 11β-HSD1 and 11β-HSD2, sense 
probes were applied to test kidney and placental tissue sections to determine the 
specificity of binding. Sections hybridised with sense probes showed no signal 
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Figure 5.4: Representative figure of the comparison between antisense and 
sense probes. Clusters where silver grains were super imposed on top of cells 
(black arrows) represent cells expressing the target mRNA. Positive cells were 
observed for antisense probes for 11b-HSD1 (B) and 11b-HSD2 (D and F). No 
signal was detected for respective sense probes (A, C and E). As the expression of 
11b-HSD2 in the labyrinth zone (LB) is lower and fainter than that of the junctional 
zone (JZ), E and F show these cells at a higher magnification. Positive cells in (F) 
(black arrow) have silver grains at a density 5x higher than that of the background 
and than that of the sense probes (E) where the black clusters were not specific, 
and not clustered on top of cells. Photomicrographs are taken at 10x magnification. 
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Data analysis and quantification: Placental 11β-HSD2 (both JZ and LB) was 
quantified by Ms Joana Fernandes. Images were taken at 20X magnification, from 
one section per placenta. For the JZ, data was analysed from 13-18 images cross 
the entire JZ. Grain density was measured by dividing the sum of the area 
containing silver grains over the sum of the total area of the JZ for each image. For 
the LB, 4 images were taken across the LB and the grain density was measured by 
dividing the area containing silver grains over the total area sampled, and were 
averaged across the four images. 11β-HSD1 and 2 in the foetal hippocampus were 
quantified with images taken at 20X magnification. For each foetal brain, 7-8 
sections were analysed, where one image was taken per section at the Ammon’s 
horn region, which approximately translates to the CA2 region of the GD20 
hippocampus. Grain density was measured using Fiji software, with the method 
detailed in section 2.7.5 and were averaged across the 7-8 sections.  
5.2.5 Western blotting 
Western blotting was carried out for the detection of 11β-HSD2 protein expression in 
the placenta. 
Sample homogenisation and protein quantification: 1/8th of a placenta, comprising 
both JZ and LB, was excised and homogenised on ice in 1.5 mL Eppendorf tubes 
using a handheld homogeniser in RIPA lysis buffer (Pierce, ThermoFisher) with a 
protease inhibitor (HALT inhibitor cocktail, ThermoFisher). The homogenate was 
centrifuged at 4oC for 20 min at 10000 g, and the supernatants were removed and 
their protein concentration quantified using a bicinchroninic (BCA) assay (Micro BCA 
Protein Assay Kit #23235, ThermoFisher). Standard calibrants with concentrations 
of 125 – 2000 µg/ml were serially diluted from 2 mg/ml BSA protein standards 
(Sigma). The working solution was prepared by mixing reagent A, B and C in the 
ratio A:B:C=25:24:1 respectively, and mixed with the sample in a 1:20 
sample:reagent ratio. Samples were diluted 1:40 with PBS and 10 µL was aliquoted 
into 96-well plates in triplicate. 200 µL of working solution was added and the plate 
was placed on a shaking platform for 1 min, then incubated at room temperature for 
2 hr. Optical density was read at 570 nm, on a Synergy HT spectrophotometer. A 
linear standard curve (y=mx + c) was generated in Excel and the protein 
concentration of each sample was determined.  
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SDS-PAGE (Sodium dodecyl sulphate polyacrylamide gel electrophoresis): To 
ensure equal sample loading, samples were diluted to a loading concentration of 50 
µg with RIPA Lysis buffer. NuPAGE reducing agent (10x) and loading buffer (4x; 
LDS sample buffer containing loading dye) were then added in appropriate ratios to 
each sample and incubated at 70ᵒC for 10 min. Samples, together with a MagicMark 
XP protein ladder, were loaded in pre-cast NuPAGE 4-12% Bis-Tris protein gels, 
secured on the XCell SureLock Mini Cell platform. 1X NuPAGE MOPS SDS 
Running Buffer was used, and the run voltage was set at 85V for 15 min and then at 
185V until the dye front reached the bottom of the gel. All reagents were from 
ThermoFisher Scientific. 
Semi-dry transfer: Following SDS-PAGE, gels were equilibrated in transfer buffer for 
10 min (0.1M Tris, 0.2M glycine, 5% (v/v) methanol). Meanwhile, Immobilon-FL 
PVDF Membrane (Merck Millipore, Livingston, UK) was reactivated in methanol, and 
also placed in transfer buffer for 10 min for equilibration. Semi-dry transfer was 
performed in a Novex Semi-Dry Blotter (ThermoFisher Scientific), where the gel and 
membrane was sandwiched between filter paper stacks soaked with transfer buffer. 
Transfer was carried out at 280 mA for 1 hr. Membranes were air-dried after transfer 
to permanently bind proteins to the membrane. 
Immunoprobing and detection: PVDF membranes were reactivated in methanol for 2 
min, rinsed with ddH2O, and in PBS for 2 min. Membranes were then blocked in 
Odyssey blocking buffer (Li-Cor Bioscience, Cambridge, UK) for 1 hr. Primary 
antibody targeting the 11β-HSD2 protein (Abcam, #ab80317) was diluted in blocking 
buffer with 0.1% (v/v) Tween (1:250), then incubated with the membrane overnight 
at 4oC with gentle agitation. The optimal dilution of primary antibody was determined 
in a trial run. Following overnight incubation, membranes were washed in PBS (10 
min x 5 times) and incubated with a fluorescent secondary antibody (Goat anti-rabbit 
IgG IRDye 680RD, Li-Cor, 1:5000), 1 hr in RT, also diluted in blocking buffer with 
0.1% (v/v) Tween-20, protected from light. Following another set of 5 x 10 min 
washes with PBS, blots were then visualised on the Li-Cor Odyssey Infrared 
Imaging System, using the ImageStudio software. To probe for the internal loading 
control β-actin, the blots were then stripped for 20 min using a mild stripping buffer 
(15 g/L glycine, 1 g/L SDS, 1% v/v Tween 20, protocol from Abcam), then washed 
twice with PBS. Primary antibody targeting β-actin (Sigma, #A5411), was diluted in 
blocking buffer with 0.1% (v/v) Tween-20 (1:50000), then added to the membrane 
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for 1 hr incubation in RT. Membranes were then washed five times with PBS, and 
then incubated with fluorescent secondary antibody (Donkey anti-mouse IgG IRDye 
680 RD, Li-Cor, 1:10000) for another hour in RT. Washes and imaging was carried 
out in the same way as before, with exposure time modified according to the signal 
of each of the proteins probed.  
Data analysis: Densitometric analyses were carried out on ImageJ (NIH, 
Washington, DC), using commands from the “AnalyzeàGels” submenu, where both 
the size and the grey density of each band was taken into account. The grey value 
obtained for the protein of interest was then normalised to the grey value obtained 
for the loading control. Two technical duplicates were run for every sample (i.e. two 
independent Western blot runs), and a mean value was taken from both runs.  
5.2.6 Statistical analysis  
Comparisons between stressed and non-stressed dams were carried out using a 
Student’s t-test, carried out using Prism 6.0 (section 2.6). For the placentae and 
foetal tissues, two-way ANOVAs were carried out with R-Studio (section 2.6, 
Appendix A), with stress and sex as the main factors investigated. Pairwise 
comparisons were carried out using Student’s-Newman-Keuls test to determine 
significant differences between groups. All data are presented as bar graphs with 
standard error of mean (s.e.m.), overlaid with individual data points to reveal 
variability. Significance level was set at 0.05 in all cases. 
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5.3 RESULTS 
5.3.1 Glucocorticoids are increased in the maternal circulation but not in the 
foetal brain following maternal stress 
Maternal plasma: Stressed dams had significantly greater plasma concentrations of 
ACTH (1.4-fold; p=0.0028, t=3.75, df=12; Fig 5.5A), corticosterone (3.7-fold; 
p=0.0052, t=4.18, df=6.30; Fig 5.5B) and 11-DHC (1.7-fold; p=0.0174, t=3.10, 
df=6.98, Fig 5.5C) compared to the non-stressed controls.  
 
Maternal liver: Corticosterone and 11-DHC concentrations in the maternal liver of 
stressed dams were not statisticaly different from that of the control dams (Fig 5.5D-
E; p=0.079, t=1.92, df=12 for corticosterone; p=0.23,	t=1.30, df=7.93, for 11-DHC). 
 
Placenta: There was a significant main effect of stress on both placental 
corticosterone concentrations (F1,24=7.49, p=0.011) and 11-DHC concentrations 
(F1,24=5.71, p=0.025) but no main effect of sex, nor any stress x sex interactions (Fig 
5.5F-G). Post-hoc pairwise comparisons revealed that stressed male placentae had 
significantly greater concentrations of both corticosterone (p=0.0098) and 11-DHC 
(p=0.03) as compared to the control male placentae, but this difference was not 
observed when comparing control and stressed female placentae. 
 
Foetal plasma: There was a significant main effect of stress on foetal plasma 
corticosterone concentrations (F1,23 = 6.89, p=0.015; Fig 5.5H). There was no main 
effect of sex nor any stress x sex interactions. Post-hoc SNK pairwise comparisons 
showed that plasma corticosterone concentrations were significantly greater in the 
stressed female foetuses as compared to the control females (p=0.017), albeit to a 
smaller extent (1.3-fold) as compared to that observed between the stressed and 
controls dams (3.7-fold)(Fig 5.5H). In contrast, there was no significant difference in 
plasma corticosterone between the stressed males and the control males (p=0.259). 
Plasma 11-DHC concentrations did not differ between control and stressed foetuses 
for either sex. Absolute concentrations of foetal plasma corticosterone are also 
three-fold greater than that of the maternal concentrations, while foetal 11-DHC 
concentrations are two-fold greater than that in the maternal circulation.  
 
Chapter 5: Role of steroids in foetal programming 227 
Foetal liver: There was a significant main effect of stress on foetal liver 
corticosterone concentrations (F1,24=11.5, p=0.0024; Fig 5.5J), without a main effect 
of sex nor any interactions. Liver corticosterone concentrations were significantly 
greater in stressed foetuses compared to control foetuses, for both males (p=0.012) 
and females (p=0.048). 11-DHC concentrations were not different in any of the four 
groups (Fig 5.5K). However, there was a significant main effect of stress on 11-
DHC:corticosterone ratios in the liver (F1,24=5.01, p=0.035, graphs not shown; 
Male/Control: 0.144 ± 0.040, Male/PNS: 0.070 ± 0.005, Female/Control: 0.143 ± 
0.046, Female/PNS: 0.077 ± 0.013), however, post-hoc analyses were not 
significant (p=0.11 for males, p=0.15 for females). Absolute concentrations of foetal 
liver corticosterone are also on average six-fold greater than that of the maternal 
concentrations, while foetal liver 11-DHC concentrations are more than 10-fold 
higher than that in the maternal liver. 
 
Foetal brain: There were no significant differences in concentrations of either 
corticosterone or 11-DHC in the foetal brain (Fig 5.5L-M). 11-DHC:corticosterone 
ratios were not different between all four groups as well.  
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Figure 5.5: Effects of maternal stress on ACTH, corticosterone and 11-DHC 
concentrations in the mother, placenta and foetuses. Maternal stress resulted in 
greater plasma ACTH (A), corticosterone (B) and 11-DHC (C) concentrations in the 
stressed dams, compared to the non-stressed dams (Con). Concentrations of liver 
corticosterone (D) and 11-DHC (E) were not different between control and stressed 
dams. Greater concentrations of corticosterone were also observed in the liver of 
both stressed male and female foetuses (H). Corticosterone concentrations were 
increased in the foetal liver following gestational stress, in both males (p=0.012) and 
females (p=0.048). (J) In the foetal plasma, corticosterone was increased following 
maternal stress in female foetuses, but not in males. There were no changes in the 
concentrations of 11-DHC in foetal liver (I), plasma (K) or brain (M) following 
maternal social stress. Asterisks denotes significant differences between control 
(con) and stress groups, determined by post-hoc SNK pairwise comparisons (where 
* p<0.05, ** p<0.01). Note the difference in Y axes ranges, due to the differences in 
concentrations especially between maternal and foetal compartments, where foetal 
plasma and liver have greater corticosterone and 11-DHC concentrations than the 
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5.3.2 Placental 11β-HSD2 expression was not compromised by stress 
Junctional zone mRNA expression: A main effect of stress was observed in mRNA 
expression for 11β-HSD2 in the JZ of the placenta (F1,24 = 11.7, p=0.0022)(Fig 5.6A 
and C). Pairwise SNK comparisons revealed that stressed male placenta had 
significantly higher 11β-HSD2 mRNA expression compared to control male placenta 
(p=0.004); whilst in females, this difference was not statistically significant (p=0.11). 
There was no main effect of sex (F1,24 = 2.27, p=0.14) nor any interaction between 
sex and stress (F1,24 = 1.16, p=0.29). There were no significant differences between 
males and females, and post-hoc testing showed that the comparison between the 
control female and control male group was not significantly different (p=0.08; Fig 
5.6A).  
 
Labyrinth zone mRNA expression: In the LB, a two-way ANOVA did not reveal any 
significance differences between the four groups, and there was no main effect of 
stress (F1,22=1.12, p=0.30), no main effect of sex (F1,22=0.778, p=0.38), nor any 
stress x sex interactions (F1,22=0.909, p=0.35) (Fig 5.6B and D).   
 
Protein expression: Western blot detection of 11β-HSD2 protein in placental 
homogenates (consisting of both junctional and labyrinth layers) did not reveal any 
significant changes between control and stressed placentae (Fig 5.7A-B; no main 
effect of stress: F1,24=1.64, p=0.21; no main effect of sex: F1,24=0.442, p=0.52; no 
stress x sex interactions: F1,24=0.329, p=0.57).  
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Figure 5.6:	Effects	of	maternal	stress	on	11β-HSD2	mRNA	and	protein	expression	in	male	
and	female placenta. In the JZ (A), a significant main effect of stress was observed 
(two-way ANOVA), and post-hoc SNK testing revealed a significant increase in the 
placentae from males (p=0.004) following stress, while in females no significant 
changes were observed (p=0.11). (B) In the LB, a trend towards an increase was 
observed only in the male stressed placentae. Representative images of 11β-HSD2 
mRNA hybridisation in the JZ (C) and the LB (D) of male placenta. Representative 
images of 11β-HSD2 mRNA hybridisation at the JZ (C) and LB (D) of male control 
and stressed placentae at 10X magnification. 
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Figure 5.7: Effects of maternal stress on protein expression in male and 
female placenta. 1/8th of the placenta, consisting of both JZ and LB, was used to 
quantify 11β-HSD2 protein expression using Western blot. (A) No differences in 
11β-HSD2 protein expression were observed between any of the four groups. (B) 
Representative Western blots of 11β-HSD2 protein (right) and β-actin loading 
control, after stripping and re-probing (left). Asterisks represent significant 
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5.3.3 Glucocorticoid sensitivity in the placenta  
Glucocorticoid sensitivity of the placenta was investigated by quantifying GR mRNA 
expression in both the JZ and LB. GR mRNA expression was not significantly 
different in all four groups in both the JZ (Fig 5.8A-B; no main effect of stress: F1,24 = 
0.611, p=0.44; no main effect of sex: F1,24 = 0.004, p=0.95; no interaction: F1,24 = 
0.99, p=0.33) and LB (Fig 5.8C-D; no main effect of stress: F1,24 = 0.75, p=0.40; no 
main effect of sex: F1,24 = 0.315, p=0.58; no interaction: F1,24 = 2.46, p=0.13). No 





Figure 5.8: Placental GR mRNA expression following maternal stress. GR 
mRNA expression in the JZ (A) and LB (C) remain unchanged following stress for 
both male and female placentae. Representative images of GR mRNA hybridisation 
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5.3.4 Glucocorticoid metabolism in the foetal brain 
11β-HSD1 and 11β-HSD2 mRNA was also probed for in the foetal hippocampus to 
determine if there are any changes in local glucocorticoid regulation that might not 
be revealed with LC-MS detection of steroids in the whole brain. There were 
however, no significant differences in 11β-HSD1 (Fig 5.9A-B; no main effect of 
stress: F1,24 = 0.911, p=0.35; no main effect of sex: F1,24 = 0.0088, p=0.93; no 
interaction: F1,24 = 0.0024, p=0.96) or 11β-HSD2 (Fig 5.9C-D; no main effect of 
stress: F1,24 = 0.951, p=0.34; no main effect of sex: F1,24 = 3.44, p=0.077; no 
interaction: F1,24 = 0.31, p=0.58) mRNA expression in the foetal hippocampus in 
either males or females.  
 
 
Figure 5.9: Effects of maternal stress on 11β-HSD1 and 11β-HSD2 in the foetal 
hippocampus. No differences were observed in (A) 11β-HSD1 and (C) 11β-HSD2 
mRNA expression in the foetal hippocampus between stressed and control (Con) 
groups, in either males or females. Representative images of 11β-HSD1 mRNA 
hybridisation (C) and 11β-HSD2 mRNA hybridisation (D) in the hippocampus of 
male control and PNS foetuses at 20X magnification. 	
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5.3.5 Effects of stress on steroid concentrations in the placenta and foetuses 
Concentrations of progesterone and its metabolites DHP and allopregnanolone, 
pregnenolone, DOC and its metabolites DHDOC and THDOC, and testosterone 
were quantified in the placenta, foetal liver and foetal brain.  
Progesterone, DHP and allopregnanolone: 
Apart from a main effect of stress that was borderline significant for placental 
progesterone concentrations (F1,24=4.28, p=0.05; Fig 5.10A), there were also no 
effects of sex, nor any stress x sex interactions, on progesterone concentrations in 
the placenta. Nonetheless, post-hoc testing showed that there were no significant 
differences among all four groups for placental progesterone concentrations. In the 
foetal liver (Fig 5.10B) and foetal brain (Fig 5.10C) progesterone concentrations 
were not significantly different across all four groups. DHP (Fig 5.10D-F) and 
allopregnanolone (Fig 5.10G-I) concentrations were not different between control 
and stressed placenta, foetal liver and foetal brain in both sexes. No sex differences 
were observed as well. 
Pregnenolone: 
There were no main effects of stress in the placenta, foetal liver nor foetal brain on 
pregnenolone levels (Fig 5.10J-L). However, in the foetal brain (Fig 5.10L), there 
was a main effect of sex (F1,24=7.39, p=0.012) and the sex x stress interaction was 
close to significance (F1,24=3.31, p=0.081). Post-hoc testing showed that stressed 
female foetuses had significantly higher brain pregnenolone concentrations 
compared to control females (p=0.0376), but this difference was not observed in 
male foetuses (p=0.714). Additionally, the stressed female foetuses also had higher 
brain pregnenolone concentrations as compared to the stressed male foetuses 
(p=0.038). There were also main effects of sex for placental pregnenolone on the 
two-way ANOVA (F1,24=5.23, p=0.03), however, post-hoc analyses did not reveal 
any significant differences between the four groups (Fig 5.10J).  
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Figure 5.10: Progesterone, DHP, allopregnanolone, and pregnenolone 
concentrations in the placenta, foetal liver, and foetal brain. Asterisks denotes 
significant differences between control and PNS groups (where * p<0.05) using SNK 
pairwise comparisons. Hashes denote significant differences between male and 
female groups (where ## p<0.01) using SNK pairwise comparisons. Two-way 
ANOVA showed a significant main effect of sex on foetal brain pregnenolone. No 
significant differences in concentrations were observed for other steroids across the 
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DOC, DHDOC and THDOC: 
There were no significant effects of stress on DOC (Fig 5.11A-C), DHDOC (Fig 
5.11D-F) or THDOC (Fig 5.11G-I) concentrations in the placenta, foetal liver nor 
foetal brain. A main effect of sex, however, was observed for foetal liver THDOC 
concentrations (F1,24=8.03, p=0.009; Fig 5.11H), where post-hoc pairwise 
comparisons showed control female foetuses had higher liver concentrations of 
THDOC compared to control male foetuses (p=0.026). A main effect of sex was also 
observed for foetal brain DHDOC concentrations on the two-way ANOVA 
(F1,24=4.61, p=0.042; Fig 5.11F), however, post-hoc analyses revealed that there 
were no significant differences between all four groups.  
Testosterone: 
Lastly, there were no effects of stress on testosterone concentrations in the 
placenta, foetal liver or foetal brains (Fig 5.11J-L). However, a main effect of sex 
was observed for testosterone concentrations in the foetal liver (F1,24=22.6, p<0.001; 
Fig 5.11K) and foetal brain (F1,24=52.2, p<0.001; Fig 5.11L). There were no main 
effects of stress nor any interactions. Female foetuses had significantly lower brain 
and liver testosterone concentrations compared to male foetuses, regardless of 
stress status.  
Chapter 5: Role of steroids in foetal programming 237 
 
Figure 5.11: DOC, DHDOC, THDOC, and testosterone concentrations in the 
placenta, foetal liver, and foetal brain. Two way ANOVA revealed that there was 
a main effect of sex for foetal liver THDOC (H) and a main effect of sex for 
testosterone in the foetal liver (K) and brain (L). No effect of stress was observed for 
any of the steroids investigated. Hashes denote significant differences between 
male and female groups (where # p<0.05, ## p<0.01, ### p<0.001) using SNK 
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5.3.6 Summary of results 
 
 
Figure 5.12: Summary of results from Chapter 5.  denotes elevated levels, 
while  denotes decreased levels, whilst ↔ denotes no difference, compared within 
each sex by stress status (“with stress”), or by sex (regardless of stress status 
unless otherwise stated). Abbreviations: M: Male, F: Female, CORT: Corticosterone, 
11-DHC: 11-dehydrocorticosterone, DOC: Deoxycorticosterone, DHDOC: 
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5.4 DISCUSSION 
In this study, pregnant dams were stressed for five days and were killed immediately 
after the last bout of stress on GD20. Plasma and tissues from pregnant dams, 
placenta and foetuses were analysed. The primary aim is to test the hypothesis that 
excessive maternal glucocorticoid crossover, contributed by changes in placental 
11β-HSD2, is the main mechanism mediating foetal programming. The second 
hypothesis is that programming effects could be caused by changes in neuroactive 
steroid levels following stress. Results are summarised in Fig 5.12, and several key 
observations refute these two hypotheses. 
Firstly, foetal circulatory corticosterone concentrations did not parallel the increase 
in maternal circulatory corticosterone concentrations, and there was limited trans-
placental crossover of corticosterone following the stressor from mother to foetus. 
There was a minor increase in corticosterone in the foetal liver, but importantly 
corticosterone changes were not observed in the foetal brain. Placentae from 
stressed dams expressed significantly greater 11β-HSD2 mRNA in the JZ compared 
to placentae from control dams, which may imply greater protection by the 
“glucocorticoid barrier” instead.  
Secondly, there were minimal changes in neuroactive steroid concentrations 
induced by stress in the placenta, foetal liver and brain. Additionally, compared to 
those observed in the adult offspring, sex differences in foetal tissues were more 
subtle and only observed for certain steroids.  
5.4.1 Changes in maternal and foetal glucocorticoid levels following stress 
As expected, there was a significant difference in plasma corticosterone 
concentrations between stressed and non-stressed dams immediately after social 
stress at GD20, which is likely to be a result of activation of the maternal HPA axis 
(Fig 5.5). Despite this robust increase in the maternal circulation, only a modest 
increase was observed in the plasma of female foetuses, and no change was 
observed in the male foetuses (Fig 5.5). Additionally, although maternal 
corticosterone concentrations in the stressed group was three-fold greater than in 
the control group, foetal corticosterone concentrations in the stressed group was 
only 1.3-fold greater than the control group, and this was only observed in the 
female foetuses. The data obtained here corroborates previous findings in mouse 
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studies where a similar sex difference in foetal corticosterone was observed, with a 
modest increase in the female foetuses but not in the males (Montano et al., 1993). 
One of the tenets of the glucocorticoid programming hypothesis is centred around 
the assumption that circulating foetal concentrations of glucocorticoids are 
considerably lower (often, 5- to 10- fold lower) than that of the maternal circulation 
(reviewed in (Chapman et al., 2013)). Excess glucocorticoids, which are small and 
lipophilic, would therefore have the tendency to cross over the placenta via simple 
diffusion, unless inactivated by placental 11β-HSD2. However, contrary to these 
assumptions, absolute values of foetal circulating corticosterone concentrations 
were in fact, higher than maternal concentrations (Fig 5.5). At baseline, foetal 
corticosterone concentrations were three times that of maternal values at GD20 (Fig 
5.5), and even following stress, maternal circulating values barely exceeded that of 
foetal values. Similarly, baseline 11-DHC concentrations were also found to be two-
fold greater in the foetal circulation as compared to the maternal circulation and did 
not exceed foetal values even after stress (Fig 5.5).  
These observations, seemingly discrepant from previous assumptions, were 
possibly due to dynamic corticosterone levels across different gestational stages. 
When gestational stage is considered, the concentrations obtained in this study are 
similar to those of previous studies. The values of basal plasma corticosterone in 
non-stressed rats obtained here using LC-MS (maternal: 82 ng/ml, foetal: 275 ng/ml) 
were close to the values obtained previously using a fluorometric quantification 
method (Dupouy et al., 1975) or RIA (Ward and Weisz, 1984), where foetal plasma 
concentrations were found to be 300-400 ng/ml, whilst maternal concentrations 
ranged from 100-200 ng/ml on GD19. Even with stress, reported increases in foetal 
corticosterone were never to the same extent as that seen in the pregnant rat dam 
(Williams et al., 1999, Takahashi et al., 1998, Bingham et al., 2013). For instance, 
Williams et al. (1998) showed that stress at GD19 increased maternal corticosterone 
from 156.1 ng/ml to about 400 ng/ml, whilst foetal concentrations increased from 
250 ng/ml to about 310 ng/ml. In light of these ratios, maternal-to-foetal transfer of 
corticosterone is likely to be complex and does not merely occur via simple diffusion 
down a concentration gradient. This will be further discussed in the subsequent 
sections. 
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In terms of functional significance, it is difficult to conclude whether this modest 
increase in circulating corticosterone in the female foetuses reported here could 
have a major influence on foetal growth and development. However, potential 
implications will be discussed in light of the concentrations in the foetal brain and 
liver (section 5.4.4), as these are the tissues where the impact of glucocorticoids are 
particularly relevant. 
5.4.2 Changes in placental 11β-HSD2 expression following stress 
Sex-dependent changes in placenta 11β-HSD2 mRNA expression were observed 
following five days of chronic maternal social stress. Male stressed placentae had 
greater 11β-HSD2 mRNA expression compared to male control placentae, where 
the difference was significant in the LB and trending towards significance in the JZ. 
Conversely, 11β-HSD2 mRNA expression was not significantly increased in female 
stressed placentae as compared to control females, in both the LB and the JZ. 
Nonetheless, when the 11β-HSD2 mRNA expression is compared between the 
male and female control groups, there was a trend for female control placentae to 
have greater expression of 11β-HSD2 mRNA as compared to control males in the 
LB (p=0.08), suggesting that female placentae may have greater baseline 
expression of 11β-HSD2 mRNA to begin with.  
These observations seem to correlate to those observed in humans, where 
placental 11β-HSD2 is more highly expressed in female placentae than in males 
(Mericq et al., 2009). In another human study, it also seems that maternal distress 
can impact placental 11β-HSD2 expression sex-dependently, as	maternal distress is 
associated with increased 11β-HSD2 mRNA levels in male placentae. Although 
reduced 11β-HSD2 mRNA expression was reported for the female placentae, 
baseline values were not known, rendering it difficult to directly compare between 
the sexes (Mina et al., 2015). 
Whilst these observations may appear to explain changes in foetal circulatory 
corticosterone, where the increase in 11β-HSD2 mRNA expression in the stressed 
male placenta may have prevented excessive glucocorticoid crossover in stressed 
male foetuses, various clues, discussed in this section and in section 5.4.3 and 
5.4.4, suggest that the link between placenta 11β-HSD2 expression and foetal 
corticosterone levels are not straightforward. 
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Firstly, it has to be noted that here, 11β-HSD2 mRNA was in fact lowly expressed in 
the LB (Figure 5.6), the location of exchange between maternal and foetal blood, as 
compared to the JZ. The regional expression pattern of 11β-HSD2 in the JZ and LB 
at GD20 in this study was therefore closer to that of a term placenta than that of a 
GD16 placenta (Waddell et al., 1998). In support, the cellular expression pattern 
observed also corresponded to that in a term placenta, where there was an intense 
positive signal for 11β-HSD2 mRNA in some JZ trophoblast cells, but it was 
completely absent in others (Waddell et al., 1998). Therefore, given the low 
expression of 11β-HSD2 mRNA in the LB at GD20, it seems that the contribution of 
11β-HSD2 on controlling the passage of maternal glucocorticoid to the foetus may 
not be as integral as once thought. 
Secondly, although increased 11β-HSD2 mRNA expression in the LB implies 
greater conversion of corticosterone to 11-DHC, greater plasma 11-DHC 
concentrations were not observed in the male foetal circulation. Instead, there was a 
robust increase in 11-DHC concentrations in the maternal circulation, which could 
potentially be related the higher expression of 11β-HSD2 in the JZ, given that the JZ 
is in contact with maternal blood vessels. 11β-HSD2 in the placental JZ thus could 
have played a role in the converting the excess maternal corticosterone into 11-
DHC, which then exited through the maternal circulation instead of entering the 
foetal blood vessels. The increase in 11β-HSD2 mRNA in placenta during late 
pregnancy could therefore represent a compensatory mechanism to instead 
regulate maternal levels of corticosterone that accompanied repeated social stress. 
As these mRNA expression changes in 11β-HSD2 are most likely to represent 
longer term changes induced by five days of chronic stress, there could be other 
implications. Given that expression patterns of 11β-HSD1 and 2 switch from GD16 
to 20 (Fig 5.1), the higher expression in male LB could represent stressed male 
placentae experiencing a slower reduction in 11β-HSD2 expression as compared to 
control male placentae during late pregnancy. It is possible that this slower reduction 
in 11β-HSD2 expression could alter the amount of glucocorticoids they are exposed 
to basally and during fluctuations of the glucocorticoid circadian/ultradian rhythm, 
thereby affecting the normal growth trajectory of males.  
Despite these changes in mRNA expression for 11β-HSD2, no increase in 11β-
HSD2 protein levels could be detected on the Western blot in PNS males. Whilst the 
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translation of transcribed mRNA into protein is the central dogma of molecular 
biology, the relationship between mRNA and protein expression have been found to 
be increasingly dynamic and can be affected by biological factors such as 
translation efficiency and protein half-life etc (Liu et al., 2016b, Maier et al., 2009). 
Post-transcriptional modifications is known to occur in human placenta for instance, 
and pre-eclamptic placenta have different degrees of modifications as compared to 
placentae in normal pregnancies (Taniguchi et al., 2020). Therefore, it may be 
possible that gestational stress also altered the post-transcriptional modification of 
the 11β-HSD2 mRNA, resulting no net changes in 11β-HSD2 protein expression. 
Additionally, it is worthwhile to note that in this study, an increase in expression of 
11β-HSD2 mRNA was only observed in the JZ, both JZ and LB were used for 
Western blotting detection of proteins, and there is a possibility that it may have 
masked any differences (if any) in the JZ. In future studies, the placenta can be 
dissected into the various sub-regions under a dissecting microscope, where the two 
zones can be differentiated based on their colour, given their different 
vascularisation characteristics (Ain et al., 2006). 
5.4.3 Other mechanisms regulating trans-placental glucocorticoid transfer 
The ability to measure 11-DHC concentrations in the maternal and foetal 
compartments in this study also sheds light on the complexity of the trans-placental 
glucocorticoid transfer. As mentioned in section 5.4.2, 11-DHC concentrations were 
increased in the maternal circulation but were unchanged in the foetal compartment 
following stress, despite changes in 11β-HSD2 mRNA expression.  
Recent studies utilising ex vivo placental perfusion have revealed that the kinetics of 
the glucocorticoid diffusion appear to be more complicated than previously thought. 
In the GD21 rat placenta, the rate of 11β-HSD2-mediated corticosterone to 11-DHC 
conversion is found to be dependent on concentrations of perfused corticosterone, 
and there is a limit as to how much 11-DHC could be produced, possibly due to the 
saturation of enzyme activity (Staud et al., 2006). There also seem to be no 
differences in characteristics of maternal-to-foetal versus foetal-to-maternal transfer, 
indicating the possibility of a bi-directional transfer of corticosterone (Staud et al., 
2006).  
Similar studies on human placenta have additionally revealed that the 
“glucocorticoid barrier” is not merely contributed by 11β-HSD2. Using near-term 
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placenta collected from C-section births, when active cortisol was perfused through 
the maternal blood vessels, a five-fold higher inactive cortisone release was found in 
the maternal circulation than in the foetal circulation (Stirrat et al., 2018), which 
seems to correlate to the increased patterns of maternal 11-DHC increase observed 
in this study following stress, where the converted 11-DHC appears to be returned 
to the maternal circulation. Additionally, in these perfusion studies, even when 11β-
HSD2 is completely inhibited using carbenoxolone, less than 10% of the total 
injected glucocorticoid actually crosses the placenta into the foetal compartment 
(Stirrat et al., 2018).  
It has thus been suggested that there are several factors other than 11β-HSD2 
action controlling the crossover of corticosterone, such as placental vascularity and 
flow rate of the blood in maternal and foetal vessels, or the role of efflux transporters 
that regulate active transport of cortisol (e.g. ABC transporters or P-glycoprotein) 
(Stirrat et al., 2018). It is not known if these other mechanisms can be affected by 
maternal stress, or if the increase in corticosterone in the foetal plasma of females 
observed here are due to compromises in any of these other mechanisms. 
Nonetheless, the ability of the LC-MS method to quantify and compare the levels of 
corticosterone and its inactivate metabolite 11-DHC may allow for similar perfusion 
studies in the future.  
5.4.4 Changes in the foetal HPA axis following maternal stress 
Considering plasma was collected from decapitated foetuses, and not directly from 
the umbilical vein which would more closely represent trans-placental passage (Fig 
5.2), one cannot rule out the possibility that the foetuses’ own adrenal glands 
contribute to circulating foetal corticosterone concentrations following maternal 
stress. One way to determine this is to measure ACTH levels in the placenta, as 
ACTH cannot cross the placenta. Hence, an increase in ACTH in the foetuses would 
indicate activation of the foetal HPA axis by maternal stress and production of 
corticosterone of foetal origin is highly possible. This was not carried out as the 
pooled foetal plasma volume was too low to be able to detect foetal ACTH in this 
experiment. 
However, previous studies seem to suggest that whilst single stressors can 
stimulate an increase in ACTH secretion in the foetus, this is not the case for chronic 
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stressors, both on a basal level (e.g. a day after the last stressor), and shortly after 
the last stressor.  
Studies utilising a single maternal restraint stress on GD20 have reported that foetal 
plasma ACTH concentrations are increased, together with foetal corticosterone in 
stressed rat foetuses (Ohkawa et al., 1991b). Additionally, c-Fos concentrations in 
the foetal rat PVN are elevated with 30 min after a single 30 min acute stressor 
(restraint/ immobilisation/ forced walking) on GD21, indicating activation of the brain 
regions involved in stimulating the HPA axis (Fujioka et al., 2003). 
Conversely, in one model of chronic restraint stress (GD11-20) in pregnant rats, 
basal ACTH concentrations in the foetal plasma were reduced, although this was 
investigated at GD21, a day after the last stressor (Mairesse et al., 2007).  Even 
when plasma was collected immediately, or up to 90 min after the last stressor, no 
increase in foetal ACTH concentrations was observed, in the case of chronic 
variable maternal stress (from GD14-21) during the rat pregnancy (Williams et al., 
1999). In the foetal rat brain,  PVN c-Fos activation following chronic maternal 
immobilisation stress from GD17-21 tends to be of lower magnitude compared to 
that following exposure to a single stressor on GD21 (both investigated 30 min after 
cessation of a 30 min maternal restraint stress), suggesting that central mechanisms 
of foetal response to in utero stress for chronic stress are different to those for acute 
stress (Tobe et al., 2005).  
5.4.5 Changes in placenta glucocorticoid metabolism and action following 
maternal stress  
The abundance of GR expression in the placenta also suggests that the near-term 
placenta is itself a prominent target of glucocorticoid action (Mark et al., 2009, 
Thompson et al., 2002).  
Local glucocorticoid content in placenta: 
When the content of corticosterone was measured in the placenta, stressed male 
placentae showed greater corticosterone and 11-DHC concentrations compared to 
the controls, but this was not observed in the placentae from females. This pattern 
corresponds to that seen in a mouse study by Montano et al., where there was an 
increase in the placental corticosterone concentrations in male placentae but not 
females (Montano et al., 1993). As the placental homogenate does not only 
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represent intracellular content, it is not possible to determine if the differences are a 
result of changes in local glucocorticoid conversion (i.e. 11β-HSD1 and 11β-HSD2 
action), or if it is contributed by corticosterone and 11-DHC found in the foetal blood 
vessels and the maternal blood sinuses, derived from foetal and/or maternal 
sources, or if the glucocorticoids are produced by the placenta’s own steroidogenic 
machinery.  
Nonetheless, the values detected in our study correspond to those previously 
reported in other rat studies, in terms of absolute values (Schmidt et al., 2019b), 
corticosterone to 11-DHC ratios (Heussner et al., 2016) and placental:maternal 
corticosterone ratios (Mark et al., 2009). Although tissues from both zones were 
used for corticosterone quantification here, corticosterone concentrations are not 
reported to be different between the two zones in the rat placenta (Mark et al., 
2009).  
Simultaneous quantification of placental 11β-HSD1 mRNA expression could provide 
more information about the local glucocorticoid conversion processes occurring in 
the placenta. Far less studies have been carried out to investigate how stress may 
affect the expression of 11β-HSD1 in the placenta. In a previous study using a rat 
model, whilst there was no effect of chronic mild stress during GD11-20 on 11β-
HSD1 nor 11β-HSD2 protein levels at GD21, higher maternal corticosterone levels 
was correlated with lower 11β-HSD1 protein levels in the placenta (Lan et al., 2017). 
Prenatal betamethasone administration in mice on the other hand, does not alter 
11β-HSD1 protein expression (Ni et al., 2018). Placental 11β-HSD1 may possibly be 
further stimulated by glucocorticoids and GR activation in a feed-forward 
mechanism, although this has only been investigated in the liver of wild-type mice 
(Morgan et al., 2014). As male placenta had increased corticosterone and 11-DHC 
concentrations, it is possible that there may also be sex differences in placental 11β-
HSD1 expression.  
Other factors affecting placental glucocorticoid action: 
Ultimately, it is equally important to investigate whether the expression of target 
receptors are modified following maternal stress, in order to determine functional 
implications of altered steroid concentrations. GR mRNA expression patterns 
observed in this study were similar to what has been described in previously 
published studies in the rat, where GR was present in both the JZ and the LB (Heller 
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et al., 1986, Waddell et al., 1998). In this study, gestational stress did not lead to 
differences in GR mRNA expression in control versus stressed placentae, either n 
the JZ or in the LB, indicating that the number of GRs are unlikely to be altered by 
gestational stress.  
However, it is still not possible to conclude if there were any differences in 
glucocorticoid action on GR, as glucocorticoid action not only depends on the 
density of GR, but also on their phosphorylation status, isoform expression, and the 
number or the function of chaperone proteins they are associated with, to name a 
few (Oakley and Cidlowski, 2013, Scheschowitsch et al., 2017). For instance, sex-
dependent alterations in the expression of GR isoforms is observed following 
maternal dexamethasone exposure in the mouse, leading to impairment of placental 
development (Cuffe et al., 2017b). Sex difference in glucocorticoid resistance have 
been postulated to occur through differential expression of various GR isoforms in 
the human placenta (Saif et al., 2014). These GR isoforms arise through splice 
variants, which were not considered for the GR riboprobe used here, which targets 
sequences corresponding to the GR steroid-binding-domain (riboprobe sequence 
first published in (Diaz et al., 1998)).  
Additionally, it is not known if chaperone proteins associated with GR, such as 
FKBP51 or FKBP52 which are also expressed in the placenta (Tranguch et al., 
2007), may be altered by maternal stress. In humans, maternal stress during the 
second trimester decreased placental FKBP51 mRNA only in female foetuses 
(Togher et al., 2018), while placental FKBP52 protein expression seem to be 
disrupted in pre-eclamptic and IUGR pregnancies (Acar and Ustunel, 2015).  
5.4.6 Foetal exposure to glucocorticoids following stress: Foetal liver and 
brain 
Despite glucocorticoid changes in the female foetal circulation, ultimately, the 
physiological effects of glucocorticoids in the foetus are dependent on their action in 
the target organs. 
Foetal liver:  
Greater hepatic corticosterone concentrations were observed for stressed foetuses, 
regardless of sex. Given that the umbilical vein directly drains into the foetal liver 
(Fig 5.2), the foetal liver is the first organ to be perfused by placental blood (Murphy, 
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2005, Lautt, 2009). The majority of the blood bypasses the liver via the ductus 
venosus into the inferior vena cava and the rest of the body, however, a proportion 
of it perfuses the liver. At the same time, the liver is also perfused by the hepatic 
portal vein, where corticosterone produced by the foetal adrenal glands could be 
transported into the liver (Murphy, 2005, Lautt, 2009). As it is not possible to 
differentiate between the contributions of these different sources of corticosterone, 
the observed results in this study could represent intracellular corticosterone content 
in liver tissue, corticosterone in the blood from the umbilical vein, as well as from the 
production from the foetal adrenal glands.  
This also the first time foetal and maternal corticosterone are compared in the same 
study, possibly due to prior constraints in measuring liver glucocorticoids using RIA. 
Here, it is observed that foetal hepatic glucocorticoid content is far greater than that 
in the maternal liver. Although the reason for this is not known, it is likely to be 
related to the glucocorticoid surge in foetuses that occurs at late pregnancy. 
Additionally, there are also dynamic changes in expression of CBG mRNA through 
gestation, where foetal CBG mRNA expression is greater compared to maternal 
concentrations at GD15, but decreases to a low level at birth (Smith and Hammond, 
1991, Leeper et al., 1988). Although foetal liver glucocorticoids were measured at 
GD20 in this study, which again represents a snapshot instead of the dynamic 
changes that are occurring in late pregnancy, there is a possibility that hepatic CBG 
have further aided the sequestering of corticosterone in the foetal liver. The high 
concentrations of hepatic corticosterone in the foetus is likely required for the 
functional maturation of the liver, as the glucocorticoid surge is accompanied by 
increased glucose production and glucogenic proteins (Hyatt et al., 2008).   
The implications of altered liver corticosterone in the foetus is not known, but this 
difference could presumably affect the typical growth trajectory or function of the 
liver at GD20. Previous studies have observed that gestational stress, with 
increased maternal corticosterone levels, affects hepatic gluconeogenic capacity in 
rat foetuses, potentially leading to the programming of metabolic diseases (Franko 
et al., 2017). Using the same social stress model, it was found that there were 
changes in the expression of genes regulating glucose-insulin homeostasis and lipid 
metabolism in the offspring during adulthood (e.g. Pgc1a) (Brunton et al., 2013). 
Similar changes in Pgca1a are also observed in adult rats that were exposed to 
dexamethasone prenatally (Drake et al., 2010). Although it is not known if foetal liver 
Chapter 5: Role of steroids in foetal programming 249 
corticosterone concentrations were altered in these previous experiments, these 
studies suggest that processes related to hepatic lipid metabolism seem particularly 
sensitive to changes in glucocorticoid metabolism and action, and may be 
associated with changes in GR protein expression for example (Maeyama et al., 
2015). 
Additionally, given the peculiar way in which the foetal liver is perfused (Fig 5.2), it is 
also not known if liver perfusion and blood flow is affected by stress. In human 
pregnancies, under circumstances of reduced oxygen or nutrition, a higher 
proportion of blood from the umbilical vein bypasses the liver and is directed 
preferentially to other parts of the body (e.g. the brain) via the ductus venosus 
(Godfrey et al., 2012). Whether or not this process occurs in this model of social 
stress in the rat, and whether an alteration of blood flow (if any) would affect the 
transport of glucocorticoids in the blood and the action of glucocorticoids on the liver 
and other target organs, is unclear. As the first foetal organ to be exposed to 
placental blood, the foetal liver could have an important role to play in determining 
the circulatory glucocorticoid and steroid concentrations in the foetus. 
Although not investigated in this study, the liver also expresses 11β-HSD1, and 
stress could have affected the activity of hepatic 11β-HSD1, leading to changes in 
corticosterone metabolism in the liver itself. In sheep, exposure to a synthetic 
glucocorticoid results in elevated hepatic CBG and 11β-HSD1 expression in the 
foetal liver (Sloboda et al., 2002),	while in	rats, prenatal stress tends to increase 
foetal hepatic 11β-HSD1 mRNA levels (Mairesse et al., 2007). In another study, 
restraint stress was also shown to increase 11β-HSD1 mRNA in the GD18 mouse 
liver, and this effect persisted through adolescence, where differences manifested 
as increased 11β-HSD1 protein concentration coupled with an increase in GR for 
the stressed groups (Maeyama et al., 2015). Whilst 11-DHC:corticosterone ratio 
were not significantly altered following stress, changes in 11β-HSD1 expression in 
the foetal liver may still occur, and may contribute towards the development of 
metabolic dysregulation in adulthood. Previous studies have shown that 11β-HSD1 
overexpression in transgenic mice results in insulin resistance and hypertension 
(Paterson et al., 2004), while liver-specific 11β-HSD1 KO mice seem to be protected 
from the effects of glucocorticoids and do not develop negative metabolic 
phenotypes (Harno et al., 2013a). Therefore, an investigation into foetal 11β-HSD or 
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other steroidogenic enzymes to determine if the steroidogenic capacity of the foetal 
liver changes with maternal stress could be a future line of work. 
Foetal brain: 
No significant changes were found in corticosterone concentrations in the foetal 
brain. As target tissue availability of corticosterone is controlled by uptake from the 
circulation, the levels of plasma proteins such as CBG and albumin could have 
contributed to this observation, especially in female foetuses. This has not been 
studied in the rat, but prenatally stressed piglets indeed showed increased plasma 
CBG concentrations at the third postnatal day (Kanitz et al., 2003), which could 
imply reduced glucocorticoid uptake in target tissues. 
Additionally, in this study, 11β-HSD1 and 11β-HSD2 mRNA were unchanged with 
stress in the foetal hippocampus, which indicates that long-term changes in local 
glucocorticoid metabolism did not occur in the foetal brain. Nevertheless, from our in 
situ hybridisation results and those previously reported (Diaz et al., 1998, Moisan et 
al., 1992), the expression patterns of 11β-HSD1 and 11β-HSD2 seemed to be quite 
low in the foetal brain at GD20 even for control animals, therefore it raises the 
question of whether 11β-HSD enzymes in the foetal brain play a significant role in 
modulating brain development during late pregnancy.  
In brain-specific 11β-HSD2 KO mice, foetal brain corticosterone content was not 
different from controls (Wyrwoll et al., 2015). Expression of 11β-HSD2 in the brain 
however, was also found to be extremely low in controls on GD17.5 to begin with. 
Moreover, in adulthood, these 11β-HSD2 KO mice do not show anxiety-like 
behaviour, but only depressive-like behaviour. Considering that anxiety is also one 
of the hallmark phenotypes observed in adult offspring in the prenatal social stress 
model, our data supports their contention that 11β-HSD2 in the foetal brain perhaps 
does not play an important role in the programming of anxiety behaviour (Wyrwoll et 
al., 2015).  
Whilst a brain-specific 11β-HSD1 KO mouse model is available (Harno et al., 
2013b), little has been studied about its effect on offspring behavioural 
dysregulation. As mentioned earlier, there is also a need to investigate the 
expression levels of target receptors of glucocorticoid action such as GR and MR 
(Diaz et al., 1998) in order to obtain a clearer picture of glucocorticoid metabolism in 
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the foetal brain. The investigation into other components of the HPA axis in the 
foetal brain would also be practical, as stress seemed to be able to also change 
expression of these indices, such as CRH mRNA in the PVN of rat foetuses (Fujioka 
et al., 1999). 
To summarise this section, whilst corticosterone could play a role in the 
programming of the foetal liver following stress, it probably does not play a direct 
role in determining programming outcomes in the foetal brain.   
5.4.7 Other changes in the maternal compartment following chronic stress  
Maternal liver glucocorticoid metabolism: 
In the maternal liver, there was only a trend towards greater corticosterone and 11-
DHC concentrations in stressed livers as compared to non-stressed livers, despite 
robust increases in the maternal circulation. Again, concrete conclusions cannot be 
drawn about whether this was an effect of chronic or acute stress, as there was no 
comparison to a pregnant rat that has only been through one stressor. Moreover, it 
is recently found in mouse studies that the maternal liver exhibits dramatically 
reduced glucocorticoid signalling and responsiveness during pregnancy, with 
hepatic GR downregulation via epigenetic silencing (Quinn et al., 2019). As 
excessive glucocorticoid action can impair growth, this adaptation has been 
proposed to temporarily increase maternal liver growth to meet the metabolic 
demands of pregnancy. Hence, given that the maternal hepatic corticosterone and 
11-DHC only showed a trend towards an increase, it is possible that the pregnant 
liver may be actively metabolising excess corticosterone produced from the 
maternal adrenal glands, as a compensatory mechanism to avoid increased 
glucocorticoid signalling in the liver, which may be pathogenic. If chronic stress were 
to disrupt this process, it could lead to metabolic imbalances during pregnancy, 
promoting the risk of IUGR (Quinn et al., 2019). This also brings about the idea that 
changes in glucocorticoid metabolism following stress is global in the mother, and 
that aberrant glucocorticoid signalling in other maternal organs during pregnancy 
may conceivably also lead to aberrant foetal outcomes. 
Impacts on maternal health: 
Although maternal glucocorticoid metabolism was investigated in GD20, there is a 
possibility that these changes following chronic social stress may result in long-term 
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changes in the maternal HPA axis beyond the pregnancy. Repeated stress 
exposure during pregnancy is also known to result in elevated levels of 
corticosterone during the postnatal period in rat dams (Pfister and Muir, 1989) and a 
decreased GR expression in CA3 of the hippocampus of the pregnant rat (Pawluski 
et al., 2015). As 11β-HSD1 expression in the PVN usually increases towards the 
end of pregnancy (Johnstone et al., 2000), there is a possibility repeated stress can 
abrogate the normal increase, leading to problems with HPA axis negative feedback 
inhibition. These longer-term changes may have implications such as poorer 
maternal care, as well as a higher risk for post-partum mood disorders, evident from 
rat studies where stress induces depressive-like behaviours in dams post-partum 
(Smith et al., 2004, O'Mahony et al., 2006), especially because the period 
immediately after parturition is a window of vulnerability where there is a dramatic 
alteration in various hormonal systems (Bosch et al., 2007, Slattery and Neumann, 
2008). Although not a focus of this study, the possible impacts on maternal health is 
still a much needed area of research, as not only does it affect the well-being of the 
mother, in the context of this thesis, maternal behaviour during the postnatal period 
is also one of the mechanisms mediating the outcomes of prenatal stress (section 
1.5.4). 
5.4.8 Changes in neuroactive steroids concentrations in the foetal brain and 
liver following stress 
In general, absolute concentrations of neuroactive steroids were much higher in the 
foetal rat brain as compared to adult values obtained in Chapter 4, as expected 
(Brunton et al., 2014). This was also the first time concentrations of GABAergic 
neuroactive steroids such as allopregnanolone and THDOC were determined in the 
foetal brain, whilst concentrations of its precursors progesterone and DOC 
corresponded with that shown in a recently published LC-MS study (Schmidt et al., 
2019b). However, previous studies did not quantify the steroids based on foetal sex.   
Allopregnanolone:  
Placental, foetal brain, and liver allopregnanolone concentrations were not different 
between the stressed and non-stressed groups. In the foetal brain, there was no 
evidence of an insult-mediated increase in allopregnanolone protection, unlike that 
observed in the foetal sheep (Nguyen et al., 2003a, Nguyen et al., 2004), nor was 
there a no loss of allopregnanolone protection, unlike that observed following 
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umbilical occlusion in guinea pigs foetuses (Bennett et al., 2013). As the normal 
response to an acute stressor in rat foetuses during late pregnancy has not been 
characterised, it was not possible to determine if these observations were 
confounded by the effects of chronic stress. Additional measurements of 
steroidogenic enzyme expression in the foetal brain could perhaps shed light on 
this.    
Pregnenolone:  
Pregnenolone concentrations were increased only in the stressed female foetal 
brain but not in the males. This raises the question of whether or not the increase in 
pregnenolone was responsible for mediating some of the sex differences in 
behavioural and physiological outcomes in the PNS offspring in the social stress 
model (i.e. PNS males show greater anxiety behaviour, whereas PNS females do 
not, but PNS females tend to show greater HPA axis dysregultionthan the PNS 
males). Again, it is not known if this observation is confounded by chronic stress, nor 
the source of pregnenolone, as quantification of p450scc expression in the foetal 
brain was not carried out. In terms of functional significance, pregnenolone could be 
sulfated into PregS, which has neuroprotective effects via the NMDA receptor, 
enhancing neurite outgrowth and neuronal survival (Xu et al., 2012). 
Sulfotransfereases mRNA are expressed in both human and rat brain foetal brain 
(Suiko et al., 2017), thus the higher pregnenolone in female brains could possible be 
converted to PregS, providing better protection against insults by promoting 
neuronal survival.  
DOC, DHDOC and THDOC: 
As for the neuroactive DOC metabolites DHDOC and THDOC, stress did not affect 
concentrations in the foetal brain and liver. Unlike progesterone, DHP and 
allopregnanolone, the concentrations of DOC, DHDOC and THDOC were largely 
similar to those found in the adult. A modest sex difference was observed in these 
steroid concentrations, which will be discussed in the next section. Although these 
steroids are neuroactive, the exact role of DOC metabolites in modulating foetal 
growth is not known. It has been suggested that the role of DOC metabolites only 
increases in the postnatal stages, where there could be a switch from 
neuroprotection via allopregnanolone alone, to neuroprotection mediated by both 
allopregnanolone and THDOC, utilising the DOC precursor from the neonatal 
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adrenal glands (Hirst et al., 2008). Nonetheless, one point to note is that as the 
reduction of DOC into its metabolites DHDOC and THDOC occur via similar 
pathways, utilising the same steroidogenic enzymes 5α-reductase and 3α-HSD. The 
observation that they are present in the foetal brain and liver, albeit in smaller 
amounts, could mean that the effects seen in earlier experiments involving 5α-
reductase inhibition and effects on prenatal stress outcomes need to be re-
interpreted with caution (Paris et al., 2011). Since finasteride blocks the reduction of 
all 5α-reduced steroids, it will effectively affect several hormonal systems (e.g. 
progesterone, DOC and even testosterone metabolism pathways), thus the effects 
of such a blockade cannot be attributed to the loss of allopregnanolone actions 
alone.  
To conclude, similar to the effects of glucocorticoids in the foetal brain, there is 
probably a limited direct effect of steroidal changes in the programming of brain 
development. Nonetheless, comparisons with acutely-stressed foetuses would be 
helpful, as the steroidal response of rat foetuses to a single acute stressor during 
late pregnancy has not yet been established.  
5.4.9 Sex differences in the steroidal milieu during late pregnancy 
In Chapter 4, it was determined that there was a robust sex difference in the 
absolute amount of each neuroactive steroid in the brain of adult male and female 
rats. Here, at GD20, sex differences in neuroactive steroids in the brain were 
generally not observed, except for testosterone, where a significant difference was 
found between male and female foetal brain. A similar difference was also observed 
for testosterone in the foetal liver. Concentrations of progesterone and its 
metabolites were not different between males and females, whilst there were 
modest sex differences in THDOC content in foetal liver. 
Testosterone:  
It is known that plasma testosterone concentrations in the rat are different between 
male and female foetuses in late pregnancy, especially during GD17-19 where the 
testosterone surge occurs in males (Ward et al., 2003). Here, foetal plasma 
testosterone could not quantified due to the low amounts of foetal plasma collected, 
however, testosterone levels were found to be significantly greater in males as 
compared to females in the foetal liver and foetal brain. This is in contrast with the 
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results obtained using RIA (Kellogg and Frye, 1999, Konkle and McCarthy, 2011) 
which reported that females and male rat foetuses did not show differences in 
testosterone concentrations in the brain. However, these discrepancies could 
probably be attributed to inaccuracies in quantification using the testosterone RIA 
kit, as one of these studies also oddly reported no differences in adult 
concentrations of testosterone between males and females (Konkle and McCarthy, 
2011), which was not the case given our results in Chapter 4, and that of other 
studies using validated LC-MS methods (Hojo and Kawato, 2018, Caruso et al., 
2013). Absolute concentrations of testosterone obtained by these RIA studies also 
did not correspond to those obtained using LC-MS, and values were up to a 
hundred-fold higher, indicating cross-reactivity or an inappropriate enhancement of 
signal due to interferences in the testosterone RIA, when applied to foetal brain 
samples. This again highlights the need to carry out steroid quantification studies 
using improved and validated methods, especially in tissues like the brain, which 
contains high levels of interfering substances like lipids. 
Here, although stress did not change concentrations of testosterone in any of the 
tissues, differential testosterone concentrations between males and females may 
still have implications, due to the “organisational” effects of testosterone (Chapter 1), 
by its interaction with other mediators of the stress response (Goel and Bale, 2009),. 
For instance, testosterone can enhance serotonergic signalling (Goel et al., 2011) 
and is important for controlling the expression of androgen receptors (Bingham and 
Viau, 2008), both of which may influence HPA axis activity (Chen et al., 2016, Goel 
et al., 2011). Indirect effects of testosterone can also arise from action of its 
downstream metabolite DHT (Wilson, 2001), as well as the actions of oestradiol 
(McCarthy, 2008), which is critical for the development of the neurocircuitry which 
typifies masculinisation of the brain (Wu et al., 2009). Although concentrations of 
DHT or oestradiol were not investigated here, there is a possibility that their levels 
can be perturbed, especially since expression of 5α-reductase isoform 1 (Ordyan 
and Pivina, 2005) and aromatase activity (Weisz et al., 1982) in rat brain foetuses 
has been shown to be affected by prenatal stress. 
Progesterone:  
Similarly, previous studies have established that progesterone concentrations do not 
differ between males and females foetuses, possibly due to the overwhelming 
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amounts and importance of progesterone during pregnancy (Weisz and Ward, 
1980). It was also shown in this study that DHP and allopregnanolone do not differ 
in the male and female foetal brain, unlike that of adult rats observed in Chapter 4. 
However, progesterone could exert its sex specific effects in another way, through 
differential progesterone receptor (PR) expression for example. PR density in the 
sexually dimorphic medial preoptic area (mPOA) is high in foetal males, while they 
are virtually absent in the females (Wagner et al., 1998), which has implications in 
sexual differentiation. 
THDOC: 
Control female foetuses had greater THDOC concentrations in the liver as 
compared to control male foetuses, but no differences were observed in the brain. It 
is not known if these differences are due to differential expression of steroidogenic 
enzymes between males and females. Whilst 5α-reductase 2 is only expressed in 
the rat brain during late foetal and early postnatal life, and could be induced or 
modulated by the testosterone surge in male foetuses, 5α-reductase 1 is 
constitutively expressed in the rat brain and liver at all stages of brain development 
and do not seem to show a sex difference (Melcangi et al., 1998). In human studies, 
an array of steroidogenic enzymes in the foetal liver has been characterised and 
notably, 5α-reductase 3 (SRD5A3) was found to be differentially expressed in 
female foetal liver, where a lower expression was seen (O'Shaughnessy et al., 
2013). Although this isoform has not been studied in the rat, it supports the 
contention that sex differences in steroidogenesis can also arise from within the 
foetal liver itself.  
Placental sex differences:  
No differences in sex steroid concentrations were observed in this study between 
the placentae of males and females, possibly due to their central role in maintaining 
critical aspects of the pregnancy such as placental vasculature (Maliqueo et al., 
2016). Nonetheless, the sex difference in placenta is likely to manifest in other ways 
(Bale, 2011), as seen in the differential 11β-HSD2 mRNA expression earlier in this 
study, for instance.  
Although testosterone content was not different in male and female placenta, there 
are differences in the expression levels of steroidogenic enzymes that controls the 
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synthesis of androgens into the foetal compartment, observed in human studies 
(O'Shaughnessy et al., 2019) and rodent studies alike (Howerton and Bale, 2014). 
The placenta can therefore contribute to the differential steroid milieu between 
female and male foetuses and play a role in the sexual differentiation of male 
foetuses. 
5.4.10 Limitations 
A major limitation recurring in this study is the inability to differentiate between the 
effects of acute stress or chronic stress, as immediate effects of the acute stressor 
at GD20 has been superimposed on the possibly longer-term effects of the chronic 
stressor (applied from GD16-20). A way to tease this apart is to introduce an 
additional group of pregnant dams which undergo only one single stressor at GD20, 
to determine the acute response at that stage. Differences could then be inferred to 
be the outcome of prior chronic stress (e.g. sensitisation to the stressor, or long term 
changes). It may also be worthwhile to carry out the tissue collection at GD21, 24 
hours after the last chronic stressor, which removes the confounding effects of the 
acute stressor but at the same time, allows for the determination of the basal level of 
steroids.  
Secondly, the placenta, foetal liver and foetal brain tissues analysed here were not 
from the same feto-placental unit, while the foetal blood has been pooled. It is 
difficult to draw concrete conclusions about secretion patterns of the placenta into 
the foetal plasma or uptake of steroids from the peripheral circulation into the foetal 
brain and liver, as individual correlations could not be made. This is especially so 
when the differential intrauterine position is known to introduce considerable 
variability in steroid concentrations in litter-bearing animals such as rodents (Ryan 
and Vandenbergh, 2002). For instance, female foetuses located between two male 
foetuses have a slightly different hormonal milieu than those which are not, and 
generally exhibit greater testosterone concentrations. Intrauterine positions have 
been found to affect the outcome of prenatal stress, affecting certain postnatal 
characteristics in female mice (vom Saal et al., 1990). 
5.4.11 Conclusions and future work  
In conclusion, this chapter showed that maternal corticosterone does not play a 
direct role in the transmission of stress signals from mother to foetus, as there were 
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only small increases in corticosterone concentrations observed in the foetal 
compartment. In addition, neuroactive steroid protection did not appear to be 
compromised, in the maternal, placental and foetal compartments. This was the first 
time the effects of repeated maternal social stress has been investigated in the 
pregnant dam, placenta and the offspring at GD20, as previous studies with this 
prenatal social stress model have always been focussed on the effects of offspring 
during adulthood. 
Limitations have been highlighted in the preceding section. In order to add weight to 
the results observed in this study, ex vivo experiments can be designed, where ex 
vivo organ culture of either the entire rat placenta, or large pieces of the human 
placenta could be used. This has been employed by numerous studies of human 
placenta to study endocrine activity, the advantage being that cellular elements are 
maintained in their normal state of organisation (Ringler and Strauss, 1990). 
Manipulations, such as exposing placental organ cultures to corticosterone, can 
then be carried out. Media could be collected to determine whether there are any 
differences in the secretion of steroid metabolites, whilst placenta can be sectioned 
to determine if mRNA changes still occur in a similar manner as the in vivo results. 
To study the role of the placenta in trans-placental transport, or the synthesis and 
metabolism of compounds thoroughly, a perfusion system can also be implemented, 
however, this requires extensive expertise (Goeden and Bonnin, 2013). 
Ultimately, as per the allostasis framework, it is necessary to acknowledge that 
corticosterone concentrations and 11β-HSD2 expression represent only a small 
aspect of an integrated physiological system regulating the impact of glucocorticoid 
action. There are other important aspects both upstream (e.g. synthesis or CBG 
binding) and downstream (e.g. metabolism or receptor availability) of glucocorticoid 
concentrations, that could potentially modulate corticosterone effects, in each 
component of the maternal-placental-foetal triad. Therefore, a small observed 
difference may have a large impact when it is amplified by other changes, but at the 
same time, care has to be taken to not overly interpret the biological significance of 
a statistically significant difference, as compensatory actions can occur in another 
aspect of the system. It would therefore be prudent to also consider as many other 
types of evidence as possible, both within the HPA axis and outside of it, as 
maternal stress activates not just neuroendocrine systems, but also autonomic and 
immune systems. Larger multi-analyte approaches like the LC-MS method detailed 
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here, is a good starting point to carry out these investigations. It is also imperative to 
put each experiment into context and take gestational stage, time of stressor etc into 
consideration, and not to make comparisons between studies at face value.  
Lastly, the fact that the placenta undergoes adaptations following maternal stress 
support mounting evidence that it is involved in the foetal programming of chronic 
diseases (reviewed in (Sferruzzi-Perri and Camm, 2016)). Nonetheless, how the 
placenta regulates the communication between mother and foetus is not 
straightforward and remains poorly understood. More research focussing on the 
placenta needs to be carried out, and it remains to be determined which other 
signals, apart from neuroendocrine signals investigated here, may be contributing to 
this complex communication at the maternal-foetal interface.
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6.1 INTRODUCTION 
In chapter 5, the role of steroids in the transmission of stress signals from the 
mother to the foetus was explored. It was concluded that although corticosterone 
and neuroactive steroid concentrations were increased following maternal stress in 
the maternal component, they were unlikely to participate directly in the transmission 
of the stress signals. The complexity of the communication between the mother and 
foetus was also acknowledged, and the results begin to unravel the dynamic and 
central role the placenta may play in modulating the transmission of the stress 
signals during pregnancy.  
Thus far, the thesis has been focussed on analysing the role of neuroendocrine 
factors (e.g. corticosterone and neuroactive steroids) in mediating the outcomes of 
prenatal stress. However, as proposed in the concluding remarks of the previous 
chapter, maternal stress not only activates neuroendocrine systems, but also 
immune, metabolic and autonomic systems, and there is likely to be considerable 
cross-talk between these systems. Additionally, mechanisms of prenatal stress span 
several levels, and changes at a systems level are likely to also lead to changes at a 
molecular and cellular level. This prompted the exploration of other biochemical 
mechanisms outside of the HPA axis in attempting to elucidate the mechanisms of 
prenatal programming. Several questions start to arise, such as – does stress on an 
organism level also lead to stress at a cellular level? Could targeting the negative 
effects stress has at the cellular level be one of the ways in which one can modify 
the outcomes of prenatal stress in a systemic and organism level?  
In the present study, it was hypothesised that stress experienced by the pregnant 
dam also results in stress at the cellular level, manifesting as increased oxidative 
stress in all three components of the maternal-placental-foetal triad. Using an 
antioxidant administered to the mother, which serves both as an experimental 
manipulation and a possible therapeutic invention, the aim here was to determine 
the role oxidative stress may play in mediating the effects of prenatal stress, and 
whether antioxidant therapy to the mother could be a viable intervention for prenatal 
stress-related pathologies. The study also attempts to dissect the role the placenta 
may play in the direct transmission of stress signals from the mother to the foetus.  
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6.1.1 Oxidative stress during pregnancy   
Oxidative phosphorylation is the cellular process through which energy, in the form 
of ATP, is generated from oxygen via a series of reactions in the mitochondrial 
electron transport chain. While this process is essential for energy production, it also 
produces reactive oxygen species (ROS), which includes free radicals which are 
highly reactive due to the presence of unpaired electrons (e.g. superoxide anion), or 
their non-radical intermediates (e.g. hydrogen peroxide) which still exhibit high 
reactivity. Whilst ROS are generally regarded as harmful by-products of energy 
metabolism, in moderate concentrations, they are in fact important regulatory 
mediators of signalling processes and participate in various cellular functions, such 
as the regulation of redox-sensitive transcription factors and protein kinases (Droge, 
2002). However, in high concentrations, ROS may react with cellular components 
indiscriminately, leading to lipid peroxidation, DNA/protein oxidation and eventual 
cellular damage and apoptosis. As such, there exists endogenous antioxidant 
defences to scavenge ROS, and these protective defences may be enzymatic (e.g. 
superoxide dismutase (SOD), catalase, glutathione peroxidase) or non-enzymatic 
(e.g. vitamin C or E) in nature. Therefore, it is only when this balance between ROS 
and antioxidant defences are perturbed that harmful effects of ROS may manifest. 
Oxidative stress is therefore defined as the imbalance between a pro-oxidant and an 
antioxidant state, favouring the pro-oxidant state, which can lead to negative 
consequences or pathological conditions (Burton and Jauniaux, 2011).  
Incidentally, normal pregnancy in itself represents a state of constant mild oxidative 
stress, due to the higher metabolic demands of growth, especially in the feto-
placental unit (Myatt and Cui, 2004). The placenta contributes significantly to 
superoxide anion production during pregnancy, but at the same time, all the major 
antioxidant defence systems including catalase, glutathione peroxidase and vitamins 
C and E are also present in the placenta (Myatt and Cui, 2004). In the mother, a 
systemic inflammatory response also occurs during pregnancy, resulting in the 
constant generation of large amounts of ROS in other maternal tissues (Burton and 
Jauniaux, 2011). Nonetheless, this state of mild oxidative stress seems to be 
required for the normal progression of pregnancy and normal placental function. 
During early pregnancy for instance, mild oxidative stress is necessary for normal 
placentation to occur (Nezu et al., 2017). In the foetal compartment, a certain 
amount of oxidative stress is also required for normal organogenesis and foetal 
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growth (Dennery, 2010). Thus, the pro-oxidant to antioxidant ratio needs to be tightly 
controlled, in the maternal, placental and foetal compartments, to ensure normal 
progression of the pregnancy. Given how delicate the balance is and how many of 
these processes involving oxidative stress are inter-linked, any slight perturbation in 
the balance (e.g. from environmental insults or stress) could set off a cascade of 
feed-forward loops that can result in deleterious outcomes (Burton and Jauniaux, 
2011). Therefore, as much as oxidative stress is a characteristic of normal 
pregnancies, it is also recognised to play a role in the pathophysiology of pregnancy 
complications and undesirable offspring outcomes.  
6.1.2 Increased oxidative stress in compromised pregnancies  
Oxidative stress status in the mother: 
In compromised pregnancies (e.g. preeclampsia, gestational diabetes, preterm birth 
and IUGR) mothers usually exhibit oxidative stress levels that exceed what is 
considered normal (Cuffe et al., 2017a). In humans, maternal oxidative stress status 
are easily modifiable by lifestyle factors such as smoking, alcohol intake and diet 
(Block et al., 2002). Maternal psychosocial factors also play a role, and 
socioeconomic disadvantage, which is presumably linked to higher psychological 
stress, is associated with higher oxidative stress levels, detected in urine samples 
(Eick et al., 2018). Moreover, activation of the HPA axis following various stressors 
is also associated with increased cellular oxidative stress (Spiers et al., 2014). 
Depending on the severity of the insults and the extent of the perturbations, 
maternal oxidative stress can result in slight changes in placental function that do 
not endanger the pregnancy, or it can lead to severe pregnancy complications.  
Clinical studies have shown that the pathological outcomes of maternal oxidative 
stress differ according to the trimester: oxidative stress during the first trimester is 
associated with miscarriage, while oxidative stress in the second or third trimester 
are linked to preeclampsia, gestational diabetes and preterm birth, which can have 
grave consequences for the foetus (Sultana et al., 2017). Similarly, in rodent 
studies, greater maternal oxidative stress levels have been observed in 
experimental models of preeclampsia (Beausejour et al., 2007), gestational diabetes 
(de Souza et al., 2010) and maternal obesity (Bouanane et al., 2009).  
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As oxidative stress is often involved in every stage of the pregnancy compromise, 
changes in maternal oxidative stress levels can therefore be considered (i) a 
consequence of insults during pregnancy, (ii) a cause of pregnancy complications, 
and (iii) in general, also a biomarker for compromised pregnancies (Figure 6.1).  
Oxidative stress status in the placenta: 
Although oxidative stress indices have more commonly been determined from 
maternal plasma or urine, placenta oxidative stress often lie at the centre of these 
compromised pregnancies (Burton et al., 2009, Burton et al., 2016, Schoots et al., 
2018). Oxidative stress can affect placental function through altering processes 
involved in trophoblast differentiation, proliferation and apoptosis, or through 
affecting placental angiogenesis and vascular reactivity and the remodelling of 
placental blood supply (Myatt and Cui, 2004). Secretory patterns of growth factors 
and cytokines may also change, for instance in the case of diabetes (Desoye and 
Hauguel-de Mouzon, 2007) or hypoxia (Malek et al., 2001). These changes in turn 
all impact foetal growth, which can then lead to compromised foetal outcomes via 
prenatal programming (Thompson and Al-Hasan, 2012, Burton et al., 2016). For 
instance, oxidative stress during pregnancy has been implicated in an increased 
cardiovascular risk for the offspring during adulthood, in both human studies and in 
experimental animal models (Rodriguez-Rodriguez et al., 2018).   
Oxidative stress in the foetus:  
Given that redox processes are also important in foetal growth, it is likely that the 
above perturbations can lead to changes in oxidative stress status in the foetus as 
well (Dennery, 2010). For instance, maternal exposure to environmental pro-
oxidants also causes increased oxidative stress in the foetal brain 24 hr later, 
consequently resulting in microglia activation and inflammation which can lead to 
neurodevelopmental anomalies (Akhtar et al., 2017).  
As maternal oxidative stress is intracellular, the transmission of this oxidative stress 
signal from mother to foetus will be indirect, possibly through above-mentioned 
changes in the placenta, which then subsequently cause foetal oxidative stress. 
Impacts of these oxidative changes in the foetal brain can still be observed in the 
brains of adult offspring, for instance, in the form of mitochondrial damage in the 
hippocampus (Song et al., 2009). Additionally, given that oxidative changes can 
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underlie many neuropsychiatric disorders (Salim, 2014) and metabolic disorders 
(Roberts and Sindhu, 2009), it is therefore not a surprise that oxidative stress is 
involved in every stage of developmentally-linked disease, from foetal programming 
to the manifestation of the disease at adulthood (Fig 6.1).  
 
 
Figure 6.1: The involvement of oxidative stress in all stages of compromised 
pregnancies, thereby causing foetal programming and poor offspring 
outcomes. Maternal and placental oxidative stress is coloured in yellow while 
oxidative stress experienced by the offspring is shown in green. As maternal 
oxidative stress is intracellular, the transmission of this oxidative stress signal from 
mother to foetal tissues will be indirect. 
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6.1.3 Mitochondrial dysfunction in compromised pregnancies  
At an organism level, the placenta is responsible for the large amounts of ROS 
produced, but at a cellular level, the mitochondria are the main site of ROS 
production. Mitochondria are the energy powerhouse of the cell and is involved in 
energy production via oxidative phosphorylation at the electron transport chain, 
rendering it very susceptible to ROS-mediated damage and the impacts of cellular 
stress (Javadov and Kuznetsov, 2013). Mitochondria are multifunctional organelles, 
apart from their central role in meeting cellular energy demands, they also regulate 
other cellular functions like apoptosis (Holland et al., 2017). Altered mitochondrial 
function can then in turn impact placental function, and influence processes such as 
glucose transport and even steroidogenesis, ultimately playing a role in the foetal 
programming of brain functions (Hoffmann and Spengler, 2018). Mitochondrial 
behaviour is also extremely dynamic, and they can alter their shape via fusion or 
fission, and also increase or decrease in numbers in response to stressors (Youle 
and van der Bliek, 2012). In addition, once slight damage to the mitochondrial 
membrane or proteins occur, it may also drive a positive feedback loop and feed-
forward mechanism where it triggers the failure of an entire network of mitochondria 
(Aon et al., 2006).  
The mitochondria have also recently been suggested to play an integral role in 
modulating the effects of psychological stress. Through a systematic review of both 
animal and human studies, Picard and McEwen have gathered evidence that acute 
and chronic stressors influence mitochondrial function, mostly in an adverse 
manner, especially in the brain (Picard and McEwen, 2018b). They went on further 
to introduce the concept of mitochondrial allostatic load, and proposed that the 
mitochondria represent a major intersection point between endocrine and immune 
systems that together can affect the outcome of psychological stress (Picard and 
McEwen, 2018a). Therefore, given that allostatic load at an organism and system 
level are both increased during gestational stress and early life stress respectively 
(section 1.2.2), it is likely that on a cellular level, alterations in mitochondria allostatic 
load could also occur in these conditions.   
Mitochondria dysfunction also seem to be related to anxiety-related social disorders, 
which could be pertinent for the model of social stress used in this study. Anxious 
rats that are prone to become subordinate during a social encounter exhibit reduced 
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mitochondrial complex I and II protein, have decreased ATP production and 
increased ROS production in the nucleus accumbens (Hollis et al., 2015). In terms 
of the HPA axis, mitochondria can also change their function and morphology in 
response to glucocorticoids (Hoffmann and Spengler, 2018), and an increase in 
protein carbonylation and mitochondrial dysfunction has also been observed with 
increased glucocorticoids in in vitro studies using a rat cell line (Tang et al., 2013). 
As such, the links between maternal psychological stress and foetal programming 
could perhaps be narrowed down to the dysfunction of mitochondria at a cellular 
level. 
6.1.4 Antioxidant treatments during pregnancy  
Theoretically, given the central role of oxidative stress in pregnancy complications, 
antenatal antioxidant therapy should reverse these processes associated with 
oxidative damage and negative gestational outcomes. Therefore, there has been 
tremendous interest in the use of antioxidants to protect the foetus against the 
harmful effects of oxidative stress in conditions such as preeclampsia (Miller et al., 
2012). However, as much as in vitro and preclinical studies have showed potential, 
antioxidant therapy in human clinical studies in recent decades have not produced 
promising results (Duhig et al., 2016). Extensive clinical studies have been carried 
out on the use of vitamin C and E during pregnancy to prevent complications 
associated with preeclampsia, yet most studies concluded that vitamin C and E 
have no effect in preventing preeclampsia or improving foetal outcomes (Poston et 
al., 2006, Rumbold et al., 2006, Polyzos et al., 2007). As ROS play important roles 
endogenously, the timing and dosage of antioxidant administration, the type of 
antioxidant given, and how it is given, could all be factors that affect its efficacy. The 
fact that these clinical trials have yielded disappointing results perhaps also 
suggests that these protective agents were not being localised to where they need 
to be (for instance, the mitochondria, or the placenta) in order to counter the 
oxidative damage (Smith and Murphy, 2011).  
In recent years, several mitochondria-targeted antioxidants have been developed 
(Smith and Murphy, 2011). Mitochondria-targeted antioxidants are chemically 
tagged versions of natural antioxidants such as vitamin E and coenzyme Q, which 
modifies their physical properties to allow for their concentration in the mitochondria. 
These drugs were found to be stable, well-tolerated and efficacious in rodent studies 
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when ingested through the drinking water, and they protected the mitochondria from 
oxidative damage far more effectively than untargeted antioxidants, indicating their 
improved efficacy (Smith et al., 2003). In rats, mitochondrial-targeted antioxidants 
are also effective in countering oxidative stress in various experimental models of 
disease, such as cardiac injury, Parkinson’s disease, and Alzheimer’s disease 
(Smith and Murphy, 2011). In rat hypoxic pregnancies, orally administered 
mitoquinone (MitoQ) treatment in pregnant rats increases placental perfusion and 
prevents the activation of mitochondrial stress, suggesting that mitochondria-
targeted antioxidants may indeed be beneficial in preventing pregnancy 
complications (Nuzzo et al., 2018).  
Apart from targeting the mitochondria on a cellular level, in order for an antioxidant 
to be able to successfully exert its effects, on an organism/system level, it also has 
to reach the target tissues (i.e. the placenta) in sufficient concentrations, but also not 
cause any adverse or unintended off-target effects on the foetus. There is a severe 
lack of progress in the past decades in developing interventions that can target 
placental dysfunction, due to the difficulties in preventing the treatment in the mother 
from affecting the foetus (Sibley, 2017). In recent years however, there has been a 
renewed interest in the development of strategies to deliver drugs and therapeutic 
agents directly to the placenta, for instance, with the use of drug delivery systems 
with placental-homing peptides that can deliver drugs specifically to placental 
trophoblast cells, without affecting the foetus (King et al., 2016). 
6.1.5 MitoQ-NP 
In this study, MitoQ-NP, which consists of the antioxidant mitoquinone (MitoQ) 
loaded in a nanoparticle delivery system (NP), was used as the antioxidant to 
counter oxidative stress. MitoQ is made up of coenzyme Q covalently attached to a 
lipophilic triphenylphosphonium (TPP) cation. Coenzyme Q is an important 
component of the electron transport chain, and is a major antioxidant, where it 
exerts protective effects on lipids, protein and DNA (Bentinger et al., 2007). When 
administered to pregnant women, coenzyme Q was shown to reduce the risk of 
preeclampsia (Teran et al., 2009). The lipophilic TPP cation of MitoQ allows for the 
compound to be concentrated a thousand fold within the mitochondria as compared 
to other cellular compartments (due to the presence of the large mitochondrial 
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membrane potential), thereby enhancing the beneficial effects of coenzyme Q in the 
mitochondria (Murphy and Smith, 2007).  
Nanoparticles are defined as particles ranging from 1 to 1000 nm in size, and have a 
wide variety of uses. Nanoparticles as drug delivery systems can exist as liposomes, 
micelles or a matrix, where drugs can be adsorbed, dissolved, conjugated or 
encapsulated (Singh and Lillard, 2009). Nanoparticles are advantageous in that they 
aid stability of the drug when it is transported in the bloodstream, allowing for lower 
doses of the drug to be used. Depending on the material of the nanoparticle, the use 
of biodegradable materials can also allow sustained release of the drug over a long 
period of time (Singh and Lillard, 2009). There is great potential for the manipulation 
of physical and chemical properties of the nanoparticles, such as size and surface 
chemistry, which allows the optimal delivery of the drug to the target tissues. It can 
therefore be potentially useful in delivering drugs to the placenta without affecting 
the foetus. Transplacental passage of nanoparticles are regulated by their size 
(Refuerzo et al., 2017) and in general, nanoparticles that are of size 100nm will not 
cross the trophoblast layer into the foetus (Menezes et al., 2011). The nanoparticle 
used in this study has a size of 180 nm, and contains an outer hydrophilic shell 
made up of a naturally occurring poly-amino acid poly(γ-glutamic acid) (γ-PGA), 
which aids the stabilisation of the nanoparticle in the bloodstream. It has an inner 
hydrophobic core made up of L-phenylalanine ethylester (Phe), allowing for the 
adsorbtion of the hydrophobic drug (Kim et al., 2009).  
In an in vitro model of a bilayered trophoblast barrier using a placental trophoblast-
derived choriocarcinoma cell line, it was previously shown that these γ-PGA-Phe 
nanoparticles accumulate on the top layer of the trophoblasts and do not pass 
through it (Sood et al., 2011). In the case of in vivo administration of MitoQ-NP, the 
drug does not cross the placenta barrier and were not found in the foetal liver nor in 
the foetal brain (Phillips et al., 2017). However, as these NPs do not have a 
placental-homing component (King et al., 2016), apart from being present in large 
amounts in the placental trophoblasts, they were found to also located in the 
maternal brain and liver (Phillips et al., 2017).  
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6.1.6 Effects on MitoQ-NP on offspring outcomes in compromised 
pregnancies 
MitoQ-NP has been previously used in two separate in vivo rat studies and was 
found to be efficacious in preventing the increase of ROS in maternal brain, 
maternal liver and placenta following maternal hypoxia. The negative effects on the 
adult offspring were also rescued, indicating that increased oxidative stress is likely 
to be a mechanism involved in foetal programming associated with maternal hypoxic 
stress. In these studies, pregnant rats were intravenously injected with MitoQ-NP on 
GD15 and were then immediately exposed to hypoxic conditions for 6 (Phillips et al., 
2017) or 7 days (Aljunaidy et al., 2018). In both cases, when pregnant rats were 
killed at the end of the hypoxic stress procedure, increased ROS production in the 
placenta was observed, and MitoQ-NP was effective in preventing this increase. 
Fluorescent labelling also showed that the NPs are sequestered in the trophoblast 
layer of the placenta and did not cross over to the foetus (Phillips et al., 2017).   
In the first study (Phillips et al., 2017), maternal MitoQ-NP treatment prevented the 
lower birthweight in offspring with dams that underwent hypoxia. When 
neuroanatomical markers were examined in PND30 offspring, it was noted that 
maternal Mito-NP could normalise changes in the offspring brain associated with 
maternal hypoxia, such as decreased dendritic length and increased tyrosine 
hydroxylase positive (TH+, a marker for dopaminergic neurons) cell process length 
in the thalamic reticular neurones. The decrease in the number of parvalbumin 
(PV+, a marker for GABAergic neurones) positive cells in the offspring brain 
following hypoxia was also rescued with maternal MitoQ-NP, indicating an effect of 
maternal MitoQ-NP treatment on offspring GABAergic neurone development. When 
transcriptome analysis was carried out on the foetal brains, it was observed that 
maternal MitoQ-NP could partially normalise some of the 510 genes that were 
differentially regulated compared with the non-hypoxic controls. 
In the later study (Aljunaidy et al., 2018), whether maternal MitoQ-NP treatment 
could prevent programming of cardiovascular dysfunction was subsequently 
explored. Male and female rat offspring were assessed during adulthood (at 7 and 
13 months) for cardiac and vascular function. At 7 months, while male and female 
offspring presented the same cardiac diastolic dysfunction, maternal MitoQ-NP 
treatment rescued cardiac dysfunction only in the female offspring, but not in the 
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males. At 13 months, vascular sensitivity to vasoconstrictors were analysed and 
there were sex- and age-dependent effects of hypoxia and maternal MitoQ-NP 
treatment. This study showed that changes induced by stressors and maternal 
antioxidant treatment during gestation can have significant impacts on the offspring 
phenotype during adulthood and more than 1 year after birth. 
As the maternal stressor used in these two previous studies were hypoxia, it is not 
known if the same observations of increased placental ROS production, and 
subsequent rescue with MitoQ-NP treatment, will be observed if other stress 
paradigms are used. Here, using the same treatment regimen (where one dose of 
MitoQ-NP was given intravenously to the pregnant dam, prior to the induction of the 
stress), it was investigated if MitoQ-NP treatment could bring about similar beneficial 
effects in the case of maternal social stress. 
Previously, maternal MitoQ-NP treatment was shown to rescue neuroanatomical 
defects such as decreased dendritic length and GluN1 expression in the cortex 
following hypoxic stress (Phillips et al., 2017), indicating that these outcomes are 
under the control of maternal mitochondrial oxidative stress during pregnancy, and 
are sensitive to perturbations in utero. It is therefore possible that these 
neuroanatomical deficits may also be observed in the social stress model, in limbic 
regions such as the hippocampus and the amygdala. In addition to changes in 
dendritic length and GluN1 expression, it is possible for alterations to occur in 
GABAA and GABAB receptor subunit expression, as GABA receptor expression 
patterns are also sensitive to stress-related changes in early life (Skilbeck et al., 
2010). They also play an important role in the modulation of anxiety behaviour, 
responses to stress, and mediate the action of neuroactive steroids during 
adulthood, all of which may be impaired in PNS offspring (Gunn et al., 2011). 
Changes in GABAA receptor subunit composition have been shown to occur 
following chronic stress (Locci and Pinna, 2017), and can underlie the development 
of other stress-related neuropsychiatric diseases in adulthood (Jie et al., 2018). 
In this study, GABA and NMDA receptor expression patterns will be analysed 
alongside several behavioural tests, to determine if MitoQ-NP is also able to rescue 
offspring deficits associated with prenatal social stress exposure. Two GABAA 
subunits GABAAα1 (Gabra1) and GABAAα2 (Gabra2), the GABAB1 (Gabbr1) subunit, 
and the GluN1 subunit of the NMDA receptor (Grin1) will be investigated. The 
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structure of the GABAA and NMDA receptor, especially with respect to their 
regulation by neuroactive steroids, was introduced in Chapter 1. The GABAB 
receptor, on the other hand, are not known to be targets of steroids (Cryan and 
Kaupmann, 2005). The GABAB receptor is heterodimeric, made up of the B1 and B2 
subunits. Each of the subunits are G-protein coupled receptors, and upon binding of 
GABA, exert downstream effects by phosphorylation-mediated mechanisms (Enna, 
2007). 
6.1.7 How is the oxidative stress signal transmitted to the foetus?  
In as much as oxidative stress is observed to be increased in the placenta following 
insults, and maternal MitoQ-NP treatment is able to prevent this increase, oxidative 
stress is ultimately an intracellular phenomenon, and there needs to be a way in 
which this is communicated to the foetus, to result in the observed detrimental 
effects. Oxidative stress may cause tissue damage, resulting in the changes in the 
fine structure of the placenta, and therefore the altered transport of nutrients. 
However, in the case of hypoxia, the placenta did not seem physically or structurally 
altered, as there were no changes in the size of labyrinth zone or maternal decidua, 
nor in the foetal capillary network in the labyrinth zone following the stressor or 
MitoQ-NP treatment (Phillips et al., 2017). It may be that placenta structure is less 
amenable to changes during late pregnancy, as the process of placentation occurs 
in the earlier stages of pregnancy. Since increased oxidative stress did not result in 
structural changes in these studies, it was proposed that the secretory functions of 
the placenta could be impaired.  
By using human placenta explants or a model placenta barrier maintained in culture 
media, it was first shown that the placenta can indeed respond to hypoxic stress in 
vitro by secreting damaging ‘factors’ into the culture media (Curtis et al., 2014). 
When the conditioned culture media containing these damaging “placental 
secretions” were applied to embryonic cortical neurones in vitro, these neurones 
exhibited reduced synaptic activity, dendritic length, branching complexity and spine 
density. When the same conditioned culture media containing these “placenta 
secretions” were injected into a developing brain of a PND4 rat, there was a 
decreased density of PV+ neurones in the developing rat’s cortex, hippocampus and 
reticular nucleus, a marker of GABA producing neurones, suggesting that these 
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damaging factors have the propensity to directly affect brain development, 
especially the development of GABAergic circuits. 
A similar investigation was carried out in Phillips et al. (2017), and the culture media 
in this instance was conditioned by placenta from hypoxic pregnancies (the pregnant 
dam was exposed to 6 days of hypoxia as described in section 6.1.5). The culture 
media (also termed ‘conditioned media’) was then applied to embryonic cortical 
neurones in a similar manner, and there were decreases observed in dendritic 
length, process lengths of tyrosine hydroxylase (Th; a marker for dopaminergic 
neurones) positive neurones (TH+) and a decrease in GluN1 receptor expression. 
Some of these observations could be recapitulated in certain brain regions of adult 
offspring, described in section 6.1.5, suggesting that the changes observed in the 
adult brain could be due to the direct effect of the damaging factors produced by the 
hypoxic placenta on neurones. Additionally, when foetal plasma was collected and 
also applied to embryonic cortical neurones, similar in vitro patterns of alteration as 
that of the “conditioned media” were observed, suggesting that the damaging factors 
secreted by the placenta ex vivo was possibly being secreted into the foetal 
circulation. It was therefore hypothesised that these damaging factors affected the 
foetal brain in utero and neuroanatomical changes persisted into adulthood, and 
therefore plays a direct and crucial role in foetal programming.  
In this study, ithe same procedure was performed, where placental-conditioned 
media and foetal plasma from stressed and MitoQ-NP treated animals was collected 
and then applied to neuronal cultures in vitro. This could provide clues on whether 
“placental secretions”, associated with placental oxidative stress, could be the 
factors that are also directly involved in the transmission of social stress signals from 
mother to foetus.  
6.1.8 Aims of this chapter 
This study aims to use MitoQ-NP administered to the pregnant mother as an 
experimental manipulation to establish if, and how, oxidative stress may play a role 
in mediating the effects of prenatal social stress. At the same time, the study aims to 
also determine whether this mitochondrial-targeted and nanoparticle-delivered 
antioxidant therapy administered to the mother could be a viable intervention for 
prenatal stress-related disorders in the offspring.  
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This study spans two developmental time points, where two experiments on two 
separate cohorts of rats were carried out. Pregnant rats in cohort 1 were killed 
during GD20 to investigate the direct effects of the MitoQ-NP treatment during 
gestation on the maternal, placental and foetal compartments. In cohort 2, the 
offspring were tested during adulthood to ascertain the effects of maternal MitoQ-NP 
treatment on behavioural and neuroanatomical phenotypes (Figure 6.3).  
It was first investigated whether maternal and/or foetal ROS levels were altered by 
gestational social stress, which would point to the involvement of oxidative stress in 
the transmission of stress signals and/or foetal programming. It is hypothesised that 
maternal social stress, like maternal hypoxia exposure, can increase the oxidative 
stress status of the mother and placenta.  
Then, it was investigated if maternal MitoQ-NP treatment could rescue the 
behavioural and/or biochemical deficits observed in the adult offspring when they 
have been prenatally stressed using the gestational social stress model. It is 
hypothesised that maternal MitoQ-NP treatment, which prevents the increase in 
maternal oxidative stress, may rescue the deficits seen in the adult PNS offspring. 
Next, assuming that oxidative stress is indeed involved and MitoQ-NP can indeed 
normalise aberrant phenotypes, how the oxidative stress signal is transmitted from 
the mother and dam is then explored. The focus is placed on the placenta, where a 
similar ex vivo experiment was carried out (as in section 6.1.7), to determine if there 
were such “damaging factors” in the placentae from socially stressed dams. It is 
hypothesised that deficits observed in PNS offspring in adulthood can arise from 
prenatal programming at the foetal stage, as a result of “damaging factors” secreted 
by the placenta into the foetal circulation. 
Finally, it was also determined whether MitoQ-NP administration could potentially 
affect the pregnant dam in any other way or if there are any other knock-on effects, 
thus maternal plasma steroid concentrations and placenta 11β-HSD2 positive cell 
counts were also quantified. It is hypothesised that there is likely to be considerable 
cross talk between cellular stress and neuroendocrine responses/glucocorticoid 
regulation following stress.  
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Specific questions, summarised in Fig 6.2, are as follows: 
1. Is oxidative stress status altered with gestational social stress? Can it be 
prevented by MitoQ-NP administration? (cohort 1) 
• Maternal oxidative stress status: Are ROS levels increased in the placenta, 
maternal brain and liver? 
• Foetal oxidative stress status: Are ROS levels increased in the foetal brain 
and liver? 
• If so, can maternal MitoQ-NP treatment prevent the increased ROS levels in 
the mother placenta and the foetus?  
 
2. Can the prevention of oxidative stress (via maternal MitoQ-NP treatment) rescue 
the adverse phenotypes associated with prenatal social stress in adult offspring? 
(cohort 2) 
• Can maternal MitoQ-NP treatment rescue the anxious behaviour in adult 
male offspring? (Light-dark box and elevated plus maze) 
• Is there a depressive-like phenotype in the offspring, and does maternal 
MitoQ-NP treatment alter it? (Sucrose preference test and forced swim test) 
• Can maternal MitoQ-NP treatment rescue the social memory deficits in adult 
female offspring? (Social olfactory memory test) 
• Can maternal MitoQ-NP treatment normalise HPA axis hyperactivity 
observed in offspring following restraint stress? 
• Can maternal MitoQ-NP treatment alter biochemical changes in the brain of 
adult offspring?  
o CRH mRNA expression in central amygdala (linked to anxious 
behaviour) 
o In the basolateral amygdala and hippocampus (CA1, CA2 and CA3): 
Ø GluN1 protein expression 
Ø GABA receptor subunits (GABAAα1, GABAAα2 and GABAB1) 
protein expression  
Ø Parvalbumin positive cell count 
Ø Dendritic length of neurones 
 
3. How is the oxidative stress signal being transmitted to the offspring and what is 
the role of the placenta? (cohort 1) 
Chapter 6: Role of oxidative stress in foetal programming 278 
• Is the placenta secreting damaging factors that are causing changes to foetal 
cortical neurones? Does MitoQ-NP treatment prevent the effects of these 
damaging factors? 
• Are these damaging factors present in the foetal circulation? Does MitoQ-NP 
treatment prevent the effects of these damaging factors? 
 
4. Are neuroendocrine outputs in the maternal component altered? (Batch 1) 
• Does maternal MitoQ-NP impact the HPA axis response of the mother? 
• Does maternal MitoQ-NP treatment alter neuroactive steroid production in 
the mother?  
• Can MitoQ-NP alter other functions of the placenta (e.g. 11β-HSD2)? 
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Figure 6.2: Summary of study aims and specific questions   
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6.2 METHODS 
6.2.1 Preparation of MitoQ-NP drug 
MitoQ-NP was prepared in the University of Bristol by Dr Tom J Phillips, in the same 
manner as previously described (Phillips et al., 2017). Mitoquinone (MitoQ) was a 
kind gift from the laboratory of Prof Mike Murphy, MRC Mitochondrial Biology Unit, 
University of Cambridge (Kelso et al., 2001, James et al., 2005). Various patents for 
MitoQ have been held by Prof Mike Murphy and the company Antipodean 
Pharmaceuticals. The γ-PGA-Phe nanoparticles (NPs) used in this study were a 
kind gift from the laboratory of Prof Mitsuru Akashi, Osaka University (Kim et al., 
2009). Briefly, equal volumes of γ-PGA-Phe NPs (10 mg/mL) and MitoQ (2 mg/mL) 
were mixed in 0.2 M NaCl, and incubated at 4°C for 12 hr, resulting in MitoQ being 
adsorbed by hydrophobic and electrostatic interaction to these γ-PGA-Phe NPs. The 
mixture containing MitoQ-NP was then centrifuged, washed and resuspended in 
PBS, into a concentration of 125µM MitoQ-NP for injection. MitoQ-NP was 
transported from University of Bristol to the Roslin Institute in a chilled shipment with 
ice packs. Application of a patent for the use of MitoQ-NP as a drug to target 
compromised pregnancies by the University of Bristol is ongoing (Case et al., 2016). 
6.2.2 Animals, drug administration and social stress 
Two batches of experiments were carried out in this study. Cohort 1 was focussed 
on the pregnant dam, placenta and foetus during GD20, while cohort 2 focussed on 
the offspring during adulthood. Gestational social stress and drug administration 
were carried out in the same manner for both cohorts.  
The generation of pregnant rats and social stress procedure were carried out as 
described in section 2.2. Briefly, female Sprague Dawley rats (n=7-8 each group) 
were mated with a male and the morning in which the vaginal plug was found was 
designated as GD1. Pregnant rats were left undisturbed and group housed until 
GD16. On GD16, rats were weighed and 4% (w/w) lidocaine cream was applied 
topically to the tail before they were placed in a warm chamber for 5 min for tail vein 
dilation. Rats were gently restrained in a towel and the injection was performed by 
experienced animal technicians from the Roslin Institute Biological Resource 
Facility. 125µM MitoQ-NP was injected intravenously into the tail vein at a volume of 
0.34 ml/kg, and 0.9% sterile saline was injected as the vehicle. The volume was 
calculated to ensure at least 0.5µM of MitoQ-NP in the maternal circulation upon 
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injection, a dose which was shown to be effective in counteracting oxidative stress in 
previous in vivo and in vitro studies (Phillips et al., 2017). Approximately 1 hr after 
the injection, rats were exposed to 10 min social stress, using the modified resident-
intruder paradigm as previously described (Chapter 2). Social stress was repeated 
on GD17 to GD20 (i.e. on 5 consecutive days). Non-stressed controls were returned 
to individual IVCs after the injection. This experimental set-up generated four 
treatment groups: Control/Vehicle, Stress/Vehicle, Control/MitoQ-NP and 
Stress/MitoQ-NP.  
For cohort 1, after the final stressor on GD20, the pregnant rats were killed by 
conscious decapitation and maternal, placental, and foetal tissues were collected 
(section 6.2.5.1). 
For cohort 2, after the final stressor, pregnant rats were returned to their home 
cages and were left undisturbed until parturition. Offspring stayed with the dams 
throughout lactation until postnatal day (PND) 23, where they were weaned and 
separated into cages according to sex. Offspring were group housed with their 
littermates, so that each cage had approximately 5-7 rats. Various procedures were 
carried out on the offspring at different ages, listed on Table 6.1. One rat of each sex 
was used from each litter to minimise cage/litter-related effects.  
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Cohort Age Sex Procedures Kill method Tissues 





None  Perfusion Brain: 
IHC 
2-2 PND30 1 male 
per 
litter 














1. Light-dark box  
2. Elevated plus 




(4 days later)  
4. Forced Swim 
Test (4 days 
later) 
N.B.: Rats were 
returned to home 

















4 days prior to blood 
sampling 
CO2 overdose None 








CO2 overdose None 
 
Table 6.1: Details of juvenile and adult offspring used for experiments. Each 
batch of offspring were used for different purposes and were killed at the end of the 
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Figure 6.3: Experimental set up. Two cohorts of rats were used in the study.  
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6.2.3 Assessment of behavioural phenotypes 
The light-dark box (LDB), elevated plus maze (EPM), sucrose preference test and 
forced swim test (FST) were conducted on the same rats to determine anxiety- and 
depressive-like behaviour. To minimise the effects of behavioural experience on 
results, experiments were conducted on the rats from the least to the most stress-
inducing in the above-mentioned order, with a few days of rest between each test 
(cohort 2-3, Table 6.1). Apart from the sucrose preference test, where isolated 
housing was necessary for three days, rats were returned to their home cage and 
housed with other littermates after each test. Behavioural testing occurred in a 
separate room and rats were brought to the room immediately before a test in a 
transport container. Social olfactory memory test (section 6.2.3.3) was carried out on 
a separate group of female rats (cohort 2-5, Table 6.1).  
6.2.3.1 Anxious behaviour  
The light-dark box (LDB) (Bourin and Hascoet, 2003) and elevated plus maze (EPM) 
(Pellow and File, 1986) are two tests that assess anxiety-like behaviours, 
specifically, the approach-avoidance aspect of anxiety. Behaviour in the test is 
based on the innate aversion of rats to open and brightly lit spaces, and reflects the 
conflict between the desire to explore a novel environment and the distress of being 
in an open and brightly lit area. At ca. 9 weeks of age, rats were first tested on the 
LDB and were returned to the home cage for four days, before being tested again 
on the EPM. 
 
Light-dark box: The light-dark box consisted of a transparent Perspex box and a 
black lidded opaque Perspex box (both 40 x 40 x 40 cm), placed side by side, with 
an opening (10 x 8 cm) for the rats to freely move between these boxes (Figure 
6.4A). Rats were introduced into the dark chamber, and were allowed to explore 
freely for 5 mins. A decreased amount of time spent in the light chamber or a longer 
latency to enter indicate anxiety-like behaviour. 
 
Elevated plus maze: The EPM consisted of 2 open arms and 2 closed arms (each 
60 cm long and 10 cm wide) forming a plus shape, elevated 60 cm above the 
ground (Figure 6.4B). The 2 closed arms, which are located opposite each other, 
have 35 cm high black walls. Rats were introduced to the centre of the maze where 
the arms crossed, facing one of the open arms, and were allowed to explore the 
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maze freely for 10 mins. A reduced amount of time spent or lower number of entries 
in the open arms indicate anxiety-like phenotype. 
 
For both tests, the test arena was back-lit with infrared lighting and the entire 
duration of the test was recorded and animals tracked with an infrared video 
camera. The time spent in each zone, latency to enter each zone, number of entries 
into each zone, and distance travelled were monitored and automatically coded 
using EthoVision XT software v12 (Noldus, Wageningen, Netherlands). Zones were 
manually drawn using tools available in the software and a test run was carried out 
before each cohort to optimise camera and video contrast settings, which ensures 
the fidelity of the automatic coding. The test arenas were cleaned with 70% ethanol 
followed by distilled water and dried between each test animal to remove any 





Figure 6.4: Anxious behaviour was characterised with the light-dark box (A) 
and elevated plus maze (B). 
 
6.2.3.2 Depressive-like phenotype 
Two different aspects of a depressive-like phenotype was tested in this study, when 
offspring were ca. 11 weeks of age. Sucrose preference test was used to assess 
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anhedonia (Moreau, 2002), while the forced swim test (Porsolt et al., 1978) was 
used to characterise behavioural despair. 
Sucrose preference test: Rats were given the choice to consume either water or 
2% sucrose for a 48 hr period. Rats were singly housed in clean IVCs with two 
bottles per cage one day prior to the first testing day, with two bottles both 
containing filtered tap water. On the first testing day, one water bottle remained as 
filtered tap water while the other was substituted for 2% sucrose. After 24 hr, the 
bottles were weighed and the positions of the water and sucrose bottles were 
swapped, to reduce any side preferences. The test continued for another 24 hr, after 
which bottles were weighed again. Preference for sucrose consumed over the 48 
hour period was calculated by (sucrose consumption in 48 hr)/(total amount of fluids 
in 48 hr) x 100%. Preference for sucrose consumed on separate testing days were 
also calculated by (sucrose consumption in 24 hr)/(total amount of fluids consumed 
in 24 hr) x 100% to determine if there were any variabilities across testing days.  
Forced swim test: Despite its criticisms (de Kloet and Molendijk, 2016, Commons 
et al., 2017), the forced swim test is widely used as a model for assessing 
depressive-like behaviour, based on its predictive validity in screening for 
antidepressants (Lucki, 1997, Slattery and Cryan, 2012), where drug efficacy relates 
to a decrease in immobility time. The same glass cylinder as in the acute swimming 
stress procedure in Chapter 4 (diameter, 25 cm; height, 50 cm) was filled with water 
(22-23oC) to a depth of 30 cm. However, unlike the acute swim stress paradigm, the 
forced swim test involves two swimming bouts spaced 24 hr apart. On the first day 
(“pre-test” day), the rats were forced to swim for 10 min in the cylinder, and were 
gently dried using a towel and returned to the home cage thereafter. This pre-test 
exposure to the stressor ensures baseline mobility on the next day (“test” day), 
which allows for differences between treatments to be more easily observed 
(Slattery and Cryan, 2012). Rats were forced to swim for 5 min on the “test” day, 
and videos were recorded and coded manually using EthoVision v12, with a 
pharmacologically validated time-sampling technique (Lucki, 1997). In this sampling 
method, the 5 minute bout was divided into sixty 5 second bins, and the 
predominant behaviour in each bin was recorded. Three behaviours were recorded, 
namely (i) climbing, where there is vertical movement of the forepaws against the 
walls of the cylinder, (ii) swimming, where there is horizontal or circular movement in 
the cylinder, with the crossing of quadrants, and (iii) floating, where the rat assumes 
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a passive position without struggling, making only movements necessary (e.g. 
gentle paddling using only one foot) to keep its head above the water. 
6.2.3.3 Social olfactory memory testing  
Social olfactory memory testing was carried out only in the female offspring at ca. 12 
weeks of age (cohort 2-5, Table 6.1) as it was previously shown that PNS females, 
but not males, showed a deficit in social olfactory memory (Grundwald et al., 2016). 
Wooden beads (25 mm diameter) were impregnated with a social odour by being 
kept for 5 days in a cage housing unfamiliar female conspecifics. This was based on 
the observation that urinary scents are among the strongest chemical signals in 
rodents, encoding complex information that regulate rodent social behaviour 
(Beynon and Hurst, 2004).  
The social olfactory memory test consists of two sessions, an “exposure” phase and 
a “choice” phase. Before the “exposure” phase, rats were placed in the test arena 
(i.e. a clean open top cage without bedding) for acclimatisation for 2 hr, with food 
pellets and water provided. In the “exposure” session, rats were first introduced to a 
wooden bead (designated as the “familiar” bead) and were allowed to freely interact 
with it for 4 min. Time spent interacting with the “familiar” beads was recorded to 
ensure rats investigated the object adequately (>5 s of interaction time). The beads 
were immediately disposed of after the exposure, and the cages were wiped with 
70% ethanol to remove any residual odour. Rats remained in the test arena and the 
testing room during a 3 hr “consolidation” period. After 3 hours, the “choice” session 
was carried out where rats were exposed to two beads simultaneously for 4 min, a 
fresh “familiar” bead (with the same odour as before) and a bead with a “novel” 
odour. Rats were recorded on video camera and the time spent interacting with 
each object (which includes sniffing, biting, or holding object) was scored manually 
on Observer XT (Noldus). Preference score was calculated as time spent 
investigating “novel” bead divided by the total time spent investigating both beads 
during the testing session. A total of 8 different scents were used, and “familiar” and 
“novel” scents were assigned at random for each rat.  
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Figure 6.5: Diagrammatic representation of the social olfactory memory test 
carried out in female rats. Rats were first exposed to a bead with a “familiar” 
odour, and testing was carried out 3 hr later where rats were given a choice of a 
“familiar” or “novel” odour. Time spent investigating each bead was measured. 
 
 
6.2.4 Blood sampling following restraint stress 
Blood sampling for determining the HPA axis response to restraint stress was 
carried out on rats from cohort 2-4 (Table 6.1). Rats were first surgically cannulated 
4 days prior to the restraint stress and blood sampling procedures.  
6.2.4.1 Jugular vein cannulation 
Surgical cannulation of rats was performed by Dr Paula J Brunton using aseptic 
technique, as previously described (Brunton and Russell, 2010), with my assistance 
throughout. The surgical procedure followed closely the protocol by (Thrivikraman et 
al., 2002), where rats were fitted with a cannula in the right jugular vein. Anaesthesia 
was first induced in a Perspex chamber with 3% isoflurane in 1.2 L/min oxygen, and 
then maintained at 2-3% throughout the surgery through inhalation. The rat was 
then prepared for surgery, with the incision site shaved and cleaned with 70% 
ethanol. The rat was then placed ventral side up on a heat pad, and the right 
external jugular vein was exposed following a skin incision rostral to the right 
clavicle. Two ligatures were then placed loosely around the vein, with the cranial 
ligature tightened to prevent blood flow from the head into the heart. A V-shaped 
incision was then made in the vein, into which a sterile silicone cannula (internal 
diameter, 0.5 mm; outer diameter, 1 mm; filled with sterile heparinised saline, 50U 
heparin/ml 0.9% saline) was inserted. Once the cannula was inserted 3 cm into the 
vein, the patency of the cannula was tested, where there should be no resistance to 
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the withdrawal of blood. A second ligature was then tightened to secure the cannula 
in position. Once the cannula was secured, it was tunnelled under the skin and 
exteriorised at the centre of the nape of the neck. The cannula was then closed off 
with a stainless steel blocker and secured with adhesive taped sutured to the skin. 
Wounds were closed with suture thread (Ethicon Mersilk) and swabbed with 
betadine. Rats were administered carprofen (2 mg/kg) intramuscularly as a post-
surgery analgesic prior to regaining consciousness, after which time they were 
monitored closely for signs of pain or distress. Rats were housed individually in 
specialised open top blood-sampling cages after surgery. 
6.2.4.2 Blood sampling and restraint stress 
On the day of blood sampling, the jugular vein was connected to a 75cm length of 
PVC tubing, also filled with sterile heparinised saline, and then left undisturbed for 1 
to 2 hr before commencing blood sampling. A blood sample was taken immediately 
before the rats entered the restraint tubes (0 min time point), and at 15 min, 30 min, 
60 min, 90 min, and 120 min from the start of the restraint procedure. Circular 
restraint tubes (Stoelting, Dublin, Ireland) containing the rat were placed for 30 min 
in a laminar airflow cabinet, under bright light. The time points at 15 min and 30 min 
were taken whilst rats were still in the restraint tubes. Blood samples were collected 
in 1 ml syringes containing 0.02 mL 5% (w/v) EDTA and then transferred to 1.5 mL 
Eppendorf tubes kept on ice. 0.3 mL of blood was collected per time point, and 
withdrawn blood was replaced with sterile 0.9% saline after each sample collection. 
Blood were centrifuged at 1500 g for 20 min at 4oC, and the plasma was removed. 
Plasma was aliquoted into two tubes and kept at -20oC and -80oC until further use. 
6.2.5 Killing and tissue collection 
6.2.5.1 Conscious decapitation 
In cohort 1, pregnant rats were killed by conscious decapitation at GD20. Dams in 
the stressed group (7 dams) underwent social stress using the modified resident-
intruder-paradigm from GD16 to 20 of gestation in an adjacent room, and were 
brought to the cull room and killed immediately after the last stressor on GD20 
(approximately 11 mins from the induction of stress). Unstressed control dams (7 
dams) were removed from the home cage, brought into the cull room and were 
immediately killed. Killing was carried out in a separate room, and was conducted 
swiftly by placing the rats in a pliable plastic cone and performing conscious 
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decapitation using a guillotine. Social stress followed by decapitation was carried out 
between 10:00 – 14:00 each day. 
Trunk blood was collected immediately from pregnant dams, into collection tubes 
containing 0.5 mL of 0.5% (w/v) EDTA and were kept on ice. Foetuses and placenta 
were then removed from the uterus and sex was determined based on anogenital 
distance. Foetuses were decapitated and trunk blood was collected using EDTA-
coated capillary collection tubes (Microvette CB 300 µL, Sarstedt, Germany), also 
kept on ice. Foetal trunk blood were pooled by sex due to the small volumes of 
blood that could be obtained. The umbilical cord and maternal decidua were 
removed, and placentae were gently dabbed in clean tissue to remove excess 
blood. Placentae were either placed into culture media immediately (for placental-
conditioned media), or snap frozen in liquid N2 (for DCF assay), or frozen on dry ice 
(for ISH). Maternal and foetal brains and liver were collected in Eppendorf tubes and 
snap frozen in liquid N2 (for DCF assay and IHC). Both maternal and foetal trunk 
blood were centrifuged at 1500 g for 20 min at 4oC, and the plasma was removed. 
Plasma was stored at -20oC until further use. Some of the tissue and plasma 
samples were shipped to the University of Bristol on dry ice for further analysis. 
6.2.5.2 CO2 overdose  
In cohort 2, rats were killed by CO2 overdose. Rats were placed in a chamber with a 
rising concentration of CO2 until respiration ceases. Rats were then decapitated for 
confirmation of death, and also for brain collection (in the case of Batch 2-2, 2-3; 
Table 6.1) for in situ hybridisation, where they were frozen on dry ice. 
6.2.5.3 Cardiac Perfusion-Fixation 
Perfusions were carried out by Dr Paula J Brunton and Dr Tom J Phillips from the 
(University of Bristol, UK). Solutions were prepared the day prior to perfusion, 
filtered and chilled. PND30 juvenile rats from Batch 2-1 (Table 6.1) were deeply 
anaesthetised with 3% isoflurane and trans-cardially perfused first with 20 mL 
heparinised saline, followed by approximately 50 mL 4% paraformaldehyde (PFA; 
pH 7.3) in PBS, using a butterfly needle connected to a syringe pump. Brains were 
removed and transferred into 15% sucrose in 4% PFA for 24 hr. Brains were then 
transferred to 30% sucrose and sent to the University of Bristol in a chilled shipment 
for immunohistochemistry processing and analysis by Dr Tom J Phillips.  
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6.2.6 Radioimmunoassays 
6.2.6.1 Corticosterone RIA 
The corticosterone assay was carried out following the manufacturer’s instructions 
using 125I- corticosterone RIA kits (MP Biomedicals, Eschwege, Germany). The 
principle of the RIA is based on competitive binding, where a limited amount of anti-
corticosterone rabbit antibody and 125I-labelled corticosterone is introduced into the 
sample. With increasing endogenous corticosterone, less 125I-labelled corticosterone 
will be able to bind to the available antibody. Goat anti-rabbit gammaglobulin (the 
secondary antibody) with polyethylene is then added, which precipitates the 
corticosterone-primary antibody complex. Excess unbound 125I-corticosterone is 
removed following centrifugation and aspiration, and the amount of radioactivity 
(cpm) in the precipitate is then measured on a gamma counter. The radioactivity is 
inversely proportional to the amount of endogenous corticosterone present in the 
sample.  
Corticosterone RIA were carried out on the maternal/foetal plasma (cohort 1) and 
male and female samples (cohort 2-3; Table 6.1). All samples from cohort 1 were 
analysed in one RIA while males and females from Batch 2-3 were analysed on 
separate days. Briefly, plasma was diluted 1:200 with steroid diluent buffer.100 µL of 
samples, standard calibrants, and low and high concentration quality controls were 
added to assay tubes in duplicate. 100 µL of 125I-corticosterone and 100 µL of anti-
corticosterone antibody was then added to each tube. Following a 2 hr incubation, a 
precipitant solution was added. After centrifugation and aspiration of supernatants, 
the radioactivity of the pellets (in cpm) were counted in a gamma counter.  
Additionally, three other standards were also prepared in duplicate and their 
radioactivity measured, (i) total count standard: where an aliquot of 125I-
corticosterone was used to measure total cpm, (ii) non-specific binding: where only 
the 125I-corticosterone and secondary antibody were added, (iii) Bmax: which consists 
of only 125I-corticosterone, primary and secondary antibody but no sample, allowing 
us to determine maximum binding. An inverse linear regression curve, plotted using 
percentage binding (cpm obtained for sample/ cpm obtained for Bmax) against the 
known concentrations, was then generated on AssayZap software (Biosoft, 
Cambridge, UK). The amount of corticosterone present in the sample was then 
intrapolated. The range of detection was 7.7 ng/ml to 1000 ng/ml, and cross-
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reactivity was reported by the manufacturer to be <0.34% with any other steroids 
commonly found in plasma.   
6.2.6.2 ACTH RIA 
Total ACTH in the plasma of male and female rats in Batch 2-4 (Table 6.1) were 
measured using the MP Biomedicals ACTH Double Antibody RIA Kit (Cat. 
07106102) as per the manufacturer’s instructions, by Dr Paula J Brunton. The 
principle of the ACTH RIA is similar to that of the corticosterone RIA, with 125I-ACTH 
as the antigen and anti-ACTH as the corresponding primary antibody. 100 µL of 
undiluted plasma sample kept in -80oC was used, and samples were run in 
duplicate.  
6.2.7 Oxidative stress assay  
Levels of ROS were measured in maternal, placental and foetal tissues (cohort 1) 
using the 2′,7′-dichlorofluorescein diacetate (DCF-DA) assay. In this assay, a two-
step reaction occurs to generate the fluorescent 2′,7′-dichlorofluorescein DCF, which 
is a surrogate marker for ROS levels in the cell (Kalyanaraman et al., 2012). Upon 
permeating cells, DCF-DA is first hydrolysed by intracellular esterases into form the 
intermediate DCFH. In the second step of the reaction, DCFH is subsequently 
oxidised by ROS to form the fluorescent DCF.  
Tissues collected from cohort 1 were shipped on dry ice to the University of Bristol, 
where the DCF assay was performed by Dr Tom J Phillips, as previously described 
(Phillips et al., 2017). Briefly, the foetal brain, liver, placenta, maternal brain and liver 
were cut sagittally (10 µm) on the cryostat and thaw mounted on slides. Sections 
were then incubated with 20 µM DCF-DA solution (Sigma-Aldrich) in Hanks' 
Balanced Salt solution (HBSS) at 37oC in a humidifying chamber for 15 min, before 
counter-staining with DAPI for cell nuclei. Slides were then immediately imaged 
using a confocal microscope where fluorescent DCF levels were quantified 
(excitation: 495 nm, emission: 529 nm).  
6.2.8 In situ hybridisation  
In situ hybridisation was carried out to probe for CRH mRNA in the central amygdala 
(CeA) of PND30 (Batch 2-2; Table 6.1) and 12 week old male offspring (Batch 2-3; 
Table 6.1), and 11β-HSD2 mRNA in the placenta (Batch 1).  
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Tissue sectioning: Frozen brains and placenta were mounted (but not embedded) 
on OCT (Tissue-Tek) and 16µm sections were cut using a cryostat at -19oC (Leica 
CM1850), then thaw-mounted on Polysine adhesion slides (ThermoScientific). 
Brains from 12 week male offspring (cohort 2-3) were cut by MSc student Joanne 
Palsma. In each case, every 4th section was collected on each slide, and each slide 
consisted of 4 (12 week males) or 5 (PND30 males) sections. The amygdaloid 
complex was identified in reference to a rat brain atlas (Paxinos and Watson, 2007). 
Marker sections were collected on gelatine subbed slides (1% gelatin with 
chromium), and fixed with acetic alcohol fixative (4% w/v formaldehyde and 5% v/v 
acetic acid in ethanol) and stained with 1% toluidine blue for visualisation. Tissue 
sections on slides were stored in -80oC until in situ hybridisation.  
In situ hybridisation: In situ hybridisation was carried out as described in Chapter 2, 
with specific conditions for each probe detailed in Table 6.2. Briefly, plasmids 
containing cDNA of the gene of interest were first linearised with the respective 
restriction enzymes. The linearised cDNA was then used to synthesise the sense 
and antisense 35S–UTP labelled riboprobes by RNA transcription, catalysed with the 
specific RNA polymerases. Probes were then hybridised with tissue sections on 
slides overnight at 55oC, which had been fixed and pre-hybridised beforehand (see 
Chapter 2). Post hybridisation washes, which consisted of 2X SSC (RT for 30 min, 
once) followed by 0.1X SCC (60oC for 50 min, three times), were then carried out. 
Hybridised probes were then exposed to radiosensitive autoradiographic emulsion in 
4oC (Table 6.2) before development and counterstaining. Compositions of buffers 
and optimal conditions for reactions are described in Chapter 2.  
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Table 6.2: Conditions for in situ hybridisation. AS: Antisense, S: Sense. 
Hybridisation was carried out at 55oC for both probes, while post-hybridisation 
washes consisted of the first step of 2x SSC at RT for 30min, followed by 0.1x SSC 
at 60°C for 50 min three times. Both probes were kindly donated by Prof Megan 
Holmes (University of Edinburgh).  
 
Data analysis and quantification: Quantification of hybridisation was carried out by 
positive cell counts at 20X magnification. Cells were considered positive when the 
silver grains were imposed on the cell at a density 5x higher than that of the 
background. Counts were averaged across 4 or more sections for the CeA 
bilaterally, and across 5 sections for the placental junctional zone. 
6.2.9 Immunohistochemistry of PND30 brains 
Perfused PND30 brains (Batch 2-1, Table 6.1) were processed for 
immunohistochemistry by Dr Tom J Phillips. Three brains per group per sex were 
used.  
Tissue sectioning, fixing and permeabalisation: Cryostat sections (12 μm) were cut 
coronally and mounted on slides as contiguous triplicates. For GABAAα1, GABAAα2, 
GABAB1, parvalbumin, and MAP2 staining for dendrites, sections were fixed in cold 
methanol (-20°C) for 10 min. For GluN1 staining, sections were first fixed in 2% 
PFA, and then permeabilised in 0.3% Triton X-100 in PBS for 15 min.  
Immunostaining: Sections were blocked with 5% goat serum, 0.3% Triton X-100 in 
PBS for 2 hr at 4°C to reduce non-specific binding. Sections were then incubated 
overnight at 4oC with primary antibody in PBS with 1% BSA and 0.3% Triton X-100 
(except for GluN1 staining, which was incubated for two overnights). Primary 
antibodies were used against MAP2 (1:500, Abcam #ab32454; rabbit polyclonal), 
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#ab33299; rabbit polyclonal), GABAAα2 (1:200, Abcam #ab193311; mouse 
monoclonal), GABAB1 (1:500, Abcam #ab55051; mouse monoclonal) or GluN1 
(1:500, Merck Millipore #ab9864; rabbit monoclonal). After sections were washed, 
sections were incubated with secondary antibody for 2 hr at 4oC. Secondary 
antibodies were either anti-rabbit IgG (Alexa Fluor 555), anti-mouse IgG (Alexa 
Fluor 488 or 568) from Thermo Fisher Scientific, all prepared at 1:500. Vectashield 
Mounting Medium (with DAPI counterstain to visualise nuclei)(Vector Laboratories, 
USA) was used to mount coverslips.  
Data analysis and quantification: 5 sampling views were taken in each hemisphere 
for each brain region in each of the 3 sections, resulting in 30 sampling views per 
rat, except for GluN1, 10-12 images were taken for each region. Sections were 
visualised on a SP5II confocal microscope (SP5II, Leica) at 40X magnification. 
Images were quantified on ImageJ, where they were converted to greyscale and the 
total pixel number was determined, subsequently subtracted from the background to 
obtain a mean grey value.  
6.2.10 E18 cortical cultures experiments 
6.2.10.1 Preparation of placenta conditioned media 
Conditioned tissue culture media were prepared using fresh rat placentae isolated 
from cohort 1. Immediately after collection, whole placentae were incubated 
individually at 37°C in 21% O2 and 5% CO2, in 1.5 mL of warmed neurobasal culture 
medium in 12 well plates. Neurobasal culture medium (Gibco) was supplemented 
with 1X B-27 supplement (Gibco), 2 mM L-glutamine and 250 μM penicillin-
streptomycin (ThermoFisher), prepared in sterile conditions. After 24 hr, the media 
around the explants was collected using a syringe, filtered through a disk filter (0.22 
μm, MF-Millipore) into Eppendorf tubes, and frozen on dry ice. Placental-conditioned 
media was shipped to the University of Bristol on dry ice and was kept at -80oC until 
further use.  
6.2.10.2 Cortical cultures 
Preparation of cortical cultures were carried out by Dr Tom J Phillips at the 
University of Bristol. Cortical cultures were prepared from dissociated rat embryonic 
day 18 cortical tissue and grown on glass coverslips as described previously (Curtis 
et al., 2014), in neurobasal culture medium (section 6.2.10.1). Placenta conditioned 
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medium (section 6.2.10.1) or foetal plasma (section 6.2.5.1) was then applied to the 
cortical cultures for 6 days starting from the 12th day of in vitro culture.  
6.2.10.3 Immunocytochemistry of cortical cultures 
Cortical cultures were investigated for GluN1, GABAAα1, GABAAα2, GABAB1 
receptors, parvalbumin, and MAP2 (a dendritic marker). Cortical cultures were fixed 
in supercold methanol (−20oC) and blocked with 5% BSA, 5% normal goat serum in 
PBS for 30 min. They were incubated with primary antibodies (same as in section 
6.2.9) overnight at 4oC, the secondary antibody (same as in section 6.2.9) for 2 hr at 
room temperature under minimal light conditions, washed with PBS and similarly 
mounted in DAPI mounting media. Five images per coverslip were taken on a 
confocal microscope (SP5II, Leica). Images were taken at 64x magnification (with 
oil) and quantified similarly using ImageJ.  
6.2.11 LC-MS quantification of steroids in maternal plasma 
LC-MS quantification of steroids in maternal plasma was carried out as described in 
Chapter 2 and 3. 100 µL of neat maternal plasma from cohort 1 (stored in -20oC) 
was processed as described in Chapter 3, along with 7 calibration standards. 
Plasma samples were extracted twice with methanol/1% formic acid, and underwent 
C18 solid phase extraction. All samples were derivatised at the same time using 1 
mg/ml Girard’s T reagent, in methanol/ 0.2% formic acid, dried and reconstituted in 
50% methanol. LC-MS detection of steroids (DOC, DHDOC, THDOC, progesterone, 
DHP, allopregnanolone, pregnenolone, testosterone) were carried out with the 
transitions outlined in Table 3.4.  
6.2.12 Data analysis and statistics  
Two-way ANOVAs were carried out using R-Studio or PRISM 6.0 (for DCF assay 
and IHC studies only), with stress and maternal antioxidant treatment as the main 
factors investigated. Males and females were analysed separately. Pairwise 
comparisons were carried out using Student’s-Newman-Keuls test or Bonferroni-
corrected pairwise comparisons (for DCF assay and IHC studies only) to determine 
significant differences between groups. In all cases, asterisks represent differences 
between control and PNS groups (where * p<0.05, ** p<0.01, *** p<0.001), while 
hashes represent differences between vehicle and MitoQ-NP treated groups (where 
# p<0.05, ## p<0.01, ### p<0.001). 
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6.3 RESULTS 
6.3.1 Corticosterone concentrations following stress were not affected by 
MitoQ-NP administration 
Maternal: As expected, a main effect of stress was observed on the maternal 
plasma corticosterone concentrations (F1,23 = 25.2, p<0.001; Fig 6.6A). There were 
no main effects of drug treatment, nor any interactions. Both vehicle and MitoQ-NP 
treated stressed groups had significantly greater maternal corticosterone 
concentrations compared to their respective control groups. MitoQ-NP 
administration to the pregnant dam did not result in different plasma corticosterone 
concentrations compared to controls (Control/Vehicle vs Control/MitoQ-NP, p=0.37). 
Foetal: There were no differences in plasma corticosterone in all four groups for 
both the male (Fig 6.6B) and female foetuses (Fig 6.6C). The potential actions of 
maternal MitoQ-NP administration were thus unlikely to occur through the alteration 
of circulatory corticosterone concentrations.  
 
 
Figure 6.6: Plasma corticosterone concentrations in the pregnant dam and 
foetuses, measured by radioimmunoassay. At GD20, corticosterone 
concentrations were significantly greater in stressed dams regardless of antioxidant 
treatment (A). There were no differences in all four groups for pooled plasma 
corticosterone in male foetuses (B) or for females foetuses (C). n=7 per group 
except for foetal male stress/vehicle group where n=6. Asterisks represent 
significant differences between controls and stressed groups in SNK multiple 
pairwise comparisons, where ** p<0.01. Con: Control, MQ-NP: Veh: Maternal 
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6.3.2 Social stress was associated with greater ROS production in the 
maternal compartment and placenta, which could be blocked by 
administration of MitoQ-NP 
There were significant main effects of stress, treatment and stress x treatment 
interactions on DCF levels (reflecting ROS levels) in the placenta, maternal brain 
and maternal liver (Fig 6.7A-C). There were significant differences between the 
vehicle-treated control and stressed groups in all three tissues, where stressed 
groups had significantly greater DCF levels, indicating the presence of greater ROS 
production. Therefore, social stress resulted in greater ROS production in the 
maternal compartment and placenta.  
MitoQ-NP treated stressed groups had significantly lower DCF levels as compared 
to vehicle-treated stress groups. DCF levels in the placenta, maternal brain and liver 
of MitoQ-NP treated stressed groups were also not different from that of vehicle or 
MitoQ-NP treated control groups, suggesting they had similar ROS content as the 
control groups (Fig 6.7A-C). Therefore, administration of maternal MitoQ-NP could 
abrogate the increased ROS production in placenta, maternal brain and maternal 
liver following stress, indicating the efficacy of the antioxidant treatment in the 
maternal compartment. 
Despite MitoQ-NP not crossing over into the foetal compartment, there was a 
significant main effect of stress and a stress x treatment interaction on DCF levels in 
the foetal liver (Fig 6.7D). DCF levels in the vehicle-treated stressed group were 
higher than that of the vehicle-treated control group. The MitoQ-NP treated stressed 
group had lower DCF levels than the non-treated stress group, but DCF levels were 
still greater than the vehicle-treated control group, indicating greater ROS content. 
The administration of MitoQ-NP to the dam attenuated ROS production in the 
stressed foetal liver. 
Neither maternal stress nor maternal MitoQ-NP administration were associated with 
any ROS changes in the foetal brain (Fig 6.7E).  
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Figure 6.7: Reactive oxygen species content in placenta, maternal and foetal 
tissues following prenatal stress and maternal MitoQ-NP treatment. At GD20, 
elevated ROS was observed in the stressed rats in the placenta (A), maternal brain 
(B), maternal liver (C), foetal liver (D) but not the foetal brain (E). Maternal MitoQ-NP 
treatment abrogated the elevated ROS levels in all these tissues, although the 
rescue in the foetal liver (D) seemed to be partial. Oxidative stress was measured by 
quantifying mean fluorescent intensity of DCF and the assay was carried out by Dr 
Tom Phillips of University of Bristol. Asterisks represent differences between control 
and PNS groups (where ** p<0.01), while hashes represent differences between 
vehicle and MitoQ-NP treated groups (where # p<0.05). Con: Control, Veh: Maternal 
vehicle treatment, MQ-NP: Maternal MitoQ-NP treatment, DCF: Dichlorofluorescin 
 
 



































Stress: F1,20 = 39.5, p<0.001***
Treatment: F1,20 = 15.7, p<0.001***



































Stress: F1,20 = 32.1, p<0.001***
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Treatment: F1,20 = 22.7, p=0.001***




































Stress: F1,20 = 60.2, p<0.001***
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Interaction: F1,20 = 13.2, p=0.0017**
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6.3.3 Maternal MitoQ-NP administration rescued the anxiety phenotype in the 
adult male offspring 
Anxiety testing (LDB and EPM) was carried out in the offspring of pregnant rats from 
cohort 2 at about 9 weeks of age. Anxious behaviour was characterised by 
decreased exploration time in the light box in the LDB and a lower frequency of 
entry into the open arms of the EPM, and an increased latency to enter the light box 
in the LDB. 
6.3.3.1 Light-dark box (LDB) 
Males: There was a significant main effect of PNS status (F1,27 = 4.50, p=0.04) and a 
PNS status x treatment interaction that was close to significance (F1,27 = 2.77, 
p=0.11) on the amount of time males spent in the light box (Fig 6.8A). Post-hoc 
analyses showed that vehicle-treated PNS males spent significantly less time 
exploring the light box than control males (p=0.011), as expected (Brunton and 
Russell, 2010). PNS males with maternal MitoQ-NP treatment however, spent 
significantly more time in the light box compared to the PNS males from vehicle-
treated dams (p=0.027), and time spent in the light box was not different from that of 
the control males from vehicle-treated dams. This indicates that maternal treatment 
with MitoQ-NP normalised anxiety-like behaviour induced by maternal stress in the 
PNS males to control levels. A similar pattern of behaviour was observed for the 
number of entries into the light box (Fig 6.8B), however, this was not significant. 
PNS males from vehicle-treated dams tended to have a greater latency to enter the 
light box as compared to the controls (Fig 6.8C), but this was not observed for the 
PNS males from matermal MitoQ-NP treated dams. This observation however, did 
not reach statistical significance using a two-way ANOVA.  
There was an additional main effect of maternal MitoQ-NP treatment (F1,27 = 5.20, 
p=0.03) on total distance travelled within the arena (Fig 6.8D). PNS males with 
maternal MitoQ-NP treatment had significantly greater exploratory activity in both 
light/dark boxes, as compared to PNS males from vehicle-treated dams (p=0.039). 
This measure was not different between the vehicle-treated control and PNS males.    
Females: There were no significant differences across any of the four groups in all 
parameters investigated in the light-dark box, as expected (Fig 6.8F-I) (Brunton and 
Russell, 2010). 




Figure 6.8: Effects of prenatal stress and maternal MitoQ-NP administration on 
anxiety-like behaviour in the light dark box. Results from the male offspring are 
in the left panel (A–E) and females in the right panel (F- I). (A) Male PNS offspring 
spent less time in the light box than control offspring, and this was rescued by the 
maternal administration of MitoQ-NP. (B) No significant differences were observed 
in the number of entries into the light box. (C) Some PNS offspring showed an 
increased latency to enter the light box, but group means were not significantly 
different when analysed by two-way ANOVA. (D) Total distance travelled was 
significantly greater in PNS male offspring with maternal MitoQ-NP administration as 
compared to the vehicle-treated PNS male offspring. (E) Representative heat maps 
depicting differential amount of time male control and PNS offspring spent exploring 
the dark and light areas of the LDB. No difference was observed in any of the four 
groups for the females, in the time spent in light box (F), entries into light box (G), 
latency to enter light box (H) and total distance travelled. n=8 per group except for 
male PNS/MitoQ-NP group, where one outlier was removed. Asterisks represent 
differences between control and PNS groups (where * p<0.01), while hashes 
represent differences between vehicle and MitoQ-NP treated groups (where # 
p<0.05).  Con: Control, PNS: Prenatal stress, Veh: Maternal vehicle treatment, MQ-
NP: Maternal MitoQ-NP treatment. 
E Dark Box          Light Box Dark Box          Light Box






















































































































































































































Total distance travelledH I
Chapter 6: Role of oxidative stress in foetal programming 302 
 
6.3.3.2 Elevated plus maze (EPM) 
Males: A similar finding as for the LDB was observed in the EPM, where there was a 
main effect of PNS status (F1,26 = 7.57, p=0.01) and a PNS status x treatment 
interaction that was close to significance (F1,26 = 3.36, p=0.07) on the frequency of 
entries into the open arm (Fig 6.9A). PNS males had a significantly lower frequency 
of entering the open arms as compared to control males (p=0.0042; Fig 6.9E), and 
this seemed to be normalised in the maternal MitoQ-NP treated PNS groups 
(p=0.06). In terms of number of entries into open arms, there was a main effect of 
PNS status (F1,26 = 4.82, p=0.03) but no interaction was observed (Fig 6.9C). 
Vehicle-treated PNS males made significantly fewer entries into the open arms as 
compared to vehicle-treated controls, while maternal MitoQ-NP treatment seemed to 
reverse this effect (p=0.09). A similar trend was observed for time spent in open 
arms (Fig 6.9B), although this did not reach significance. There were no differences 
across all 4 groups for total entries into all arms (Fig 6.9D). 
Females: There were no significant differences across all four groups for the time 
spent (Fig 6.9G) or the frequency to enter the open arms (Fig 6.9F). There was a 
significant PNS status x treatment interaction (F1,28 = 9.25, p=0.005) for total entries 
into all arms. PNS females seemed to have a decreased exploration in the EPM (Fig 
6.9I), where they had significantly lower entries into all arms as compared to the 
control groups (p=0.0269). Maternal MitoQ-NP treated PNS females, however, had 
significantly greater total entries as compared the vehicle-treated PNS females 
(p=0.0092; Fig 6.9I), which indicated that maternal MitoQ-NP adminstration could 
have increased the total exploration in the EPM in the female PNS offspring. 
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Figure 6.9: Effects of prenatal stress and maternal MitoQ-NP administration on 
anxiety behaviour on the elevated plus maze in male and female adult 
offspring. Results from male offspring are presented in the left panel (A – E) and 
females presented in the right panel (F- I) (A) Male PNS offspring had a lower 
frequency of entering open arms as compared to control offspring, and this seemed 
to be rescued by the maternal administration of MitoQ-NP. (B) Male PNS offspring 
made fewer entries into the open arms as compared to control offspring, and this 
seemed to be rescued by the maternal administration of MitoQ-NP. (C) No 
differences in the time spent in the open arms across all groups for male offspring. 
(D) Total entries into all arms was not different across all groups for the male 
offspring. (E) Representative heat maps depicting differential amount of time male 
control and PNS offspring spent exploring the open and closed arms of the EPM. In 
females, there were no differences observed in all four groups for females, 
frequency of entries into open arms (F), number of entries into open arms (G) and 
time spent in open arms (H). (I) PNS females, however, had decreased total entries 
into both arms, and this was normalised by maternal MitoQ-NP administration. 
Asterisks represent differences between control and PNS groups (where * p<0.05), 
while hashes represent differences between vehicle and MitoQ-NP treated groups 
(where ## p<0.01). Con: Control, PNS: Prenatal stress, Veh: Maternal vehicle 
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6.3.4 Effects of PNS and maternal MitoQ-NP treatment on sucrose preference 
in the adult offspring 
A two-way ANOVA did not reveal any significant differences in the percentage of 
sucrose consumption across all groups in the combined data from across two days 
of testing (Fig 6.10A and 6.10D). In males (Fig 6.10A), there was no difference in 
the intake of sucrose across all groups. Most male rats, regardless of PNS status or 
maternal MitoQ-NP treatment, showed a strong preference for sucrose as compared 
to water, except for one rat per group which seemed to have either no preference 
(one PNS/veh rat) or prefer water (one rat for each of the MitoQ groups). In females 
(Fig 6.10D), a two-way ANOVA did not reveal any significant preferences, but the 
PNS/Veh group seemed to exhibit a binging effect where all rats in that group 
exhibited a strong preference for sucrose over water. 
The data was also broken down by testing days. In male offspring, there were no 
differences in sucrose consumption patterns across all four groups on both testing 
day 1 (Fig 6.10B) and day 2 (Fig 6.10C). In the female offspring, there was a PNS 
status x maternal MitoQ-NP treatment interaction on testing day 1 (F1,28=4.81, 
p=0.037; Fig 6.10E). The average sucrose consumption in the control group was 
close to being significantly lower than that of the PNS group (p=0.059) and 
control/MitoQ-NP group (p=0.079) on testing day 1. This trend was not observed 
when compared to the PNS/MitoQ-NP group, and it was also not present on testing 
day 2. On testing day 2, although the two-way ANOVA was not significant 
(F1,28=2.63, p=0.12; Fig 6.10F), pairwise comparisons showed a significant 
difference between the percentage of sucrose consumed between the vehicle-
treated PNS group and the maternal MitoQ-NP-treated PNS group (p=0.048). 
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Figure 6.10: Sucrose preference test in male and female offspring. Two-way 
ANOVA did not reveal any significant differences in the groups in terms of 
percentage sucrose consumption. Data points above the dotted line (50%) indicated 
that rats preferred sucrose, while data points below the dotted line indicated that rats 
preferred water. The bottles were switched between Day 1 and Day 2 to ensure that 
there were no side preferences “Combined” (A and D) refers to consumption over 
the 48 hr period, while “Day 1” and “Day 2” refers to consumption on the respective 
testing days (24 hr each). Con: Control, PNS: Prenatal stress, Veh: Maternal vehicle 
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6.3.5 Maternal MitoQ-NP administration, but not PNS, altered adult offspring 
behaviour during the forced swim test 
Males: In the male offspring, there was a main effect of maternal antioxidant 
treatment on floating (F1,27 = 9.57, p=0.0045; Fig 6.10A) and swimming (F1,27 = 7.88, 
p=0.009; Fig 6.10B) behaviours, but not climbing behaviours. No main effect of PNS 
status was observed for any of the behaviours measured. Post-hoc SNK testing 
showed that floating behaviour occurred less frequently for offspring from MitoQ-NP 
treated dams as compared to the offspring from vehicle-treated dams, regardless of 
PNS status (Fig 6.10A).  
Females: In the female offspring, there was a main effect of maternal antioxidant 
treatment on climbing behaviours only (F1,27=5.88, p=0.022; Fig 6.10F). SNK 
multiple pairwise comparisons showed that female control offspring from MitoQ-NP 
treated dams had increased frequency of climbing bouts as compared to control 
offspring from vehicle-treated dams, whilst a trend for an increase was observed in 
the PNS groups. Similar to males, no effect of PNS status was observed for any of 
the behaviours in the female offspring.  
  




Figure 6.11: Maternal MitoQ-NP administration differentially altered male and 
female offspring behaviours in the forced swim test. Frequency of floating, 
swimming and climbing behaviours did not change with PNS for both the male (A-C) 
and the female (D-F) offspring. Maternal MitoQ-NP treatment resulted in less 
floating behaviours (A) and increased swimming behaviours (B) in males, but did not 
alter climbing behaviour (C). Maternal MitoQ-NP treatment increased climbing 
behaviour in females (F) but did not alter floating (D) nor swimming (E) behaviours. 
Hashes represent an effect of drug administration in the post-hoc SNK test, where 
#p<0.05.  N=8 per group. Con: Control, PNS: Prenatal stress, Veh: Maternal vehicle 
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6.3.6 Maternal MitoQ-NP administration does not affect performance in the 
social olfactory memory test in the female offspring 
There was a main effect of PNS status that was close to significance on the 
preference for novel odour (F1,29 = 3.81, p=0.06, Fig 6.12B). PNS females seemed to 
show a deficit in social olfactory memory, although this did not reach significance.  
When the actual time spent interacting with the beads was investigated within each 
group (Fig 6.12C), in the control/veh group, time spent investigating familiar and 
novel beads was significantly different (p=0.043), and more time was spent 
investigating the novel object. In the control group with maternal antioxidant 
treatment, a similar trend was observed (p=0.179). In the PNS groups however, 
there were no differences in time spent investigating either objects, further indicating 
a deficit in social memory in PNS offspring that was not rescued by maternal MitoQ-
NP administration.  
There were no statistically significant differences in the investigation time of the 
“familiar” bead during the exposure phase, 3 hrs before the test phase (Fig 6.12A), 
indicating that any possible differences between groups during the test phase were 
probably not due to the lack of interaction with the object during the exposure phase. 
  




Figure 6.12: Social/olfactory memory testing in female offspring. (A) 
Investigation time of the “familiar” bead during the 4 min exposure phase. (B) 
Results during the ‘choice’ phase (3 hr later): Data presented as a preference score 
for the novel odour. The horizontal line at 0.5 indicates chance level, where there 
was no preference for either the novel or the familiar odour. Control groups seemed 
to show a greater preference for the novel odour, as compared to the respective 
PNS groups (regardless of maternal antioxidant treatment), although this did not 
reach significance. (C) Results during the ‘choice’ phase (3 hr later): Data presented 
as time spent with familiar/novel beads, where the Control/Veh group showed 
significantly greater time spent investigating the novel beads as compared to the 
familiar beads. This was not observed in the other groups, although a trend was 
observed for the Con/MitoQ NP group. *p<0.05, paired Student’s t-test.  
 
6.3.7 Maternal MitoQ-NP treatment had no effect on HPA axis responses to 
stress in the adult offspring 
There were no significant differences detected in plasma ACTH and corticosterone 
concentrations in all four groups, in both sexes, before, during, and following 30 min 
of restraint stress (Fig 6.13).  
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Figure 6.13: ACTH and corticosterone responses to 30 min restraint stress. A 
basal blood sample was taken (0 min) before rats were restrained, and blood 
samples were taken at 15, 30 (before being removed from restraint tube), 60, and 
90 min after the start of restraint, via a jugular vein cannula. The period of restraint is 
represented by the shaded grey bar (A, C, E, G). No differences in corticosterone 
secretion was present in any of the groups. Con: Control, PNS: Prenatal stress, 
Veh: Maternal vehicle treatment, MQ-NP: Maternal MitoQ-NP treatment. 
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6.3.8 Maternal MitoQ-NP adminstration normalised increased CRH mRNA 
expression in the central amygdala in male offspring  
An increase in CRH mRNA expression is associated with the anxiety phenotype in 
males (Brunton and Russell, 2010), and here this was also observed for both 
juvenile (PND 30; Fig 6.14B) and adult PNS offpsring (Fig 6.14A).  
In the adult offspring, there was a main effect of PNS status (F1,25 = 12.07, p=0.002), 
a main effect of maternal MitoQ-NP adminstration (F1,25 = 4.99, p=0.035) and also a 
significant PNS status x maternal treatment interaction (F1,25 = 6.79, p=0.015; Fig 
6.14A). Post-hoc SNK testing in adult male offspring showed that the PNS/Veh 
group had significantly higher CRH mRNA expression as compared to the Con/Veh 
group (p<0.001). PNS males with maternal MitoQ-NP adminstration had significantly 
lower CRH mRNA expression levels as compared to PNS males without maternal 
MitoQ-NP adminstration (PNS/MitoQ-NP vs PNS/Veh, p=0.003), and CRH mRNA 
levels were also not different from those in control rats, indicating that maternal 
MitoQ-NP adminstration normalised the PNS-induced increase in CRH gene 
expression in the central amygdala (Fig 6.14A).  
In the juvenile offspring, a similar pattern was observed, however, the two-way 
ANOVA did not reach significance (PNS status x maternal MitoQ-NP adminstration 
interaction, F1,16=3.41, p=0.08; Fig 6.14B). 
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Figure 6.14: CRH mRNA expression in the central amygdala (CeA) of male 
offspring. (A) CRH mRNA expression in the CeA was greater in 11 week old 
PNS/veh offspring as compared to the respective control group, and this normalised 
with maternal MQ-NP treatment. (B) CRH mRNA expression also tended to be 
greater in PND30 juvenile PNS/veh offspring as compared to the respective control 
group, although this was not significant on the two-way ANOVA and post-hoc SNK 
pairwise comparisons. Group numbers: n=6-8 for adult offspring, n=5 for juvenile 
offspring (C) Representative image of the CeA and its anatomical position with 
respect to the optic tract (OT) at 2x magnification, in PND30 juvenile male rat brain 
sections. (D) Representative image of Male Con/Veh and Male PNS/Veh CeA at 10x 
magnification, showing positive cells with silver grain staining, in PND30 juvenile 
male rat brain sections. Con: Control, PNS: Prenatal stress, Veh: Maternal vehicle 
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6.3.9 PNS and maternal MitoQ-NP treatment altered neurochemical markers in 
the juvenile offspring brain in a region- and sex-dependent manner 
Several other neurobiochemical markers were also quantified in the offspring brain, 
and these were carried out by Dr Tom J Phillips at the University of Bristol. Graphs 
with statistical analyses are attached in Appendix D, and a summary of the changes 
are presented in Figure 6.15. In general, there was a region- and sex-dependent 
decrease in the expression of several receptors and neuronal markers (e.g. 
parvalbumin for GABA producing cells, MAP2 for dendrites), and these deficits were 
partially or completely normalised by maternal MitoQ-NP treatment. 
Across the board, GABAAα1, GABAAα2 and GABAB1 expression and GluN1 
expression were observed to be lower in the PNS offspring, although the changes 
were also dependent on brain region and sex. For instance, in the hippocampus, the 
CA3 region seemed to be largely spared from the GABA receptor expression 
abnormalities, whilst the hippocampal CA1 and CA2 regions seemed to be more 
susceptible to decreases in GABAAα1, GABAAα2 and GABAB1 receptor subunit 
expression in the PNS offspring. Although there were modest sex differences in 
receptor subunit expression in the hippocampus of PNS offspring, this difference 
was starker in the BLA, where male PNS offspring displayed significanty lower 
GABAAα1 and GABAAα2 subunit expression as compared to controls, but females 
were unaffected. Similarly, dendritic length of neurones and PV+ cell counts seemed 
to be decreased predominantly in the PNS males as compared to the control males, 
however this observation was not observed in females, except for in the 
hippocampal CA1 region.  
Maternal MitoQ-NP administration could rescue some deficits associated with PNS, 
especially in the BLA. In the hippocampus, this normalisation seemed to be sub-
region specific, where maternal MitoQ-NP treatment had an ostensibly larger effect 
in the CA1 region than in the CA2. As for dendritic length and PV+ cell counts, a 
partial rescue was also observed, with normalisation in certain regions following 
MitoQ-NP adminstration (e.g. hippocampal regions CA2 and CA3) but less so in 
other regions (e.g. hippocampal CA1). 
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Figure 6.15: Impact of prenatal stress with and without maternal MQ-NP 
treatment on neurochemical characteristics in the brain of PND30 juvenile 
offspring. Dendritic length, the number of parvalbumin positive cells, GABA and 
GluN1 receptor expression were determined by immunohistochemistry. Green stars 
and orange boxes represent decreased expression in the PNS condition. Green 
stars also represent a normalisation of the expression of these markers with MitoQ-
NP administration, while orange boxes represent no rescue observed. Grey dashes 
represent no differences between control and PNS groups. PNS: Prenatal stress, 
Veh: Maternal vehicle treatment, MQ-NP: Maternal MitoQ-NP treatment, PV+: 









Lower expression in PNS
Not rescued by MQ-NP
Lower expression in PNS
Rescued by MQ-NP
Male Female
No change across all groups



























Biochemical changes in the juvenile brain 
Chapter 6: Role of oxidative stress in foetal programming 315 
6.3.10 PNS and maternal MitoQ-NP treatment altered effects of placental-
conditioned media and foetal plasma when exposed to neuronal cultures 
The next aim was to determine if placental secretions play a direct role in foetal 
programming. Placental-conditioned media was collected and applied to E18 
neuronal cultures. The same procedure was also carried out using foetal plasma. A 
summary of the results are presented in Fig 6.16 and graphs with statistics output 
are included in Appendix D.  
The dendritic length of neurones was shorter, and GluN1, GABAAα1, GABAAα2, and 
GABAB1 expression was lower in cortical neurone cultures exposed to placental-
conditioned media from stressed dams, compared to those exposed to placental-
conditioned media from control dams. These changes were not observed when 
placental-conditioned medium from stressed dams treated with MitoQ-NP was 
applied to the neuronal cultures, except in the case of GABAB1 which was still 
observed to be lower than controls. The data indicate that maternal MitoQ-NP 
treatment resulted in the placenta secreting factors that could abrogate the stress-
induced changes in dendritic length, GluN1, GABAAα1, GABAAα2, but not GABAB1.  
When plasma from stressed foetuses were applied to the neuronal cultures, the 
observations of decreased dendritic length, lower GluN1, GABAAα1, GABAAα2, and 
GABAB1 expression were also observed when compared to neurones exposed to 
plasma from control foetuses. This corresponded with the patterns observed when 
conditioned media from stressed placenta were applied. However, foetal plasma 
from the stress/MitoQ-NP group could only prevent the changes in dendritic length, 
GluN1 and GABAAα2 expression in the neuronal cultures, but not the changes in 
GABAAα1 and GABAB1 expression.  
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Figure 6.16: Changes in neuronal characteristics of E18 cortical cultures when 
exposed to conditioned media from placenta or foetal plasma. Green stars and 
orange boxes represent decreased expression in the PNS condition. Green stars 
also represent a normalisation of the expression of these markers with MitoQ-NP 
administration, while orange boxes represent no rescue observed.  PNS: Prenatal 
stress, Veh: Maternal vehicle treatment, MQ-NP: Maternal MitoQ-NP treatment, 
PV+: parvalbumin positive. Graphs with statistical analyses are presented in 
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6.3.11 Maternal MitoQ-NP administration resulted in altered 11β-HSD2 gene 
expression in the placenta 
11β-HSD2 mRNA-expressing positive cells in the placenta JZ were also quantified. 
There was a stress x MitoQ-NP administration interaction in both male (F1,24=6.14, 
p=0.021, Fig 6.17A) and female placenta (F1,24=5.93, p=0.023, Fig 6.17B). No main 
effects of stress nor MitoQ-NP administration were seen. 
Stressed placenta tended to show greater number of 11β-HSD2 positive cells 
compared to controls, in both males (p=0.185) and females (p=0.094). MitoQ-NP 
treatment in control dams significantly increased 11β-HSD2 positive cell counts in 
the placental JZ in the males (p=0.018), but not in the females (p=0.244). In the 
males, placenta from stressed/MitoQ-NP dams had a significantly lower 11β-HSD2 
gene expression compared to placenta from control/MitoQ-NP dams (p=0.043). In 
females, placenta from stressed/MitoQ-NP dams had significantly lower 11β-HSD2 
gene expression compared to placenta from stressed vehicle-treated dams 
(p=0.034). In both sexes, stressed/MitoQ-NP groups did not show differences in 
11β-HSD2 positive cell counts compared with the control/vehicle group.  
 
 
Figure 6.17: Changes in 11β-HSD2 positive cell count in the placenta. (A) 
Males (B) females. Asterisks represent significant differences between control and 
PNS groups (where * p<0.05), while hashes represent differences between vehicle 
and MitoQ-NP treated groups (where # p<0.05). Con: Control, Veh: Maternal vehicle 
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6.3.12 Maternal stress and MitoQ-NP administration alters circulating steroid 
concentrations 
Plasma neuroactive concentrations were measured using LC-MS, in order to 
determine if there were any unexpected effects of MitoQ-NP administration in the 
dam, and/or if there was any cross-talk between the neuroendocrine and cellular 
stress systems following gestational stress.  
As expected, corticosterone concentrations in the maternal plasma was affected by 
stress (F1,24=33.8, p<0.001), whilst the main effect of drug treatment was not 
significant (F1,24=3.11, p=0.09; Fig 6.18A). Stressed groups had greater 
corticosterone concentrations as compared to the control groups, in line with the 
trend observed in Figure 6.6 where RIA was used to measure corticosterone. For 
11-DHC, there was both a main effect of stress (F1,24=19.6, p<0.001) and a main 
effect of drug treatment (F1,24=6.30, p=0.019), but no stress x treatment interactions 
were observed (Fig 6.18B). Post-hoc testing showed that stressed groups had 
greater 11-DHC concentrations as compared to the control groups, and additionally 
in the control groups, MitoQ-NP treatment also resulted in an increase in plasma 11-
DHC concentrations.  
A main effect of stress (F1,24=11.4, p=0.0023; Fig 6.18C), but no effect of treatment, 
was observed for maternal plasma DOC concentrations. Post-hoc testing showed 
DOC concentrations were significantly increased following stress only in the MitoQ-
NP treated groups (Fig 6.18C), but not the vehicle-treated groups (p=0.152). There 
was no effect of stress or treatment for plasma DHDOC (Fig 6.18D) and THDOC 
(Fig 6.18E) concentrations. 
The two-way ANOVA also revealed a main effect of MitoQ-NP treatment that was 
close to significance for maternal plasma progesterone (F1,24=3.70, p=0.066, Fig 
6.18F), DHP (F1,24=3.39, p=0.080, Fig 6.18G) and allopregnanolone (F1,24=3.61, 
p=0.07, Fig 6.18H) concentrations. Post-hoc SNK pairwise comparisons revealed 
lower levels of these steroids in the PNS/MitoQ-NP groups compared with the 
PNS/Veh groups, and the difference was significant for allopregnanolone (p=0.029) 
but close to significance for progesterone (p=0.062) and DHP (p=0.054). For all 
three analytes, it seemed that plasma concentrations were dramatically decreased 
with stress and MitoQ-NP treatment but only in four out of the seven dams in the 
group.   
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For plasma pregnenolone, there was a main effect of stress that was close to 
significance (F1,24=3.94, p=0.058, Fig 6.18I), however, pairwise comparisons did not 
reveal any significant differences when individual groups were compared. Lastly, a 
stress x MitoQ-NP treatment interaction was observed for maternal plasma 
testosterone concentrations (F1,24=5.99, p=0.0022, Fig 6.18J). MitoQ-NP treated 
control groups had significantly greater plasma testosterone concentrations than the 





Chapter 6: Role of oxidative stress in foetal programming 320 
 
Figure 6.18: Changes in the maternal plasma steroid concentrations, 
measured by LC-MS. Asterisks represent differences between control and PNS 
groups (where * p<0.05, ** p<0.01, *** p<0.001), while hashes represent differences 
between vehicle and MitoQ-NP treated groups (where # p<0.05). Con: Control, Veh: 
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6.3.13 Summary of results  
 
Figure 6.19: Summary of results obtained in this study. Results obtained from 
the maternal component are presented in purple, the results obtained from the 
placenta in orange and the foetus in green. In the adult offspring, the results from 
the behavioural characterisations and other neuronal characteristics are 
summarised in the right-hand panel in blue. (↑) indicates an increase, (↓) indicates a 
decrease, M: Males, F: Females  
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6.4 DISCUSSION 
Results of this study are summarised in Figure 6.19. In summary, this study first 
showed that maternal social stress was associated with increased pro-oxidant 
production (in the form of ROS) in the maternal brain, liver and placenta. This 
conclusion was further supported by the use of a maternally targeted antioxidant, 
which prevented the increase of ROS in these three regions investigated. Stress-
induced deficits in behaviour and alterations in neurobiological characteristics of the 
adult PNS offspring were partially or completely prevented with maternal antioxidant 
treatment, indicating that maternal/placental ROS play a role in contributing to these 
negative outcomes in the offspring. 
The study also investigated how oxidative stress may participate in foetal 
programming, and the role of the placenta was examined. The results suggest that 
the stressed placenta secretes “damaging factors” into the foetal circulation, and 
these “damaging factors” could alter neuronal characteristics (i.e. dendritic length, 
GluN1 and GABAA and GABAB receptor subunit expression) of in vitro neuronal 
cultures. Neutralisation of maternal/placental ROS using MitoQ-NP could reduce the 
effects of these “damaging factors”, and several PNS-induced alterations in 
neuronal characteristics were completely prevented. These patterns of deficits (with 
stress) and normalisation (with maternal MitoQ-NP administration) of neuronal 
markers seemed to mimic that observed in the juvenile offspring brain. It was 
therefore postulated that foetal programming is possibly a result of the action of 
these “damaging factors” on neurones during foetal development. Together, these 
observations add to the list of mechanisms that are known to contribute to the 
transmission of stress signals from mother to foetus, thereby leading to foetal 
programming.  
Lastly, this study extends the possible use of MitoQ-NP in countering pregnancy-
related disorders, in addition to that of hypoxia and pre-eclampsic pregnancies as 
reported in previous experiments on rats and placental explants (Phillips et al, 2017, 
Aljunaidy et al., 2018, Scott et al., 2018). It is a proof-of-concept that interventions 
during pregnancy which target maternal oxidative stress have the potential to 
prevent negative offspring outcomes associated with prenatal social stress. 
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6.4.1 Gestational social stress is associated with an increase in oxidative 
stress 
Maternal and placental oxidative stress: 
In line with our hypothesis, following psychosocial stress in the pregnant dams, 
there was an increase in ROS levels in the maternal brain, liver and placenta, 
implying a greater oxidative stress status in the maternal compartment and in the 
placenta. This association between psychosocial stress and increased maternal pro-
oxidant levels is unsurprising, as it has been shown in both rat and human studies 
that psychosocial stress can lead to increased oxidative stress in the liver (Ishtiaq et 
al., 2018) and brain (Schiavone et al., 2013). In another social defeat model, socially 
defeated male rats also show increased inflammatory markers and decreased 
antioxidant defences in the brain (Patki et al., 2013). Conversely, preventing the 
increase of ROS with antioxidant treatment in rats can reduce impairments 
associated with social defeat (Solanki et al., 2017). The present study showed for 
the first time that psychological stress during pregnancy in the rat results in 
increased ROS not only in the brain and liver, but also in the placenta. This also 
corresponds to observations in human pregnancies, where maternal psychosocial 
lifetime stress can contribute to placental mitochondrial malfunctioning and the 
decrease in mitochondrial DNA copy number, conditions which are found associated 
with increased mitochondrial oxidative stress (Brunst et al., 2017).  
Psychosocial stress results in the activation of multiple pathways, and whilst not all 
of the pathways are investigated here, it was observed that social stress resulted in 
greater plasma corticosterone concentrations in the female dams (as expected, see 
section 5.3.1). The increase in ROS production observed in the maternal brain, liver 
and placenta could potentially be attributed to a downstream effect of increased 
glucocorticoids, as it is known that HPA axis activation can result in ROS production, 
due to increased mitochondrial respiration and oxidative phosphorylation (Spiers et 
al., 2014, Du et al., 2009). In vitro studies also showed that the activation of the 
cytosolic GR by glucocorticoids can trigger downstream molecular pathways such 
as nitric oxide production (Flaherty et al., 2017) or NADPH oxidase activation (Seo 
et al., 2012), all of which may contribute to the production of pro-oxidant species. In 
a gestational corticosterone overexposure model where corticosterone was 
administered to pregnant mouse dams on E12.5 (and the placenta collected on 
E14.5), although decreased placental H2O2 concentration was found, an increase in 
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protein carbonylation and glycation, which are cellular outcomes of oxidative stress, 
was observed in the placentas of female foetuses (Bartho et al., 2019). 
Undoubtedly, psychosocial stress is accompanied by the production of a barrage of 
endocrine factors both within the HPA axis (e.g. ACTH, CRH, POMC, vasopressin, 
melanocyte-stimulating hormone (MSH) etc.) and in the sympatho-adrenal system 
(e.g. catecholamines like noradrenaline and adrenaline), but also inflammatory 
cytokines (e.g. tumour necrosis factor α (TNF-α), interleukins like IL-1 and IL-6 etc) 
(Manoli et al., 2007). All these mediators are involved in signalling pathways in the 
mitochondria, affecting mitochondrial biogenesis and metabolism (Manoli et al., 
2007), and may all interact in a complex manner which can result in different cellular 
outcomes. 
Foetal oxidative stress status:  
ROS production was also quantified in the foetal compartment. Whilst prenatal 
stress was reported to be associated with increased oxidative stress in the rat 
offspring brain, many of these studies examined offspring during adulthood or 
adolescence (Zhu et al., 2004, Glombik et al., 2015, Song et al., 2009) but not 
during foetal stages, therefore does not show the role of ROS in foetal programming 
during pregnancy.  
Here, maternal stress did not result in elevated pro-oxidant levels in the foetal brain 
at GD20, but an elevation was observed in the foetal liver of stressed dams. This 
difference in oxidative stress status between the foetal brain and liver was also 
observed in a previous study by Phillips et al., 2017, where the foetal brain also 
seemed to be protected from the effects of hypoxia. In another model of prenatal 
stress in rats (ischemia-reperfusion), the foetal brain was better protected from 
oxidative stress as compared to other tissues like the heart and muscle following the 
stressor (Fantel et al., 1998). Together, these data suggest that the development of 
aberrant behaviours later in life is probably not associated with any changes in the 
oxidative stress status of the foetal brain in utero. This also underscores the need to 
limit antioxidant treatment to just the maternal compartment, akin to what was done 
in this study. Whether or not the increase in ROS is directly associated with 
increased glucocorticoids, which was found to be similarly elevated in the foetal liver 
but not in the foetal brain in the previous chapter (section 5.3.1), remains to be 
investigated.  
Chapter 6: Role of oxidative stress in foetal programming 325 
The implications of increased ROS levels in the foetal liver is also not known, but 
could presumably lead to negative effects in the growth and development of the 
liver, especially since the period before birth also represents a period where the 
endogenous antioxidant defence of the foetal liver is at its lowest (Gonzalez et al., 
1995).  
Pro-oxidant and antioxidant balance: 
There are a few other potential issues worth noting in the analysis of oxidative stress 
status here. Apart from using the DCF assay, other additional tests which measure 
ROS-induced modifications could have been examined, such as the end products of 
lipid peroxidation (e.g. malondialdehyde or 4-hydroxynonenal), DNA oxidation (e.g. 
8-hydroxy-2'-deoxyguanosine for DNA damage) or protein carbonylation for instance 
(Frijhoff et al., 2015).  
Additionally, although increased ROS is likely to imply higher oxidative stress, one 
can recall from the introduction that “oxidative stress” is defined as the imbalance 
between pro- and antioxidant levels, where pro-oxidant activity in a cell is greater 
than that of antioxidants. As endogenous antioxidant defences were not 
simultaneously measured in these experiments, it is possible that psychosocial 
stress may have also upregulated some endogenous antioxidant defences, such 
that there is no overall increase in oxidative stress in these pregnant rats. However, 
several other studies in rats have reported quite the contrary, and instead showed 
that chronic stress and glucocorticoids generally lead to a decrease in the 
production and activity of antioxidant enzymes like superoxide dismutase (SOD), 
catalase and glutathione peroxidase, thereby further tipping the balance between 
pro-oxidants and antioxidants (Zafir and Banu, 2009, Sato et al., 2010). 
Sex differences in oxidative stress status: 
Additionally, sex differences were not taken into consideration in the analysis of 
oxidative stress status. In sheep studies, not only did endogenous antioxidant 
defences differ between different foetal tissues (liver, muscle, brain, kidneys and 
lungs), there was a sex difference in antioxidant enzymatic activity as well as lipid 
peroxidation levels, where females appeared to have lower antioxidant enzyme 
activities, and were therefore considered more at risk of oxidative injury in utero in 
the face of environmental stressors (Al-Gubory and Garrel, 2016). In human studies, 
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sex-specific alterations were observed in the pro-oxidant versus antioxidant balance 
in preterm placentae in response to antenatal betamethasone exposure, and male 
placentae had higher pro-oxidant indices as compared to females (Stark et al., 
2011). Whilst male placentae were reported to have higher antioxidant defences in 
normal human pregnancies, the antioxidant protection was lost in the case of 
compromised pregnancies, such as in maternal obesity (Evans and Myatt, 2017). 
Chronic hypoxia also resulted in higher expression of heat shock protein (HSP) 70 
and HSP27 levels in female placentae as compared to males in mice, indicating 
greater oxidative stress in females (Matheson et al., 2016).  
Together, these studies indicate the presence of sex differences in oxidative stress 
status, both in normal and compromised pregnancies, although there did not seem 
like there was a consistent pattern on which sex tended to be more susceptible or 
more protected. Given that sex differences in behaviour and neuroendocrine outputs 
are consistently observed in PNS offspring of this social stress model, it would be 
neccessary to determine if these differences can be correlated to different oxidative 
stress levels in the placenta or foetal tissues during foetal development in future 
studies.  
6.4.2 MitoQ-NP was effective in preventing the increase in oxidative stress  
MitoQ-NP administration was effective in preventing the increase in ROS production 
following stress, in the maternal liver, brain and placenta. Stressed dams that were 
treated with MitoQ-NP had ROS levels that were similar to controls. It is thus 
possible to conclude that given MitoQ-NP’s efficacy in preventing the increase in 
ROS levels in stressed dams, any differences between MitoQ-NP/stressed groups 
and saline-treated/stressed groups can be attributed to the normalisation of 
maternal ROS production.  
Since the tissues were collected on GD20, five days after the single dose of MitoQ-
NP injection on GD16, MitoQ-NP can be inferred to be efficacious in preventing the 
ROS increase throughout the duration of the chronic stressor. Whilst previous in 
vitro studies showed that there was a sustained release of MitoQ over 24 hours from 
the NPs (Phillips et al., 2017), it is not known if its efficacy here can be attributed to 
a similar sustained release of MitoQ over the five day period, or if there were other 
permanent changes in the physiology of the pregnant dam. 
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Apart from effects on the maternal and placenta tissue, maternal MitoQ-NP 
administration also seemed to result in a modest inhibition of ROS production in the 
stressed foetal liver, but ROS levels were not completely normalised to control 
levels. Although it has been shown that NPs are sequestered in the maternal tissues 
and do not cross the placenta (Phillips et al., 2017), it is not known whether MitoQ 
itself can be released into to the foetal circulation. However, it has been previously 
reported that MitoQ uptake is extremely low in the foetal compartment when it was 
administered to pregnant rat dams via drinking water, even without the presence of 
NPs (Nuzzo et al., 2018). Moreover, in the hypoxia model, maternal MitoQ-NP did 
not rescue the ROS increase in the stressed foetal liver (Phillips et al., 2017). 
Similarly, there was no effect of MitoQ-NP administration on ROS levels in the foetal 
brain, as observed in this study. These data suggest that the effect of MitoQ-NP on 
the foetal compartment could be indirect and probably not due to a direct crossover 
of MitoQ.  
6.4.3 Maternal MitoQ-NP administration prevented anxiety behaviour in PNS 
male offspring 
Behavioural analysis: 
Maternal MitoQ-NP administration prevented the anxiety phenotype of PNS male 
offspring in adulthood, and this was supported by data from both the light-dark box 
and the elevated plus maze. It is known that females and males can show 
differences in anxiety-like behaviour (Zimmerberg and Farley, 1993, Johnston and 
File, 1991), however, no differences in baseline exploratory or anxiety-like behaviour 
was observed in this study. Whilst a sex difference was not observed in the control 
animals at baseline, unlike the male PNS offspring, female PNS offspring did not 
show anxiety-like behaviour, and the performance was largely unaltered by maternal 
MitoQ-NP administration. The finding that PNS females do not show anxiety 
phenotype is in line with findings from previous studies, and it has been previously 
reported that anxiety-like	behaviour in the females was related to oestrous cycle 
stage instead of prenatal stress status, with females at pro-oestrous and oestrous 
stages showing less anxiety-like behaviour (Brunton et al., 2015, Brunton and 
Russell, 2010, Marcondes et al., 2001). Both the LDB and EPM test for approach-
avoidance behaviours, which are ethologically relevant, as these behaviours are 
based on the rodent’s innate conflict between the drive to explore novel 
environments and aversion to brightly lit open spaces (Rodgers, 1997). Moreover, 
Chapter 6: Role of oxidative stress in foetal programming 328 
deficits in behaviour in both tests have been consistently replicated in PNS male 
offspring using the social stress model (here, and in Brunton and Russell, 2010, 
Brunton et al., 2015), indicating that this sex-dependent anxious phenotype is a 
robust outcome of prenatal social stress.   
Whilst the LDB and EPM are similar, the underlying neurobiology between two tests 
are different and can yield different results in response to different anxiolytic agents 
(Cryan and Sweeney, 2011). However, the fact that MitoQ-NP could rescue the 
robust anxious phenotype in both tests provides strong evidence that it is a valuable 
intervention to potentially prevent developmentally programmed anxiety disorders in 
the offspring. This is not the first time a maternal antioxidant treatment has been 
shown to block programmed anxiety behaviour in offspring, as a previous study 
showed that the antioxidant TEMPOL could also prevent glucocorticoid-induced 
anxiety when administered to pregnant mouse dams (Roghair et al., 2011). 
Notwithstanding, the value of MitoQ-NP treatment here, lies in that the antioxidant 
effects were targeted at the maternal mitochondria, and is unlikely to have any direct 
effects on the foetus. It is however, worthwhile to note that MitoQ-NP cannot be 
considered an anxiolytic per se as it was administered to the mother and not the 
offspring themselves in this study.  
Apart from the measures related to the approach drive and aversion drive (i.e. 
measures associated with activity in the lit or open areas), indices of general activity 
in the test environment were also analysed in this study. In the LDB, PNS males 
travelled shorter total distances, and this was not observed in the PNS group with 
maternal MitoQ-NP administration, indicating a normalisation of such behaviour. In 
the EPM, the total number of entries PNS female rats made into both arms was 
lower than in controls, indicating lower exploratory behaviour. Again, this behaviour 
was normalised in the female PNS/MitoQ-NP group. Whilst these two indices may 
represent a drop in general locomotor activity, a possible confounding factor for 
these tests, they may also represent altered emotional states (Fraser et al., 2010). 
These observations could thus also be interpreted as PNS offspring (both males and 
females) showing more negative emotional states, resulting in decreased 
exploration of a novel environment in general. If so, these data would further support 
the contention that maternal MitoQ-NP treatment may be valuable in preventing 
abnormal affect-related behaviours following prenatal stress. 
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Anxiety-related changes in the brain: 
In support of the behavioural observations, in situ hybridisation studies showed that 
the greater CRH mRNA expression in the CeA usually observed in PNS males was 
also prevented by maternal administration of MitoQ-NP, both in juvenile rats and 
adult rats. As CRH overexpression in transgenic mice is associated with anxious 
behaviour (Stenzel-Poore et al., 1994, van Gaalen et al., 2002), this observation 
could at least partly underlie the behavioural changes in the LDB and EPM. This is 
the first time an increase in CRH mRNA expression in the central amygdala (CeA) 
was observed in juvenile male PNS offspring, as previous findings were all from 
adult rats. Apart from directly mediating adult anxiety behaviour, elevated levels of 
CRH were also previously found to be associated with poorer dendritic branching in 
the developing rat cortex, which also extend into adulthood (Curran et al., 2017). 
Here, dendritic length seemed to be generally reduced in various brain regions in 
the PNS juvenile rat brain (Fig 6.16). Whether or not a similar decrease in dendritic 
length also occurred in the CeA, where increased CRH gene expression was 
observed, remains to be investigated. 
This study also investigated other mechanisms apart from amygdala CRH which 
may explain the observed anxious behaviour. Anxiety can result from dysregulation 
of the inhibitory neural circuits that control communication between the different 
limbic regions (Nuss, 2015). In particular, deficient inhibitory tone in the amygdala, 
arising from the imbalance in signalling activities of GABA and glutamate for 
instance, can lead to anxiety-like behaviours (reviewed in (Quirk and Gehlert, 
2003)). Blocking GABAA receptors in the BLA tends to increase anxious behaviours, 
while enhancing GABAA function can attenuate these behaviours (Quirk and 
Gehlert, 2003, Sanders and Shekhar, 1995). In KO mice models, deletion of 
GABAAα1 subunit in the amygdala and BNST results in heightened anxiety on the 
EPM and open field test (Gafford et al., 2012) and GABAB1 KO mice also exhibited 
increased anxiety in the LDB (Mombereau et al., 2004). 
In this study, alterations in GABAA and GABAB receptor subunit expression occurred 
with prenatal stress. GABAAα1 and GABAAα2 receptor subunit protein expression 
were lower	in the BLA of the PNS males, and was normalised by maternal MitoQ-NP 
treatment. This observation, which was not present in female PNS offspring, 
correlates with the anxious behaviour observed in the LDB and EPM, which was 
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also only present in male PNS offspring but not the females. Nonetheless, as only 
two GABAA receptor isoforms were investigated in this study, it is not possible to 
fully determine how exactly GABA neurotransmission is altered in the PNS rats, due 
to their pentameric nature and that the arrangement of subunits can also heavily 
influence their electrophysiological characteristics (Sigel and Steinmann, 2012). 
Nevertheless, the presence of these changes allude to the fact that GABAergic 
neurotransmission may be altered in some way in the PNS offspring, and maternal 
oxidative stress could play a role in altering the normal development of GABA 
neurotransmitter circuits.  
Given that the intervention here was targeted at the pregnant mother during 
gestation, the above changes in amygdala CRH and GABA receptor subunit 
expression may already be present during foetal or earlier postnatal development. 
Previous studies have shown that inducing CRH overexpression in the forebrain and 
several limbic regions of transgenic mice during early life can contribute to increased 
anxious behaviour in adulthood (Kolber et al., 2010), whilst prenatal stress induced-
changes in various sub-regions of amygdala have been found in neonatal brains as 
early as PND7 (Kraszpulski et al., 2006), further supporting the possibility that 
detrimental changes might already have occurred before PND30. During early 
postnatal development in the rat, GABAAα1 and GABAAα2 subunit expression 
patterns also undergo a switch, which possibly provides a window of vulnerability for 
detrimental changes to occur (Davis et al., 2000). A future line of work could 
therefore be to examine the foetal (or neonatal) amygdala for the same neuronal 
markers, to establish if these changes present at even earlier stages in the 
offspring’s life.  
Taken together, the behavioural and corresponding immunohistochemical data 
suggest that maternal oxidative stress during pregnancy contributes to programming 
of an anxious phenotype in the offspring, and that maternal MitoQ-NP treatment is a 
viable means of preventing the development of an anxious phenotype.   
6.4.4 Prenatal stress did not result in depressive-like behaviour 
Apart from anxiety, depression is also one of the major psychopathologies that 
occur as a result of early life stress (Weinstock, 2017). Depression is a complex 
psychological disorder that is multi-faceted in humans, but certain features such as 
anhedonia and helplessness can be tested in rodent models. Two tests were used 
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in this study to assess whether prenatal social stress results in “depressive-like 
behaviour” in the adult offspring: (i) sucrose preference test for anhedonia, and (ii) 
the forced swim test, which is thought to represent behavioural despair.  
Sucrose preference test 
In the sucrose preference test, there were no significant differences between the 
total amount of sucrose consumed in the control and PNS rats, for both males and 
females, which may at first glance, indicate that PNS rats do not exhibit anhedonia. 
However, a closer look into the individual consumption patterns revealed that PNS 
females seemed to consume more sucrose than the control females, and this 
pattern was not observed in the males. There also exists additional confounds 
related to the sucrose preference test (Strekalova et al., 2011) that may offer various 
interpretations of these results. 
Firstly, the higher consumption of sucrose during the test, as the PNS female rats 
here tended to show, could represent a sucrose-binging phenotype, which is known 
to be affected by dysregulation in the HPA axis (Calvez and Timofeeva, 2016), and 
can be affected by sex and testosterone exposure (Culbert et al., 2018). 
Additionally, rats need to be singly housed for the test, which might have affected 
the sucrose drinking patterns, as social isolation is a known stressor that can also 
result in HPA axis disruptions (Hawkley et al., 2012). The tendency for PNS females 
to binge on sucrose could therefore have been an outcome of prenatal stress, but 
may also be driven by a different susceptibility (from males) to the inevitable 
isolation stress brought about by the test paradigm. Indeed, protracted social 
isolation has been shown to increase the amount of sucrose consumed in mice 
(Coudereau et al., 1999). Furthermore, it was reported that female rats are generally 
more affected during isolation stress, manifesting as an increased inflammatory 
response (Hermes et al., 2006) and decreased excitability of PVN CRH neurones 
(Senst et al., 2016). Although speculative, these changes may interact and manifest 
as differences in sucrose consumption patterns between males and females.  
Additionally, there seemed to be a sex difference at baseline in terms of how control 
males and females performed in the sucrose preference test. While all but one 
control male preferred sucrose from the first day, in the control females, it seemed 
like there was a larger difference between the sucrose consumption of female rats 
on the first and second day of testing. On the first testing day, four out of eight 
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control female rats preferred water over sucrose, but this was not apparent on the 
second testing day. Although rats were acclimatised to the testing cage one day 
prior to the test day, they were still sucrose-naïve and neophobic responses could 
still have occurred on the first testing day. Whilst a previous rat study showed that 
prenatal stress increased neophobic responses (Pfister et al., 1981), the reverse 
was observed here, and it was instead some of the control females, instead of the 
PNS females, that seemed to exhibit a neophobic behaviour. Nonetheless, the 
pathways underlying neophobia and variations in sucrose consumption are 
complicated and have been reported to be controlled by oxytocin signalling 
pathways (Amico et al., 2005), or the dopaminergic system (Tonissaar et al., 2006), 
both of which were not investigated here.  
In any case, stressed females with maternal MitoQ-NP administration seemed to 
show a more similar pattern of sucrose consumption as the control females than the 
PNS females, which suggest that prenatal stress or maternal antioxidant treatment 
could have interacted and differentially altered these abovementioned pathways. 
Nonetheless, it is worthwhile to note that the statistical tests were inconclusive here, 
and this is compounded by the presence of a large inter-individual variability in 
sucrose consumption patterns, which has been reported to be quite common by 
other groups as well (Brennan et al., 2001, Tonissaar et al., 2006). Ultimately, given 
the prevalence of such variability, more rats need to be tested on this paradigm 
before any definite conclusions can be drawn. 
Forced swim test 
Prenatal social stress also did not result in changes in behaviour in the forced swim 
test in both males and females. While prenatal stress is generally suggested to 
increase FST immobility time in the offspring in several rat studies (Morley-Fletcher 
et al., 2003, Montes et al., 2016, Alonso et al., 1991), the lack of an effect here could 
be due to variability induced by differential maternal stress paradigms, as maternal 
restraint instead of social stress was used for all of these previous studies. 
Nonetheless, it is worth noting that differences in methodology of the swimming test 
itself could also contribute to the contradictory results (Bogdanova et al., 2013). For 
instance, factors related to the experimental animal, such as sex, age, body weight, 
strain of rat, experience of previous behavioural testing can all affect behaviour in 
the FST, while subtle modifications in the methodology of the FST itself, such as 
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water temperature, size of the pool, lighting and duration of swim can all markedly 
affect the outcome of the results (Kara et al., 2018).  
While males and females were analysed separately here, sex is indeed a factor that 
can affect behaviour in the FST (Bogdanova et al., 2013, Kokras et al., 2015). There 
are however, conflicting conclusions in the literature on how FST behaviours may be 
different, with a third of reviewed studies reporting that females exhibit more 
immobility, one-third reporting that females present less immobility than males, and 
a last third reporting that males and females show no significant differences in 
immobility (reviewed in (Kokras et al., 2015)). Additionally, some studies have also 
pointed out that pro-oestrous and oestrous female rats had greater immobility, 
although other studies reported no differences across oestrous stage (Consoli et al., 
2005, Bogdanova et al., 2013). In this study, despite PNS not having an effect on 
FST behaviour, it was observed that maternal MitoQ-NP administration altered FST 
behaviour in a sex-dependent manner, where an increase in active-coping 
behaviours was observed, but the styles of active-coping was different for males and 
females (i.e. increased cimbing in females, and increased swimming in males after 
maternal MitoQ-NP administration). Additionally, while females did not have different 
frequency of floating bouts as compared to males at baseline, it was observed that 
females had greater frequency of climbing bouts compared to males at baseline. 
This highlights the importance of analysing specific types of behaviours (i.e. floating, 
climbing and swimming) rather than only investigating immobility time, due to 
inherent differences in FST performance between males and females.  
In terms of the relevance and interpretation of these behaviours, if one were to 
regard the FST as a test for behavioural despair, then it appears that although 
prenatal social stress was not “pro-depressant”, maternal MitoQ-NP, remarkably, 
has “antidepressant effects”. However, it has been proposed in the recent years that 
instead of being a representation of despair or helplessness, the FST should be 
interpreted as a measurement of stress coping strategy (Commons et al., 2017, 
Slattery and Cryan, 2012, de Kloet and Molendijk, 2016). In fact, in the most recent 
“state-of-the-art” article, it was reported that amongst published work in the three 
years preceding June 2018, the number of studies interpreting floating behaviour to 
be “depressive-like” has massively decreased, whilst the number of studies referring 
to FST as a test of “coping” behaviour has increased (Molendijk and de Kloet, 2019). 
In light of these shifting trends in the field, it could therefore be proposed that here, 
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PNS also did not affect the coping strategy of offspring in the FST. As a two-session 
swimming test was used, which involved a 10 min preconditioning session and a 5 
min test 24 hr later, the coping strategy would therefore also encompass an element 
of learning and memory (de Kloet and Molendijk, 2016, Bogdanova et al., 2013). 
Hence, it can also be concluded that learning and memory processing following 
acute swim stress do not seem to be affected in PNS offspring.  
Secondly, it is also worth noting that as MitoQ-NP was administered to the pregnant 
dam and not the offspring, the MitoQ-NP drug itself should not be interpreted as 
constituting an antidepressant effect per se. Instead, it could be contended that 
maternal antioxidant treatment could have altered neurodevelopmental pathways 
which regulate stress coping behaviours during adulthood. Regardless, symptoms of 
depression and the stress response share similar regulatory mediators and 
circuitries (Gold et al., 1988). The fact that alterations in behaviour exist in the FST 
following maternal antioxidant administration suggest that these pathways are 
sensitive to environmental changes (especially that of oxidative stress status) in 
utero and have the propensity to be developmentally programmed. 
The observed FST behaviour is therefore probably due to a complex interaction of 
various factors, which may include disruptions to serotonergic or noradrenergic 
signalling, to name a few (reviewed in (Cryan et al., 2005)). Although GABA 
targeting modulators are not often used as antidepressants, GABA 
neurotransmission can still play a crucial role in modulating behaviours related to 
depression (Möhler, 2012, Kalueff and Nutt, 2007). Of note, neuroactive steroids 
can increase mobility in the FST, possibly through enhancing GABA signalling, 
although the response can also be modulated by serotonergic agents (Khisti and 
Chopde, 2000). Additionally, blockade of the glutamatergic NMDA receptor has 
been associated with the production of fast-acting antidepressant responses, albeit 
in mice (Autry et al., 2011), while changes in NMDA receptor action (e.g. GluN1 and 
GluN2A) using an NMDA receptor antagonist in the hippocampus and striatum 
following prenatal stress in rats can also result in increased immobility time in the 
offspring (Sun et al., 2013). These studies show the involvement of glutamatergic 
signalling in modulating the behaviour on the FST as well. In this study, although 
several receptor expression studies of GluN1, GABAA and GABAB have been 
carried out, there was no single marker with expression patterns explicitly different 
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between maternal MitoQ-NP treated groups and vehicle groups, suggesting that the 
observed behaviour may not be attributed to receptor expression differences.  
Concluding this section, firstly, given the concerns surrounding the interpretations of 
these two tests, one must be prudent in analysing the observed behaviour, and not 
hastily draw conclusions on whether the PNS model here is “pro-depressant” or if a 
drug is an “antidepressant”, or to ascribe the behaviour as advantageous or 
disadvantageous to an organism. In any case, regardless of these interpretations, 
the fact that the PNS offspring did not differ in the behaviour to the controls indicate 
that the FST might not be a robust behavioural phenotyping test for the social stress 
model. Nonetheless, the observation that maternal MitoQ-NP influenced offspring 
behaviour adds weight to the idea that the development of neuronal circuits 
regulating affect/stress coping during development are vulnerable to maternal 
environmental changes in utero, especially changes associated with oxidative 
stress. 
6.4.5 Maternal MitoQ-NP did not affect social memory performance in female 
offspring  
There seemed to be an impairment of olfactory social memory in the PNS female 
offspring, although statistics did not reach significance. The average investigation 
time during the exposure phase and during the test phase were largely similar to 
those reported in previous studies using the same paradigm (Grundwald et al., 
2016) but a larger variability seemed to be present in this study. The variability in the 
data could have been attributed to the lack of consideration of oestrous cycle stages 
in the females, which has been shown to affect social recognition memory in mice 
(Sanchez-Andrade and Kendrick, 2011). Although the use of an inanimate bead 
instead of a live juvenile rat is a modification from the original social recognition test 
(Thor and Holloway, 1982), the inanimateness of the object is unlikely to cause any 
problems, as previous studies have showed that this method of using beads 
impregnated with odour has been effective in substituting for a juvenile conspecific 
(Grundwald et al., 2016). It may in fact even be advantageous to use an inanimate 
object impregnated with odour instead of juvenile conspecifics, as interactions with a 
live rat can be confounded by anxiety (Starr-Phillips and Beery, 2014).  
However, the way in which the odours were coated on the beads in this experiment 
could have been a problem. It has been previously shown that rats discriminate 
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individual conspecifics based on their individually distinctive odours, and were able 
to associate olfactory signatures (i.e. urine, glandular, vaginal or salivary secretions) 
on objects as representations of these individual conspecifics (Gheusi et al., 1997). 
Here however, beads were impregnated with odour by being buried in the bedding 
of cages housing groups of rats, therefore would take up the scent of more than one 
rat in the cage. If the olfactory system of the rat is indeed adapted towards 
processing the olfactory cues of individual conspecifics for social recognition, the 
presence of more than one scent on the bead could have been confusing and might 
have affected how rats responded and remembered these scents. A similar 
experiment, but with beads coated with the scent of individual rats should be 
conducted in the future. Nonetheless, here, maternal MitoQ-NP administration did 
not seem to improve social memory in female PNS offspring. 
The deficits in the social memory in this model have been attributed to decreased 
V1a vasopressin receptor expression (Grundwald et al., 2016), which was not 
investigated in this study. It has also been proposed that the hippocampal CA2 
region is critical for the formation of social memories (Hitti and Siegelbaum, 2014, 
Chevaleyre and Piskorowski, 2016). GABA antagonists were also found to alter 
social memory performance, through increasing excitatory inputs from CA2 to the 
CA1 (Meira et al., 2018) and lateral septum (Leroy et al., 2018). Here, neuronal and 
receptor characterisation did not reveal differences in the hippocampal CA2 
between controls and PNS in terms of the number of PV+ cells nor dendritic 
markers, but GABAAα2 and GABAB1 expression was lower following PNS (Fig 6.15). 
The lower GABAAα2 and GABAB1 expression was not normalised in the PNS 
offspring with maternal MitoQ-NP treatment, which correlated with the observed 
behaviour. Alterations in GABAAα2 and GABAB1 expression patterns in the CA2, 
which were unchanged by maternal MitoQ-NP, could be a possible underlying 
neurochemical explanation to the observed social memory deficits. 
Additionally, it has been suggested that hippocampal NMDA neurotransmission is 
also important in the regulation of social memory (Gao et al., 2009). NMDA 
administered subcutaneously before the social memory test in male rats improved 
performance (Hlinak and Krejci, 2002). Here, whilst GluN1 expression was not 
different between controls and PNS in the CA1 region, its expression was 
decreased in both the CA2 and CA3 region and this decrease was not normalised 
by maternal MitoQ-NP expression. Deletion of GluN1 in the CA3 of the 
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hippocampus results in mice with decreased social approach (Finlay et al., 2015), 
while GluN1 knockout in the dentate gyrus of mice results in reduced social memory 
(Segev et al., 2018). The decrease in GluN1 in certain hippocampal regions in PNS 
females could therefore be potentially another underlying mechanism of the social 
memory deficits. 
In conclusion, in contrast to the observations in the tests for anxiety and depressive-
like behaviour, it does not seem like maternal MitoQ-NP had an effect on 
performance in the social memory test. This seemed to correlate with decreased 
expression of several GABA and glutamate receptors in the certain brain regions 
which are known to be involved in social memory, which were not normalised with 
maternal MitoQ-NP administration. Nonetheless, this merely describes a co-
occurrence and further tests need to be carried out to elucidate the exact role these 
receptors play in regulating social memory. This also suggests that the programming 
of socially-related offspring behaviours might not be attributed to maternal oxidative 
stress. Social memory could very well be affected by other signals in utero, or even 
postnatal maternal care for example, as disruptions in maternal care can result in 
stark deficits in social memory and social interaction in rats during adulthood 
(Todeschin et al., 2009). 
6.4.6 HPA axis hyperactivity in the offspring was not observed  
In this study, prenatal social stress did not result in a hyperactive HPA axis in PNS 
offspring in this study, for either ACTH or corticosterone concentrations in both 
males and female rats, which contrasted with previous studies using this model 
(Brunton and Russell, 2010). Although similar paradigms were used (e.g. restraint 
stress in adult offspring), these experiments were carried out in different facilities 
with different cage set-ups, and subtle differences in environmental conditions are 
likely to have contributed to these discrepancies.  
In both cases, blood sampling was carried out in specialised open-top cages which 
facilitated blood-taking from a venous cathether, and rats were transferred to these 
cages immediately after the surgery. However, in previous studies carried out in 
another facility, rats were housed in conventional open-top cages from birth until the 
surgery, whilst in this study, rats were housed in IVCs. It is known that IVC housing 
alters the behaviour of mice in the various behavioural tasks, in a strain and sex-
dependent manner (Mineur and Crusio, 2009). Housing differences may therefore 
Chapter 6: Role of oxidative stress in foetal programming 338 
be a potential confounding factor which can explain why the previous results using 
the same social stress model could not be replicated. Additionally, as rats were 
given an analgesic (carprofen) in this study following cannulation surgery, it is not 
known this could have interfered with HPA axis responses. Carprofen is a non-
steroidal anti-inflammatory drug (NSAID), and given that inflammatory processes 
can also modulate the stress response, it is unclear if carprofen administration 
would have confounded the results. 
Whilst these potential confounds also reflect one of the conclusions in chapter 4, 
that the HPA axis is sensitive to many environmental changes, it is worth noting that 
MitoQ-NP had no effect on HPA axis responsivity either, in both males and females, 
indicating that the effects of MitoQ-NP are selective, and apply to certain behaviours 
or physiological parameters, and not the others.  
6.4.7 The role of the placenta in the transmission of stress signals from 
mother to foetus 
Thus far, the discussion has been centred on the observations that (i) MitoQ-NP 
was able to effectively abrogate increased oxidative stress following maternal social 
stress (sections 6.4.1 and 6.4.2); and (ii) the effect of maternal MitoQ-NP 
administration on behaviours in offspring (sections 6.4.3 to 6.4.6). Here, the 
discussion proceeds to unravel how MitoQ-NP may exert its effect, and the focus 
placed on the placenta – the maternal-foetal interface. 
Placental secretion of “damaging factors” into the foetal circulation: 
The idea that placenta explants can secrete factors ex vivo is not new- in the 1970s, 
reports showed that active factors present in placental-conditioned media can affect 
the growth of cells in cultures (Burgess et al., 1977). Here, it was shown that when 
placental-conditioned media from stressed pregnancies was applied to embryonic 
cortical neuronal cultures, it caused changes in receptor expression, and these 
changes were not observed when placental-conditioned media from stressed 
pregnancies with MitoQ-NP pre-treatment were applied (Fig 6.16). Likewise, similar 
deficits (with stressed pregnancies) and normalisations (with MitoQ-NP treated 
stressed pregnancies) were observed when foetal plasma was applied to the 
neuronal cultures (Fig 6.16). It is therefore suggested that the placental secretions 
and foetal plasma contained ’factors’, both of which can affect neuronal growth in a 
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similar way. On a side note, although it has been proposed that it was “damaging 
factors” that were causing this effect (Curtis et al., 2014, Scott, 2018), given the 
various functions the placenta has, it is likely that apart from an increase of 
“damaging factors”, the lack of “protective factors” resulting from oxidative stress 
could also contribute to these detrimental changes.  
Generally, the directionality of change in the phenotypes of neurones in the E18 
cortical cultures when exposed to conditioned media or foetal plasma seemed to 
correspond to the patterns observed in the juvenile offspring’s brain (comparing Fig 
6.15 and Fig 6.16). In vitro neuronal cultures have generally been proposed to be 
good surrogates for in vivo neuronal platforms (Belle et al., 2018), and 
electrophysiological studies show no major differences in the firing patterns between 
embryonic and adult neurones (Evans et al., 1998). Certain adult patterns of 
neurone subtype characteristics, such as the 1:5 GABAergic/glutamatergic ratio, are 
already established during early stages of embryonic development before E14.5 
(Sahara et al., 2012). Although these indicate that the in vitro embryonic model is 
valuable, one must note that there are many characteristics between the two 
experiments that are discordant, thus, caution should be taken when comparing the 
results of these experiments. Firstly, the neurones in vitro are obtained from cortical 
neurones, whereas in the juvenile rats, brain regions investigated were not cortical 
in nature (i.e. hippocampus and basolateral amgydala). Secondly, even if the 
neurones were from the same regions of interest, in vitro systems lack the 
complexity and connections between different sub-regions of the brain. Thirdly, the 
in vitro neuronal cultures were embryonic in nature and did not undergo maturation, 
unlike those studied in vivo. The postnatal period is an important period where 
dramatic changes in the cellular composition of the brain (e.g. neurone-to-glia ratio) 
can occur (Bandeira et al., 2009). The GABA neurotransmission network also 
undergoes crucial reconfigurations that can be affected by neurosteroids for 
instance (Brown et al., 2016), accompanied by the postnatal switch between 
GABAAα1 and GABAAα2 receptor subtypes (Laurie et al., 1992, Fritschy et al., 1994). 
Postnatal influences, which were not considered here, thus have a great propensity 
to alter the neuronal characteristics that could have been programmed in utero, 
therefore it may not be conclusive to make the direct association between the in vivo 
juvenile brain and in vitro embryonic culture results. 
Chapter 6: Role of oxidative stress in foetal programming 340 
Nonetheless, this in vitro/ex vivo study provides strong evidence that the placenta 
actively secretes factors that can alter neuronal growth and dynamics, and it is 
through this manner that it may play a role in shaping the pregnancy and contribute 
to foetal programming (Burton et al., 2016). In order to have a clearer understanding 
of how these secretions may alter neuronal characteristics in utero, the same 
immunohistochemistry experiments can be carried out in the foetal rat brains. This 
experimental set-up would allow for a more appropriate comparison between in vitro 
results and in vivo results (in the foetal rat brain), as a similar time point could be 
investigated. An alternative way of investigating the effects of these placental 
secretions is to inject the conditioned media directly into the brains of postnatal rats 
(as previously done so in Curtis et al., 2013), then allow the juvenile offspring to 
develop until PND30, and similar behavioural and biochemical characterisations as 
that of the PNS juvenile rat brains could be carried out.  
The current results also suggest these placental factors may be secreted and 
released into the foetal circulation, evident from the similar pattern of results from 
the conditioned media and foetal plasma data (Fig 6.16). However, it should be 
recognised that there would certainly be differences between the contents of the 
conditioned media and foetal plasma. Similar to what was proposed in the previous 
chapter, contents of the foetal plasma would also contain molecules secreted by the 
foetal tissues, and further metabolism of the contents of the transported placental 
secretions could have taken place. Furthermore, given that there is a two-way 
transfer of substances across the placenta, the placental-conditioned media may 
also contain molecules secreted into the maternal compartment.  
At this juncture, one yet unaddressed gap is clearly evident – it is still not known 
what exactly these “damaging” or “protective” factors in the placenta conditioned 
media/ foetal plasma are. As mentioned above, metabolomics approaches which 
can screen for a large number of proteins, amino acids and other compounds, can 
be used to elucidate differences between normal and compromised pregnancies in 
clinical studies (Fanos et al., 2012). Previously, placental-conditioned media from 
hypoxia-exposed dams have been shown to have higher levels of glutamate and 
tryptophan (Curtis et al., 2014). In the same study, application of glutamate 
NMDA/AMPA antagonists rescued the decrease in dendritic length observed in 
cortical cultures, further supporting the idea that increased glutamate could have led 
to these detrimental morphological changes. Other metabolomic studies using 
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placental-conditioned media from human placental explants have also identified 
perturbations in glutamate and tryptophan metabolism e.g. in pre-eclampsic 
pregnancies (Dunn et al., 2009, Horgan et al., 2010). Tryptophan metabolism, thus, 
could also be an area of particular interest as it is known that the placenta secretes 
serotonin, for which tryptophan is a precursor (Bonnin et al., 2011). Placental-
derived serotonin was found to be important for foetal brain development, thereby 
could play a crucial role in foetal programming.  
Apart from the secretion of hormones, amino acids and molecules, with the recent 
boom in epigenetics, it has also been demonstrated that the human placenta can 
also secrete microRNAs into both the maternal and foetal compartments (Chang et 
al., 2017). MicroRNAs regulate mRNA expression levels and have been shown to 
be involved in the pathogenesis of neurodevelopmental disorders (reviewed in (Sun 
and Shi, 2015)). In the study by Phillips et al. 2017, there was indeed differentially 
secreted microRNAs between stressed and non-stressed placentae, and some of 
these differences were abrogated with maternal MitoQ-NP administration. 
MicroRNAs are secreted into exosomes, which are extracellular vesicles that can 
cross the blood brain barrier, therefore can exert direct effects on the brain (Scott, 
2017). When a transcriptomic analysis of the foetal brains was carried out in Phillips 
et al., 2017, predicted target genes of those differentially altered microRNAs were 
also differentially altered in the foetal brain, strongly suggesting that these 
microRNAs play a direct role in the neuronal development in the foetal brain.  
Other changes in the placenta: 
Besides being able to affect epigenetic processes in the foetal brain as mentioned 
above, the placenta itself is also susceptible to epigenetic changes (Maccani and 
Marsit, 2009). Apart from secreting microRNAs, the placenta itself is also a target of 
microRNAs (Hayder et al., 2018). Another common epigenetic alteration in the 
placenta is DNA methylation (Bianco-Miotto et al., 2016), where methylated CpG 
islands located in gene promoter regions can affect the binding of transcription 
factors and therefore the expression of target genes. Oxidative stress can alter the 
methylation of genes in the placenta (reviewed in (Thompson and Al-Hasan, 2012)). 
The expression of important placental genes such as 11β-HSD2 mRNA are known 
to be heavily controlled by methylation, where hypomethylation is observed to lead 
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to an increase in placental 11β-HSD2 mRNA expression in clinical samples 
(Alikhani-Koopaei et al., 2004).  
It was established in the previous chapter that gestational social stress can increase 
11β-HSD2 mRNA expression in the placental JZ. Here, surprisingly, there was also 
a trend towards an increased 11β-HSD2 expression in the junctional zone following 
MitoQ-NP administration alone. Peculiarly, this was not observed when both stress 
and the antioxidant were administered. It is not known what could have caused the 
changes in 11β-HSD2 mRNA expression, but methylation changes in the placenta 
following MitoQ-NP administration might occur. The increase in 11β-HSD2 
expression following MitoQ-NP administration only in the non-stressed condition but 
not in the stressed condition indicates that the placenta responds differently to 
disequilibrium in redox balance, and it may be that both ends of the perturbation (too 
much, or too little ROS) could influence methylation of the 11β-HSD2 gene. It is 
difficult to ascribe functional significance to these changes, and it is also not 
possible to determine if these would result in downstream effects in glucocorticoid 
regulation in the dams, or if it represents a compensatory effect. The small sex 
difference in male and females, which was also observed in the preceding chapter, 
is however worth commenting on, as it further supports the contention that male and 
female placenta can respond differently to the same environmental cues. The 
administration of folic acid, which has known antioxidant properties, to pregnant rats 
results in a decrease in  11β-HSD2 mRNA expression in male, but not female 
placentas (Penailillo et al., 2015). It is likely that there are complex interactions 
between oxidative stress, placenta sex, and epigenetic mechanisms (for instance, 
placental OGT, which is X-linked and involved in chromatin regulation and 
transcriptional control (Bale, 2011) which deserve further investigation. It also hints 
to the fact that changes to the pro-oxidant/ antioxidant balance may have knock-on 
effects on other systems.  
6.4.8 Other changes in the maternal compartment 
Although MitoQ-NP is considered safer in that it does not cross into the foetal 
compartment, other maternal side effects such as changes to steroid production 
may still occur, especially since mitochondria are an important site of steroid 
production (Miller, 2013)(Fig 3.1). In this study, corticosterone production following 
stress, as a result of HPA axis activation, did not seem to be affected by MitoQ-NP 
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administration. However, MitoQ-NP administration seemed to alter the plasma 
concentrations of several steroids differentially in control and stressed dams, 
suggesting that there is a complex interaction between stress and the antioxidant 
status in pregnancy.  
Additionally, insofar as neuroactive steroids in pregnancy are concerned, most of 
the studies have focussed on the role of allopregnanolone and little is known about 
the role of other steroids such as DOC and its metabolites. These results therefore 
also provide a reference interval for future studies on steroid metabolism in rat 
pregnancies, and can also shed light on some of the lesser studied steroids that 
may have an important role to play in mediating the impact of insults during 
pregnancy. 
Testosterone:  
Firstly, there was an increase in plasma testosterone concentrations following 
MitoQ-NP administration in the control groups, but not in the stressed groups. 
Testosterone has been regarded as a pro-oxidant, at least in the cardiovascular 
system, and can increase ROS production in vitro (Tostes et al., 2016). As ROS is 
important for normal cellular signalling, too much antioxidants may also disrupt 
cellular function. Following this argument, there is a possibility that the increase in 
testosterone levels could have been a compensatory action, perhaps an attempt at 
reinstating the pro- vs antioxidant balance which was altered by the antioxidant 
treatment.  
The implications of this testosterone increase in control/MitoQ-NP dams are 
unknown, as it was not determined here if the increased testosterone was being 
transferred to the foetus. However, increases in plasma testosterone in pregnant 
rats are often associated with poorer offspring outcomes, leading to offspring anxiety 
(Hu et al., 2015), IUGR (Sathishkumar et al., 2011), hypertension (Chinnathambi et 
al., 2014) and altered sexual function (Ramezani Tehrani et al., 2013). Although the 
control/MitoQ-NP offspring did not show any anxious behaviour in this study, it 
cannot be ascertained if other disruptions to the control/MitoQ-NP offspring would 
have occurred.  
Progesterone, DHP and allopregnanolone: 
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A trend towards an increase in plasma allopregnanolone, DOC and pregnenolone in 
the pregnant dams was observed with social stress alone, and this possibly reflects 
the acute production of neuroactive steroids after an acute challenge (chapter 4). 
However, when MitoQ-NP was given prior to chronic social stress, maternal plasma 
progesterone, DHP and allopregnanolone seemed to decrease instead. A large 
variation was observed, and extremely low levels of these steroids were particularly 
obvious in a few rats. 
Progesterone and its metabolites is known to have antioxidant and protective 
properties following insults (Zampieri et al., 2009). However, given their importance 
in maintaining the pregnancy, it thus seems extremely counterintuitive, or even 
dangerous, that a lower concentration is observed in the case of gestational stress. 
However, the relationship between antioxidant status and progesterone production 
is likely to be complex. The production of progesterone is dependent on the 
antioxidant enzyme SOD (Sawada and Carlson, 1996), and the administration of a 
supraphysiological dose of antioxidant (MitoQ in this case) could have affected the 
body’s own antioxidant production (of SOD, for instance) in the corpus luteum, 
affecting the endogenous production of progesterone. Nonetheless, this is merely a 
postulation and whilst offspring of stressed/MitoQ-NP treated dams seemed to show 
a rescue in several aberrant behaviours, it is not known if this slightly lower 
progesterone, DHP and allopregnanolone could have any other downstream side 
effects on the mother or the pregnancy.  
Oxidative stress and glucocorticoids: 
Lastly, although MitoQ-NP did not alter corticosterone concentrations, the cross-talk 
between the oxidative stress system and glucocorticoid metabolism is stil 
noteworthy. Whilst it is possible that the stress-induced ROS increase is a 
downstream effect of corticosterone production, conversely, the glucocorticoid 
system can also be regulated by changes in oxidative stress status. Increased H2O2 
negatively regulates GR function in vitro, decreasing downstream target gene 
expression (Makino et al., 1996). Pituitary corticotroph cells with elevated H2O2 are 
also unable to properly regulate negative feedback inhibition in vitro (Asaba et al., 
2004). Antioxidant treatment in rats on the other hand, can also result in the 
activation of the HPA axis, through downregulation of GR and MR in the pituitary 
gland (Prevatto et al., 2017). Therefore, as much as glucocorticoids can result in the 
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detrimental tipping over of ROS, changing of the redox balance could also affect 
HPA axis and glucocorticoid function in different ways, and indiscriminate 
antioxidant administration may bring about unintended effects. For instance, whilst 
combined glucocorticoid and antioxidant therapy can be safe and beneficial for 
pregnancy compromises like that of pre-term births, glucocorticoids alone, or 
antioxidant therapy in healthy infants, do not offer the same beneficial effects 
(Camm et al., 2011) . 
Converging point between steroids and oxidative stress? 
Given the seemingly complex interactions between oxidative stress status and 
steroid production and action, there are likely to be various converging points 
between these two systems. Of note, the nuclear factor erythroid 2-related factor 2 
(Nrf2) signalling pathway seems to be a possible candidate that lies in the 
intersection between all these processes (Kovac et al., 2015, Li and Kong, 2009).  
Nrf2 is a transcription factor that is heavily involved in the antioxidant response (da 
Costa et al., 2019). In physiological conditions, Nrf2 activity increases in parallel with 
ROS, where it translocates to the nucleus to activate endogenous antioxidant 
defences and other protective cellular mechanisms (Tebay et al., 2015). MitoQ is 
known act through various pathways that involve Nrf2 activity (Zhou et al., 2018, 
Zhang et al., 2019, Hu et al., 2018). Nrf2 activation is one of the downstream effects 
of steroid-receptor binding for progesterone (Zhang et al., 2017), whilst Nrf2 
knockout models show that the production of teststerone could be affected (Chen et 
al., 2015). Social defeat in rats also prevents Nrf2 translocation and increases the 
vulnerability to depression (Bouvier et al., 2017), indicating that Nrf2 may play a role 
in stress responses as well. Mouse studies have started to explore the links 
between Nrf2 and pregnancy, where Nrf2 activity is crucial for maintaining maternal 
hepatic adaptations to pregnancy (Zou et al., 2013). 
In terms of interaction of Nrf2 and the glucocorticoid system, a previous study in cell 
lines reported that increased glucocorticoids was accompanied by a suppression of 
the Nrf2-dependent antioxidant response (Kratschmar et al., 2012), whereas a more 
recent study reported that maternal corticosterone treatment to pregnant mice did 
not in fact alter protein expression of Nrf2 (Bartho et al., 2019). Whilst the 
involvement of Nrf2 in gestational social stress is only speculative, it could be a 
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potentially important common target between the neuroendocrine and oxidative 
stress system during pregnancy that is worth investigating in the future. 
While these changes in plasma steroid concentrations are present, it cannot be 
ascertained if these are compensatory mechanisms to restore disequilibrium in 
oxidative stress status, or merely a co-occurrence, therefore it is difficult to ascribe 
functional significance to these changes. However, the presence of these somewhat 
paradoxical changes attests to the idea that antioxidant therapy may affect 
numerous other endogenous systems via common cellular signalling pathways. 
6.4.9 Limitations of MitoQ-NP and implications of MitoQ-NP as a potential 
therapeutic intervention for stress-induced prenatal programming 
Whilst MitoQ treatment has been widely accepted to be beneficial, there is also a 
need to acknowledge studies that report otherwise, which can give us a fuller 
understanding of the mechanistic actions of the drug. In contrast to the results here, 
MitoQ has been reported to cause damage to mitochondria in mouse kidney tissue 
(Gottwald et al., 2018), and can instead increase ROS production in some cancer 
cells (Pokrzywinski et al., 2016). It is likely that these ill-effects could arise through 
improper dosage, and effects are also dependent on the inherent oxidative state in 
different conditions, which would be different for different diseases.  
The antioxidant paradox 
Beyond MitoQ, these paradoxical observations seem to be also related to a much 
broader issue prevalent in the field of antioxidant research, in that whilst antioxidants 
seem to show promise in controlled animal or in vitro oxidative stress-related 
models, these strategies have not had much success in the clinics. This has been 
termed as the “antioxidant paradox” (Halliwell, 2000).  
Although ROS are involved in the pathophysiology of various diseases, they also act 
as important mediators of normal signalling processes. Thus, the indiscriminate 
lowering of the levels of oxidative stress could be damaging, tipping the delicate 
redox balance required for normal cellular functions. There needs to be a careful 
balance between ROS and antioxidants, especially so in the case of pregnancy, 
where a slight pro-oxidant state may be necessary (Fig 6.20). Thus, there is a need 
to determine the optimal dosage of antioxidants to use (Finkel and Holbrook, 2000, 
Poljsak et al., 2013). In the context of this study, dosage would also be dependent 
Chapter 6: Role of oxidative stress in foetal programming 347 
on release patterns of MitoQ from the nanoparticles, and it is thus necessary to 
measure the concentration of MitoQ in the maternal brain, liver, plasma and foetal 
plasma. This can be achieved using LC-MS, where protocols have already been 
developed by various groups (Li et al., 2007). 
At the same time, reversing oxidative stress is also clearly more complicated than 
simply the addition of an antioxidant. This is further compounded by the fact that 
each species of ROS (either a hydroxyl radical, superoxide, or nitric oxide radical) 
have different chemical properties and reaction rates (Halliwell, 2013). Likewise, 
antioxidants do not all work in the same manner, and administration of one type of 
antioxidant may result in compensatory actions in other endogenous antioxidant 
systems, which can be difficult to control for. 
It has become increasingly clear that antioxidants may not have any effectiveness 
(or perhaps, can be counter-effective) unless there is a pre-existing deficiency or 
compromise (Fig 6.20). This may mean that the antioxidant intervention should only 
be administered to those at risk of disease, or those that already have a perturbation 
in the oxidative stress status. In this study, the treatment was given on GD16, the 
same day as when where the chronic stressor began. In reality, this may not be a 
very sensible method of therapeutic intervention, as it seemed impractical to be 
administering a treatment before or around the same time the chronic stressor is 
beginning. Predicting these “high risk groups” with oxidative stress perturbations will 
also be much harder in human populations, and it may therefore be challenging to 
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Fig 6.20: Importance of achieving the pro-oxidant vs antioxidant balance. 
Schematic showing how a balance between pro-oxidant and antioxidant species is 
needed to ensure optimal cellular functioning. When ROS exceeds antioxidant 
defences (pink zone), for instance, following psychological stress, oxidative damage 
to cellular components occurs. Pregnancy represents a constant state of mild 
oxidative stress (blue zone), and there is slightly greater levels of oxidative stress 
compared to the non-pregnant state (green zone). This pro-oxidant state is 
presumably required for adaptations to pregnancy. When antioxidants are given 
indiscriminately or in an inappropriate dose, it could also result in the disruption of 
normal cellular processes, which rely on ROS (yellow zone). Too much or too little 
antioxidants can therefore be harmful, and a careful titration of antioxidant dosage is 
required in order for interventions to be effective.   
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Possible side-effects of nanoparticles 
Another major drawback in this study not yet mentioned, is the use of saline instead 
of NPs as vehicle, and the effects of NP injection alone were not investigated. Whilst 
the unique size and physical and chemical properties of nanoparticles confers it 
advantage in terms of accessibility to target organ/ tissues and penetrability into 
cells/ organelles, it also gives it the propensity to modify various biological 
processes and possibly cause harm (Nel et al., 2006). Depending on the type and 
formulation of NPs, they can cause toxicity, either from the constituents of the NPs 
itself, or from its degradation products (De Jong and Borm, 2008). Ironically, one of 
the harmful effects of NPs can be the increase in oxidative stress and cellular DNA 
damage (Nel et al., 2006). Also, despite being sequestered in layered “barrier” 
organs like the placenta or the gastrointestinal tract where they are unable to get 
past the first layer of cells, NPs can still induce downstream signalling processes 
which can potentially harm other surrounding cells without the need to be physically 
present in these cells (Bhabra et al., 2009).  
However, it has been previously established that the formulation of NPs used in this 
study (γ-PGA-Phe) do not have toxic effects on cells, and upon injection in mice, do 
not provoke any injury to the tissue or activate any NP-specific immune response 
(Khalil et al., 2017). It was further observed in our studies that the rats did not 
present any discomfort or tissue damage at the site of injection.  
Moving forward, there needs to be more thorough studies analysing the distribution 
and degradation patterns of NPs, before the drug can be brought into the clinic as a 
therapeutic invention. This could be carried out with the use of the fluorescent 
tagged NPs, for instance (Phillips et al., 2017). Maternal tissues could also be 
collected after weaning to study the long-term effects (if any) of NPs on the mother. 
If the efficacy and long-term safety of these NPs can be ascertained, these NPs can 
also potentially be used as a drug delivery system for other drugs (Refuerzo et al., 
2017).  
Despite these limitations and confounds in the experimental set up, this study adds 
on to the list of conditions for which maternal MitoQ-NP has been effective against, 
for instance, the effects of preeclampsia (Scott et al., 2018), the effects of 
gestational hypoxia on offspring neuronal characteristics (Phillips et al., 2017) and 
cardiac abnormalities (Aljunaidy et al., 2018), and most recently, DNA damage in a 
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mouse model of childhood leukemia initiation (Mansell et al., 2019). Additionally, 
maternal administration of MitoQ-NP to pregnant dams signifies the first time any 
maternal interventions have been attempted in this model of social stress, as 
previous forms of intervention (e.g. neurosteroid administration) were often targeted 
at the offspring after they were born and in adulthood (Brunton et al., 2015).  
6.4.10 Conclusions and future work 
The ability of MitoQ-NP to partially rescue the deleterious effects of maternal social 
stress in this study provided strong evidence that oxidative stress is involved in the 
transmission of prenatal stress from mother to foetus. Nonetheless, it has also been 
proposed that in spite of the generally positive results observed here, antioxidant 
therapy is not a magic bullet that can prevent all the negative effects of prenatal 
stress, as indiscriminate use can in fact be harmful.  
Additionally, as proposed by Ghezzi et al (2017), given the centrality of ROS in 
various processes, it is actually not surprising to find that most disorders do indeed 
involve oxidative stress (Ghezzi et al., 2017). “Oxidative stress” can be contributed 
by a broad range of cellular processes and involves various mediators and players. 
Insofar as the conclusion “prenatal programming is mediated by oxidative stress” 
stands, a more thorough understanding of specific mechanisms that constitute 
“oxidative stress” is required for this conclusion to be of mechanistic and therapeutic 
significance. This is especially so for pregnancy-related disorders, as processes 
regulating oxidative stress following maternal stress are not intrinsically different 
from those observed in normal pregnancies, where a mild state of oxidative stress 
exists (Jauniaux et al., 2006). This study also offers an alternative way of viewing 
gestational stress, in that a stressed pregnancy represents an end of a continuum 
that is common to all pregnancies, and differs from normal pregnancies merely in 
terms of the magnitude of the oxidative stress processes. As such, any form of 
intervention targeting such processes need to be implemented with care.  
A few suggestions on possible future work have been proposed throughout this 
discussion. To summarise, in order to strengthen the conclusions of this study, one 
can (i) repeat the experiment to investigate additional oxidative stress markers, (ii) 
quantify MitoQ, as ultimately, successful application of MitoQ-NP in the clinics will 
require greater understanding of the pharmacological properties of the nature of the 
drug, including their rates of absorption, tissue distribution and metabolism, (iii) run 
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large scale metabolomics studies to determine the identity of the placental 
secretions (and then in the subsequent stages, investigate the effects the depletion 
of these specific molecules, which can better prove mechanistic action).  
Given the limitations of using antioxidants as an intervention, this discussion also 
identified a few other possible downstream targets that can be investigated, for 
instance, transcription factors like Nrf2, which may control the interaction between 
steroidogenesis and oxidative stress, or mediators of the serotonin signalling 
pathway, identified as being important in regulating stress coping behaviour. In fact, 
Nrf2 agonists are currently being used to treat multiple sclerosis and seem to be 
more successful in clinical trials when compared to antioxidant therapies (Dodson et 
al., 2019, Cuadrado et al., 2019). Additionally, in line with what is proposed in 
chapter 4, this study has also shown that alterations in GABA transmission is 
involved in the mediating the outcomes of prenatal stress, and interventions aimed 
targeting the GABA neurotransmission during development might also be of 
therapeutic value (reviewed in (Braat and Kooy, 2015)). 
All in all, despite its focus on “oxidative stress”, this study revealed how multifactorial 
the possible contributors to foetal programming truly are, which is not surprising 
given that that “oxidative stress” and ROS signalling are involved in almost every 
single cellular process. Additionally, although this study initially set out to investigate 
mechanisms of prenatal stress beyond the HPA axis, towards the end of the 
chapter, it became clearer the HPA axis and neuroendocrine system cannot be 
completely disregarded, as any kind of intervention is likely to also affect aspects of 
the HPA axis. Eventually, an integrational and multi-level and -system investigation 
is needed, where data from human studies, in vivo animal models, and in vitro 
molecular and cellular studies from various systems are considered in parallel, in 
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The overarching aim of this thesis was to build on existing knowledge and further 
investigate the mechanisms underlying the outcomes of prenatal stress. To recap, 
this thesis had three broad aims. The first aim was to first develop a LC-MS method 
for the quantification of steroids, followed by addressing two questions to further 
elucidate mechanisms underlying the developmental programming of diseases in 
adulthood: “What are the mechanisms that are transmitting the stress signals from 
the mother to the foetus to result in foetal “programming”?” (Aim 2) and “what are 
the mechanisms underlying the expression of “programmed” phenotypes in the 
prenatally stressed adult offspring?” (Aim 3). Aim 2 allows for the formulation of 
interventions that can prevent such outcomes, while Aim 3 allows for the formulation 
of interventions that may possibly reverse such outcomes.  
Following the successful development and validation of a LC-MS technique 
(Chapter 3; Aim 1), the concentrations of neuroactive steroids between control and 
prenatally stressed offspring were then compared, where it was determined that 
modest deficits in neuroactive steroid production exist in PNS offspring when 
compared to control offspring, following exposure to acute swim stress (Chapter 4, 
Aim 2). The same LC-MS method was then used to investigate the role of steroids, 
especially glucocorticoids, in the transmission of stress signals from mother to 
foetus (Chapter 5, Aim 3). Using a maternal targeted antioxidant, Chapter 6 then 
explored the role of oxidative stress and the placenta in the transmission of stress 
signals (Aim 2), and additionally, also investigated some of the neurochemical 
mechanisms that underlie adult offspring behaviour (Aim 3).  
The discussion first provides a compilation of the key findings across all chapters. 
Some commonalities (e.g. the presence of sex differences) will be further examined. 
Overall limitations and the translatability of the work are then considered, and lastly, 
future directions that can be taken to better understand the mechanism mediating 
the outcomes of prenatal stress will be explored. 
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7.1 Key findings of the thesis  
7.1.1 Foetal “programming”: What are the mechanisms involved in 
transmitting the stress signals from mother to foetus?  
The mechanisms mediating the transmission of the stress signals were examined in 
Chapter 5 and 6 (Figure 7.1). The widespread assumption in the field of foetal 
programming is that stress signals are communicated to the foetus by the direct 
diffusion of maternal glucocorticoids through the placenta, resulting in foetal 
overexposure to maternal glucocorticoids (Wyrwoll and Holmes, 2012, Cottrell and 
Seckl, 2009). However, in this thesis, it was shown that whilst there was an 
activation of the maternal HPA axis, the was no evidence for increased 
corticosterone concentrations in the foetal brain. Furthermore, there was also an 
increase in 11β-HSD2 mRNA expression in the placenta, possibly indicating 
increased protection from the “glucocorticoid barrier”. The role of maternal 
glucocorticoids in foetal programming therefore does not involve a direct crossover, 
and is likely to occur through complex mechanisms involving glucocorticoid 
modulation of other aspects of maternal physiology. There were also no major 
changes in the concentrations in a panel of neuroactive steroids in the foetal brain 
following gestational stress. Alteration of steroid production machinery in the foetal 
brain during development therefore does not seem to be involved in adverse foetal 
programming.  
Apart from an increase in maternal glucocorticoids following gestational stress, there 
was also an increase in oxidative stress in the maternal compartment and in the 
placenta following gestational stress. It was suggested that the stressed placenta 
can secrete damaging factors into the foetal circulation, and through an in vitro 
experiment, it was revealed that these placental secretions from stressed placenta 
have the propensity to alter neuronal characteristics. Most importantly, the use of a 
maternal antioxidant prevented placental secretions and foetal plasma from altering 
these neuronal characteristics. These, as yet unidentified placental secretions that 
are dependent on maternal/placental oxidative stress are therefore a plausible 
mechanism that communicate stress signals from the mother to the foetus, and the 
next step is to determine the exact identity of these damaging factors using 
untargeted metabolomic/proteomic methods.  
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Putting the results from Chapter 5 and 6 together, a speculative hypothesis of how 
prenatal stress may be transmitted to the offspring is also presented in Figure 7.2. 
These two mechanisms are not mutually exclusive, and could each represent part of 
the puzzle regarding the mechanisms mediating the outcomes of prenatal stress. 
Corticosterone may exert its effects through the activation of a downstream cascade 
that increases cellular oxidative stress, rather than through direct crossover of the 
placenta. Nonetheless, this remains only speculative and will need to be tested with 
further experiments involving maternal adrenalectomy with substitutive 
corticosterone therapy for instance.  
As for the prevention of these outcomes, this work has shown that maternal 
antioxidant therapy with a nanoparticle drug delivery system was effective in 
rescuing many of the deficits associated with PNS in the rat model (Chapter 6). 
Mechanisms regulating the transmission of stress are likely to be complex, and on a 
translational viewpoint, pharmacological intervention may not be always feasible in 
human populations. Nonetheless, increased understanding of the roles 
corticosterone and oxidative stress may play in the transmission of stress signals 
can guide intervention approaches, which need not be pharmacological in nature, 
and may stem from environmental or dietary, or in the case of humans, 
psychological or societal perspectives.  
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Figure 7.1: Summary of differences in stressed groups as compared to non-
stressed controls at GD20 following social stress. Data summarised from 
Chapters 5 and 6. An up arrow (↑) denotes that stressed group exhibited an 
increase in the parameter as compared to controls, while a down arrow (↓) denotes 
that stressed group exhibited a decrease in the parameter as compared to the 
control group. A double-ended horizontal arrow (↔) indicates no differences 
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Figure 7.2: Conclusions and proposed mechanisms mediating the 
transmission of stress signals from mother to foetus. CORT: corticosterone  
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7.1.2 What are the mechanisms underlying the expression of “programmed” 
phenotypes in the adult prenatally stressed offspring? 
The second focus of the thesis investigated the mechanisms that underlie the 
observed phenotypical outcomes in the PNS adult offspring (e.g. heightened anxiety 
and HPA axis dysregulation), and also characterised additional behavioural 
outcomes related to depressive-like behaviour (Figure 7.3). Due to the involvement 
of GABA neurotransmission in many mood and affect related disorders, it was first 
hypothesised in Chapter 4 that deficiencies in the production of GABAA-modulating 
neuroactive steroids could underlie the anxiety and HPA axis dysregulation 
observed in PNS offspring. However, no differences in the concentration of these 
neuroactive steroids between control and PNS rats were observed under basal 
levels. Nonetheless, following acute swim stress, PNS offspring seemed to exhibit 
lower THDOC, but not allopregnanolone production, in various brain regions, 
indicating that there could be a deficit in metabolism pertaining to the DOC pathway, 
rather than the progestogen pathway in PNS offspring. Although the concentrations 
of these GABAA allosteric modulators were largely not affected in the PNS groups, it 
was shown in Chapter 6 that the expression patterns of the GABAA receptors were 
altered, suggesting altered baseline GABA neurotransmission could still be a 
contributory factor underlying the behavioural outcomes in the PNS offspring. 
Changes in GABAA subunit expression were also sex- and region dependent, while 
absolute neuroactive steroid concentrations were generally found to be greater in 
the female brain as compared to the male brain.  
Although attempts to reverse these outcomes during adulthood were not carried out 
in this study, decreased GABAA receptor expression may explain why neuroactive 
steroid supplementation in adulthood is effective in normalising HPA axis responses 
to stress (Brunton et al., 2015). As PND30 brains were studied for neurochemical 
and neuroanatomical changes, this also indicates that many of these neurochemical 
changes are present before puberty, and that the trajectory for behaviour deficits 
seem to be already determined before adulthood. In order to further investigate 
whether these changes begin at an earlier stage, neurochemical characteristics in 
foetal brains could be investigated, and this would then possibly allow for the 
alteration of the trajectory of development before negative behavioural symptoms 
arise. 




Figure 7.3: Summary of differences in stressed PND30 and adult offspring 
compared to respective non-stressed controls. Data summarised from Chapters 
4 and 6. (↑) denotes that stressed group exhibited an increase in the parameter as 
compared to controls, while (↓) denotes that stressed group exhibited a decrease in 
the parameter as compared to the control group.  
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7.2 Sex differences as a recurring theme  
In this study, sex differences in the brain and behaviour was a recurring theme that 
was observed across all chapters, for most of the parameters tested. Sex 
differences occurred on two levels, basally (i.e. males and females are biologically 
different), and on a level altered by changes such as stress or the prenatal 
environment (i.e. males and females respond differently to environmental stimuli).  
Baseline sex differences fit into the organisational-activational framework of sexual 
differentiation, which posits that sex hormones permanently organise the CNS 
during early development; while in adulthood, sex hormones serve to activate these 
systems that have been organised prenatally (Arnold, 2009). At GD20, testosterone 
concentrations were very different in males and females. This is a critical stage of 
sexual differentiation, where the developing foetal brain is in the process of being 
altered by the organisational effects of testosterone and oestradiol, after 
testosterone conversion via aromatase. Regretfully, oestradiol could not be detected 
using this LC-MS method, but concentrations of other neuroactive steroids (e.g. 
progesterone and DOC and their metabolites) could be quantified. It was found that 
although concentrations of these neuroactive steroids were not different in the 
brains of male and female foetuses (Chapter 5), a sex difference became apparent 
in the adult brains, where females generally show greater concentrations (Chapter 
4). The difference in baseline neuroactive steroid concentrations in adult rat brains 
can be considered a consequence of both “organisational” (in that it is a permanent 
and long-lasting effect arising from foetal development) and the constant 
“activational” effects of sex hormones (in that it is dependent on the continued 
production of sex hormones from the gonads). According to the organisational-
activational framework, there would also exist many other important sex differences 
in the brain (e.g. anatomical or circuitry differences), all of which may possibly 
contribute to differential responses between males and females to challenges, either 
in adulthood or during development (Bangasser and Wicks, 2017). Additionally, 
apart from this basic framework, sex differences in placental function also exist due 
to the action of sex chromosomes, which can also contribute to the baseline sex 
differences observed in adulthood (Bale, 2016).  
In this work, there were indeed differences in how males and females responded to 
acute stress (Chapter 4), which partly recapitulated the results reported in a 
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previously published study (Sze et al., 2018). Prenatal stress also resulted in 
different outcomes in male and female offspring (Chapter 5 and 6), which 
corroborates general observations in various developmental programming models 
(Aiken and Ozanne, 2013). These sex differences are a result of complex 
interactions between the “organised” sex differences in the brain of the adults, 
including neuroactive steroid concentrations, as well as other factors like the 
inherent differences between XX and XY placentae (Bale, 2016). Although it 
seemed like males presented higher vulnerability to developmental compromises in 
this study, which was similar to that proposed in some studies (Gobinath et al., 
2014), comparisons between male and female vulnerability eventually depends on 
the nature of the stressor and on the offspring trait that is being investigated (Glover 
and Hill, 2012, Weinstock, 2007).  
Ultimately, regardless of which sex seem more “vulnerable” to the effects of stress, it 
is critical to include both males and females in the dataset and to analyse results by 
sex, as has been done in most parts of this thesis. This has two important 
implications. Firstly, it can further shed light on the mechanisms of observed 
phenomena, and secondly, it can also have therapeutic implications (McCarthy et 
al., 2012). Since stress processes heavily involve steroid hormones, by completely 
omitting one sex, fundamental misinterpretation of the experimental results may 
occur. Even if the phenotypical endpoints do not show a sex difference, the 
underlying physiology of males and females are still by and large different, and this 
sex convergence is likely to reveal the presence of compensatory mechanisms (De 
Vries, 2004, McCarthy et al., 2012). By not taking sex into consideration, there can 
be inaccuracies in mechanistic conclusions, which then could result in dire 
consequences in terms of formulating interventions, especially for the population 
that is understudied (in most cases, females).  
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Figure 7.4: Sex differences present in this study. Sex differences in the response 
to acute stress, or to stressors in early development are dependent on the inherent 
sex differences at baseline between males and females. It is of note that other than 
the parameters observed here, anatomical, neurochemical and circuitry differences 
exist in males and females that are all a consequence of the organisation-
activational actions of sex hormones, and likely underlie observed 
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7.3 Limitations of this work 
The limitations of each experiment, whether methodological or interpretational in 
nature, have been discussed separately in each chapter. Three general themes 
arise: (i) experimental techniques, (ii) experimental design, and (iii) reproducibility of 
the experiments.  
7.3.1 Experimental techniques 
This thesis consisted of a wide array of experimental techniques, from traditional 
methods used in physiology studies (e.g. in situ hybridisation and 
radioimmunoassays) to new techniques such as LC-MS and nanotechnology drug 
delivery systems in an attempt to answer different aspects of the same biological 
question. Whilst in situ hybridisation is a highly sensitive method used to detect 
mRNA expression in an anatomically specific manner, a change in mRNA 
expression does not equate to changes in protein expression, therefore 
immunohistochemistry could also have been additionally carried out to verify altered 
mRNA expression results translates to differences in protein expression. The HPA 
axis has also been investigated only by the quantification of corticosterone, and 
functional assessments (e.g. using the dexamethasone suppression test) or the 
expression of the receptors (e.g. GR) could be carried out to determine if there were 
any deficits in negative feedback mechanisms. Apart from investigating these 
biological markers in the brain, this work also correlated these 
neurochemical/endocrine observations to functional consequences using 
behavioural tests, and the limitations of each test have been discussed in Chapter 6. 
7.3.2 Experimental design: Descriptive versus mechanistic science 
The second drawback is that some experiments in this thesis were purely 
“descriptive” but not “mechanistic” in nature (Casadevall and Fang, 2009). 
“Mechanistic” studies require the determination of causal relationship between event 
A and B, and in general, three kinds of experiments need to be performed. Firstly, A 
and B should be measured without any manipulations, to first show a correlation 
under biologically realistic conditions. Negative manipulations (e.g. gene knockouts 
or receptor antagonists) can then be performed, where the magnitude/intensity of A 
is decreased, and the effects on B measured. However, negative manipulations 
typically cannot distinguish between background factors necessary for the effect and 
a genuinely triggering cause (Bickle, 2015), thus a third kind of experiment, where 
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positive manipulations are used (e.g. overexpressing or receptor agonists of A) 
should also be carried out. Only when all three kinds of experiments consistently 
point towards the same conclusion, can a causal mechanism confidently be 
determined (Silva et al., 2013).  
The studies in Chapter 4 and 5 were descriptive in nature, as concentrations of 
neuroactive steroids were measured under biologically realistic conditions and no 
manipulations were carried out. Given the pervasive nature of neuroactive steroids 
and the fact that they are made in multiple regions of the brain by the same 
enzymatic mechanisms, certain negative manipulation methods (e.g. ablating the 
tissue that produces the steroid or giving a receptor antagonist) would be difficult to 
apply, or may not result in any conclusive data. More sophisticated methods with 
regional specific conditional gene knockout/ adenoviral delivery of genes to 
manipulate steroid synthesis may be required to tease apart the exact role of 
specific neurosteroids in regulating specific functional outcomes. Nonetheless, this 
“descriptive” study is still important in that it was necessarily, as a first step, to 
establish if there were any differences on a baseline level before any manipulations 
were given. 
In Chapter 6, negative pharmacological manipulation with the use of an antioxidant 
indicated that ROS production (the causal agent) was necessary and sufficient to 
cause negative programming effects. However, it also suggested this that 
experimental method can have limitations as it may manipulate a system beyond the 
limits of normal functioning (in this case, normal ROS signalling could have been 
affected). Therefore, results should still be analysed with caution.  
7.3.3 Reproducibility 
The third limitation is that there exists certain instances where the results in this 
study were not reproducible from previous published studies, especially in the case 
of measuring HPA axis responses to stress. Possible explanations of these 
discrepancies have been separately discussed in each chapter. In general, the 
neuroendocrine response to stress and behavioural assays are extremely sensitive 
to environmental changes, and even changes to bedding, diet, or drinking water in 
different animal units can result in large impacts on experimental results due to the 
alteration of the gut microflora (Franklin and Ericsson, 2017).  
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Additionally, there were several instances in this work where trends towards 
statistical significance were observed (p-value between 0.05 and 0.10). A repeat of 
the same experiment, with increased n numbers to increase power, are required to 
verify these results, but these are not always feasible due to cost or logistical issues. 
However, it is still of interest to report and discuss these data in this work albeit with 
accompanying nuances and caveats, as it shows the dynamic nature of stress 
responses. Throughout the thesis, different offspring from each dam were taken for 
each data point, which reduces ‘within’ litter effects, whilst individual data points in 
each group have been plotted. Together, they reflect the heterogeneity of offspring 
outcomes, but also the variability in the stress responses of the pregnant dam. The 
inherent variability of stress responses are known and not new, as there are often 
puzzling reports on how variable results can emerge even from virtually identical 
experimental designs (Murthy and Gould, 2018), and can be attributed to subtle 
differences related to baseline housing and testing differences, natural variation in 
responses to stress and maternal care, and also individual variabilities that are 
present. Nonetheless, these are taken into account by presenting each of the 
individual data points for each group where possible.  
7.4 Complexity of the mechanisms mediating the outcomes of prenatal stress 
It is important to acknowledge again that stress responses, whether acute or 
chronic, are modulated by a wide range of physiological systems and are inherently 
complicated. In as much as simplicity in experimental design is required to properly 
tease apart mechanisms, complexity exists in neuroendocrine mechanisms, and 
these supposed “caveats” could actually be key mechanistic factors that can explain 
a phenomenon (Karatsoreos, 2016).  
The concept of allostasis, introduced in section 1.2.2, may provide a holistic 
framework for better understanding the mechanisms mediating the outcomes of 
prenatal stress. To recap, allostasis refers to the adaptive changes that occur 
following stress. Allostasis therefore can be occurring both in the pregnant dam in 
response to five days of chronic stress, and also in the PNS offspring, where stress 
experienced in utero constitutes part of the allostatic load. For the pregnant rat, 
pregnancy itself can already be considered an allostatic state due to alterations in its 
physiological systems, not only in HPA axis functioning but also metabolism, 
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immune and vascular function (section 1.4.1). Thus, when an additional allostatic 
load (here, chronic social stress) is superimposed on this “allostatic state”, it could 
further push the allostatic load past a tipping point to result in “allostatic overload” 
(Russell and Brunton, 2019). For instance, the placenta, which exists in a mildly 
oxidative state (Myatt and Cui, 2004), was subject to further allostatic load (in the 
form of further oxidative stress) induced by chronic social stress, and “allostatic 
overload” may manifest as the secretion of damaging factors into the foetal 
circulation (Chapter 6). In the PNS offspring, this chronic stress in utero, which 
exposes the foetus to damaging placental factors, could represent part of the “wear-
and-tear” that it will experience throughout its life course (McEwen, 2004). This 
allostatic load that occurs early in life could set the trajectory towards poorer adult 
outcomes and the development of mood-related disorders during adulthood. In both 
cases, chronic gestational social stress pushes the allostatic state closer to that of 
an allostatic overload, thereby increasing the risk of pathology.  
The allostatic load is contributed by multiple players spanning different levels of 
organisation, and could include structural remodelling of neural architecture, 
changes in baseline levels of neurotransmitters and receptors, or their intra-cellular 
and extracellular modulators, resulting in altered HPA axis function, among many 
others (McEwen et al., 2015). Beyond the main mediators of the HPA axis (CRH, 
ACTH, glucocorticoids), there also exists a diverse array of neuroactive steroids, 
which may each play a different role in the regulation of stress responses (reviewed 
in Chapter 4). This diversity of steroid mediators was addressed in Chapter 3, with 
the development of a technique to quantify a panel of steroids that are in involved in 
mediating stress responses. Although steroids and the HPA axis are the focus of the 
initial part of the thesis, the change of one allostatic system could lead to knock-on 
changes in other mediator systems (inflammatory molecules, cytokines, reactive 
oxygen species), thereby affecting the final outcome. Chapter 6 then addressed 
some of these other mediator systems, such as oxidative stress and reactive oxygen 
species. Maternal antioxidant treatment in this case, can also be viewed as an 
intervention that can alleviate the allostatic load, bringing it further away from the 
tipping point. This also allows us to integrate the findings from previous studies, into 
a single model in order to further our understanding of the mechanisms mediating 
prenatal programming and offspring outcomes. For instance, although PNS female 
offspring may not have deficits in allopregnanolone concentrations per se, the use of 
allopregnanolone treatment in adult female PNS offspring in the 2015 study 
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(Brunton et al., 2015) could be viewed as a way in which allostatic load can be 
reduced, thereby rescuing aberrant outcomes.  
7.5 Translatability of the research  
Given the complexity of the mechanisms mediating prenatal stress (section 7.4) and 
the various caveats in the study (section 7.3), this inevitably raises the question - 
how translatable is this work to humans?  
Firstly, one could argue that the physiology of the rat and humans are inherently 
different, and that maternal glucocorticoids may not be regulated in the same way. 
As mentioned in the introduction, there are several differences between the rat and 
human placenta, for instance, the lack of placental CRH production in rats 
(Alcántara-Alonso et al., 2017). In human epidemiology studies, it has also been 
recognised that HPA axis outputs (i.e. cortisol) were not robust biological measures 
of maternal distress, casting doubt on the significance of glucocorticoid metabolism 
in the transmission of stress signals in humans (Golden et al., 2011). However, the 
purpose of using animal models is not to completely transfer the results to the 
human condition. As long as the model generates logical data, it is meant to 
complement studies in humans in order to move the field forward (Bonney, 2013).  
Inherent to all in vivo animals models is also the conundrum that whilst the careful 
control of variables is a necessity in deriving mechanistic knowledge, this degree of 
control is precisely the obstacle to the translatability from bench to bedside, since 
humans do not exist in controlled environments (Dipietro, 2012). This is especially 
pertinent for the field of stress research, as socioeconomic factors like poverty are in 
fact the main contributors to poor offspring outcomes (Blair and Raver, 2016). 
However, understanding basic physiological mechanisms could be the starting point 
in guiding interventions (in a medical aspect) or other changes (e.g. social or 
political) which can positively impact those at risk.  
Again, the allostatic framework may allow for the better translation of in vivo studies, 
as it allows for the socio-psychological and physiological phenomena to be linked 
together (Sterling and Eyer, 1988). An allostatic load index which includes various 
biomarkers can be formulated (Juster et al., 2010), and this has been done for 
pregnant mothers for the risk of preterm birth and preeclampsia (Barrett et al., 2018) 
as well as for preterm infants (Casavant et al., 2019). Placental markers (Hodyl et 
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al., 2017) and other factors such as socio-economic factors (Seeman et al., 2010), 
or ethnic and sex-based differences (Rodriquez et al., 2019) can also be taken into 
consideration. Most recently, a rat cumulative allostatic load measure (rCALM) has 
been proposed as a preclinical translation tool to more relevantly assess the burden 
of chronic stress in the rodent model (McCreary et al., 2019). Eventually, processes 
related to stress and pregnancy should be studied using a multi-level approach 
comprising of different expertise from different fields (i.e. not only in the biological 
but also psychological and socio-economic domains), in order to better understand 
how early life environment can shape birth outcomes (Dunkel Schetter, 2011). 
7.6 Concluding remarks 
All in all, this thesis analysed the role of glucocorticoids, neuroactive steroids, and 
oxidative stress in mediating the outcomes of chronic gestational social stress, using 
a rodent model. It highlights the importance of sex differences and steroid influences 
in the study of stress-related mechanisms, and proposes for the conclusions here to 
be viewed using the allostasis framework. It also demonstrates the nature of 
collaborative research, where expertise in chemistry and nanotechnology could be 
used to complement traditional physiological techniques. The thesis resonates with 
a commentary by Carl Woese in the article “A new biology for a new century”, 
 
“Science is an endless search for truth. Any representation of reality we 
develop can be only partial. There is no finality, sometimes no single best 
representation. There is only deeper understanding, more revealing and 
enveloping representations. Scientific advance, then, is a succession of 
newer representations superseding older ones, either because an older one 
has run its course and is no longer a reliable guide for a field or because the 
newer one is more powerful, encompassing, and productive than its 
predecessor(s). Science is impelled by two main factors, technological 
advance and a guiding vision. A properly balanced relationship between the 
two is key to the successful development of a science: without the proper 
technological advances the road ahead is blocked. Without a guiding vision 
there is no road ahead; the science becomes an engineering discipline, 
concerned with temporal practical problems.” (Woese, 2004) 
 
Indeed, the field has progressed immensely since the first epidemiological 
associations carried out in 1989, which was first met with some scepticism. Exactly 
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30 years down the road, the field has expanded from reporting epidemiological 
associations to the dissection of molecular mechanisms, and is still continuing to 
progress at a tremendous pace (Limesand et al., 2019). This work represents only a 
tiny aspect of all the possible mechanisms underlying the foetal programming of 
adulthood diseases. Molecular mechanisms like epigenetics for instance, is a key 
player in foetal programming (Vo and Hardy, 2012, O'Donnell and Meaney, 2017), 
while the role of the gut microbiota and transgenerational transmission of prenatal 
stress may also provide interesting perspectives. To disentangle the contribution of 
each and every mediator system requires the individual pharmacological 
manipulation of each system, which is beyond the capability of any single laboratory. 
Similar to what has been done in this work, progress requires a concerted effort 
from various groups and researchers around the world, sharing technologies and 
insights to contribute to this pool of knowledge that has been built up over the past 
30 years. The deeper and more integrated understanding of these mechanisms can 
then hopefully bring about new ways for the prevention, reversal, or management of 
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Appendix A: Two or three-way ANOVA on R-studio 
 
TWO WAY ANOVA  
 
Using the example of male plasma corticosterone in Chapter 3 (Figure 3.5A), where 
Factor 1 is Prenatal stress and Factor 2 is Acute Stress, generate Excel file with the 
following parameters and column names: 
 
Filename: maleplasma; Column 1: Prenatal; Column 2: Acute; Column 3: Cort  
 
Step 1: Visualising the data in order to determine if there is equal variance 
 
boxplot(Cort~ Prenatal*Acute, data=maleplasma) 




Figure A1: Example of a 
check for equal variance. 
The spread of the data and 
the presence of any 















Figure A2: Example of 
a normality check. All 
data points should 
closely follow the 
straight line and should 









Step 3: Run two-way ANOVA 
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This will generate a read-out:  
 
Anova Table (Type III tests) 
Response: Cort 
               Sum Sq Df  F value    Pr(>F)     
(Intercept)    265771  1 122.1706 8.452e-13 *** 
Prenatal         3317  1   1.5249    0.2253     
Acute           59510  1  27.3559 8.631e-06 *** 
Prenatal:Acute    246  1   0.1131    0.7387     
Residuals       73964 34                        
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
A main effect of “Acute stress” is observed. There is no main effect of “Prenatal” 
stress nor Prenatal:Acute stress interaction. 
 





This will generate a read-out:  
 
Pairwise comparisons using t tests with pooled SD  
data:  Cort and interaction(Prenatal, Acute)  
 
          Con.Basal PNS.Basal Con.Swim 
PNS.Basal 0.53984   -         -        
Con.Swim  0.00147   0.00785   -        
PNS.Swim  6.1e-05   0.00039   0.26168  
 
P value adjustment method: none 
 
 
THREE WAY ANOVA 
 
For three way ANOVA, similar techniques apply, but with three factors instead of 
two factors. Using the example of male and female plasma corticosterone, where 
Factor 1: Prenatal Stress, Factor 2: Acute Stress, Factor 3: Sex (i.e. data from 
Figure 3A and 3G), generate Excel file with the following parameters: 
 
Filename: plasma;  
Column 1: Prenatal; Column 2: Acute; Column 3: Sex; Column 4: Cort  
 
Step 1: Visualising the data in order to determine if there is equal variance 
 
boxplot(Cort~ Prenatal*Acute*Sex, data=plasma) 
stripchart(Cort~ Prenatal*Acute*Sex, data=plasma, vertical=TRUE, 
method="jitter", add=TRUE) 
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plasmacort <- lm(Cort~ Prenatal*Acute*Sex, data=maleplasma) 
 
Step 3: Run three-way ANOVA 
 




This will generate a read-out:  
 
Anova Table (Type III tests) 
Response: Cort 
                   Sum Sq Df  F value    Pr(>F)     
(Intercept)        719630  1 179.0282 < 2.2e-16 *** 
Prenatal               19  1   0.0047   0.94538     
Acute              198517  1  49.3867 1.113e-09 *** 
Sex                 11980  1   2.9804   0.08869 .   
Prenatal:Acute       3569  1   0.8879   0.34929     
Prenatal:Sex         6113  1   1.5208   0.22162     
Acute:Sex            9202  1   2.2893   0.13477     
Prenatal:Acute:Sex   6760  1   1.6818   0.19895     
Residuals          281375 70                        
--- 
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1 
 
 
A main effect of “Acute stress” is observed. There were no three way interactions 
observed. There were no interactions of neither Prenatal or Acute stress with Sex. 
 
If variance is not equal and log transformation is required: 
 
plasma$Cortlog <- log(plasma$Cort) 
 
which generates a new column of log-transformed values.  
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Appendix B: Published paper “Sex-dependent changes in 
neuroactive steroid concentrations in the rat brain following 
acute swim stress” (Chapter 3) 
 
Main text: Page -451- to -469 
Supplementary information: Page -471- to -478- 
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amygdala	 and	 brainstem).	 Corticosterone,	 DOC	 and	 progesterone	 concentrations	





significantly greater in the brain and this effect was more pronounced in females 
than	males.	Basal	plasma	and	brain	concentrations	of	allopregnanolone	were	signifi‐
cantly	higher	in	females;	moreover,	stress	had	a	greater	impact	on	central	allopregna‐
nolone	 concentrations	 in	 females.	 Stress	 had	 no	 effect	 on	 circulating	 or	 brain	
concentrations	of	testosterone	in	males.	These	data	indicate	the	existence	of	sex	and	
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1  | INTRODUCTION
Steroid	hormones	play	a	crucial	 role	 in	regulating	physiological	 re‐
sponses	to	stress.	They	can	exert	their	actions	in	target	tissues	by	
binding	 to	classical	 steroid	 receptors,	which	 then	act	as	 transcrip‐
tion	 factors	 in	 the	 nucleus	 to	 alter	 gene	 expression.	 Additionally,	
steroids	can	act	in	a	nonclassical	manner.	Neuroactive	steroids	are	
active	metabolites	of	classical	steroid	hormones	that,	 independent	
of	 their	 source	 (ie,	 peripheral	 or	 central),	 exert	 rapid	 nongenomic	
effects	on	neuronal	excitability	by	binding	to	membrane	bound	ion	
channel‐linked	receptors,	thus	 influencing	neurotransmission.1 The 
brain	itself	can	produce	neuroactive	steroids	(referred	to	as	“neuros‐
teroids”),	via	local	de	novo	synthesis	from	cholesterol	or	through	the	
conversion of peripherally derived adrenal or gonadal steroids.1,2 In 
support	of	 this,	 the	brain	possesses	many	 steroidogenic	 enzymes,	
including 5α‐reductase	 and	 3α‐hydroxysteroid	 dehydrogenase	
(3αHSD)	which	 are	not	only	mainly	 expressed	by	glial	 cells,3‐5 but 
also found in neurones.6	 Furthermore,	 neurosteroids	 continue	 to	
be detected in the brain after combined adrenalectomy and go‐
nadectomy,7 providing evidence for local neurosteroidogenesis. 
Nevertheless,	the	synthesis	of	neurosteroids	is	reliant	upon	the	ex‐
pression	of	 the	prerequisite	 steroidogenic	 enzymes,	which	 exhibit	
significant regional differences in the brain.8
The major neuroendocrine response to stress is mediated via 
activation	 of	 the	 hypothalamic‐pituitary‐adrenal	 (HPA)	 axis,	which	
results in a net increase in circulating glucocorticoids following ac‐
tivation	 of	 corticotrophin‐releasing	 hormone	 (CRH)	 neurones	 in	
the	medial	 parvocellular	 paraventricular	 nucleus	 (mpPVN)	 and	 ad‐
renocorticotrophic	 hormone	 (ACTH)	 secretion	 from	 the	 anterior	
pituitary.	Glucocorticoids,	synthesised	in	the	adrenal	cortex,	act	at	
multiple targets in the body to facilitate the necessary metabolic 
and	behavioural	adaptations	required	for	stress	coping	and	restoring	
physiological	homeostasis.	Moreover,	glucocorticoids	provide	neg‐
ative‐feedback	 control	 of	 the	HPA	 axis	 through	 actions	 on	 gluco‐
corticoid	and	mineralocorticoid	receptors	in	the	brain	and	pituitary,	
crucial for terminating the stress response.
In	 addition	 to	 glucocorticoids,	 stress	 also	 results	 in	 a	 rapid	 in‐
crease in the secretion of other steroid hormones such as progester‐
one9	and	11‐deoxycorticosterone	(DOC)10	from	the	adrenal	cortex.	
In	the	brain,	these	steroids	can	be	further	metabolised	into	neuro‐
active	 steroids,	 such	 as	 5α‐dihydroprogesterone	 (DHP)	 and	5α‐di‐
hydrodeoxycorticosterone	(DHDOC)	by	5α‐reductase,	which	in	turn	
may	be	 converted	 into	 allopregnanolone	 and	 tetrahydrodeoxycor‐
ticosterone	(THDOC),	respectively,	by	3αHSD	(Figure	1),	which	are	





prevents	 the	 up‐regulation	 of	CRH	mRNA	 in	 the	mpPVN	 induced	
by	 adrenalectomy,	 attenuates	 stimulated	CRH	 release	 from	 hypo‐




itive	 allosteric	modulators	of	GABAA receptors; by prolonging the 
opening	time	of	chloride	ion	channels	within	GABAA	receptors,	they	
enhance	the	inhibitory	actions	of	GABA.19‐22	Given	that	the	PVN	is	
substantially	innervated	by	GABAergic	neurones23,24 and the major‐
ity	of	mpPVN	CRH	neurones	express	GABAA	receptors,
25 this pro‐
vides a means by which local neurosteroids may modulate inhibitory 
tone	over	the	HPA	axis.
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It	is	well	established	that	there	are	sex	differences	in	both	basal	
and	 stress‐induced	 activity	 of	 the	 HPA	 axis	 in	 rodents.	 Females	
generally display greater concentrations of circulating corticoste‐
rone under nonstress conditions and this is particularly evident at 
the onset of the dark phase.26,27	 In	addition,	the	HPA	axis	 is	more	
responsive	to	both	physical	and	psychological	stressors	in	females,	
than	males,	 as	 reflected	 by	 greater	 secretion	 of	 ACTH	 and	 corti‐




in males than in females.32‐34	Given	 that	 these	 regions	project	 in‐
directly	 to	 the	PVN	 (eg	 via	 a	 relay	 in	 the	bed	nucleus	of	 the	 stria	
terminalis)	and	exert	a	net	inhibitory	effect	on	HPA	axis	activity,35‐37 
lower stress responses in males may reflect greater inhibitory signal‐
ling	from	limbic	brain	regions	to	the	PVN.
The	 sex	 differences	 in	HPA	 axis	 activity	 have	 been	 largely	 at‐
tributed	to	gonadal	steroids,	given	that	oestradiol	typically	has	stim‐
ulatory	actions,	whereas	androgens	have	inhibitory	effects	on	HPA	
axis	 function.	 For	 example,	 ovariectomy	 decreases,38‐40 whereas 
orchidectomy	 increases,27,41‐47	 the	 HPA	 axis	 response	 to	 stress	
and these effects of gonadectomy can be normalised with testos‐
terone41,42,44,46 or oestradiol38	 replacement	 in	males	 and	 females,	
respectively.	However,	 the	effect	of	 testosterone	on	HPA	axis	ac‐
tivity is evidently mediated via the neuroactive metabolite of tes‐
tosterone,	 3β‐androstandiol	 (3β‐diol).48	 Likewise,	 studies	 indicate	
that progesterone may counteract some of the stimulatory effects 
of	oestradiol	on	HPA	axis	activity,49 although this is likely mediated 
via its 3α‐hydroxy	A	ring‐reduced	neuroactive	metabolite,	allopreg‐
nanolone.12,13	Despite	these	findings,	it	is	not	known	whether	there	
are	 sex	differences	 in	 the	 stress‐induced	neuroactive	 steroid	 con‐






amus.11,50‐52 In studies where male and females have been directly 
compared,	this	has	been	under	nonstress	conditions.53,54	To	date,	no	
study	has	 simultaneously	measured	 stress‐induced	 concentrations	
of	multiple	steroids	in	several	different	brain	regions.	Moreover,	to	
the	best	of	our	knowledge,	no	study	has	compared	changes	in	cen‐
tral steroid levels in response to stress in male and female rats in 
the	same	experiment.	Traditional	detection	methods	such	as	radio‐
immunoassays	 incur	 limitations:	 cross‐reactivity	 issues	may	hinder	
accuracy,	whereas	low	throughput	and	low	sensitivity	makes	quan‐






and female rats under nonstress and acute stress conditions. We 
aimed	to	establish:	(i)	which	steroids	(from	our	panel)	are	increased	
in	the	brain	by	acute	stress;	(ii)	whether	there	are	sex	and/or	regional	
differences	 in	 stress‐induced	 central	 steroid	 concentrations;	 and	
(ii)	whether	circulating	steroid	concentrations	correlate	with	 those	
found in the brain following stress.
2  | MATERIAL S AND METHODS
2.1 | Animals
Male	and	female	Sprague‐Dawley	rats	were	bred	in	the	rodent	facil‐











male	(randomly	cycling)	rats	between	10.00	am and 12.30 pm. Forced 
swimming	was	 used	 because:	 (i)	 it	 is	 a	 robust	 activator	 of	 the	HPA	
axis57,58;	(ii)	sex	differences	in	ACTH	and	corticosterone	secretion	have	
been demonstrated using this stressor57;	and	(iii)	it	is	a	combined	physi‐
cal	 and	 psychological	 stressor,	 and	 thus	 activates	 stress‐responsive	




a towel and returned to their home cage. Thirty minutes after the onset 
of	swimming	stress,	rats	were	rapidly	transferred	to	a	separate	room	
and	 killed	 by	 conscious	 decapitation.	 This	 time‐point	 has	 previously	
been shown to correspond with peak levels of immediate early gene 













RI,	 USA)	 and	 all	 solvents/chemicals	 used	 were	 high‐performance	
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liquid	chromatography	(HPLC)‐MS	grade.	Stock	solutions	of	steroid	
standards	(1	mg	mL‐1)	were	prepared	in	methanol	(Honeywell	Riedel‐
de	 Haën,	 Seelze,	 Germany)	 and	 stored	 at	 −20°C.	 Steroids	 were	
combined and diluted in methanol into a working stock solution con‐
taining a concentration of 10 μg	mL‐1	of	each	steroid	(except	for	allo‐
pregnanolone and progesterone with a concentration of 25 μg	mL‐1).	
On	 the	 day	 of	 sample	 processing,	 standards	were	 further	 diluted	
100‐fold	in	a	surrogate	matrix	4%	(w/v)	bovine	serum	albumin	(BSA)	
(VWR,	Leicester,	UK)	 in	PBS,	 followed	by	a	serial	2.5‐fold	dilution	
in	 4%	BSA	 to	 produce	 seven	 calibrants.	 The	 calibration	 standards	
used	ranged	from	41	to	10	000	pg	mL‐1	for	corticosterone,	DOC	(4‐
pregnen‐21‐ol‐3,20‐dione),	DHDOC	(5α‐pregnan‐21‐ol‐3,20‐dione),	
testosterone,	 pregnenolone	 and	 DHP	 (5α‐pregnane‐3,20‐dione),	
and	102.4	to	25	000	pg	mL‐1 for progesterone and allopregnanolone 








processing	 (n	=	7	per	group	per	 sex,	 except	 for	 the	 frontal	 cortex,	




1%	 formic	 acid	 (Fisher	 Scientific,	 Loughborough,	 UK).	 For	 plasma	
and	standards,	400	μL	of	methanol	containing	1%	formic	acid	was	











Steroids	 in	 both	 plasma	 and	 brain	 samples	 were	 extracted	 by	
solid	 phase	 extraction	 using	DSC‐Discovery	 C18	 100	mg	 columns	
(#52602‐U;	 Supelco,	 Belfont,	 PA,	 USA).	 Columns	 were	 activated	
with	1	mL	of	methanol	and	equilibrated	with	another	1	mL	of	30%	
methanol.	Diluted	supernatants	 from	homogenates	 (approximately	
3	mL)	 were	 then	 loaded,	 followed	 by	 two	 1‐mL	 washes	 of	 50%	
methanol.	All	steps	were	assisted	by	centrifugation	at	50	g	(average	
flow	 rate	of	0.5	mL	min‐1).	 Steroids	were	eluted	with	1	mL	of	85%	


















HPLC	system	coupled	 to	an	AmaZon	ETD	 ion	 trap	mass	spectrom‐
eter	 (Bruker	 Daltonics,	 Bremen,	 Germany).	 Separation	 of	 steroids	
on	reverse	phase	HPLC	was	achieved	on	the	ACE	UltraCore	2.5	μm 
Super	 C18	 column	 (75	mm	 by	 2.1	mm	 inner	 diameter;	 Advance	
Chromatography	Technologies,	Aberdeen,	UK)	maintained	at	40°C.	
Gradient	 elution	 was	 performed	 (see	 Supporting	 information,	
Table	S1)	with	the	mobile	phase	consisting	of	50	mmol	L‐1 ammonium 




fragmentation.	 Injections	 for	 all	 samples,	 including	 calibrants,	were	
carried out in duplicate. The method allowed us to simultaneously 
determine	 the	 concentrations	 of	 eight	 steroids:	 corticosterone,	
DOC,	DHDOC,	pregnenolone,	progesterone,	DHP,	allopregnanolone	
and	 testosterone	 (Figure	2)	with	 a	 total	 runtime	of	 19	minutes	 (see	





the validation criteria and thus these data are not included.
Data	 were	 acquired	 using	 hystar	 software	 (Bruker	 Daltonics,	
Bremen,	 Germany)	 and	 peak	 area	 under	 the	 curve	was	 extracted	
and automatically integrated using quantanalysis,	version	2.0	(Bruker	
Daltonics).	The	ratio	of	the	peak	area	of	the	target	analyte	and	the	
peak	 area	 of	 progesterone‐d9	was	 used	 to	 construct	 the	 calibra‐
tion	 curve.	 The	 seven‐point	 calibration	 curves	 were	 linear	 for	 all	
analytes	 (see	Supporting	 information,	Table	S3).	Concentrations	of	
samples	were	extrapolated	and	converted	to	ng	mL‐1	(for	plasma)	or	




and the concentrations of steroids detected in the plasma and brain 








circulating and brain concentrations of steroids were determined 
using	Pearson’s	correlation	coefficients	(sigmaplot,	version	11.0),	and	
males	and	females	were	analysed	separately.	In	each	case,	P	≤	0.05	





and	 sex	 (F1,24	=	54.7,	 P	<	0.001)	 on	 corticosterone	 secretion	 and	
also	 a	 significant	 stress	×	sex	 interaction	 F1,24	=	4.38,	 P	=	0.047).	
Plasma corticosterone concentrations were significantly greater in 
the	 stressed	 group	 compared	 to	 the	 control	 group	 in	 both	 sexes,	
with females displaying significantly greater plasma corticosterone 
concentrations compared to males under both stress and nonstress 
conditions	(Figure	3).
3.1.2 | Brain
There were no significant differences detected in basal corticoster‐
one concentrations between males and females in any of the brain 
regions	 (Figure	3).	There	were	 significant	main	effects	of	 stress	 in	
each	of	the	five	brain	regions	examined	(frontal	cortex,	F1,23	=	50.6,	
P	<	0.001;	 hypothalamus,	 F1,23	=	26.7,	 P	<	0.001;	 amygdala,	
F1,23	=	14.8,	P	<	0.001;	hippocampus,	F1,24	=	45.4,	P < 0.001; brain‐
stem,	 F1,24	=	21.3,	 P	<	0.001),	 with	 corticosterone	 concentrations	
being significantly greater in the stressed rats compared to the non‐
stressed	rats	 in	both	sexes	(Figure	3).	There	was	a	significant	main	
effect	of	sex	observed	only	in	the	brainstem	(F1,24	=	5.30,	P	=	0.03),	
where	 corticosterone	 concentrations	 were	 1.8‐fold	 greater	 in	
stressed females compared to stressed males.
3.1.3 | Correlations between central and circulating 
corticosterone





There was no significant difference in plasma DOC concentrations 
between	males	 and	 females	under	nonstress	 conditions;	 however,	
F I G U R E  2  Representative	chromatogram	of	the	analytes.	For	some	analytes,	a	double	peak	was	observed	as	a	result	of	the	presence	
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There were no differences in basal concentrations of DOC be‐
tween	males	and	females	in	any	of	the	regions	studied	(Figure	4).	
There were significant main effects of stress in all five brain re‐
gions	 (frontal	 cortex:	 F1,23	=	72.0,	 P < 0.001; hypothalamus: 
F1,23	=	37.1,	 P < 0.001; amygdala: F1,23	=	56.7,	 P < 0.001; hip‐
pocampus: F1,24	=	103.1,	 P < 0.001; brainstem: F1,24	=	105.1,	
P	<	0.001).	Central	DOC	concentrations	were	significantly	greater	
in the stressed groups compared to the basal groups for both 
sexes	 (Figure	4).	 There	 were	 additional	 main	 effects	 of	 sex	 ob‐
served	for	the	hippocampus	(F1,24	=	5.34,	P	=	0.03)	and	brainstem	
(F1,24	=	14.4,	P	<	0.001)	and	a	stress	×	sex	interaction	in	the	brain‐
stem	 (F1,24	=	12.9,	 P	=	0.001).	 Comparing	 the	 stressed	 groups,	
females had significantly greater DOC concentrations in the hip‐
pocampus and brainstem compared to males but not in the frontal 
cortex,	hypothalamus	or	amygdala	(Figure	4).
3.2.3 | Correlations between central and 
circulating DOC
There were significant positive correlations between DOC con‐






F I G U R E  3  Effect	of	swim	stress	on	corticosterone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	
the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	


































S NS S NS S NS S NS S





































































































     |  7 of 19SZE Et al.
Steroid Region
Males Females
r P value R P value
Corticosterone Frontal	cortex 0.89 <0.001*** 0.88 <0.001***
Hypothalamus 0.81 <0.001*** 0.55 0.051*
Amygdala 0.51 0.062 0.73 0.005**
Hippocampus 0.82 <0.001*** 0.62 0.017*
Brainstem 0.62 0.019* 0.70 0.006**
DOC Frontal	cortex 0.80 0.001*** 0.90 <0.001***
Hypothalamus 0.76 0.002** 0.75 0.003**
Amygdala 0.75 0.002** 0.85 <0.001***
Hippocampus 0.87 <0.001*** 0.88 <0.001***
Brainstem 0.84 <0.001*** 0.88 <0.001***
DHDOC Frontal	cortex −0.07 0.826 0.23 0.459
Hypothalamus 0.04 0.888 0.60 0.032*
Amygdala 0.80 0.001*** 0.92 <0.001***
Hippocampus 0.19 0.525 0.68 0.008**
Brainstem −0.23 0.427 −0.16 0.591
Pregnenolone Frontal	cortex −0.010 0.738 −0.02 0.942
Hypothalamus 0.14 0.631 0.40 0.170
Amygdala 0.53 0.051* 0.56 0.045*
Hippocampus 0.06 0.828 0.48 0.079
Brainstem −0.25 0.388 −0.15 0.619
Progesterone Frontal	cortex 0.94 <0.001*** 0.90 <0.001***
Hypothalamus 0.98 <0.001*** 0.82 0.001***
Amygdala 0.99 <0.001*** 0.83 <0.001***
Hippocampus 0.94 <0.001*** 0.89 <0.001***
Brainstem 0.93 <0.001*** 0.88 <0.001***
DHP Frontal	cortex 0.17 0.571 0.18 0.552
Hypothalamus −0.28 0.342 0.50 0.086
Amygdala 0.83 <0.001*** 0.94 <0.001***
Hippocampus 0.01 0.747 0.66 0.011*
Brainstem −0.20 0.491 0.11 0.710
Allopregnanolone Frontal	cortex −0.03 0.918 −0.02 0.952
Hypothalamus 0.04 0.907 0.35 0.246
Amygdala 0.59 0.026* 0.54 0.055
Hippocampus 0.43 0.127 0.35 0.227
Brainstem 0.41 0.143 −0.11 0.710










TA B L E  1   Correlation between central 
and circulating steroids
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3.3.2 | Brain
There	were	significant	main	effects	of	stress	in	all	brain	regions,	ex‐
cept	for	the	amygdala	(frontal	cortex,	F1,23	=	16.1,	P < 0.001; hypo‐
thalamus,	F1,23	=	8.46,	P	=	0.008;	hippocampus,	F1,24	=	7.67,	P	=	0.01;	
brainstem,	F1,24	=	5.68,	P	=	0.025)	(Figure	5).	There	were	significant	
main	 effects	of	 sex	on	DHDOC	concentrations	 in	 the	 frontal	 cor‐
tex	 (F1,23	=	6.09,	 P	=	0.02)	 and	 brainstem	 (F1,24	=	4.35,	 P	=	0.048).	
In	the	frontal	cortex,	DHDOC	concentrations	were	greater	in	both	
the stressed males and females compared to their respective con‐
trol	 groups,	with	 stress‐induced	 concentrations	 being	 significantly	
greater	 in	females	compared	to	males.	However,	 in	the	hypothala‐
mus,	hippocampus	and	brainstem,	stress	resulted	in	greater	DHDOC	
concentrations only in females.








There were no significant differences in plasma pregnenolone con‐
centrations	between	any	of	the	groups	(Figure	6).
F I G U R E  4  Effect	of	swim	stress	on	DOC	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	the	stressed	
group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	significant	sex	
differences	with	the	same	stress	status	(#P < 0.05; ##P < 0.01; ###P	<	0.001).	After	stress	exposure,	sex	differences	were	detected	for	DOC	
concentrations	in	the	plasma,	hippocampus	and	brainstem.	n	=	6‐7	rats	per	group
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3.4.2 | Brain
There	 was	 a	 significant	 main	 effect	 of	 sex	 (frontal	 cortex,	
F1,23	=	5.44,	 P	=	0.029;	 hypothalamus,	 F1,23	=	7.75,	 P	=	0.01;	 amyg‐
dala,	 F1,23	=	20.2,	 P < 0.001; hippocampus F1,24	=	27.3,	 P < 0.001; 
brainstem,	 F1,24	=	19.1)	 and	 stress	 (frontal	 cortex,	 F1,23	=	39.2,	
P	<	0.001;	 hypothalamus,	 F1,23	=	10.4,	 P	=	0.004;	 amygdala,	
F1,23	=	40.9,	P < 0.001; hippocampus; F1,24	=	39.9,	P < 0.001; brain‐
stem,	 F1,24	=	26.7)	 in	 all	 of	 the	 brain	 regions	 examined	 (Figure	6).	
There	was	also	a	significant	sex	×	stress	interaction	in	the	brainstem	
(F1,24	=	4.89),	 amygdala	 (F1,23	=	12.8,	 P	=	0.002)	 and	 hippocampus	
(F1,24	=	7.25,	P	=	0.01).	There	was	no	difference	in	basal	levels	of	preg‐
nenolone	in	the	brain	between	the	sexes	(Figure	6).	Following	stress,	
both males and females had greater pregnenolone concentrations 
than	their	respective	control	groups	in	all	brain	regions,	except	for	
the	hypothalamus,	where	only	females	showed	significantly	greater	
pregnenolone concentrations compared to nonstressed females. For 
each	brain	region	examined,	stress‐induced	pregnenolone	concen‐
trations	were	greater	in	females	versus	males	(Figure	6).
3.4.3 | Correlations between central and circulating 
pregnenolone
For	 both	males	 and	 females,	 the	 only	 significant	 correlation	 ob‐
served with plasma concentrations of pregnenolone was in the 
amygdala	(Table	1).	No	other	significant	correlations	were	detected	




and	 sex	 (F1,24	=	49.7,	 P	<	0.001)	 and	 also	 a	 significant	 stress	×	sex	








































































































NS S NS S NS S NS S
NS S NS S NS S NS S NS S NS S
10 of 19  |     SZE Et al.
interaction	(F1,24	=	10.8,	P	=	0.003)	in	plasma	progesterone	concen‐
trations.	Under	basal	 conditions,	 circulating	progesterone	was	 sig‐
nificantly	greater	 in	 females	compared	to	males	 (Figure	7).	 In	both	




regions	 examined	 (frontal	 cortex:	 stress	 F1,23	=	62.6,	 P < 0.001 
and	 sex	 F1,23	=	13.6,	 P	=	0.001;	 hypothalamus:	 stress	 F1,23	=	48.3,	
P	<	0.001	 and	 sex	 F1,23	=	28.7,	 P < 0.001; amygdala: stress 
F1,23	=	50.7,	P	<	0.001	and	sex	F1,23	=	23.0,	P < 0.001; hippocampus: 
stress F1,24	=	53.9,	P	<	0.001	and	 sex	F1,24	=	38.9,	P < 0.001; brain‐
stem: stress F1,24	=	31.9	and	sex	F1,24	=	18.8).	There	were	also	stress	
×	 sex	 interactions	 observed	 for	 the	 hypothalamus	 (F1,23	=	8.14,	




Following	 stress,	 progesterone	 concentrations	 in	 all	 five	 brain	 re‐
gions were significantly higher than those measured under basal 
conditions	 in	 both	 sexes.	 Moreover,	 in	 each	 case,	 stress‐induced	
progesterone concentrations were greater in females than in males 
(Figure	7).
3.5.3 | Correlations between central and circulating 
progesterone
There were significant positive correlations between circulating pro‐
gesterone concentrations and those measured in all five brain re‐
gions	for	both	males	and	females	(Table	1).
F I G U R E  6  Effect	of	swim	stress	on	pregnenolone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	
the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	
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trations in the hypothalamus were significantly greater in females 








3.6.3 | Correlations between central and 
circulating DHP
There	were	significant	positive	correlations	observed	between	DHP	





F I G U R E  7  Effect	of	swim	stress	on	progesterone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	
in	the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	
denote	significant	sex	differences	within	the	same	stress	status	(#P < 0.05; ##P < 0.01; ###P	<	0.001).	Following	stress,	sex	differences	in	
progesterone	concentrations	were	detected	in	the	plasma	and	all	regions	of	the	brain.	n	=	6‐7	rats	per	group.	Note	the	difference	in	the	
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tions	were	significantly	greater	 in	females	than	 in	males	 (Figure	9).	
There was no main effect of stress on plasma allopregnanolone con‐
centrations	in	either	sex	(Figure	9).
3.7.2 | Brain
There	were	 significant	main	 effects	 of	 sex	 on	 allopregnanolone	
concentrations	for	each	of	the	brain	regions	examined	(frontal	cor‐
tex,	F1,23	=	14.9,	P	<	0.001;	hypothalamus,	F1,23	=	13.1,	P	=	0.001;	
amygdala,	 F1,23	=	80.2,	 P	<	0.001;	 hippocampus,	 F1,24	=	20.9,	
P	<	0.001;	 brainstem,	F1,24	=	40.2,	P	<	0.001).	 A	 significant	main	
effect of stress was observed for allopregnanolone concen‐
trations	 in	 the	 frontal	 cortex	 (F1,23	=	5.71,	 P	=	0.03),	 amygdala	
(F1,23	=	27.6,	P	<	0.001)	and	brainstem	(F1,24	=	9.08,	P	=	0.006).	A	
stress	×	sex	 interaction	 was	 additionally	 observed	 in	 the	 amyg‐
dala	 (F1,23	=	14.8,	P	<	0.001).	 Basal	 allopregnanolone	 concentra‐
tions were significantly greater in females than in males in all of 
the	brain	regions,	except	the	hypothalamus,	where	a	tendency	for	
higher	 levels	 was	 observed	 (P	=	0.07)	 (Figure	9).	 Stress	 resulted	
in significantly greater allopregnanolone concentrations in the 
frontal	cortex,	amygdala	and	brainstem	compared	to	nonstressed	
females	(Figure	9).	Similar	trends	were	observed	in	the	male	brain,	
although this only reached statistical significance for the frontal 
cortex.
F I G U R E  8  Effect	of	swim	stress	on	DHP	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	in	the	stressed	
group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	significant	sex	
differences	within	the	same	stress	status	(#P < 0.05; ##P	<	0.01).	Under	nonstress	conditions,	DHP	concentrations	were	greater	in	the	
hypothalamus	of	females	compared	to	males	and	a	similar	trend	was	detected	in	the	brainstem	(P	=	0.06).	Following	stress,	significant	sex	
differences	in	DHP	concentrations	were	detected	in	the	hypothalamus,	amygdala	and	brainstem.	n	=	6‐7	rats	per	group.	Note	the	difference	
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3.7.3 | Correlations between central and circulating 
allopregnanolone
In	both	sexes,	only	allopregnanolone	concentrations	in	the	amygdala	




There was no significant effect of stress on plasma testosterone 
concentrations	 in	males	(1.05	±	0.28	ng	mL‐1 in nonstressed rats vs 





regions in females. There was no significant effect of stress on central 
testosterone	concentrations	 in	male	 rats	 (frontal	 cortex,	2.20	±	0.45	
vs	2.20	±	0.58	ng	g‐1;	hypothalamus,	2.79	±	0.62	vs	3.15	±	1.23	ng	g‐1; 
amygdala,	0.88	±	0.17	vs	1.03	±	0.24	ng	g‐1;	hippocampus,	1.17	±	0.21	
vs	1.71	±	0.61	ng	g‐1;	brainstem,	2.03	±	0.19	vs	2.90	±	0.35	ng	g‐1 in the 
stressed	and	nonstressed	groups,	respectively).
F I G U R E  9  Effect	of	swim	stress	on	allopregnanolone	concentrations	in	the	plasma	and	brain.	Asterisks	denote	significant	differences	
in	the	stressed	group	(S)	compared	to	the	nonstressed	group	(NS)	within	the	same	sex	(*P	<	0.05;	**P	<	0.01;	***P	<	0.001);	hashes	denote	
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3.8.3 | Correlations between central and circulating 
testosterone
Concentrations	of	testosterone	in	the	frontal	cortex,	amygdala,	hy‐




on the circulating and central steroid profile in male and female rats. 
Several	key	findings	emerged	in	the	present	study.	We	show	for	the	
first	 time	 there	 are	 clear	 sex	 differences	 in	 the	 brain’s	 steroid	 re‐
sponse	to	acute	swim	stress	in	the	rat,	with	females	typically	show‐
ing markedly greater concentrations in most cases. We also report 
that,	although	concentrations	of	corticosterone,	progesterone	and	
DOC in the brain are positively correlated with those measured in 
the	circulation,	this	is	not	the	case	for	pregnenolone,	DHP,	DHDOC	
and	allopregnanolone,	supporting	the	concept	of	the	de	novo	syn‐
thesis of these neurosteroids in the brain in response to stress.7,11 
Lastly,	 although	 the	effect	of	 stress	on	 the	 steroidal	milieu	of	 the	
brain	was	 largely	 global,	 we	 did	 find	 evidence	 for	 regional	 differ‐
ences	 (Figure	10),	 particularly	 for	 DHDOC	 and	 allopregnanolone,	
which may be of functional relevance.




ticosterone	 under	 basal	 conditions	 and	 a	 larger	 increase	 in	ACTH	
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heightened	sensitivity	of	the	anterior	pituitary	to	CRH	and	the	ad‐
renal	gland	to	ACTH,	as	well	as	a	greater	capacity	for	glucocorticoid	
synthesis	in	the	adrenal	glands,66 probably as a result of the actions 
of oestradiol.39	In	the	brain,	CRH	mRNA	expression	in	the	mpPVN	
is	 increased	 following	 stress	 to	 a	 greater	 extent	 in	 females	 than	
in	males,31	which	may	be	 further	 compounded	by	diminished	GR‐
mediated	 negative‐feedback	 control	 of	 the	HPA	 axis	 in	 females.67 
Interestingly,	despite	sex	differences	 in	the	plasma,	corticosterone	
concentrations in the female brain were not different from those 
in	 males,	 except	 for	 in	 the	 brainstem.	 This	 is	 consistent	 with	 the	
finding of similar circadian corticosterone rhythms and concentra‐
tions	in	the	brains	of	males	and	females,	despite	differences	in	the	









have	 been	 reported	 in	 the	 brain,70 suggesting that differences in 
local corticosterone synthesis could also potentially contribute.
Under	 nonstress	 conditions,	 circulating	 progesterone	 concen‐
trations	 were	 greater	 in	 females	 than	 males,	 which	 is	 consistent	
with previous findings53,71;	however,	there	was	no	sex	difference	in	
plasma	DOC	 concentrations.	 Following	 stress,	 circulating	 concen‐




hydroxylase	 gene	 expression	 and	 activity	 in	 the	 rodent	 brain,72,73 
DOC is considered to be primarily synthesised from progesterone in 
the	adrenal	cortex	and	is	secreted	from	the	adrenal	glands,	together	
with	progesterone,	in	response	to	stress.9,10 Consistent with this was 
our finding of a positive correlation between circulating DOC and 
progesterone	concentrations	and	those	in	the	brain,	indicating	that	




in DOC metabolism in limbic brain regions in females or that circulat‐
ing DOC more readily accesses the brainstem.
Importantly,	DOC	and	progesterone	mediate	rapid	nongenomic	
effects indirectly via their downstream neuroactive metabolites 
THDOC	 and	 allopregnanolone	 (Figure	1),	 which	 act	 as	 allosteric	
modulators	 of	 GABAA receptor activity
1,74 to enhance inhibitory 







ulation	was	 observed	 depending	 on	 sex	 and	 brain	 region.	 For	 ex‐
ample,	DHDOC	concentrations	were	found	to	be	increased	only	in	
the	 frontal	 cortex	of	males	 following	 stress,	whereas,	 for	 females,	










and 3α‐HSD	 in	 the	 adult	 brain,76‐79	with	 sexual	 dimorphic	 expres‐
sion	being	displayed	after	 stress	exposure.80	Any	direct	effects	of	
DHDOC	and	DHP	are	unclear,	although	DHP	is	known	to	have	af‐
finity for the progesterone receptor81	and	DHDOC	can	potentiate	




activity in response to stress via potentiating the inhibitory effects 
of	GABA	are	well	established.12‐14,16,74,82,83	Unfortunately,	we	were	
unable	to	reliably	quantify	THDOC	using	our	method;	however,	we	
were	 able	 to	 measure	 allopregnanolone.	 Under	 nonstress	 condi‐
tions,	circulating	and	central	allopregnanolone	concentrations	were	
greater	in	females	than	in	males,	which	is	consistent	with	previous	
findings.54,71 We did not observe a significant increase in circulating 
allopregnanolone	concentrations	30	minutes	 after	 stress	exposure	
in	either	 sex,	 in	 contrast	 to	previous	 studies	 in	male	 rats.11,52 The 




the brain.11	 Nevertheless,	 following	 stress,	 allopregnanolone	 con‐
centrations	were	greater	in	the	frontal	cortex,	amygdala	and	brain‐
stem	of	females	compared	to	controls,	as	well	as	in	the	frontal	cortex	
of	males,	 consistent	with	previous	 findings.11,52	 Sex	differences	 in	
central allopregnanolone concentrations may result from greater 
concentrations	 of	 the	 precursors,	 progesterone	 and	 DHP	 and/
or	sex	differences	in	the	activity	of	the	converting	enzymes	in	the	
brain. The strong positive correlation between central and periph‐
eral	progesterone	concentrations,	coupled	with	a	lack	of	correlation	
between	circulating	and	central	allopregnanolone,	and	its	precursor	
DHP,	 suggests	 that	DHP	 and	 allopregnanolone	 are	 synthesised	 in	
the	brain	from	progesterone	following	stress;	however,	it	would	be	
necessary	to	measure	the	activity	of	the	converting	enzymes	in	the	
brain to confirm this. Caruso et al54 report a positive correlation 
between progesterone concentrations in the plasma and cerebral 
cortex	in	rats,	which	is	consistent	with	our	findings;	however,	in	con‐
trast	 to	 the	present	 study,	 they	also	observed	a	direct	 correlation	
between	 pregnenolone,	 DHP	 and	 allopregnanolone	 levels	 in	 the	
16 of 19  |     SZE Et al.
plasma	and	cerebral	cortex.	The	reason	for	this	difference	is	unclear;	
however,	it	is	important	to	note	that	the	correlations	performed	in	
the present study included data from both stressed and nonstressed 
rats	within	the	same	sex,	whereas,	in	the	previous	study,	correlations	
were analysed only under basal conditions with data from male and 
female	 rats	combined.	Thus,	 it	 is	 likely	 that	 the	 lack	of	correlation	




ported in the present study are of functional importance with re‐
spect	 to	 HPA	 axis	 regulation	 and	 further	 studies	 are	 needed	 to	
establish	 whether	 other	 stressors	 result	 in	 similar	 effects.	 Unlike	




preoptic	 area,	which	 exert	 considerable	 inhibitory	 tone	 over	CRH	
neurones.24,36	 Thus,	 it	 is	 conceivable	 that	 sex	differences	 in	 brain	
concentrations	 of	 neurosteroids	with	GABAA receptor agonist ac‐






pregnenolone,	 was	 also	 increased	 throughout	 the	 brain	 following	
stress,	 and	 to	 a	 greater	 extent	 in	 the	 brains	 of	 females.	 This	may	
indicate	that,	 in	females,	either	p450scc	is	more	highly	expressed/




One point to note is that the females used in the present study 
were	randomly	cycling,	which	may	be	expected	to	influence	the	ste‐
roid	concentrations	 in	 the	brain.	However,	 there	 is	very	 little	vari‐
ation	 in	brain	concentrations	of	pregnenolone,	progesterone,	DHP	
or allopregnanolone across the oestrous cycle when these are mea‐
sured	 in	 the	morning	 (as	 they	were	 in	 the	 present	 study);	 indeed,	
circadian fluctuations in these steroids are far greater than those re‐
lating to any stage of the oestrous cycle.84	Moreover,	oestrous	cycle	
stage does not affect basal corticosterone secretion85 or the corti‐
costerone response to swim stress86 when sampling is performed in 
the morning.
The	 mechanisms	 involved	 in	 stress‐induced	 increases	 in	 neu‐
roactive steroid levels in the brain have yet to be established. One 
study	has	 indicated	 that	CRH	 increases	 concentrations	of	 proges‐















Moreover,	GABA	or	GABAA receptor agonists inhibit the de novo 
synthesis of neurosteroids94 and neurosteroidogenic neurones are 
evidently	under	 tonic	 inhibition	by	GABA.94	Given	that	some	neu‐
roactive	 steroids,	 such	 as	 allopregnanolone,	 are	 potent	 allosteric	
modulators	of	GABAA	receptor	 function,
19‐21 it is conceivable that 
neurosteroids may control their own production by regulating the 
activity	of	GABAA receptors. Whether such a mechanism contrib‐






and	 indicate	 sex‐specific	 expression	 of	 steroidogenic	 enzymes	 in	
the	 brain.	 Taken	 together,	 our	 data	 also	 support	 a	 role	 for	 the	 de	
novo	synthesis	of	neurosteroids	by	the	brain	following	stress,	partic‐
ularly those derived from 5α‐reductase	activity	 (ie,	DHDOC,	DHP,	
allopregnanolone).	The	neurosteroid	 response	 to	 stress	 is	 likely	 to	
be adaptive and disparate neurosteroidogenesis may contribute to 
sex	differences	in	HPA	axis	function;	however,	it	is	unclear	whether	
greater neuroactive steroid levels in females confer an overall ad‐
vantage	 or	 disadvantage.	 Stress‐induced	 increases	 in	 neuroactive	
steroids are likely to have important neuroendocrine and/or be‐
havioural	effects	to	aid	stress	adaptation.	For	example,	 in	addition	
to	modulating	HPA	axis	activity,	allopregnanolone	is	known	to	have	
anxiolytic	 and	analgesic	 actions.82,96	 Sex	differences	 in	 the	brain’s	
response to stress may account for differences in the propensity to 
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Supplementary Figure 1 
 
 
Supplementary Figure 1: Schematic illustrating landmarks used for gross dissection of the different 
brain regions of interest.    
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Supplementary Figure 2: Workflow for sample processing. 
Brain and plasma samples were processed as above (left column), before solid phase extraction and 
derivatisation with Girard’s T (right column).  
S4 
 
 Supplementary Table 1 
LC parameters  
Injection volume 5µl; Partial loop injection 
Flow rate 0.2 ml/min 
Column temperature 40oC 
Injection needle rinse 20% Methanol 
Gradient:  
-4 min to 0 min 5% B 
0 min Sample injection 
0 min to 1 min 5% B to 20% B 
1 min to 6 min 45% B to 50% B 
6 min to 11 min 50% B 
11 min to 12 min 50% B to 100% B 
12 min to 14 min 100% B 
14 min to 15 min 100% to 5% B 
Divert to waste Before 2 min, after 12 min 
Total run time 19 min 
MS parameters  
Electrospray ionisation mode Positive 
Capillary current -4500V 
Nebulizer gas Nitrogen; 16 psi 
Dry gas 8 L/min  
Dry temperature 150oC 
 
Supplementary Table 1: Instrumentation set-up for liquid chromatography (top panel) and mass 












time (min)  
Segment Amplitude; 
Cut-Off 
Corticosterone 346.5 460.2 401.1 3.5 1 117; 0.80 
Testosterone 288.4 402.2 343.1 4.4 1 117; 0.80 
DOC 330.5 444.2 385.1 4.6 1 120; 0.95 
DHDOC 332.5 446.2 387.1 6.1 2 116; 0.80 
Pregnenolone 316.5 430.2 371.1 6.3 2 116; 0.75 
Progesterone-d9 323.5 437.5 368.3 8.2 3 116; 0.70 
Progesterone 314.5 428.2 369.1 8.4 3 116; 0.75 
DHP 316.5 430.2 371.1 8.6 3 116; 0.75 
Allopregnanolone 318.5 432.2 373.1 10.4 4 116; 0.70 
 
Supplementary Table 2: Analytical parameters 
Analytical parameters for the target compounds and the internal standard (progesterone-d9). 
Derivatisation with Girard’s T reagent produced a precursor ion [M + G.T.]+, resulting in an addition 
of 114 Da to its absolute mass. Upon fragmentation by collision-induced fragmentation, a product 
ion with neutral loss of 59.1 Da (corresponding to the loss of the trimethylamine moiety) was 
produced, which was used for identification and quantification. Detection was carried out via 
multiple reaction monitoring, where no more than 3 analytes were monitored for each segment. 
Amplitude and cut-off parameters were optimised beforehand using a direct infusion method with a 




Supplementary Table 3 
Analyte r2 LOQ  (pg/ml) LOQ (pg, on column) Calibration range (pg/ml) 
Corticosterone 0.998 41 0.41 41 - 10000 
DOC 0.998 41 0.41 41 - 10000 
DHDOC 0.997 102.4 1.02 102.4 - 10000 
Progesterone 0.998 256 2.56 256 - 25000 
DHP 0.998 102.4 1.02 102.4 - 10000 
Pregnenolone 0.998 102.4 1.02 102.4 - 10000 
Allopregnanolone 0.996 256 2.56 256 - 25000 
Testosterone 0.997 41 0.41 41 - 10000 
 
Supplementary Table 3: Details of calibration curves 
Calibration curves were constructed using the ratio of peak area of the target analyte and the peak 
area of progesterone-d9. Correlation coefficients (r2) were calculated by weighted (1/x) regression 
analysis, obtained from the means of 6 calibration curves. The lower limit of quantification (LOQ) 
was defined as the concentration on the standard curve with a peak that is identifiable, discrete with 
a relative standard deviation of less than 20% and at least five times the signal of the blank. As 
100µL of calibrant was used for sample processing, and only 5µL of the final reconstituted sample 
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Corticosterone Low 500 74 16.9 24.9 111 
 Medium 2000 71 19.5 22.9 104 
 High 8000 84 14.4 22.0 98 
DOC Low 500 78 13.1 16.3 111 
 Medium 2000 72 16.8 25.5 101 
 High 8000 92 16.3 10.0 99 
DHDOC Low 500 95 16.5 15.1 140 
 Medium 2000 82 6.6 24.9 113 
 High 8000 108 9.0 7.8 112 
Progesterone Low 1250 71 17.9 13.7 126 
 Medium 5000 80 5.5 6.5 98 
 High 20000 83 8.0 4.1 104 
DHP Low 500 73 13.0 9.3 136 
 Medium 2000 70 10.8 14.7 103 
 High 8000 82 8.3 9.5 97 
Pregnenolone Low 500 88 17.6 24.8 110 
 Medium 2000 81 8.4 16.6 89 
 High 8000 95 12.5 9.6 93 
Allopregnanolone Low 1250 88 17.1 20.6 124 
 Medium 5000 87 6.3 18.8 102 
 High 20000 94 12.2 16.8 103 
Testosterone Low 500 95 18.5 16.5 132 
 Medium 2000 105 7.7 8.8 106 
 High 8000 106 10.4 10.3 109 
 
Supplementary Table 4: Assay performance characteristics 
Assay precision was examined using low, medium or high concentration (conc) of quality control 
standards (QC low, QC medium, QC high) in 4% BSA. 100 µl of QC standards were used and were 
processed as described in the methods, along with a set of standard calibrants. Intra-assay variability 
referred to the relative standard deviation (% RSD) of the values (pg/ml) obtained from four 
independent samples in a single run, against a single calibration curve. Inter-assay variability 
referred to the % RSD of four independent samples across four different runs, against four different 
calibration curves. Recovery was determined by comparing the peak areas for QC standards spiked 
before and after solid phase extraction (n=3). Accuracy was calculated using the following formula: 
‘(obtained concentration/known concentration) x 100%’, using the means of four independent 
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Appendix C: Additional comparisons of steroid 
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Appendix C1: Three-way ANOVA analysing effects of acute stress X prenatal 
stress X sex on neuroactive steroid concentrations (Chapter 4) 
Three-way ANOVAs were carried out in R-studio using natural log transformed data 
(except for corticosterone), with sex, acute stress and prenatal stress as the main 
factors investigated.  There were no main effects of prenatal stress observed in any 
of the analytes in any of the regions, and there were also no three-way interactions 
in any of the analytes observed. Two-way interactions were present, especially for 
progesterone, DHP and allopregnanolone. This was mostly due to the differential 
response in progesterone and its metabolites following swim stress in the female 
offspring, discussed in section 4.4.4. Main effects of acute stress were observed for 
all analytes except for testosterone. Robust main effects of sex were also observed 
for almost all analytes in all tissues, indicating differences in absolute concentrations 
of steroids.  
 
 
Sex Acute Stress Prenatal Stress
Plasma ns F1,70=49.3, *** ns ns
Frontal Cortex F1,70=5.43, * F1,70=44.8, *** ns ns
Hypothalamus F1,70=10.7, ** F1,70=49.7, *** ns ns
Hippocampus ns F1,70=87.3, *** ns Prenatal Stress x Sex, F1,70=5.93, *
Amygdala ns F1,70=109.8, *** ns ns
Brainstem F1,70=14.5, *** F1,70=37.9, *** ns ns
Sex Acute Stress Prenatal Stress
Plasma F1,70=10.5, ** F1,70=74.3, *** ns Acute Stress x Sex,  F1,70=4.37, *
Frontal Cortex F1,70=14.8, *** F1,70=78.0, *** ns ns
Hypothalamus F1,70=60.5, *** F1,70=55.4, *** ns ns
Hippocampus F1,70=102.6, *** F1,70=21.4, *** ns ns
Amygdala F1,70=20.1, *** F1,70=100.6, *** ns ns
Brainstem F1,70=36.4, *** F1,70=64.6, *** ns ns
Sex Acute Stress Prenatal Stress
Plasma F1,69=219, *** ns ns ns
Frontal Cortex F1,69=119.9, *** F1,69=39.1, *** ns ns
Hypothalamus ns F1,69=29.1, *** ns ns
Hippocampus F1,69=76.3, *** F1,69=65.0, *** ns ns
Amygdala F1,69=61.3, *** F1,69=41,3. *** ns ns
Brainstem F1,69=81.6, *** F1,69=42.3, *** ns ns
Sex Acute Stress Prenatal Stress
Plasma F1,69=52.4, *** F1,69=15.2, *** ns Acute Stress x Sex, F1,69=6.67, *
Frontal Cortex F1,69=224.0, *** F1,69=26.6, *** ns ns
Hypothalamus ns F1,69=29.9, *** ns ns
Hippocampus F1,69=57.2, *** F1,69=16.2, *** ns ns
Amygdala F1,69=32.6, *** F1,69=19.7, *** ns ns
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Table C1: Results of three-way ANOVA for analysing the effects of acute 
stress X prenatal stress X sex on neuroactive steroid concentrations. * p<0.05, 
** p<0.01, *** p<0.001. Data (except for corticosterone) was log transformed before 
carrying out three-way ANOVA (Appendix A) 
  
Sex Acute Stress Prenatal Stress
Plasma F1,70=161.7, *** F1,70=27.5, *** ns Acute Stress x Sex, F1,70=2.84, p=0.09
Frontal Cortex F1,70=224.0, *** F1,70=43.6, *** ns Acute Stress x Sex, F1,70=4.92, *
Hypothalamus F1,70=73.5, *** F1,70=37.9, *** ns Acute Stress x Sex, F1,70=8.12, **
Hippocampus F1,70=194.9, *** F1,70=44.1, *** ns Acute Stress x Sex, F1,70=15.0, ***
Amygdala F1,70=198.1, *** F1,70=39.5, *** ns Acute Stress x Sex, F1,70=5.04, *
Brainstem F1,70=239.1, *** F1,70=52.7, *** ns Acute Stress x Sex, F1,70=10.2, **
Sex Acute Stress Prenatal Stress
Plasma F1,70=99.3, *** ns ns ns
Frontal Cortex F1,70=311.,8, *** F1,70=20.1, *** ns ns
Hypothalamus F1,70=53.5, *** F1,70=17.1, *** ns Acute Stress x Sex, F1,70=5.54, *
Hippocampus F1,70=229.7, *** F1,70=8.53, ** ns Acute Stress x Sex, F1,70=4.74, *
Amygdala F1,70=178.9, *** F1,70=11.5, ** ns Acute Stress x Sex, F1,70=4.78, *
Brainstem F1,70=250.2, *** F1,70=33.1, *** ns Acute Stress x Sex, F1,70=10.3, **
Sex Acute Stress Prenatal Stress
Plasma F1,70=647.6, *** F1,70=4.1, *** ns Acute Stress x Sex, F1,70=6.5, *
Frontal Cortex F1,70=297.,1, *** F1,70=20.3, *** ns ns
Hypothalamus F1,70=338.8, *** F1,70=28.3, *** ns Acute Stress x Sex, F1,70=4.94, *
Hippocampus F1,70=335.7, *** F1,70=14.8, *** ns Acute Stress x Sex, F1,70=10.4, **
Amygdala F1,70=230.7, *** F1,70=13.3, *** ns ns
Brainstem F1,70=374.1, *** F1,70=38.8, *** ns Acute Stress x Sex, F1,70=12.8, ***
Sex Acute Stress Prenatal Stress
Plasma F1,70=407.8,*** F1,70=59.0, *** ns ns
Frontal Cortex F1,70=103.9, *** F1,70=111.4, *** ns ns
Hypothalamus F1,70=87.3, *** F1,70=95.8 ns ns
Hippocampus F1,70=123.8, *** F1,70=121.0, *** ns ns
Amygdala F1,70=123.0, *** F1,70=185.9, *** ns ns
Brainstem F1,70=234.0,*** F1,70=99.3, *** ns ns
Sex Acute Stress Prenatal Stress
Plasma F1,71=499.1, *** ns ns ns
Frontal Cortex F1,71=430.7, *** ns ns ns
Hypothalamus F1,71=153.7, *** ns ns ns
Hippocampus F1,71=447.3, ** ns ns ns
Amygdala F1,71=426.0, *** ns ns ns
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Appendix C2: Two-way ANOVA for analysing differences in concentrations of 
neuroactive steroids between plasma and the brain (Chapter 4) 
In order to determine if there are differences between concentrations of steroids 
between plasma and brain regions, a two-way ANOVA was carried out, where 
region (plasma and the respective brain regions) and swimming stress were 
analysed as the main factors. Swimming stress was added as a main factor as it 
was shown to affect steroid concentrations dramatically (section 4.3, results 
section). However, as steroid concentrations between controls and PNS were 
generally not different (section 4.3), control and PNS groups were collapsed within 
each swimming stress group. Males and females were analysed separately in this 
case. F-values for main effect of region and interactions are presented in Table C2. 
Post-hoc pairwise comparisons were carried out using Student-Newman-Keuls test, 
and only results from the comparison between plasma and the various brain regions 
are presented in Table C3. Brain regions which had significantly different steroid 
concentrations as compared to plasma (P<0.05), either basally or upon acute 
stress, are presented (Table C3), with the direction of difference also reported. 
 
Table C2: Results of two-way ANOVA for analysing differences in 
concentrations of neuroactive steroids between plasma and brain regions. 
Two-way ANOVA was carried out, with swimming stress and region (plasma and the 
respective brain regions) as the main factors. ** P<0.01, ***P<0.001, n.s. not 
significant 
Main effect of region Region X Swim stress interaction Main effect of region
Region X Swim stress 
interaction
Corticosterone F5,216 = 57.7, *** F5,216 = 11.6, *** F5,216 = 36.1, *** F5,216 = 13.2, ***
DOC F5,216 = 1.2, n.s. F5,216 = 1.08, n.s. F5,216 = 5.03, ** F5,216 = 1.3, n.s.
DHDOC F5,216 = 24.5, *** F5,216 = 6.9, *** F5,216 = 45.2, *** F5,216 = 10.9, ***
THDOC F5,216 = 17.3, *** F5,216 = 4.14, ** F5,216 = 7.7, *** F5,216 = 2.46, **
Progesterone F5,216 = 25.2, *** F5,216 = 9.9, *** F5,216 = 4.7, ** F5,216 = 0.54, n.s.
DHP F5,216 = 25.7, *** F5,216 = 12.3, *** F5,216 = 28.6, *** F5,216 = 1.2, n.s.
Allopregnanolone F5,216 = 7.85, *** F5,216 = 3.4, ** F5,216 = 6.5, *** F5,216 = 0.5, n.s.
Pregnenolone F5,216 = 13.7, *** F5,216 = 4.9, *** F5,216 = 19.5, *** F5,216 = 4.1, **
Testosterone F5,216 = 9.4, *** F5,216 = 0.25, n.s. F5,216 = 48.5,*** F5,216 = 0.35, n.s.
Two-way ANOVA
Male Female
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Table C3: Results of post-hoc SNK test for analysing differences in 
concentrations of neuroactive steroids between plasma and brain regions. 
Post-hoc pairwise comparisons using Student-Newman-Keuls test comparing 
plasma steroid concentrations with steroid concentrations in each brain region are 
presented for males in panel (A) and females in panel (B). H: higher in the brain 
region as compared to plasma, L: lower in the brain region as compared to plasma, 
- : no difference in concentrations between plasma and brain regions. In general, 
corticosterone concentrations were always lower in the brain as compared to the 
plasma. For allopregnanolone, concentrations were always lower in the female brain 
as compared to female plasma. In males however, allopregnanolone concentrations 
were greater in the brain as compared to the plasma, especially in acute stress 
conditions. With the exception of DOC, where concentrations were similar in the 
plasma and brain, for other steroids, concentrations were generally greater in the 
brain regions as compared to the plasma, although for certain brain regions, 
concentrations were not different between plasma and the brain 
Basal Swim Basal Swim Basal Swim Basal Swim Basal Swim
Corticosterone L L L L L L L L L L
DOC - - - - - - - - - -
DHDOC - - - H - - - H H H
THDOC - - - H - - - - H H
Progesterone - - - H - - - H H H
DHP - - - H - - - H H H
Allopregnanolone - H - H - H - H H H
Pregnenolone - H - H - H - H H H
Testosterone - - - - - - H H - -
Basal Swim Basal Swim Basal Swim Basal Swim Basal Swim
Corticosterone L L L L L L L L L L
DOC - - - - - - - - - H
DHDOC - - H H - - - H - H
THDOC - - H H - - - - - H
Progesterone - - H H - H - - - H
DHP - - H H - - - - - H
Allopregnanolone L L - - L L L L L L
Pregnenolone - H H H - H - H - H
Testosterone - - H H - - - - H H
(A) Male
(B) Female
HypothalamusAmygdala Brainstem Frontal Cortex Hippocampus
Amygdala Brainstem Frontal Cortex Hippocampus Hypothalamus
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Appendix D: Changes in receptor expression and neuronal 
markers in juvenile offspring brain, graphs and statistical 
analyses (Chapter 6) 
 
Figure D1: Effects of prenatal stress and maternal MitoQ-NP administration on 
neurobiological markers in the juvenile offspring basolateral amygdala. Two 
way ANOVA results are reported under the graphs while results for Bonferroni-
corrected pairwise comparisons are annotated on the graphs. Asterisks represent 
differences between control and PNS groups (where * p<0.05, ** p<0.01, *** 
p<0.001), while hashes represent differences between vehicle and MitoQ-NP 
treated groups (where # p<0.05, ## p<0.01, ### p<0.001).  Con: Control, PNS: 
Prenatal stress, Veh: Maternal vehicle treatment, MQ-NP: Maternal MitoQ-NP 
treatment, ns: not significant. n=3 rats per group. Data was analysed from 30 

























































































Stress: F1,8 = 33.2, p<0.001***
Treatment: F1,8 = 22.4, p<0.01**






















Stress: F1,8 = 22.7, p<0.001***


























Stress: F1,8 = 13.5, p<0.01**
Treatment: F1,8 = 8.6, p=0.018*






































































































































Stress: F1,8 =5.69, p=0.044*
Treatment: F1,8 = 3.68, p=0.09






















































Treatment: F1,8 = 13.2 p<0.01**
Interaction: F1,8 = 45.1, p<0.001***
* #
Female BLAMale BLA
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Figure D2: Effects of prenatal stress and maternal MitoQ-NP administration on 
neurobiological markers in the hippocampal CA1 region of the juvenile 
offspring. Two way ANOVA results are reported under the graphs while results for 
Bonferroni-corrected pairwise comparisons are annotated on the graphs. Asterisks 
represent differences between control and PNS groups (where * p<0.05, ** p<0.01), 
while hashes represent differences between vehicle and MitoQ-NP treated groups 
(where # p<0.05).  Con: Control, PNS: Prenatal stress, Veh: Maternal vehicle 
treatment, MQ-NP: Maternal MitoQ-NP treatment, ns: not significant. n=3 rats per 


















































Stress: F1,8 = 32.2, p<0.001***
Treatment: ns


























Stress: F1,8 = 16.2, p<0.01**






















Stress: F1,8= 3.8, p=0.087
Treatment: ns

























Stress: F1,8 = 13.6, p<0.01**
Treatment:  F1,8 = 6.4, p=0.03*















































































Stress: F1,8 = 30.3, p<0.001***




























Stress: F1,8 = 36.4, p<0.001***


















































Stress: F1,8 = 33.7, p<0.001***



























Stress: F1,8 = 15.9, p<0.01**
















GABAA 2 GABAA 2 
GluN1 
Female CA1Male CA1
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Figure D3: Effects of prenatal stress and maternal MitoQ-NP administration on 
neurobiological markers in the hippocampal CA2 region of the juvenile 
offspring. Two way ANOVA results are reported under the graphs while results for 
Bonferroni-corrected pairwise comparisons are annotated on the graphs. Asterisks 
represent differences between control and PNS groups (where * p<0.05,).  Con: 
Control, PNS: Prenatal stress, Veh: Maternal vehicle treatment, MQ-NP: Maternal 
MitoQ-NP treatment, ns: not significant. n=3 rats per group. Data was analysed from 










































































































Stress: F1,8 = 10.8, p=0.01*






































































































































Stress: F1,8 = 4.1, p=0.07
Treatment: ns






















Stress: F1,8 = 14.5, p<0.01**
Treatment: ns





































































GABAA 2 GABAA 2 
GluN1 
Female CA2Male CA2
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Figure D4: Effects of prenatal stress and maternal MitoQ-NP administration on 
neurobiological markers in the hippocampal CA3 region of the juvenile 
offspring. Asterisks represent differences between control and PNS groups (where 
* p<0.05), while hashes represent differences between vehicle and MitoQ-NP 
treated groups (where # p<0.05).  Con: Control, PNS: Prenatal stress, Veh: 
Maternal vehicle treatment, MQ-NP: Maternal MitoQ-NP treatment, ns: not 
significant. n=3 rats per group. Data was analysed from 30 sampling views per rat 






























Stress: F1,8 = 3.7, p=0.09
Treatment: ns



















































Stress: F1,8 = 5.67, p=0.044**
























Treatment: F1,8 = 20.5, p<0.01**


































































































































Stress: F1,8 = 4.2, p=0.07
Treatment: ns















































Stress: F1,8 = 3.8, p=0.09
Treatment: ns
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Appendix E: Changes in neuronal cultures exposed to 
placental-conditioned media and foetal plasma, graphs and 
statistical analyses (Chapter 6) 
 
Figure E1: Effects of placental-conditioned media and foetal plasma on 
neuronal characteristics of E18 neuronal cultures. Placental-conditioned media 
and foetal plasma were collected then transported to the University of Bristol, where 
they were applied to neuronal cultures by Dr Tom J Phillips. Dendritic length (A, F), 
GluN1 expression (B, G); and GABA Aα2 expression (D, I) was lower in neurones for 
which placental-conditioned media and foetal plasma from stressed animals was 
applied. In several cases, this effect was not observed when placental-conditioned 
media and foetal plasma from stressed/maternal MitoQ-NP treated groups was 
applied. A similar decrease in GABAB1 was observed, but no normalisation was 
observed (E, J). For GABAAα1, a normalisation was observed in the placental-
conditioned media (C) but not for foetal plasma (H). Asterisks represent differences 
between control and PNS groups (where * p<0.05, ** p<0.01, *** p<0.001), while 













E18 neuronal culture E18 neuronal culture

























Stress: F1,16 = 16.3, p<0.001***
Treatment: F1,16 = 20.8, p<0.001***


























Stress: F1,16 = 25.4, p<0.001***
Treatment: F1,16 = 11.1, p=0.004**


























Stress: F1,16 = 10.6, p=0.005**
Treatment: F1,16 = 10.7, p=0.005**


























Stress: F1,16 = 35.5, p<0.001***
Treatment: F1,16 = 24.4, p<0.001***


























Stress: F1,16 = 156.1, p<0.001***
Treatment: ns


























Stress: F1,16 = 12.0, p=0.003**
Treatment: F1,16 = 5.7, p=0.03*


























Stress: F1,16 = 5.97, p=0.03*























































Stress: F1,16 = 5.45, p=0.033*
Treatment: F1,16 = 28.5, p<0.001***
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# p<0.05, ## p<0.01, ### p<0.001).  Con: Control, PNS: Prenatal stress, Veh: 
Maternal vehicle treatment, MQ-NP: Maternal MitoQ-NP treatment. n=5 per group.  
 
